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Abstract 
The psychosocial impact of cancer treatment is wide-ranging, including changes to 
appearance, such as hair loss. To date, there is limited published research on the 
provision of psychosocial support for breast cancer patients who are affected by 
chemotherapy-induced hair loss. The aims of the research were to explore what 
psychosocial interventions are currently available for women, whether they have 
been evaluated and whether they are meeting patients’ needs in order to inform the 
best possible provision of care for women in this situation in the future. The Medical 
Research Council’s (MRC) framework for complex interventions and the 
Appearance Research Collaboration (ARC) framework, which is a model of 
adjustment, guided the program of research. This is the first time that the ARC 
framework has been used with a breast cancer population. There were three 
overarching research questions which the program of research aimed to answer: To 
what extent are interventions effective at reducing distress associated hair loss? What 
are individuals’ experiences of current interventions which aim to support them with 
their hair loss? Are any further interventions needed?  
The first objective was to conduct a systematic review of the available evidence of 
the effectiveness of psychosocial interventions to support people affected by hair 
loss (Study 1). A systematic search yielded eight studies, reporting on five different 
interventions. Characteristics of the successful interventions included: intervention 
delivery soon after hair loss, information provision, individual based intervention; 
and an opportunity for individuals to express their concerns. However, since a 
number of interventions currently available for breast cancer patients have not yet 
been evaluated, it is unknown whether they offer any benefit.  
One intervention currently freely available to breast cancer patients, but which has 
not yet been evaluated, is Breast Cancer Care’s HeadStrong service. HeadStrong is a 
volunteer led service offering information and support in the use of head 
camouflage. A mixed methods approach was used to evaluate the HeadStrong 
service, employing parallel qualitative and quantitative approaches. In Study 2, 25 
semi-structured interviews were conducted to explore women’s experiences of this 
service. Thematic analysis identified three main themes: facing the challenges of hair 
loss, experiences of receiving support for treatment-related hair loss and meeting 
Abstract 
 
2 
 
unmet needs. A key contribution from this study is that it is the first qualitative study 
of women’s experiences of the national HeadStrong service. In study 3, sixteen 
participants elected to participate in a pre-intervention, 2 week and 3 month follow-
up to examine the short and long term impact of the HeadStrong service. A benefits 
of HeadStrong included improvements in self-reports of confidence in managing hair 
loss, using headwear to camouflage it and handling the reactions of others. 
Participants’ quality of life, emotional well-being and fear of negative evaluation 
were found to reduce over time and appearance-related distress and depression were 
all poorer at 3 month follow-up. A synthesis of the findings from study 2 and 3 
suggested the HeadStrong intervention can be important and helpful for breast 
cancer patients affected by hair loss, but it does not necessarily meet all their needs. 
The research has led to the development of a number of recommendations for the 
provision of care, including the HeadStrong session being tailored to individuals’ 
needs. It was highlighted that there is still potential to develop a range of 
interventions for this patient group.  
The final study in this program of research (Study 4) adapted Pennebaker and Beall’s 
expressive writing intervention, to explore its feasibility for breast cancer patients 
with treatment-related hair loss and to investigate whether the timing of the 
intervention and the recruitment strategy was appropriate. Nine female breast cancer 
patients completed the baseline questionnaire and four participants completed all 
follow-up questionnaires. Reasons for declining to participate included; not having 
the time or having difficulty writing. It was found that the intervention in its present 
form was not feasible for patients newly referred for chemotherapy, which may have 
been a result of aspects of the intervention and/or aspects of the study design.  
In conclusion, support needs vary between individuals and throughout their cancer 
journey; not all patients want the same support with their hair loss. The following 
recommendations are required in order to improve the provision of care to support 
this patient group; it is imperative that patients are equipped with strategies to help 
them to manage all aspects of hair loss and available interventions need to be 
tailored to individual’s needs, rather than relying on one strategy, such as 
camouflage.  
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Chapter One                                                 
Introduction to the Research Area 
1.1 Introduction 
 
In 2006 and 2012 the charity Breast Cancer Campaign (now known as Breast Cancer 
Now) arranged for a group of leading breast cancer researchers to identify the 
limitations of current research into the pathophysiology, detection, treatment, 
prevention and psychosocial aspects of breast cancer. The aim of the analysis was to 
determine the gaps which, if resolved, could most benefit patients, and to draw the 
attention of researchers and funding bodies on the highlighted areas of research 
(Eccles et al., 2013; Thompson et al., 2008). As a consequence, Breast Cancer 
Campaign’s Gap Analysis stated the need for rigorously evaluated psychosocial 
interventions to meet patients’ support needs (Thompson et al., 2008).  
One area in which there has been relatively little published research in recent years is 
the provision of psychosocial support for chemotherapy-induced hair loss. Instead, 
research has focused on medical approaches to reduce hair loss, although it still 
cannot be prevented. Research into patients’ needs has highlighted a disparity 
between doctors’ reports of perceived patient needs and patients’ reports of their 
actual needs; patients have reported issues including the changes to their bodies and 
hair loss to be significant, whereas doctors considered appearance changes to be less 
important (Mulders, Vingerhoets & Breed, 2008). If health professionals have a 
better understanding of the impact of chemotherapy-induced hair loss for 
individuals, they may be better prepared to provide practical and emotional support 
(Roe, 2011).  In essence, this is the rationale underpinning the direction adopted in 
the current program of research.  
The aim of this introductory chapter is to provide a synthesis of the literature 
encompassing psychosocial aspects of breast cancer and chemotherapy-induced hair 
loss. It begins with a description of breast cancer and chemotherapy before exploring 
the hair loss literature, including the importance of hair and the effect of its loss on 
one’s wellbeing. There is a discussion towards the end of the chapter of the current 
services and psychosocial interventions available for those affected by this condition. 
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Finally, the chapter ends with an overview of the research conducted within this 
thesis. 
 
1.2 Breast cancer 
 
Breast cancer is the most pervasive cancer in the UK, with around 49,900 people 
being diagnosed in 2011 (Cancer Research UK, 2015). Worldwide, 1.68 million 
women were diagnosed in 2012 and the female breast cancer incidence rates in the 
UK have increased by 72% since the mid-1970s (Cancer Research UK, 2015). Men 
are also affected, with around 350 in the UK diagnosed in 2011 (Cancer Research 
UK, 2015). However, for the purpose of this research the focus will solely be on 
women.  
Many women who are diagnosed with breast cancer experience psychosocial distress 
(including anxiety, depression, body image concerns, low self-esteem, and social 
isolation) as a result (Helms, O’Hea & Corso, 2008). Moreover, a cancer diagnosis 
can have a profound psychological impact which can continue years after treatment 
has ended (Salmon, Clark, McGrath & Fisher, 2015). This highlights the importance 
of interventions to support patients throughout their cancer journey, including 
through the transition at the end of treatment and beyond. 
 
1.3 Breast cancer treatment  
 
Individuals with breast cancer may receive a range of treatments including surgery, 
chemotherapy, radiotherapy, hormone therapy and biological treatments. The 
combination of treatments received depends on individual circumstances including 
the type of breast cancer, size of the tumour, stage of the cancer and whether the 
cancer cells have receptors for particular cancer drugs (Cancer Research UK, 2014). 
Some individuals have neo adjuvant treatment whereby they undergo chemotherapy, 
radiotherapy or hormone therapy to help shrink the cancer in the breast, making it 
easier to remove during surgery or adjuvant treatment after surgery to help lower the 
chance of the cancer coming back (Cancer Research UK, 2014). 
 
Chemotherapy involves the use of cytotoxic drugs to destroy cancer cells, which 
disrupts their growth (Cancer Research UK, 2014). There are a variety of 
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chemotherapy drugs available and it is quite common for a combination of around 
three drugs to be used to treat breast cancer. The National Institute for Health and 
Care Excellence (NICE) recommends that chemotherapy treatment for breast cancer 
should consist of four to eight cycles of a combination of drugs (Cancer Research 
UK, 2014). Chemotherapy regimens are cycles of treatment, with drugs administered 
daily for one or more days, followed by rest days, depending on the combination of 
agents and dosages used.  
 
Unfortunately, these anti-cancer drugs cannot differentiate between cancer cells and 
normal cells, which results in a number of adverse side effects including but not 
limited to hair loss, loss of nails, fatigue and sickness (Cancer Research UK, 2014; 
Carelle et al., 2002). However, different combinations of drugs have different side 
effects. Chemotherapy is the cancer treatment most likely to cause hair loss 
(alopecia); complete hair loss is less likely with other types of cancer treatment 
(Cancer Research UK, 2014). The psychosocial disruption as a result of 
chemotherapy may impact on patients’ perception of their ability to meet role 
demands and personal expectations (Buick et al., 2000). The psychological and 
functional impairment typically increases over the course of treatment and patients 
often report a decline in positive affect when treatment has finished (Buick et al., 
2000).  
 
The side effects of cancer treatment, body image distress and fear of recurrence can 
increase psychological distress (Helms et al., 2008; Henselmans et al., 2010; 
Mehnert, Berg, Henrich & Herschback, 2009). No two patients are the same in terms 
of their cancer or their needs (Fiszer et al, 2014; Independent Cancer Taskforce, 
2015), due to disease factors, psychological or social variables, socio-demographic 
factors or expectations based on experiences of health (Armes et al., 2009; Boyes, 
Girgis, D’Este & Zucca, 2012; Snyder et al., 2009). This suggests that there needs to 
be a flexible approach to providing a variety of supportive interventions in order to 
meet women’s varied psychosocial needs and to facilitate their adjustment to 
treatment-related hair loss. 
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1.4 Chemotherapy-induced alopecia 
 
As outlined above, chemotherapy treatment causes a number of adverse side effects 
including hair loss. Alopecia is a Greek word meaning hair loss or baldness (Welsh 
& Guy, 2009) and for the purpose of this thesis the words hair loss and alopecia will 
be used interchangeably. The term alopecia is used to describe hair loss of more than 
20% (McGarvey, Baum, Pinkerton & Rogers, 2001). Relatively little is known about 
the pathobiology of the human hair’s response to chemotherapy (Botchkarev, 2003). 
However, research has revealed that chemotherapy-induced alopecia can occur in 
two different ways depending on the phase of hair growth (Yeager & Olsen, 2011). 
Hair follicles are more vulnerable to damage during the Anagen (rapid growth) 
phase; chemotherapy during this period weakens the hair shaft causing hair to break 
off or fall out spontaneously when an individual washes or brushes their hair 
(Batchelor, 2001; Yeager & Olsen, 2011). If chemotherapy agents enter cells during 
the Telogen (resting) phase, hair loss will be much slower and rarely involves more 
than 50% of scalp hair which, as a result, produces a level of hair thinning that is 
often less noticeable to others but still very distressing for the individual (Batchelor, 
2001; Yeager & Olsen, 2011).  
 
Hair loss can range from slight thinning to complete baldness (Randall & Ream, 
2005) including hair loss from eyebrows, eyelashes, underarm, leg and pubic hair 
(McGarvey et al., 2001). The extent of hair loss depends on a number of factors 
including the type or combination of chemotherapy drugs, the dose and the phase of 
hair growth (see above) (Cancer Research UK, 2014; Roe, 2011). For example, part 
of a drug regime for breast cancer is Anthracycline therapy, which results in 
complete baldness in approximately 90% of cases (Ridderheim, Bjurberg & 
Gustavsson, 2003). It is common for hair loss to begin within one to two weeks after 
chemotherapy treatment starts (Münstedt, Manthey, Sachsse & Vahrson, 1997). In 
most instances, individuals’ hair will re-grow, however, for some it is possible that 
their hair will remain patchy depending on the type and strength of chemotherapy 
drugs used (Cancer Research UK, 2014).  
 
Hair loss can be a very distressing side-effect of treatment for women who have been 
diagnosed as having breast cancer and, for some, can be harder to cope with than the 
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loss of a breast (Freedman, 1994). Some women describe it as the most feared and 
traumatic side effect of chemotherapy (Batchelor, 2001; McGarvey et al., 2001). 
Many women play an active role in the decision-making process regarding their 
breast cancer treatment (Pozo-Kaderman, Kaderman & Toonkel, 1999) and some 
individuals refuse chemotherapy treatment as the prospect of losing their hair is too 
profound (Fawzy, Secher, Evans & Giuliano, 1995; Grevelman & Breed, 2005; Roe, 
2011). To date, research on alopecia predominately focuses on the loss of hair from 
the head and face. Hilton, Hunt, Emslie, Salinas and Ziebland (2008) propose that 
this is because talking about hair loss from the wider body challenges the secrecy 
surrounding the fact that females do not usually have a naturally hairless body.  
 
Hair loss requires individuals to adapt to an altered appearance (Ucok, 2005). People 
with chemotherapy-induced alopecia frequently experience depression and anxiety 
due to it being a constant reminder of the presence of cancer (Pickard-Holley, 1995; 
Williams, Wood & Cunningham-Warburton, 1999). The visual nature of alopecia 
can affect individuals’ body image, self-confidence, social interaction and self-
esteem (Williams et al., 1999). Rosman (2003) found that a group of women who 
experienced hair loss after chemotherapy expressed four common reactions – feeling 
unprepared, shocked, embarrassed and a loss of sense of self. Furthermore, Hilton et 
al., (2008) found that even though some individuals are given advice and suggestions 
on how to deal with bodily changes, they are unprepared for the reactions of others 
to their altered appearance.  
 
1.5 Techniques to prevent or reduce hair loss 
 
To date, most interventions for hair loss have taken a medical rather than social 
approach, focusing on lessening hair loss through the use of methods such as scalp 
cooling (Delamere, Sladden, Dobbins & Leonardi-Bee, 2008; Macduff, Mackenzie, 
Hutcheon, Melville & Archibald, 2003). Scalp cooling aims to prevent hair loss 
(Batchelor, 2001) by slowing down cellular metabolism and chemotherapy delivery 
to the scalp (Trüeb, 2009). The process of scalp cooling typically involves a patient 
wearing a gel-filled cap for approximately 20 minutes before starting their session of 
chemotherapy and continuing to wear it during chemotherapy and for 20 minutes 
after treatment has finished. The cap is stored in the freezer at -25°C for at least 12 
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hours before the patient wears it (Auvinen, Mähönen, Soininen et al, 2010), and is 
changed every 20 minutes to ensure that it remains at the necessary temperature 
(Collett, Al-Tameemi, Dunnill, Hussain & Georgopoulos, 2014). However, the 
effectiveness of scalp cooling is questionable. Six out of seven randomised trials 
found a significant advantage in the amount of hair preserved during chemotherapy 
with scalp cooling (Yeager & Olsen, 2011), however, the majority of these studies 
were from the 1970s and 1980s and as scalp cooling technology has progressed over 
time; these studies are outdated.  
 
Moreover, concerns have been expressed that scalp cooling may prevent 
chemotherapy from reaching cancer cells (Randall & Ream, 2005) and could allow a 
protective area for cancer cells to develop in the scalp (Grevelman & Breed, 2005). 
Furthermore, scalp cooling is not 100% effective for everyone; one of the studies 
that reported a significant effect found that 48% of those who received scalp cooling 
still suffered hair loss (Ron, Kalmus, Kalmus, Inbar & Chaitchik, 1997). Dougherty 
(2006) highlighted that people with a larger amount of hair experienced moderate to 
severe alopecia, which is thought to result from their hair having an insulating effect 
and preventing the scalp cooling treatment from reaching the necessary low 
temperatures needed. Additionally, a number of patients report extreme discomfort 
and numbness associated with scalp cooling (Dougherty, 2006) as well as side 
effects including severe headaches (Katsimbri, Bamias & Palidis, 2000; Rosman, 
2004), increased anxiety (Peck, Mitchell & Stewart, 2000), nausea and dizziness 
(Protiѐre, Evans, Camerlo et al, 2002). Some patients are unable to continue with 
scalp cooling for the duration of their chemotherapy, as demonstrated in a study 
where only six out of fifteen participants were able to persevere with scalp cooling 
for all six cycles of chemotherapy (Macduff et al, 2003). Finally, scalp cooling does 
not address psychosocial needs related to an altered appearance and the impact of 
hair loss on one’s quality of life, although, interestingly, Rosman (2004) found that 
women who maintained their hair through the use of scalp cooling felt that it actually 
made them less conscious of the fact that they had cancer.  
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1.6 Hair re-growth 
 
Hair re-growth normally occurs within 1-2 months following chemotherapy ending, 
however, approximately 65% of patients will notice a change in the appearance of 
their re-grown hair compared with how it looked before chemotherapy (Batchelor, 
2001), as it often lacks protein following treatment, leading to a change in texture 
(McGarvey et al., 2001). Also, re-grown hair may be curlier (Münstedt et al., 1997) 
or may be a different colour which a patient might perceive as making them look 
older, particularly if the re-grown hair is grey (Batchelor, 2001). These changes may 
impact on body image and self-esteem (Power & Condon, 2008). Patients may be 
advised to use special shampoos and to avoid dying their hair for six months until it 
has strengthened (Roe, 2011).     
 
1.7 Social significance of hair   
 
Hair can be seen to represent an individual’s identity, personality, attractiveness, 
sexuality and femininity (Benjamin, Ziginskas, Harman & Meakin, 2002; Nolte, 
Donnelly, Kelly, Conley & Cobb, 2006). It has been said that hair is a woman’s 
‘crowning glory’ (Cash, 2001). Hair is a distinctive facial characteristic, so its loss 
makes it difficult to manipulate and alter one’s appearance (Cash, 2001). “The 
expression ‘bad hair day’, is testimony to the psychological importance of hair loss” 
(Cash, 2001; p. 161). Hair is an integral part of human identity; it can provide an 
avenue through which a woman can express her identity (Freedman, 1994). As a 
result hair loss may have negative repercussions on a variety of aspects of quality of 
life (Freedman, 1994; Batchelor 2001; Lemieux, Maunsell & Provencher, 2008). 
Women who lose eyelashes and eyebrows can experience problems with identity and 
its effect on appearance can effect social interactions (Rosman, 2004). Suffering 
because of a loss of control of one’s bodily appearance and self-presentation may be 
significant and for some women can actually be as debilitating as the illness itself 
(Ucok, 2005).  
 
Hair is a sign of physical attractiveness (Kacar, Ozuguz1, Bagcioglu, Coskun, Polat, 
Karaca & Ozbulu, 2016). From an evolutionary psychology perspective, when 
choosing a mate, men and women see hair as a sign of good health and a sign of 
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sexual maturity (Muscarella & Cunningham, 1996). From a young age, women are 
socialised to develop an emotional attachment to their hair (Manning, 2011). The 
importance that society places on women’s hair is both demonstrated and influenced 
by its portrayal in the media and the attention given to advertising hair products 
(Freedman, 1994). Specifically, advertisements encourage women to buy hair care 
products and to invest time in ensuring that their hair is long, thick and shiny, which 
epitomises healthy hair (Hielscher, 2013).  
 
The cultural importance of hair has been documented in the literature for a number 
of years and a movie titled “Good Hair” demonstrated the sociocultural importance 
of hairstyle to African American women (Stilson, 2009). For example, research has 
highlighted that African American women have identified hair maintenance as an 
important barrier to engaging in exercise (Brown, 2009; Harley et al. 2009). The 
majority of Black African women invest a large amount of time and money into 
maintaining their hair, which often includes utilising hair extensions, wigs and hair 
straightening (Oyedemi, 2016). This suggests that culture may be an important factor 
and demonstrated that hair is an important symbolism across different cultures 
(Etcoff, 1999).  
 
Given the social significance attached to hair and the distress associated with its loss 
(Hunt & McHale 2005), it is not surprising many women adopt a strategy to hide and 
camouflage their hair loss in order to cope (Rosman, 2004). Batchelor (2001) argues 
that the importance placed on hair has diminished in present western society with 
individual’s becoming more accepting of people with physical disabilities; these 
shifting views should provide hope for women who lose their hair due to 
chemotherapy, as the changing perspectives will promote more acceptance of hair 
loss. However, 15 years later there is still a large focus on hair as a key aspect of 
idealised images of beauty, emphasised in media images and advertisements for hair 
products. As society places great importance on hair, it is not surprising that hair loss 
can have a significant impact on an individual’s body image, self-esteem and quality 
of life, and can result in some feeling stigmatised. 
 
 
 
Chapter One: Introduction to the Research Area 
 
11 
 
1.8 Stigma of hair loss 
 
Stigma is defined as “an undesirable or discrediting attribute that an individual 
possesses, thus reducing that individual’s status in the eyes of society” (Brown, 
Macintyre & Trujillo, 2002, p. 50). Stigma is an important issue within health 
psychology, as certain conditions are stigmatised and the prevalence of these 
stigmatising conditions are increasing with a number of individuals having a 
stigmatising attribute/condition (Stablein, Hall, Pervis & Anthony, 2015). A 
stigmatised person “is reduced in our minds from a whole and usual person to a 
tainted, discounted one” (Goffman, 1963, p.3). Research has highlighted that the 
main concern for a stigmatised individual is that they will become the target of 
prejudice and discrimination (Crocker, Major & Steele, 1998). As a result of stigma, 
society labels an individual as different and as a result stigmatisation can lead to 
prejudicial behaviour, thoughts and actions (Zierler et al., 2000). According to 
Goffman (1963) there are two different types of stigma; ‘discredited’ and the 
‘discreditable’; individuals are discredited when their alopecia is visible and are 
discreditable when they hide their hair loss.  Discredited individuals have to try to 
cope with social judgement such as staring and pointing, which can be very 
distressing and potentially lead to social isolation (Rosman, 2004).  In contrast, 
discreditable individuals such as breast cancer patients with treatment-related hair 
loss face the challenge of whether to disclose their hair loss. Since this is potentially 
stigmatising information, they are faced with the decision of who should they let 
know that they have a stigmatising condition (Stablein et al, 2015; Rosman, 2004). 
Although Goffman’s work on stigma is highly respected, a main critique of his 
theory is the helpless role it gives to people with a stigmatised condition, as it fails to 
acknowledge the resistance to being stigmatised that individuals can demonstrate 
(Carnevale, 2007).  
 
The fear of being stigmatised is a common fear amongst women diagnosed with 
breast cancer (Deniffe & Gooney, 2011). As a result, some choose to wear wigs to 
camouflage their hair loss, but wigs themselves can become a symbol of stigma 
since they can, if obvious to the observer, convey the message that an individual has 
lost their hair. Although hair loss is seen as a stigmatised event, for many patients it 
is “the price to pay for being cured” (Rumsey & Harcourt, 2005, p109). Some accept 
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alopecia as an inevitable consequence of chemotherapy, whereby image-related 
concerns may be secondary to survival issues.  
 
1.9 The use of headwear 
 
Some individuals accept their hair loss as a result of chemotherapy and are happy 
and confident to embrace their baldness (Rosman, 2004), but many patients disguise 
or camouflage hair loss through the use of wigs, hats, and scarves. Research has 
found that 83% of people reported shopping for headwear prior to hair loss in an 
attempt to cope with their anxieties about it (Borsellino & Young, 2011). Women 
engage in a variety of camouflage behaviours; total camouflage were a wig is always 
worn, and partial camouflage when a wig is not worn in some situations (e.g. when 
at home). In contrast, banalisation is where individuals do not use any form of head 
camouflage.   
 
Wearing a wig allows an individual to reclaim the image that they are used to (i.e. 
their normality) and so helps them to restore their sense of self (Ucok, 2005). Social 
relationships and the actual and imagined responses of others play a significant role 
in determining whether or not an individual chooses to engage in the use of 
headwear to hide their hair loss (Ucok, 2005). Looking ‘normal’ takes effort, and is 
usually done for the benefit of self and for the protection of others (Rosman, 2004; 
Williams et al., 1999). Some individuals feel it is important to hide their alopecia in 
order to protect their loved ones from the reminder of their cancer, but wigs 
themselves can become a symbol of the stigma of both breast cancer and hair loss 
(Rosman, 2004).  
Wigs are available through the National Health Service (NHS), although women 
may have to financially add to the amount the NHS provides for a wig if they want 
greater choice and quality (Roe, 2011). There are two main categories of wigs; 
natural hair or those made from synthetic materials, each with pros and cons. 
Synthetic wigs are generally less expensive than those made from natural hair, they 
do not require as much styling and are easier to take care of (Roe, 2011; Yeager & 
Olsen, 2011), but some patients find both types of wigs to be hot or itchy and head 
scarves and turbans offer an alternative form of camouflage. Cotton is the preferred 
fabric for scarves and turbans as it is less likely to slip off a smooth scalp than other 
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fabrics (Yeager & Olsen, 2011). Moreover, despite a number of headwear options 
being available, for some people camouflage can bring its own problems in relation 
to issues of identity, over-reliance on the camouflaged image in social interaction 
and fears that the ‘truth’ will come out (Coughlan & Clarke, 2002). Many 
individuals consider wigs to be unnatural and, as a result, emphasise feelings of 
difference (Williams et al., 1999). Therefore, headwear is helpful to an extent but has 
a number of challenges of its own. 
 
1.10 Impact of chemotherapy-induced alopecia on body image and distress 
Cash, Melnyk and Hrabosky (2004) describe body image as an overall attitude 
towards one’s body, which is influenced by investment and evaluation facets. 
Chemotherapy-induced hair loss puts people at risk of a disturbed body image as the 
greater importance they place on body image and appearance, the more likely they 
are to experience difficulty adjusting to breast cancer and all the bodily changes that 
go along with it and the side effects of treatment (White, 2000). A study by Choi et 
al. (2014) found that 55.3% of patients in their study were either ‘quite a bit’ or ‘very 
much’ distressed by their alopecia. Moreover, Kraus (1999) found that women who 
reported decreased bodily concerns demonstrated stronger self-concepts and 
identities than those who placed a high value on physical appearance.  
 
Even though chemotherapy-induced alopecia is usually believed to be temporary, the 
negative emotional repercussions can continue even after hair has re-grown and 
women may continue to feel self-conscious and experience a persisting negative self-
image (Borsellino & Young, 2011; Foster, Wright, Hill, Hopkinson & Roffe, 2009), 
including concerns around body image, specifically when the re-grown hair is 
different than before (as discussed in section 1.6) (Rumsey & Harcourt, 2005). A 
prospective longitudinal study that explored patients’ self-concept and body image 
before treatment, during complete hair loss, and after hair re-growth, found that self-
concept and body image were poorer during treatment and did not improve or return 
to pre-treatment levels when hair began to re-grow (Münstedt et al., 1997). 
Additionally, research has highlighted that women may experience persisting body 
image disturbances relating to their breast cancer diagnosis and treatment which can 
often continue once treatment has ended (Falk-Dahl, Reinertsen, Nesvold, Fossa & 
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Dahl, 2010; Hartl et al., 2003; Przezdziecki et al., 2013). This demonstrates that the 
impact of chemotherapy-induced alopecia can be long lasting, hair loss distress is 
not ‘temporary’, and psychosocial support needs to be freely available not only 
throughout the course of hair loss but remain accessible once hair has re-grown. 
Moreover, it has been highlighted that younger women diagnosed with breast cancer 
have more difficulty adjusting to hair loss than older women, with lowered overall 
quality of life ratings linked to concerns about body image, partner relationships, 
sexual functioning as well as less adaptive coping styles (Avis, Crawford & Manuel, 
2004; Fobair et al., 2006). This may be because society tends to place more 
emphasis on younger women’s appearance (Fiszer et al, 2014).  
 
Boehmke and Dickerson (2005) found that the extent of negative effects which hair 
loss had on their body image was dependent on how women coped with their 
alopecia, with some women viewing baldness as a sign of pride and courage whilst 
others reported feelings of trauma and a loss of identity. Loss of hair from other parts 
of the body, not just the head, was reported to be distressing; women reported that 
loss of hair from their nose caused them to experience a runny nose, which led 
members of the public to perceive them as sick and suggested they should go home 
from work (Boehmke & Dickerson, 2005). This demonstrates the practical issues 
related to the function of hair and the impact of hair loss.  
 
1.11 Adjustment to treatment-related hair loss  
 
The terms adjustment, coping and adaptation are used interchangeably within the 
health psychology literature (Israelashvili, 2012). A number of definitions of 
adjustment have been outlined, with it often being defined as “the lack of poor 
adjustment” (Snyder & Lopez, 2008, p. 152). However, it is unclear from this 
definition, what is meant by poor adjustment and how the authors’ differentiate 
between good and poor adjustment. Alternatively, Watson, Greer, Young, Inayat, 
Burgess and Robertson (1988) defined adjustment to cancer as “the cognitive and 
behavioural responses the patient makes to their diagnosis of cancer” (p. 203). 
Furthermore, this definition fails to acknowledge social aspects of adaptation and 
does not state what successful adjustment is (Brennan, 2001). A preferred definition 
of adjustment is “the processes of adaptation that occurs over time as the individual 
manages, learns from and accommodates the multitude of changes which have been 
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precipitated by changed circumstances in their lives” (Brennan, 2001, p. 2-3). 
Dealing with the consequences of receiving a cancer diagnosis and improving 
psychological adjustment have become recent priorities within healthcare practices 
(Raingruber, 2011).  
 
The psychological adjustment to receiving a breast cancer diagnosis can have 
implications both in the short and longer term (Boinon et al., 2014). It is argued that 
there are two different adjustment responses: positive and negative response styles. 
A positive response is seen to have a beneficial effect, as opposed to negative 
response styles, which have detrimental effects (Watson et al., 1988). A limitation of 
the adjustment literature is that the focus of research has primarily seen adjustment 
as the end point of coping, as opposed to a process of change which can fluctuate 
over time (Brennan, 2001).  
 
Within both the cancer and appearance literature, attention has been given to 
exploring the factors and processes that might facilitate adjustment. Within cancer 
research, the emphasis has been on the link between availability and perceived 
adequacy of social support and improved psychological adjustment. The social-
cognitive processing model highlights that the expression of one’s thoughts and 
feelings about cancer in a supportive environment may facilitate cognitive 
processing and psychological adjustment (Boinon et al., 2014). A positive 
correlation has been found between breast cancer patients who repress their emotions 
and high levels of distress (Iwamitsu et al., 2005). Specifically, emotional support is 
most highly correlated with psychological adjustment in cancer (Talley, Molix, 
Schlegel & Bettencourt, 2010). 
 
1.12 Current policy around provision of care for breast cancer patients 
 
In recent years the NHS has focused on ensuring that it is patient-led and aims to 
improve the quality of life of patients (Department of Health, 2005; DoH, 2011). 
Numerous cancer policy documents have highlighted that referral pathways and 
services are required to meet individuals’ needs (DoH, Macmillan Cancer Support & 
NHS improvement, 2013; Macmillan, 2014). The National Cancer Survivorship 
Initiative (NCSI) recommends a holistic needs assessment, so that each individual’s 
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support needs are met (Department of Health, Macmillan Cancer Support & NHS 
Improvement, 2013) and Breast Cancer Care (BCC) advocate that this assessment 
should include questions about body image and intimacy (BCC, 2014). It is 
recommended that all early and locally advanced breast cancer patients are offered 
prompt access to specialist psychological support (NICE, 2014). Also, patients 
should be provided with a written care plan which includes contact details for 
support services (NICE, 2009). 
 
The All Party Parliamentary Group (APPG) on Body Image highlighted the 
significant impact which a negative body image can have on an individual (APPG, 
2012). Recent steps have been taken by organisations such as Breast Cancer Care to 
ensure that current policy for the provision of care for breast cancer patients includes 
support for body image issues. Breast Cancer Care developed a policy report titled 
‘My body, myself’ and a body image awareness campaign (BCC, 2014, 
www.breastcancercare.org.uk/body) including a short film of individuals talking 
about their experiences of body image after breast cancer. The campaign also 
encourages people affected by breast cancer to write letters to their body including 
their feelings about their body and what has helped them to cope with their feelings. 
The aim of the campaign is to raise awareness of the body image issues that breast 
cancer patients may experience and to highlight that BCC are able to provide 
information and support (BCC, 2014). Breast Cancer Care recommend that national 
and regional breast cancer guidelines should address body image, intimacy and sex 
as part of routine breast cancer care and secondly, that breast units should develop 
referral pathways to relevant services which can provide support and information 
around body image issues (BCC, 2014). 
 
1.13 Support for cancer patients affected by treatment-related hair loss 
 
Although hair loss is a very distressing side effect of treatment for many women 
with breast cancer, many patients and nurses are unaware of the existing support 
groups and services aiming to improve patients’ psychological well-being (Manning 
& Dickens, 2007; Mills, 2000). Supportive care aims to treat the patient as an 
individual and improve their quality of life (QOL) by treating the symptoms of their 
illness and the side effects of treatment (Fiszer et al., 2014). Yet, despite the 
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recognition of the importance of support, to date it is relatively unclear what level of 
help and/or support patients require or expect in order to successfully manage their 
symptoms (Snyder, Blackford, Brahmer et al., 2010; Snyder et al., 2009). Results 
from a systematic review revealed that a large number of women with breast cancer 
perceive significant unmet needs throughout their cancer trajectory, with information 
and psychological needs being the most prevalent, and younger age being correlated 
with greater needs, particularly around body image concerns and sexuality (Fiszer et 
al., 2014). A greater understanding of the prevalence of the needs of breast cancer 
patients at different times along the cancer trajectory would enable health care 
providers to predict when women have particular needs and could guide the 
development of supportive care interventions (Fiszer et al., 2014). Therefore, this 
highlights the importance of needs assessment, rather than solely relying on distress 
outcomes, as not everyone who is distressed wants help.  A number of needs 
assessments have been developed but unless they are implemented into routine care 
and are used for the purpose they are designed, they are unlikely to improve patient 
care and outcomes. It is imperative that needs assessments are only conducted by 
staff who are confident in doing so and that procedures and resources are in place so 
that if needs are identified, appropriate help and support is available and accessible. 
 
At the outset of this PhD program, a search was conducted to explore what 
psychosocial interventions and supportive care are available for breast cancer 
patients, and to observe whether they are specifically set out to support those who 
are affected by treatment-related hair loss. This search found a range of interventions 
and approaches, from basic information provision to more structured interventions. 
These are now considered below.   
 
1.13.1 Structured psychosocial interventions  
 
A scoping exercise was conducted to explore what psychosocial interventions are 
currently available for breast cancer patients. It found that structured psychosocial 
interventions in this area include psycho-education (Golant, Altman & Martin, 
2003), Cognitive Behavioural Therapy (CBT) (Tatrow & Montgomery, 2006) and 
social and emotional support (Banning, 2007). A link has been found between active 
problem solving and improvements in the quality of life of patients with cancer, as a 
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result psycho-education interventions are being developed and becoming 
increasingly appealing (Golant et al, 2003), specifically, patient education has been 
found to enhance symptom management and reduce feelings of helplessness (Fawzy, 
Fawzy, Arndt & Pasnau, 1995). CBT interventions have been found to help reduced 
cancer-related distress in breast cancer patients (Tatrow & Montgomery, 2006; 
Mundy DuHamel and Montgomery, 2003). These interventions have included 
beneficial components including hypnosis, relaxation and skills training. Since social 
and emotional support are two key contributing factors to successful adjustment in 
women who have received a cancer diagnosis (Spiegel, 1997), interventions which 
provide social and emotional support have been developed. However, none of these 
interventions have focused specifically on supporting women who are affected by 
treatment-related hair loss.  
 
1.13.2 Social support 
 
Social support is an aspect of supportive care which can reduce cancer-related 
distress (Simpson, Carlson, Beck & Patten, 2002; Smith, Herndon, Lyerly, Coan, 
Wheeler, Staley & Abernethy, 2011), facilitate adjustment to cancer and improve 
QOL (Leung, Pachana & McLaughlin, 2014). Women may receive support from a 
number of sources, including their family, friends and from within the National 
Health Care System (NHS). Women who perceive more accessible, better quality 
and appropriate support are thought to cope better, leading to improved 
psychological adjustment (Boyle, 2006; Friedman, Kalidas, Elledge et al, 2006; 
Jones, 2001). The stress-buffering model of support focuses on the perceived 
availability, quality and appropriateness of support (Cohen & Wills, 1985). 
Emotional/informational support and affectionate support/positive social interaction 
have been found to be more important in improving health related quality of life 
(HRQOL) after a diagnosis of breast cancer (Leung et al., 2014).  
 
There are a number of widely used measures of social support that assess aspects 
such as patients’ need for and use of it, for example the Social Support 
Questionnaire (SSQ) (Schaefer, Coyne, & Lazarus, 1981), the Sources of Social 
Support Scale (SSSS) (Carver, 2013) and the Supportive Care Needs Survey (SCNS-
SF34) (Boyes, Girigis & Lecathelinais, 2009). Research has highlighted a number of 
problems with these measures, including their variability in terms of their length and 
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the nature (e.g. emotional, information, practical and negative support) and sources 
of support being evaluated (Heitzmann  & Kaplan, 1988), making it difficult to draw 
meaningful comparisons between studies that have used different measures.  
 
1.13.3 Role of specialist breast care nurses 
 
The multidisciplinary team (MDT) is core to the standard structure of UK supportive 
cancer care (Whelan, Griffith & Archer, 2006). UK policy recommends that all 
women diagnosed with breast cancer should have contact with a Breast Cancer 
Nurse (BCN) for information and support (Anderson et al, 2006; Lamb, Allchorne, 
Sevdalis & Green, 2011; NHS Executive, 1996; NICE, 2002). A link has been found 
between the breast care nurse role and patients’ overall well-being (Halkett, Arbon, 
Scutter & Borg, 2006). Breast care nurses are valuable members of the 
multidisciplinary breast cancer team and aim to meet patients’ healthcare needs 
through psychosocial support, education and information (Ambler et al., 1999; Amir, 
Scully & Borrill, 2004; Arving, Brandberg, Feldman, Johansson & Glimelius, 2007) 
and by doing so can enhance the patient experience (Department of Health, 2007). 
They can positively influence support and care by providing information around side 
effects of treatment including hair loss and clinical trials (Campbell, Khan, Rankin, 
Williams, & Redman, 2006), as well as psychosocial support (Cruickshank, 
Kennedy, Lockhart, Dosser, & Dallas, 2008; Voigt et al., 2011), continuity of care 
and better identification of patients with psychological problems (Baildam et al., 
2002) and are able to signpost patients to the relevant psychosocial care as and when 
required.  
 
 
1.13.4 Information provision 
 
Information provision is an important aspect of supportive cancer care (Husson, 
Mols & van de Poll-Franse, 2011) but many patients feel that the information they 
receive does not meet their needs (Power & Condon, 2008). Providing information 
which meets patients’ needs, may help to improve health related quality of life 
(HRQOL), anxiety and depression (Husson et al., 2011). Unfortunately, standard, 
mass-produced written information is generalised and not tailored to patients’ 
individual needs and, as a result, can cause confusion and may even increase levels 
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of anxiety and depression (Ong, Visser, Lammes et al, 2000; Manning & Dickens, 
2007). Anxiety can inhibit information processing, so even when the information is 
of high quality patients may have difficulty understanding it (Griggs, Sorbero, 
Mallinger et al., 2007).  
Research has highlighted that patients who had difficulties gaining their desired level 
of information can be less confident in their ability to deal with health-related issues 
(Arora, Johnson, Gustafson et al, 2002). Until relatively recently, patients would rely 
on their doctors and health professionals for information, however, the development 
of Cancer Information and Support Centres (CISCs), telephone lines, web-based 
information services and government-funded initiatives have offered an opportunity 
to improve patient access to a wide variety of information (Manning & Dickens, 
2007; Smith, Dickens & Edwards, 2005).  
A small number of studies (now somewhat dated) suggest that information about 
side-effect management and self-care strategies can have a positive value (Ream & 
Richardson, 1996), yet a systematic review consisting of 57 articles highlighted that 
between 6-93% of patients report being unsatisfied with the information provided 
throughout their cancer journey from health professionals (Harrison, 2009. In 
addition to information provided by health professionals, the provision of 
information often becomes the responsibility of families, friends and support groups 
or helplines (Manning & Quigley, 2002). Borsellino and Young (2011) highlight 
how information can help patients prepare for hair loss (i.e. promote anticipatory 
coping) by rehearsing thoughts and behaviours (such as practicing responses to 
people’s questions or having headwear available and feeling confident in using it). 
However, as evidenced above, information provision does not necessarily meet all 
patients’ needs.  
 
1.13.5 Online information and support groups 
 
Cancer support groups and charities including Breast Cancer Care and Macmillan 
Cancer Support offer information specifically on chemotherapy-induced hair loss, 
including booklets, online resources and telephone helplines. Moreover, in recent 
years a number of online discussion forums have been developed, for example 
Macmillan’s forum (https://community.macmillan.org.uk/cancer_types/breast-
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cancer/discussions), Breast Cancer Care’s online forum 
(https://forum.breastcancercare.org.uk/), and Cancer Research UK’s online forum 
(https://www.cancerresearchuk.org/about-cancer/cancer-chat/). Forums enable 
patients to share experiences and offer support to one another. However, despite 
some patients finding online forums helpful, others may find them distressing if they 
read about someone’s negative experience, or feel that others are doing better than 
they are i.e. upwards and downwards comparisons are at play. Upward comparisons 
are when an individual compares themselves to others who are in a better situation, 
whereas downward comparisons are with individuals who are in a worse situation 
(Peterson & Ritz, 2010). This further emphasises the importance of individualised 
information and support based on an individual’s need.  
 
A number of barriers to accessing face-to-face support have been highlighted by 
cancer patients, some of which include time constraints and travel barriers.  Online 
support, including forums, offers an alternative means of accessing support 
(Lieberman et al., 2005; Owen et al., 2005). They may be appealing to those that 
suffer from social anxiety, as individuals can be accessed from their own home or 
any other place of their choice, and may be more confident doing so rather than 
accessing face-to-face support which some may find anxiety provoking (Morahan-
Martin & Schumacher, 2003). An important consideration is ensuring the safety of 
individuals who access online support. Although online forums tend to have 
facilitators who regularly check the content of forums and chat rooms, it is much 
harder to identify those in need of support and to provide that support, compared to 
individuals receiving face-to-face support. 
 
1.13.6 Camouflage-based interventions 
 
The search conducted at the outset of the PhD found several organisations offering 
camouflage-based interventions for breast cancer patients experiencing treatment-
related hair loss. Out of all the available interventions (see section 1.13.1 for an 
overview of the types of interventions), HeadStrong and Look Good Feel Better 
(LGFB) are most widely available in the UK and therefore these two interventions 
are considered in more detail below. 
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1.13.7 HeadStrong  
The UK-based charity Breast Cancer Care offers a volunteer led service called 
‘HeadStrong’ (www.breastcancercare.org.uk/HeadStrong). Many of the volunteers 
have had cancer themselves; however this is not a requirement. A session may 
therefore offer social support as the volunteer can share their experiences with the 
individual. The volunteers provide information and advice to cancer patients on 
using headwear to camouflage chemotherapy-induced alopecia (Breast Cancer Care, 
2011). The HeadStrong service is advertised through Breast Cancer Care’s website 
and in oncology departments. A one-to-one session with a volunteer provides advice 
on scalp and hair care, from diagnosis until after treatment has finished. During the 
session, the volunteer demonstrates how to wear a selection of headscarves and hats 
and provides details of where they can be purchased, if wanted. Most individuals 
only attend one HeadStrong session, although they can attend as many as they wish.  
Breast Cancer Care have designed their own user surveys, which HeadStrong 
volunteers distribute to patients, to ask them about their experiences of the service. 
However, this is not a rigorous evaluation and patients may feel obliged to leave 
positive comments, especially if the volunteers hand out the user surveys and ask for 
them to completed and returned to them at the end of the session. Currently, little is 
known about the extent to which HeadStrong meets individuals’ psychosocial needs. 
Without evaluations of large services such as HeadStrong, it is impossible to know 
whether the service offers any benefits to patients and if they do what those benefits 
are. Also, evaluations of services can enable service users to feedback suggestions 
and recommendations to service providers for how the services can be enriched.  
 
1.13.8 Look Good Feel Better  
Look Good Feel Better (LGFB) (www.lookgoodfeelbetter.org) originated in 
America in 1988 from a collaboration between the Cosmetic Toiletry and Perfumery 
Association (CTPA) and the American Cancer Society. Now freely available in the 
UK, LGFB aims to improve the self-esteem and quality of life of people undergoing 
cancer treatment, through the use of complimentary group and self-help beauty 
sessions (Cosmetics, Toiletries & Fragrances Association, 2015). The LGFB 
program includes beauty professionals volunteering to teach small groups of people 
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with cancer how to use makeup, wigs, and skin and nail products in an attempt to 
improve how they feel about their appearance and reduce feelings of stigmatization 
(Look Good Feel Better, 2014). The LGFB service is advertised through cancer 
information centres which are often located in oncology departments. At the end of 
the session, individuals are given a ‘goodie bag’ including various make-up 
products. LGFB is similar to the HeadStrong service as it focuses on the use of 
camouflage to cover hair loss including the loss of eyelashes and eyebrows. 
Numerous articles describe the LGFB service (i.e. Taggart, Ozolins, Hardie, & 
Nyhof-Young, 2009; Roark, 2008; Kendrick, 2008), however, only one study has 
evaluated the service: a pilot study found that participants reported a significant 
improvement in self-image, social interaction and anxiety after attending LGFB 
(Taggart et al., 2009). Further research would consolidate these findings. However, a 
critique of LGFB is that it is provided in a group setting, as opposed to one-to-one. 
This has a number of implications. While a group setting offers an opportunity for 
social support and to hear the experience of other patients, it may not suit everyone 
and has the potential for social comparisons to be made that increase rather than 
reduce distress. LGFB focuses solely on the use of make-up to camouflage hair loss, 
it does not provide any emotional support (although attendees may feel this is 
provided through contact with other patients), and has potential to reinforce 
appearance ideals and inadvertently make people feel like they have to use make up 
to camouflage their hair loss, rather than embracing the loss of their eyebrows and 
eye lashes. 
Despite a number of charities offering information, face-to-face and online support, 
patients are reporting that their information and support needs are not being met 
(Fiszer et al, 2014; Power & Condon, 2008). To the best of the researcher’s 
knowledge there are only two widely available services which focus on treatment-
related hair loss in the UK, which are HeadStrong and Look Good Feel Better 
(LGFB). To date, it is unclear what benefit, if any HeadStrong and LGFB offer to 
women affected by treatment-related hair loss.   
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1.14 The theoretical framework for this research  
 
It is imperative that condition-specific models of susceptibility to distress are 
available for cancer survivors, to ensure that support is tailored to those most likely 
to benefit (Kaiser, Hartoonia & Owen, 2010). A number of cancer 
models/frameworks have been developed for cancer patients, including Fuerstein, 
Todd, Moskowitz, Bruns, Stoler, Nassif and Yu (2010) who have developed an 
evidence-based model which provides a framework to help cancer survivors return to 
work. Gauthier et al (2012) explored the use of the Communal Coping Model 
(CCM) in relation to the social context of cancer pain, suggesting that people 
catastrophize to express distress and prompt support. Also, it has been suggested that 
hope theory may act as a guiding theoretical framework to explain and promote 
positive coping with cancer treatment (Germann, Leonard, Stuenzi, Pop, Stewart & 
Leavey, 2015). Naus, Ishler, Parrott and Kovacs (2009) proposed a cancer survivors 
adaptation model which highlights adaptation over time through goal appraisal and 
change. These models are currently in their early stages of development and piloting, 
and to date have not been widely adopted and tested.   
 
A number of theories have been developed which can be used to explain individual 
differences in adjustment to an altered appearance, such as that resulting from cancer 
treatment (Thompson & Kent, 2001). Some models have attempted to explain 
appearance issues within a specific condition, however, White’s (2002) cognitive 
behavioural model is one of few to be proposed in relation to cancer. White suggests 
that it is important to consider the importance that an individual places on their 
appearance/part of their body that has been affected by cancer and related treatment. 
However, to date, White’s model has not been tested and ultimately there is currently 
a lack of models specifically around an altered appearance in cancer.  
 
As highlighted earlier in the chapter, not everyone who loses their hair through 
cancer treatment is equally affected by appearance-related distress (see section 1.9), 
with some people adapting positively. However, it is unclear why this is.  As there 
are a lack of theories specific to body image and hair loss in cancer, the wider altered 
appearance/visible difference literature was considered to explore a possible 
theoretical framework to guide the research in this PhD. The ARC framework was 
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chosen as it is a model of adjustment which allows the identification of factors which 
contribute to ‘resilience’ and positive adjustment (see figure 1) and it enables the 
identification and clarification of factors which have the potential to be amenable to 
change through psychosocial support and intervention (ARC, 2009). The framework 
is believed to make predictions about individual susceptibility to distress (Rumsey & 
Harcourt, 2012). An overview of the ARC framework is provided below. This is the 
first time that the framework has been used with a breast cancer population. 
The ARC framework was developed as the result of a research program which 
sought to explore the variation in adjustment to disfiguring conditions, specifically 
the psychosocial factors and process which contributed to successful adjustment 
(ARC, 2009). Within the ARC framework, the process of adjustment to an 
appearance concern is theorised as having three main features. The first is the 
predisposing factors such as demographic characteristics, disease/treatment factors; 
visibility of an individual’s altered appearance and the media. The media can be seen 
as an important predisposing factor given the importance that it places on an 
individual having healthy hair (Tiggemann & Kenyon, 1998). Understanding of their 
influence is important, however these factors are less amenable to change via 
interventions compared with cognitive and behavioural aspects of the framework 
(ARC, 2009).  
 
Intervening cognitive processes are the second feature of the framework, believed to 
contribute to the difference between good and poor adjusters to appearance concerns 
(ARC, 2009). There can be a variation in the way a person perceives their own 
looks, whether it is in a positive or negative light (Sarwer & Crerand, 2004). Some 
of the ways in which appearance can be made more salient and prone to negative 
evaluation include social comparison processes and positive or negative experiences 
of social interactions (i.e. staring, pointing) (Green & Sedikides, 2001). In support of 
the important role of intervening factors, Cash (2003) argues that body image 
investment concerns the degree to which an individual places importance on 
maintaining their appearance and the degree to which appearance is central to their 
self-worth, whereby those with high motivational salience and high self-evaluative 
salience (i.e. those who place high importance on appearance and see it as a key 
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aspect of their self-worth) are thought to have more difficulty adjusting to an altered 
appearance.  
 
The third aspect of the ARC framework is the experienced effect of appearance 
concerns, for example social anxiety and avoidance behaviours. Although considered 
as outcomes in the ARC framework, it is acknowledged that these factors can also 
influence the psychological setting for the intervening cognitive processes described 
in the paragraph above (ARC, 2009). Therefore, the outcomes can influence the 
intervening cognitive processes, and vice versa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The Appearance Research Collaboration (ARC) (2009) research 
framework. Figure in Clarke, Thompson, Jenkinson, Rumsey, and Newell. (2013). 
CBT for Appearance Anxiety: Psychosocial Interventions for Anxiety due to Visible 
Difference. Figure 3.5, p. 35. (Reproduced with copyright permission from Wiley-
Blackwell).  
 
 
 
Predisposing Factors 
 
Age 
 
Gender 
 
Ethnicity 
 
Living Status 
 
Cause 
 
Visibility of site 
 
Treatment history 
Intervening Cognitive Processes 
Dispositional Style 
Optimism/pessimism 
Socio-cognitive processing 
Perceptions of social support 
Perceptions of social acceptance 
Fear of negative evaluation 
Appearance Specific Cognitions 
Salience 
Valence 
Disguisability 
Perceived visibility when clothed 
Self/ideal discrepancy 
Social comparison 
Outcomes 
Appearance-related 
anxiety 
Well-being 
Mood 
Aggression 
Shame 
Chapter One: Introduction to the Research Area 
 
27 
 
 
1.15 The link between the ARC framework and the hair loss literature 
By identifying the factors and processes which promote successful adjustment, 
researchers are able to then focus on the factors which are amenable to change, 
which can inform the development of interventions to support breast cancer patients 
who are affected by treatment-related hair loss. Women with breast cancer typically 
receive a variety and combination of treatments (see section 1.3), which can lead to 
unpreventable hair loss for many of those undergoing chemotherapy. However, the 
severity and extent of hair loss is not a consistent predictor of adjustment (Rumsey & 
Harcourt, 2004). Along with age, the significance society puts on hair and hair loss 
status; are all factors that are unchangeable through interventions and considered as 
predisposing factors to appearance-related distress in breast cancer patients affected 
by hair loss.  
As discussed earlier in this chapter, there are a number of intervening cognitive 
processes that can effect an individual’s adjustment to their treatment-related hair 
loss. As a result of hair loss, many individuals wear wigs and head scarves to 
disguise hair loss (Kent and Thompson, 2002). However, head wear can become a 
symbol of stigma, highlighting that the individual has lost their hair (Crocker et al, 
1998), which can lead individuals to fear being negatively evaluated by members of 
the public (a discussion of stigma can be found in section 1.8). Fear of negative 
evaluation is therefore an appropriate intervening variable in the ARC model when 
relating it to hair loss. As discussed earlier, White (2000) highlighted that 
chemotherapy-induced hair loss can put women at greater risk of a disturbed body 
image if they place a higher value on appearance. It is important to remember that 
despite hair loss often being seen as a short term problem which will disappear once 
an individual’s hair starts to re-grow, unexpected problems with hair re-growth such 
as hair being a different colour and/or texture can lead to women continuing to feel 
self-conscious and experience a persisting negative self-image (Borsellino & Young, 
2011). Another important intervening factor is self-esteem, there is thought to be a 
link between higher self-esteem and a better body satisfaction (Wardle et al., 2002). 
Furthermore, treatment-related hair loss can lead to a number of outcomes including 
a negative impact on an individual’s quality of life (Leung et al, 2014); including 
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their confidence and even appearance-related distress (Helms et al, 2008). Also, 
individuals with chemotherapy-induced alopecia can experience anxiety and 
depression for a number of reasons, for example hair loss can serve as a reminder of 
an individual’s cancer (Pickard-Holley, 1995; Williams et al, 1999).  
In summary, the ARC framework of pre-disposing factors (in this thesis these 
include demographic variables, hair loss status, treatment history) and moderating 
factors (cognitive/thought processes including importance placed on appearance, 
self-esteem and fear of negative evaluation) may determine psychosocial adjustment 
to treatment-related hair loss as indicated by relevant outcomes (e.g. appearance-
related distress) (See Figure 2). 
 
A guiding theoretical framework for this research has been developed based on the 
ARC (2009) framework. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The guiding theoretical framework, informed by the ARC (2009) 
framework, in Clarke, Thompson, Jenkinson, Rumsey, and Newell. (2013). CBT for 
Appearance Anxiety: Psychosocial Interventions for Anxiety due to Visible 
Difference. Figure 3.5, p. 35. (Reproduced with copyright permission from Wiley-
Blackwell).  
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chemotherapy, but it is unclear what service users’ experiences of their services are 
and whether their needs are being met through existing interventions.  Therefore, this 
PhD thesis aims to answer the following research questions:  
1. To what extent are interventions effective at reducing distress associated 
hair loss?  
2. What are individuals’ experiences of current interventions which aim to 
support them with their hair loss? 
3. Are any further interventions needed?  
 
In order to answer these research questions in a rigorous manner, the MRC 
framework for complex interventions (outlined in chapter 2) was used to guide the 
research, alongside the ARC framework (outlined above). The ARC framework 
helped to inform the particular constructs deemed relevant and the selection of 
measures, whereas, the MRC framework informed the choice of a series of 
individual studies within the research program. For example, the initial phase of the 
MRC framework advises that relevant theory is explored to ensure the best choice of 
intervention. Therefore, the first objective was to conduct a systematic review of 
previous research that has evaluated the effectiveness of interventions to support 
people who have experienced hair loss. The findings of this review were then used to 
inform the second stage of the research which was to evaluate the HeadStrong 
service, in order to gain an insight into individuals’ experiences of the service and to 
explore whether further interventions were required. This work was guided by the 
first phase of the MRC framework which highlights the importance of identifying 
the components of an intervention. The second phase of the MRC framework 
highlights the importance of describing the components of an intervention and 
developing a protocol. Therefore, the findings from the HeadStrong evaluation 
informed the decision to explore the feasibility and acceptability of an RCT of an 
existing expressive writing intervention that has not previously been used to support 
women affected by cancer-related hair loss (see chapter 6). Figure 3 demonstrates 
the structure of the thesis and different stages of the research.  
In keeping with the recommendations of the MRC framework, the first study in this 
research program was, therefore, a systematic review of current interventions. 
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Figure 3. The structure of this thesis, including the stages of the research and 
individual studies. 
Stage One: Review 
Aim: to explore existing interventions for individuals affected by hair 
loss. 
Study 1: 
Supporting cancer patients affected by alopecia: a systematic review of 
psychosocial interventions to improve psychological outcomes for 
individuals with hair loss 
Stage Two: Current interventions 
Aim: to gain an insight into individuals’ experiences of a current 
intervention for breast cancer patients affected by treatment-related hair 
loss and to explore if additional interventions are required. 
Study 2: 
A qualitative study exploring breast cancer patients’ experiences of 
treatment-related hair loss and a camouflage based support intervention 
 
Study 3: 
A quantitative study exploring breast cancer patients’ experiences of 
Breast Cancer Care’s HeadStrong Service 
Stage Three: A new use for an existing intervention 
Aim: to explore the feasibility of an RCT to evaluate an existing 
intervention (expressive writing) that has not previously been used with 
women affected by hair loss during chemotherapy.  
Study 4: 
Feasibility of an expressive writing intervention to support breast 
cancer patients affected by treatment-related hair loss 
 
 
 
 
 
 
Figure 
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1.17 Conclusion 
Hair loss presents those affected with a variety of significant challenges. It is 
difficult to prepare individuals for chemotherapy-induced alopecia as the experience 
is different for everyone and individuals’ psychosocial needs vary (Independent 
Cancer Taskforce, 2015).  Some people adjust to an altered appearance due to cancer 
treatment with relative ease, whilst others find it more difficult. Medical 
interventions available for chemotherapy-induced alopecia, such as scalp cooling, 
are not always effective and do not address patients’ psychosocial needs. As 
highlighted above, there are a number of freely available support services (e.g. NHS 
wig service, HeadStrong, Look Good Feel Better) for breast cancer patients who are 
affected by treatment-related hair loss. However, these services tend to focus on 
disguising or covering up hair loss and offer very limited psychosocial support, and a 
scoping exercise has revealed no published evaluations of the NHS wig service and 
HeadStrong, so the benefit they offer to patients is unknown. Therefore, it is still 
important to explore what psychosocial interventions are currently available for 
patients, whether they have been evaluated and whether they are meeting patients’ 
needs in order to inform the best possible provision of care for women in this 
situation in the future. 
 
1.18 Summary of the key points in this chapter: 
 Currently there is limited published research into the provision of 
psychosocial support for breast cancer patients affected by chemotherapy-
induced hair loss. 
 An appraisal of the adjustment, social support and stigma literature has 
helped to explain the prevalence of appearance-related distress that women 
with breast cancer can experience as a result of treatment-related hair loss. 
 This is the first time the ARC framework of factors and processes influencing 
adjustment to an altered appearance has been used in research with a breast 
cancer population.  
 There are three main research aims within this thesis;  
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o To explore the effectiveness of psychosocial interventions aiming to 
improve psychosocial outcomes and appearance-related distress for 
people affected by hair loss due to chemotherapy 
o To gain an insight into service users’ experiences of current 
interventions 
o To explore whether additional interventions are required. 
 
1.19 The next stage of the research 
It is evident that the impact of treatment-related hair loss can be diverse and 
extremely distressing for individuals’ affected by treatment related hair loss, 
however, little is currently known about the psychosocial support available for 
individuals affected by hair loss or whether the available interventions have been 
evaluated. The following chapter discusses the findings from a systematic review 
which explored the available psychosocial interventions for individuals’ affected by 
hair loss. 
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Chapter Two 
Supporting Cancer Patients Affected by Alopecia: A Systematic 
Review of Psychosocial Interventions to Improve Psychological 
Outcomes for Individuals with Hair Loss 
 
2.1 Introduction 
Alopecia and its corresponding psychosocial problems have been reported in the 
literature for a number of decades (McGarvey et al., 2001; Williams et al., 1999). 
However to date, we know little about the psychosocial support currently available 
for patients affected by hair loss, nor whether these interventions have been 
evaluated. As a result, it is unclear how successful they are in meeting individuals’ 
needs and helping them to manage their distress. Lemieux, Maunsell and Provencher 
(2008) conducted a literature review to explore the effects of alopecia on quality of 
life outcomes for breast cancer patients, and suggested that rigorous evaluations of 
interventions for cancer-related hair loss are still needed (Lemieux et al., 2008). 
From a scoping exercise and discussions with experts in the field, it became apparent 
that there is still a paucity of research in this topic area, and no evidence (from 
searching the Campbell Collaboration, Cochrane, NIHR Centre for Reviews and 
Dissemination (CRD) and Database of Abstracts of Reviews of Effects (DARE) 
databases) that previous attempts have been made to conduct a systematic review of 
the evidence currently available. 
This is therefore the first systematic review to explore the effectiveness of 
psychosocial interventions in this area.  
 
2.2 Aim  
 To explore the effectiveness of psychosocial interventions for individuals 
affected by treatment-related hair loss.  
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2.2.1 Identification of the research question 
This review was seeking to answer the following questions: 
 What types of psychosocial interventions for patients experiencing 
hair loss have been evaluated? 
 
 Are these interventions effective in reducing patients’ distress? 
 What are the characteristics of effective interventions? 
 
2.3 Method 
 
2.3.1 Rationale for inclusion/exclusion criteria 
Booth and Fry-Smith’s (2004) PICO model (Population, Intervention, Comparison, 
Outcome) was used to guide the focus of the literature selection criteria (cited in 
Centre for Reviews and Dissemination, 2009). The Population were defined as 
adults (>18 years) who were experiencing clinical hair loss (it was not limited to 
cancer patients since it became apparent, when conducting a literature search and a  
scoping exercise in chapter one, that few interventions solely for breast cancer 
patients exist). Children and adolescents were excluded from the review, since the 
cognitive changes, developmental and health trajectories facing these groups mean 
they have specific and differential intervention needs to those of adults (Holmbeck, 
2002); and because it was important to relate the findings to adults with breast 
cancer in the rest of the thesis. Interventions and studies with patients with terminal 
cancer were excluded, as the psychosocial issues facing these patients differ from 
those with a good prognosis, who should hopefully regain pre-cancer quality of life 
and continue with a normal life trajectory (Downey & Engelberg, 2010). Patients 
with trichotillomania (a disorder whereby an individual has an uncontrollable urge to 
pull their own hair out) were also excluded as this is more of a behavioural issue, 
and it is believed that these patients have different interventional needs to those who 
lose their hair as a consequence of treatment or a genetic or inherited condition. 
Whilst acknowledging that randomised control trials are the gold standard for 
scientific rigour and can help to reduce selection bias and increase internal validity 
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(Blackwood, O’Halloran & Porter, 2010; Bottomley, 1997; Feneck, 2009), it was 
decided that a sensitive search strategy and an inclusive approach to synthesising 
data on a range of psychosocial Interventions and study designs was appropriate, 
making no assumptions about the nature and type of study design that may affect the 
outcomes. Any psychosocial intervention specifically designed to target patients 
experiencing clinical hair loss was sought. 
The Comparison with the intervention could be either a passive or active control 
group or pre and post intervention. Considering the relevance of Outcome measures 
to the development of the search strategy, this review focused on both quantitative 
and qualitative studies as long as they included psychosocial outcomes (i.e. quality 
of life, self-esteem, body image, appearance concerns). Lemieux et al (2008) 
informed the decision to use broad aspects of QOL as the outcome.  
 
2.3.2 Summary of the inclusion criteria 
 Adults (>18 years) who are experiencing clinical hair loss. 
 Psychosocial interventions to support patients affected by clinical hair loss. 
 Comparison with an active or passive control or a pre and post intervention 
comparison. 
 Outcome evaluation using a quantitative or qualitative measure of 
psychosocial outcomes i.e. quality of life, self-esteem, body image or 
appearance concerns related to hair loss. 
 Published in the English language. 
 
2.3.3 Exclusion criteria  
 Hair loss due to ageing 
 Studies of children/adolescents <18 years of age 
 Patients diagnosed with a terminal illness 
 Patients with trichotillomania  
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2.3.4 Search protocol 
Electronic searches were conducted on the following databases: Allied and 
Complimentary Medicine Database (AMED), Applied Social Sciences Index and 
Abstracts (ASSIA), British Nursing Index (BNI), Campbell Collaboration, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane 
Library, Embase, Medline, PubMed, PsychINFO, Science Direct, Science Citation 
Index, UK Pubmed Central. For each database specific MeSH terms were identified 
for the broad terms; hair loss (for example: alopecia, hair$) + psychosocial 
intervention (for example: psycho$ intervention, social$, exercise, social support, 
cognitive behave$) + quality of life (for example: quality of life, QOL, body image, 
appearance, self-esteem) and were entered as search terms (see appendix 1 for a list 
of databases and search terms used). Prior to conducting the systematic review, a 
meeting was held with a colleague with expertise in the topic area, in order to 
identify potential hair loss and psychosocial intervention terms. No limit was set on 
publication date; this was to remain consistent with the inclusive nature of the 
review. An initial search was carried out in February 2012 and then again in June 
2014, to capture any subsequent papers that had been published. 
The process of article selection is demonstrated in the Quorum Flow Chart (Altman 
et al., 2001) in Figure 4. During stage one, ineligible and duplicate articles were 
eliminated and the remaining abstracts were reviewed independently by two 
reviewers in stage two. Full copies of papers were retrieved for the relevant articles 
and these were then independently reviewed by the same two reviewers during stage 
three, according to the literature selection inclusion criteria. To aid with this final 
process, a Data Extraction table (see table 1) detailing the inclusion criteria was 
devised for both reviewers. Elements of the Effective Public Health Practice Project 
(EPHPP, 2010) quality assessment tool combined with elements from the 
Consolidated Standards for the Reporting of Clinical Trials (CONSORT) statement 
described by Altman et al. (2001) were used to extract data from the studies. Any 
disputes concerning the inclusion of a paper were reviewed by a third reviewer, with 
experience in conducting systematic reviews. 
Alongside electronic searches, ‘grey’ searches were also conducted, including hand 
searches of relevant articles and the journals in which the papers that had met the 
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review’s inclusion criteria had been published. Experts in the field who had 
published relevant articles (i.e. Biondo & Collins, 2003; Fox, 2003; Roark, 2008) 
proposing the benefits of psychosocial interventions were contacted to see whether 
these interventions had since been evaluated. 
 
2.3.5 Assessment of the scientific quality of the evidence 
For the purpose of the review, scientific quality was defined as “the extent to which 
a study’s design, conduct and analysis have minimised selection, measurement and 
confounding bias” (Agency for Healthcare Research and Quality, 2002, p. 2). Due to 
the variable nature of study designs included, the assessment of scientific quality 
was based on the Effective Public Health Practice Project (EPHPP) tool for assessing 
quantitative studies. Alternative tools including the Cochrane Collaboration Risk of 
Bias Tool (CCRBT) were considered, however, it was decided that the EPHPP 
would be more appropriate as studies have shown it to have better inter-rater 
agreement in both individual domain scoring and final grade assignment compared 
to the CCRBT (Armijo-Olivo, Stiles, Hagen, Biondo & Cummings, 2012). 
Additionally, Spencer, Ritchie, Lewis and Dillon’s (2003) framework was used to 
assess the quality of qualitative studies. 
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Figure 4. Quorum Flowchart.  Numbers in brackets refer to citations identified by 
electronic database and citations by other sources (grey searches). 
 
2.4. Results 
This section discusses the results of the systematic review, specifically the types of 
interventions included, their effectiveness and the quality of their evaluations. 
 
 
 
Stage 1: Potentially 
relevant studies identified 
and screened for retrieval.         
(n = 4689 + 493) 
 
Stage 2: Abstracts of 
studies retrieved and 
reviewed by 1st and 2nd 
reviewers.                        
(n = 270 + 40) 
Stage 3: Potential studies for 
review. Studies evaluated in 
detail by the 1st and 2nd 
reviewer to determine relevance 
to inclusion criteria        (n = 48 
+ 14) 
Studies with usable 
information by outcome                
(n = 4 + 4) 
Ineligible studies excluded on the basis of title, 
language, being books, medical studies and 
studies with animals (n = 4872) 
Studies excluded if clear and obvious evidence 
that:              
1. Not a hair loss population (n = 10)                                                 
2. Not a psychosocial intervention study(n = 
202)                             
3. Child/adolescent population   (n = 13)                    
4. No assessment of QOL, body 
image/appearance issues (n = 23)   
                                                                                            
Studies included in stage 3 if no abstract 
available or a lack of evidence in the abstract to 
exclude with confidence. 
Studies excluded from review if:       
1. Not a psychosocial intervention (n = 36) 
2. Not hair loss (n = 3)                                                                                                                     
3. Full article not in English (n = 4) 
4. No evaluation of intervention (n = 9) 
5. Child/adolescent population (n = 2) 
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2.4.1 Systematic literature review 
The Quorum diagram (see Figure 4) demonstrates the results of the initial database 
search (4689 abstracts) and the addition of abstracts from the grey search, which 
included articles added from bibliography checks and expert referrals (493). Articles 
were excluded because they were not written in English, were animal or medical 
studies, or were book chapters. The remaining 310 abstracts were read by two 
independent reviewers. 
Abstracts were excluded if they were not a hair loss population (10), not a 
psychosocial intervention (202), involved children (13) or if there was no assessment 
of an aspect of QOL including body image/appearance concerns (23). There was 
general agreement between reviewers on which abstracts met the inclusion criteria. 
Disagreement occurred because a number of abstracts were not clear whether the 
study was an intervention, or lacked information about evaluation. A noteworthy 
point is that, in many studies, QOL or body image was not a primary outcome and 
was therefore not highlighted in the abstract. Due to the limited information 
available, it was decided to include all the studies where agreement could not be 
reached in the next stage of the review, in an attempt to provide a thorough review of 
all the evidence available. Therefore when abstracts could not be excluded with 
confidence, full papers (62) were retrieved and reviewed by two independent 
reviewers. 
From these full papers, studies were excluded if they were not a psychosocial 
intervention (36), not a hair loss population (3), provided no evaluation of the 
intervention (9), the full articles were not available in English (4) or the population 
were children/adolescents (2). A total of 8 articles (4 of which were obtained from 
grey searches) were retained, reporting on 8 different interventions.  
It is relevant to note at this stage that the interventions described below were 
excluded on the basis that they described services that had not been evaluated:  
 Roark (2008) described the ‘Look Good…Feel Better’ program which offers 
a free cosmetic workshop to women undergoing chemotherapy.   
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 Ehmann, Sheehan and Decker (1991) explored the entrepreneurial role of 
oncology nurses and incorporated the development of a patient education 
program and booklet, along with professional education sessions.  
 Fox (2003) looked at the benefit of a web-based news group for individuals 
with alopecia universalis. The aim of the study was to assess themes of 
discussion rather than to evaluate the web-based news group as an 
intervention.  
 Kalabokes (2011) described the National Alopecia Areata Foundation as a 
support group.  
 Biondo and Collins (2003) proposed a group psychological intervention for 
women with hair loss.  
 Clarke and Evans (1990) designed an interactive TV program, available in 
waiting rooms, to offer information to patients.   
 Fawzy, Secher, Evans and Giuliano (1995) described the Positive 
Appearance Centre, designed to support patients in managing the cosmetic 
side effects related to their diagnoses and treatment.  
 Vandegrift (1994) described the development of an oncology alopecia wig 
program. 
 
The following interventions were excluded as they did not meet all the inclusion 
criteria for this review: - 
 Both Reinfold (1960) and Sandok (1964) lacked details of the intervention, 
its duration and who delivered it. In addition, Reinfold (1960) included 
participants under the age of 18 and Sandok (1964) did not include any detail 
of outcome measures.  
 A hypnotherapeutic management intervention by Willemsen, Vanderlinden, 
Deconinck and Roseeuw (2006) was not included in the systematic review as 
it included participants under the age of 18 years.  
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 Willemsen and Vanderlinden (2008) provided details of the hypnotherapeutic 
intervention and examples of individual participant cases but no evaluation. 
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Table 1. Systematic review data extraction table 
Citation Intervention Study Design 
Participant Selection, Response 
Rate, Instrument/Measures 
Data 
Analysis Findings 
Effect 
size P 
      Descriptive Statistics           
McGarvey 
et al (2010) 
Computer-imaging 
program 
RCT  
Convenience sample of female cancer  
Name Baseline 
group  
Qualitative feedback: 
pts  Statistics 
Sig 
level  
 
(HAAIR) 
Type of 
control 
patient with current diagnosis of 
breast,  Brief Symptom Comparison 
found HAAIR  system 
easy 
power 
not  was set  
 
Timing Usual care ovarian, lung, blood, melanoma with inventory (BS1-18) Yes: BSI-18- 
to use and the 
educational 
optimal 
at 
at p = 
0.05 
 
Newly diagnosed cancer 
patients Measures chemotherapy treatment associated Description 
at baseline 
more  
rules useful.100% pts 
found it 0.75 for 
 
 
Delivered by: Baseline (T1) with alopecia 18-items measuring 
pts in 
intervention 
enjoyable or glad they 
used it. testing a  
 
 
Clinical nurse specialist/ 
Following 
hair Treatment received general psychological 
not 
expressing 
Virtually trying on wigs 
and treatment 
 
 
research team loss (T2) No details distress Clinical 
changing hair styles 
was not 
effect 
size 
 
 
Process evaluation 
3 month 
follow-up Total n in study: 25 (intervention)  Name levels of 
as exhausting as in real 
life. 
  
 
With normal samples, (T3) 20 (control) Importance of Hair Psychological 
   
 
recovered cancer pts and HCP's Response rate/attrition questionnaire (IHQ) distress.  BSI-18: No significant interaction 
 
 
Fidelity 
 
T1 & T2 97.5% completed measures. Description 
 
between time of visit 
and 
  
 
Good 
 
1 pts dropped out at T3- 95%  20-item self-rating scale Intention to  intervention group. No  
  
 
Replicability 
 
completed all 3 assessments/ 1 Name treat analysis sig differences between groups. 
 
 
Good 
 
Mean age The Brief Cope No 
IHQ: T2 significant 
decline in  
 
   
51.7 (intervention) vs. 50.9 (control) Description 
 
distress from baseline in  
 
   
Ethnicity 76% white/Caucasian  24-items measuring  
 
both groups. At T3 hair 
loss 
  
   
(intervention) various coping methods. 
 
distress continued to 
decrease  
  
   
83.3% white/Caucasian (control) Items coded  into either 
 
in intervention group. 
  
   
SES Demographically representative active or avoidant 
 
No sig interaction 
between 
  
   
Degree of hair loss  coping. 
 
treatment and time (p = 
0.079) 
  
   
Complete hair loss 60% (intervention) Qualitative data 
 
Brief Cope: Pts had 
higher  
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65%(control) almost 40% 
(intervention) obtained through 
 
active than avoidant 
coping 
  
   
35% (control) ended questions. 
 
styles (p <0.001). 
  
      
Coping styles did not 
change 
  
      
significantly over time. 
  
      
Avoidance coping 
positively 
  
      
correlated with hair loss 
  
      
(p = 0.328, p = 0.032) 
  
            
 and GSI (p = 0.667, p < 
0.001)     
Willemsen Hypnosis Pre-test Convenience sample of patients Name 
 
Hypnosis intervention 
had 
1%= 
small, 
Sig 
level   
et al (2011) 
Duration of session: 1 
hour & post-test  referred for AA willing to attend a The Toronto Alexithymia  
significant effect at T1, 
T2 & T3. 
6% 
moderate 
was set 
at  
 
Sessions include 
discussions cohort study psychosomatic dermatology scale (TAS-20) 
Baseline 
group  
 
14% 
large  
p = 
0.05 
 
on various topics. 
Type of 
control consultation. Description Comparison 
Improvements at T2 
were 
for 
partial  
 
 
Next is a 40-minute 
manual- No control Treatment received 20-item self-report scale No 
maintained 6 months 
later. 
eta 
squared 
 
 
based hypnosis session. Measures No details Name 
    
 
First two sessions focused Baseline (T1) Total n in study: 24 The Symptom Check  Intention to  
SCL-90: Improvements 
found 
0.2-= 
small,  
 
 
on learning hypnotic 
relaxation 
end of 
hypnosis Response rate/attrition list (SCL-90) 
treat 
analysis 
at T2 & T3 compared to 
T1. 0.5 = moderate,  
 
and on learning self-
hypnosis. 
treatment 
(T2) 3 pts dropped out: 1 due to lack of Description No 
Significant decrease (p= 
0.001)  
0.8 = 
large  
 
 
From the third session 
6 months 
follow- motivation. 2 due to failure to Evaluates a broad range 
 
in total SCL-90 scores 
and  
for 
cohen's d 
 
 
patients received a variety 
of up (T3) concentrate while listening to of psychological problems subscale scores 
  
 
suggestions during 
hypnosis  
 
self- hypnosis audio tape. and symptoms of 
 
measuring anxiety, 
depression 
  
 
to improve self-esteem. 
 
Mean age psychopathology. 
 
and sensitivity.  
 
 
Patients received a self-hypnosis 41.95 (SD 13.79) Name 
 
Improvements in 
psychological  
 
 
CD and were asked to 
perform 
 
Ethnicity no detail SF-36 (version 2.0) 
 
well-being persisted 6 
months 
  
 
exercises on a daily 
 
SES no detail Description 
 
after treatment. 
  
 
basis. 
 
Degree of hair loss Assesses health 
 
SF-36-HRQOL: 4 
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HRQOL 
 
Timing 
 
30-49%= 14% pts related quality of life. 
 
parameters, 1 for 
physical  
  
 
Newly referred to 
Dermatology 
 
50-74% = 14% pts 
  
 (p=0.01) and 3 for 
mental 
  
 
clinic for AA 
 
75-99% = 33% pts Name 
 
HRQOL (p=0.001) demonstrated 
 
 
Delivered by: 
 
100% = 39% pts Skindex-17 
 
pts continued to report a 
better 
  
 
Research team 
  
Description 
 
QOL 6 months post 
treatment. 
  
 
Training of deliverer 
  
A dermatology specific 
 
TAS-20: significant 
  
 
No details 
  
HRQOL instrument.  
 
improvement from 
  
 
Process evaluation 
    
baseline, significant 
decrease 
  
 
No details 
    
in alexithymic 
  
 
Fidelity 
    
characteristics at T3.  
  
 
No details 
       
 
Replicability 
    
Post hoc pairwise 
comparisons 
  
 
Good 
    
showed moderate to large effect 
 
      
for TAS-20, SCL-90 
and for  
  
      
most SF-36 mental 
QOL scores  
  
            
at T2 % T3 compared to 
T1.     
Nolte et al 
Videotape Intervention 
(Best RCT Opportunity sample of Gynaecological Body Cathexis/ Self- 
 
Small but significant 
(p= 0.045)  
No 
mention 
Sig 
level  
(2006) Look Forward) 
Type of 
control patients with stage 0, 1, 2, 3, Cathexis Scale (BSCSC) 
Baseline 
group  change in body image at 
of effect 
size 
p = 
0.05 
 
45 minute video 
presenting  Standard care 
 
Description Comparison 
 course 3 but no change 
in  
  
 
make-up techniques  BI Measured Treatment received 
Two components: Items 
related  No self-esteem. 
  
 
and suggestions for hair 
and 
Pre, prior to 
the Chemotherapy 100% no other details to 46 body parts and  Intention to  
   
 
head pieces. 3rd course of Total n in study: 68 (intervention) 68 functions. Asked to  
treat 
analysis 
No intervention effect 
found 
  
 
Videotape viewed at either  
chemo and 
post (control) rate feelings No  for either body  image (p= 0.74)  
 
 
home or clinic. 
intervention 
after  Response rate/attrition on a 5 point scale.  
 
or self-esteem (p= 
0.57). 
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Timing 4th course of No details Single score derived  
    
 
After hair loss had been Chemo Mean age from mean score of the 
 
Qualitative feedback: 
all except  
  
 
established 
 
57.7  46-body items. 
 
3 pts reported videotape  
  
 
Delivered by: 
 
Ethnicity 93% Caucasian Second component:  
 
to be helpful. 
  
 
Gynaecological Oncology 
Staff 
 
SES no detail 55 items that represent 
 
One person thought the  
  
 
Training of deliverer 
 
Degree of hair loss  a sampling of various  
 
videotape should be 
provided  
  
 
No details 
 
No details conceptual aspects 
 
earlier.  
  
 
Process evaluation 
  
of self.   
 
Four pts found the 
makeup  
  
 
Evaluated by oncology 
nurses  
    
portion of the video 
unhelpful. 
  
 
for appropriateness of 
content 
    
All pts reported they 
would  
  
 
Fidelity 
    
recommend it to other 
women  
  
 
No details 
    
experiencing hair loss. 
  
 
Replicability 
    
Negative effects 
    Good         None stated     
Taggart et Look Good Feel Better pre, post-test Purposive sample of pts Name 
 
Quantitative Data: 
No 
mention 
Sig 
level 
al (2009) Workshops 
 
enrolled in 12 workshops Part A: The Negative  
Baseline 
group  
Part A: Self-image: 
significant  of effect  set at  
 
Cosmeticians  teach  skin 
care, 
  
self-Concept Scale (NSC) Comparison (p< .005) improvement  size 
p = 
0.05 
 
make-up techniques and 
wig 
Type of 
control Treatment received subscale of Derriford  No 
immediately post 
workshop but 
  
 
and hair alternatives. No control No details Appearance Scale (DAS) Intention to  not long-term. 
  
 
2 hour free sessions BI Measured Total n in study: part A 18 in  Description 
treat 
analysis: 
Part A: Social 
Interactions:  
  
 
Timing Pre, post  questionnaire stage, 3 interview stage;  High scores indicated  No 
Statistically sig 
reduction in 
  
 
Median time since 
diagnosis 7.5 
workshop and 
by  part B 10 in questionnaire stage,  lower self-image 
 
self-consciousness 
scores  
  
 
Months telephone 2-4  7 in interview stage Name 
 
(p <.01) 
  
 
Delivered by: weeks later Response rate/attrition Part A: The Social Self- 
    
 
Look Good Feel Better 
staff 
 
No details Consciousness  
 
Part B: Anxiety: 
significant  
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Training of deliverer 
 
Mean age of Appearance (SSC)  
 
reduction in anxiety 
scores   
 
No details 
 
Not enough detail (11 were 45 to 64) subscale of the DAS 
 
(p <.01)  
 
 
Process evaluation 
 
Ethnicity  
Not enough detail (47%  Description 
    
 
Pilot study 
 
Canadian born) Explored avoidance  
 
Part A: self-image: pts fell into  
 
   
SES demographically representative behaviours, distress in 
 
two categories 1) 
feeling 
  
 
Fidelity 
 
Degree of hair loss:  social situations and 
 
workshop had minimal 
impact 
  
 
No details 
 
No details  feeling misjudged due 
 
on self-image 2) those 
feeling  
  
 
Replicability 
  
 to appearance 
 
it had a positive impact. 
  
 
Good 
  
Name 
    
    
Part B: State-Trait  
 
Part A: Social 
interactions: 3 
  
    
Anxiety Inventory (STAI) 
 major themes; usual 
routine,  
  
    
state subscale 
 
no differential 
treatment;  
  
    
Description 
 
positive impact. 
  
    
Completed pre and post  
    
    
workshop. Scores 
 
Part A: social support: 
Women  
  
    
range from 20 (lowest  
 
felt comfortable 
  
    
anxiety) to 80 (highest  
 
surrounded by other 
women 
  
    
anxiety). 
 
with cancer but did not  
  
    
Name 
 
necessarily feel the workshops , 
 
    
Part A & B: Qualitative-  
 
were a source of social support. 
 
    
semi structured  
    
    
telephone interviews 
 
Part B:Anxiety: 3 major themes:  
 
    
Description 
 
sources of anxiety, 
workshop  
  
    
Interviews lasted 10-20  
 
experience, workshop outcomes; 
 
    
minutes and were 
 
 people. Workshops resulted in  
 
    
conducted 2 to 4 weeks  
 
reduced anxiety, 
satisfaction  
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post workshop with 
 
with workshop content 
and  
  
    
women who had  
 
experience. 
  
    
completed the  
            questionnaires.         
Roberts et 
Support Group 
Intervention Cohort  
Opportunity sample of Breast, 
Gynaecological cancer, Name 
 
Significant 
improvement found  
No 
mention 
Sig 
level 
al (1997) 
Uses standard group 
therapy  
 
Leukaemia, Lymphoma, Marfan's The Profile of Mood  
Baseline 
group  
on subscales of fatigue 
(p =.072),   of effect set at  
 
techniques to provide  
 
syndrome, Melanoma states (POMS) Comparison 
confusion(p = .058) and 
in  size  p = .10  
 
psychological support. 
Type of 
control Treatment received Description No total mood (p = .080). 
 
due to  
 
Psychoeducational No control 9 completed therapy 65 items or symptoms Intention to  WCCL-R: no sig 
 
small  
 
techniques incorporated 
information  Measures 2 under observation 
 
treat 
analysis: 
changes in coping 
mechanism. 
 
sample  
 
provision and problems 
solving.  6 topics were 
included. 
Pre & post 
test 3 chemotherapy 
 
No 
  
size 
 
  
    
CARES: significant 
change on 
  
 
Duration of session: 90 
mins 
 
Total n in study: 14 originally 
  
 the medical 
interactions  
  
 
Timing 
 
Response rate/attrition Name 
 
subscales (p = .031)  
  
 
11 less than 2 yrs since 
 
3 completed 3 or fewer sessions and The Cancer Rehabilitation  
 
 
 
 
diagnosis, 3 more than 
 
and were eliminated Evaluation System  
 
Qualitative data: four 
major areas  
 
 
2yrs since diagnosis 
 
Mean age 29.7 (SD 3.56) (CARES) 
 
of helpfulness identified  
 
 
Delivered by: 
 
Ethnicity 12 white, 1 Native 
American, 1  Description 
    
 
Oncology social workers 
 
African American 45-item scale with 5  
 
Concerns about 
appearance  
  
 
Training of deliverer: 
 
SES: no detail subscales. 
 
were addressed by 
group   
  
 
Experts 
 
Degree of hair loss:  
  
members on 
introduction to a  
  
 
Process evaluation 
 
No detail Name 
 
member wearing a hat 
and pts  
  
 
No detail 
  
The Ways of Coping  
 
began to share 
experiences of  
  
 
Replicability 
  
Checklist (WCCL-R) 
 
baldness. 
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Good 
       
    
Description 
    
    
68-item to assess the use of 
   
    
coping strategies in  
    
    
response to specific  
            stressors.         
Salonen  
Individual face to face 
support 
Quasi-
experimental Breast cancer patients admitted for Name Comparison  
Women with better 
body image      
et al (2011) Intervention focused on  
two-group 
design. treatment and/or follow up to an Ferrans and Powers group  
were aged > 55, (p < 
0.001)  
  
 
providing support and  
Trained 
nurses oncology clinic in Finland. Quality of Life Index- 
    
 
information according to  
gave numbers 
to  Treatment received Cancer Version (QLI-CV)   No Women who had no  
  
 
individual needs. 
pts and those 
with Breast cancer surgery, chemotherapy, Description 
 
chemotherapy (p < 
0.001) or  
  
 
Duration: 1 hr even number radiotherapy, hormone therapy. Measures satisfaction 
 
hormone therapy (p < 0.01) had  
 
  
were assigned  
 
with various domains  
 
a better body image 
than  
  
 
Timing to the intervention and the relevant  
 
women who received  
  
 
6 months after breast 
cancer  group. 
Total n in study: 204 (112 
intervention importance of each  
 
chemotherapy or 
hormonal  
  
 
Surgery 
Type of 
control group, 92 control group) domain to the individual. 
therapy as adjuvant 
therapy. 
  
 
Delivered by: Usual care 
 
 Each part consists of  
    
 
Trained nurse/Physiotherapist Response rate/attrition 33 items 
    
 
Training of deliverer: Measures Originally 359 gave informed consent: 
     
 
No detail 
Intervention 
group: 120 received telephone intervention as 
     
 
Process evaluation: 2 weeks after  61 dropped out, 108 received usual care as 70 
    
  
intervention. discontinued the study and so 202 
     
 
Fidelity  
 
received either face-to-face support 
     
 
Good 
Control 
group: or usual care. 
     
 
Replicability 6 month after  Mean age Name 
    
 
Good surgery Control: 57.7 The European Organization  
   
   
Ethnicity no details for Research and  
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SES: most women had vocational Treatment for Cancer 
    
   
education and were employed Breast Cancer- Specific  
    
   
Degree of hair loss Quality of Life  
    
   
No detail Questionnaire. (EORTC 
    
    
QLQ-BR23) 
    
    
Description 
    
        Consists of 23 items          
Zannini et Aesthetic care program 
Qualitative 
study Convenience sample of 20 Sicilian Name 
 
Seven themes emerged 
from  
  
al (2012) 
Explored the perceived 
effects  using IPA women who had suffered or who were 
Interpretative 
Phenomenological analysis 
Baseline 
group  
the analysis: Reactions 
to  
  
 
if an aesthetic care 
program   
 
suffering from chemotherapy-induced 
 
Comparison 
cancer: anger, 
incredulity and  
  
 
for Italian women affected 
by  
 
alopecia who had participated in an Description No  the desire to fight. 
  
 
chemotherapy-induced alopecia.  aesthetics program  IPA was used as it  
    
 
Study investigated what 
ways  
Type of 
control 
 
recognises the central    
 
Chemotherapy and  it's   
  
 
cultural factors influence a  No control Treatment received role of the analyst in   
 
collateral effects are  
  
 
women's choice of camouflaging  100% had received chemotherapy  making sense of the  
 
acknowledged as 
unavoidable. 
  
 
chemotherapy-induced alopecia  
with a wig. 
 
personal experiences of  
    
   
Total n in study: 20 pts.  
 
Even if it's expected,  
  
 
Timing 
 
Response rate/attrition 
  
alopecia is experienced 
as  a  
  
 
10 women in active chemo 
 
No detail 
  
traumatic event that challenges   
 
 
10 women in follow-up 
 
Mean age 53 
  
a women's femininity. 
  
 
Delivered by: 
 
Ethnicity no details 
     
 
Oncologist, social 
workers,  
 
SES demographically representative 
  
The ambivalent 
perceptions  
  
 
sociologists, hairdressers 
 
Degree of hair loss 
  
of the hair cutting/ shaving 'rite'.  
 
 
Training of deliverer 
 
Selection of women who had suffered 
     
 
Interview training 
 
or were suffering from chemotherapy- 
  
The wig is positively perceived  
 
   
induced alopecia 
  
because it camouflages 
the  
  
 
Replicability 
    
baldness and reduces the 'sick   
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Good 
    
aspect'  of a women affected by  
 
      
chemotherapy- induced alopecia.  
 
         
      
The wig is worn mostly 
for   
  
      
others, out in public, but 
in  
  
      
some cases women wear it also  
 
      
for themselves. 
  
         
      
Hair re-growth presents 
the  
  
      
visualisation of the 
healing  
  
            process     
Amiel et al Beauty Care in Hospitals Retrospective  convenience sample of professional Name 
 
A number of themes 
were 
  
(2009) Evaluated programmes: 
Qualitative 
study  service providers working in a hospital Direct observation and  
 
identified: 
  
 
simple beauty care 
delivered by a using direct  where cancer patients are treated, semi-structured  
 
Perceptions of 
physicians &   
  
 
cosmetician in the 
hospital;  
observation 
and  professionals, patient users treated for interviews  
Baseline 
group  nurse. 
  
 
beauty care provided by a  
semi-
structured Cancer 
 
Comparison 
   
 
socio-aesthetician (a  interviews. Treatment received Description No Experiences and perceptions of  
 
 
cosmetician who had done 
 
No detail To explore  Intention to  patient users. 
  
 
extra training); image 
advice;  
Type of 
control 
 
psychopathological  
treat 
analysis: 
   
 
image advice and socio-
aesthetics  No control Total n in study:  dimensions of body  Not reported 
Cancer and treatment-
related  
  
 
service. Gustave Roussy Measures 6 Professional service providers deterioration and the  
 
changes. 
  
 
Cancer Institute (IGR) 
created  
Qualitative 
analysis 11 Health professional relationship  between the  
   
 
the image advice and 
socio- 
 
60 Patient users (40 main survey) (20 patient and the beauty  
 
Psychological 
investigation of  
  
 
aesthetics. 
 
complementary service) care service. 
 
the cancer-and 
treatment- 
  
 
Timing 
 
Response rate/attrition 
  
related effects. 
  
 
No specific details 
 
Not reported 
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Delivered by: 
 
Mean age 53.18 (main survey) 
  
Beauty care 
  
 
A Sociologist delivered 
survey. 
 
48.75 (complementary service) 
     
 
A Clinical psychologist 
delivered the 
 
Ethnicity No details 
  
How they managed to 
find out  
  
 
complementary service. 
 
SES No details 
  
about the beauty care and how  
 
 
Training of deliverer 
 
Degree of hair loss 
  
frequently they used it. 
  
 
No detail 
 
No detail 
     
 
Process evaluation 
    
Identifying services 
offered. 
  
 
No detail 
       
 
Replicability 
    
Relationship with 
professional 
  
 
Good 
    
care provider.  
  
         
      
Benefits perceived by the users  
 
      
 and expectations. 
  
         
      
Characteristics of 
beauty care. 
  
         
      
Patient user 
expectation. 
  
         
            
Value of services 
provided.     
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2.4.2 Types of interventions 
The articles included in the systematic review reported on three different types of 
interventions; 4 focusing on behavioural techniques to camouflage hair loss (Taggart 
et al, 2009; Amiel et al, 2009; McGarvey et al., 2010; Nolte et al, 2006), 3 providing 
psychological support (Zannini et al, 2012; Roberts et al, 1997; Salonen et al, 2011) 
and 1 based on hypnosis (Willemsen et al, 2011). 
Details of the interventions and the theoretical basis behind their development (if 
available) are described in table 2. 
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Table 2. Description and theoretical basis of interventions included in the systematic review 
Citation Intervention Description Theoretical Basis 
Nolte et Best Look Forward'  45 min videotape with real patients Evidence of effectiveness in video 
 al (2006) Videotape' presenting make-up techniques, hair/ modelling in facilitating 
 
45 min videotape head piece solutions. Presents info clinical decision-making, reducing 
 
viewed at home or in a positive, uplifting but realistic anxiety and physiologic arousal. 
  
at clinic 
 
Manner 
  
McGarvey 
et al 
(2010) 
Computer-imaging 
program (HAAIR. 
Individual 60-90 min 
session at clinic. 
Pts facilitate photograph being taken, 4 images 
of pts faces were displayed on the screen, 
optional images available for pts to choose 
from i.e. individual with bald head, wearing 
different wigs/hair styles 
To determine whether a single session of 
HAAIR would help prepare patients in 
advance of hair loss and elicit anticipatory 
coping. Could the program desensitise 
patients to hair loss as well as educate them 
about alopecia. 
       
Willemsen 
et al 
(2011) 
Hypnosis one-to-one 
1 hour session. 1 
introductory session 
followed by 10 
individual sessions. 
Sessions include discussions family or work 
stress, quality of sleep, feeling ashamed, low 
self-esteem. Next is a 40-minute manual based 
hypnosis session; first two sessions focused on 
learning hypnotic relaxation and learning self-
hypnosis; from the third session patients 
received a variety of suggestions during 
hypnosis to improve self-esteem. Patients 
received a self-hypnosis CD and were asked to 
perform exercises on a daily basis. 
To explore whether hypnosis would improve 
psychological outcomes. 
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Taggart et 
al (2009) 
Look Good Feel 
Better Cosmeticians and hair alternative specialists Helping women manage the appearance- 
 
Workshops teach about skin care, make-up techniques related side-effects of treatment to improve 
 
2 hour, free, product  and wig and hair alternatives. a women's self-image and social 
 
neutral workshop,  interactions whilst providing social 
 8 times a month.  support. 
    
    
    
        
Roberts et 
al (1997) 
Group Support  
intervention  
Incorporation of 
psychoeducational 
techniques. 
 
90 minutes sessions 
over the course of 6 
weeks.  
Standard group therapy techniques to provide 
psychological support; establish group 
cohesion and emphasise the universality of 
young adult problems. Psychoeducational 
techniques incorporated information provision, 
problem solving and stress management. Six 
topics of discussion included; health, loss of 
physical well-being, concern about children, 
problems with relationships, financial and 
vocational concerns; feelings of 
unattractiveness. 
Evaluated the effectiveness of intervention in 
reducing psychological distress and enhance 
coping skills and quality of life of 
participants. 
     
       
Salonen et 
al (2011) 
Individual face-to-
face support 
Focus on providing 
support and 
information based on 
individual needs. 
Delivered 6 months 
after breast cancer 
Intervention was provided by physiotherapist. 
Teaching and information given about illness, 
education on general health, support and 
counselling on physical functioning and 
guidance, counselling on stress related 
problems, opportunity for participants to ask 
questions, opportunity for participants to talk 
about their feelings, providing information 
Based on Ferran's conceptual model of 
QOL, comprising of health and 
functioning, socioeconomic, 
psychological and spiritual; and family. 
Based on individualistic ideology. 
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surgery. Duration: 1 
hour. 
about support groups and rehabilitation 
services in the area. 
    
    Zannini et Aesthetic care Study investigated what ways cultural factors Trying on wigs and different hair styles 
 al (2012) program influence a women's choice of camouflaging can help patients develop anticipatory 
 
Qualitative study her chemotherapy- induced alopecia with coping and these programs are 
 
using Interpretative wigs. forms of emotional and psychological 
 
Phenomenological 
 
support. Program provides info 
 
Approach 
 
provision. 
        
Amiel et Beauty Care in Evaluated programs: simple beauty care Cancer patients offered more and more 
 al (2009) Hospitals delivered by a cosmetician in the hospital; access to beauty care in hospital. Evaluated 
 
Qualitative study beauty care provided by a socio-aesthetician beauty care as a supportive care and as 
 
 by a cosmetician who had extra training; a service providing comfort. 
 
 image advice and socio-aesthetics service 
 
 
 Gustave Roussy Cancer Institute (IGR) 
     created the image advice and socio-aesthetics   
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Taggart et al’s (2009) cosmetic/beauty care program (‘Look Good Feel Better’) was 
designed to help individuals manage the appearance related side effects of treatment, 
aiming to improve self-image and social interactions. Amiel et al (2009) evaluated 
four different aesthetic programs, delivered either by a cosmetician, socio-
aesthetician (the authors failed to state exactly what a socio-aesthetician is), image 
advisor or an image advisor combined with a socio-aesthetics service.  
Nolte et al’s (2006) videotape intervention consisted of real patients presenting 
make-up techniques and hair/head piece solutions. The aim of the video was to 
reduce anxiety and promote decision making. In contrast, McGarvey et al’s (2010) 
computer-imaging program enabled individuals to see what they would look like 
with a bald head and wearing different wigs and headwear. 
Zannini et al (2012) aimed to help individuals develop anticipatory coping and also 
offer forms of emotional and psychological support. Roberts et al’s (1997) 
intervention used standard group therapy techniques to provide psychological 
support, plus psycho-educational techniques including information provision to 
reduce distress and enhance coping skills. Salonen et al’s (2011) face-to-face 
intervention, delivered by a physiotherapist, provided support and information based 
on the participants’ individual needs, and an opportunity for participants to talk 
about their feelings. Willemsen et al’s (2011) intervention used hypnotherapy for 
general relaxation and ego strengthening.  
Nolte et al’s (2006) videotape intervention was a single 45 minute session and 
McGarvey et al’s (2010) computer-imaging program was a single 60-90 minute 
session. The hypnosis intervention (Willemsen et al, 2011) consisted of an 
introductory one hour session followed by 10 x 1 hour sessions. Look Good Feel 
Better workshops (Taggart et al, 2009) were provided eight times per week and 
lasted for two hours; participants included in the evaluation had attended at least one 
session. The group support intervention (Roberts et al, 1997) consisted of 6 x 1 hour 
sessions, and the individual face-to-face support intervention (Salonen et al, 2011) 
was for one hour (no details of number of sessions provided). The mode of delivery 
included one-to-one interventions (Nolte et al, 2006; McGarvey et al, 2010; 
Willemsen, 2011, Salonen et al, 2011) and group support (Roberts et al, 1997). 
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2.4.3 Scientific quality 
To assess the scientific quality of the studies, the EPHPP tool was used as a guide to 
assess the quantitative studies and Spencer et al’s (2003) framework was used for 
assessing the qualitative studies. The following sections summarise the scientific 
quality of the papers included in the systematic review.  
All the interventions were described; however some papers provided more details 
and clarity than others. Within psychological research, there have been discussions 
around the importance of replicating research in order to confirm the reliability of 
findings (Francis, 2012; Simons, 2014). To enable the replication of research studies, 
it is important that researchers document the process involved in their research. 
However, the ability to replicate both the interventions and studies within the 
systematic review ranged from poor (Amiel et al, 2009), where the authors had 
provided no information regarding the psychosocial element of the intervention and 
provided no interview schedule, to good, where manuals or materials were referred 
to (Nolte et al, 2006; Roberts et al, 1997; McGarvery et al, 2010; Taggart et al, 2009;  
Zannini et al, 2012; Salonen et al, 2011), interview schedules used in qualitative 
studies or a clear description of the elements of the intervention were provided 
(Roberts et al, 1997; Willemsen et al, 2011). 
It is important that a researcher has a sound theory and an evidence-based 
understanding of their topic of enquiry, in order to identify the outcomes of an 
intervention (Bos, Schaalma & Pryor, 2008). The theoretical basis underpinning the 
choice and design of the intervention within the review were generally weak. Only 
Salonen et al, (2011), Roberts et al (1997) and Nolte et al (2006) described the 
theory or model which guided their interventions and none of the interventions were 
underpinned by a model of body image. 
Positive aspects of the reporting of the studies included providing a detailed 
description of the timing (all included studies did this, except for Amiel et al, 2009 
and Roberts et al, 1997), duration (except for Zannini et al, 2012 and Amiel et al, 
2009), mode of delivery and who delivered the intervention.  Interventions  were 
provided pre and during treatment (McGarvey et al, 2010; Nolte et al, 2006; Taggart 
et al, 2009) and post treatment (Salonen et al, 2011, 6 month after cancer surgery; 
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Willemsen et al, 2011 at 6 months follow-up). In Zannini et al’s (2012) study, half of 
the participants were currently receiving treatment and half had completed it. Details 
of who delivered the interventions were generally provided but details of any 
specific training given to the intervention deliverers were lacking, with the 
exceptions of Zannini et al (2012), Roberts et al (1997) and McGarvey et al (2010) 
who stated that the clinical nurse specialist and research team delivering their 
intervention were trained in delivering it.  With regards to settings, interventions 
were delivered in hospitals (McGarvey et al, 2010; Taggart et al, 2009; Zaninni et al, 
2012; Amiel et al, 2009;  Salonen et al, 2011) or clinics (Willemsen et al, 2011; 
Nolte et al, 2006; Roberts et al, 1997). 
 
2.4.4 Participants 
All of the studies provided details of how participants were selected and recruited. 
Purposive or convenience sampling techniques were utilised (i.e. recruitment from 
hospitals or clinics by nursing or research staff). Amiel et al (2009) and Zaninni et al 
(2012) were the only two studies to specifically acknowledge that their participants 
were not a representative sample of the population of individuals receiving beauty 
care/aesthetic care in their hospitals. 
Half of the studies provided response and attrition rates, the exceptions being Nolte 
et al (2006) (videotape intervention), Taggart et al (2009) (Look Good Feel Better 
workshops), Zaninni et al (2012) (aesthetic care) and Amiel et al (2009) (beauty care 
in hospitals). Salonen et al’s (2010) response rate was 56% (originally 359 gave 
consent and 202 completed the study), there was a 79% response rate for Roberts et 
al (1997) (14 originally and 3 dropped out), 80% for Willemsen et al (2011) (24 
originally and 3 dropped out) and McGarvey et al (2010) reported a 97.5% response 
rate at T1 (baseline) and T2 (following hair loss) and 95% at T3 (3 month follow-
up). Of the studies which provided response rates, only Willemsen et al (2011) 
reported participants’ reasons for dropping out (1 participant for lack of motivation 
and 2 for not concentrating during self-hypnosis). 
All studies provided demographic characteristics of the participants (although 
Taggart et al (2009) provide very limited details), with the most common detail 
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being age (mean age ranged from 29.7 to 57.7 years). Most papers reported ethnicity 
(most participants were Caucasian) and socio-economic status (SES).  
Disease characteristics for the studies including cancer patients were outlined well, 
including degree of hair loss, type and stage of cancer, time since diagnosis and 
treatment received (as appropriate). The studies varied widely with regards to their 
sample of patients; two studies included a mix of cancers (McGarvey et al, 2010; 
Roberts et al, 1997), one study only recruited patients with alopecia areata (with 
more than 30% hair loss), alopecia totalis or alopecia universalis (Willemsen et al, 
2011), one study (Nolte et al, 2006) only included patients with gynaecological 
cancer, Salonen et al (2011) only included breast cancer patients and three studies 
included patients experiencing chemotherapy but did not state the type of cancer that 
participants had (Taggart et al, 2009; Zaninni et al, 2012; Amiel et al, 2009). 
Only four studies reported the treatment which participants were receiving; all those 
in Zaninni et al (2012) and Nolte et al (2006) had only undergone chemotherapy, 
those in Salonen et al (2011) had undergone breast cancer surgery, chemotherapy, 
radiotherapy and/or hormone therapy and those in Roberts et al (1997) were at 
various treatment stages (nine had completed therapy, two were under observation 
(the authors failed to provide specific details of what stage the patients were in their 
treatment journey when being observed), three were receiving chemotherapy).  
 
2.4.5 Design 
Study designs varied from randomised control trials (RCTs) (McGarvey et al, 2010; 
Nolte et al, 2006); pre and post-test cohort studies (Willemsen et al, 2011; Taggart et 
al, 2009; Roberts et al, 1997), quasi-experimental design (Salonen et al, 2010) to 
qualitative studies (Zaninni et al, 2012; Amiel et al, 2009). Of the two studies 
employing an RCT design, both used a usual care group as the control and provided 
details of what constituted ‘usual care’. 
The studies had varying follow-up times. Willemsen et al (2011) measured outcomes 
6 months post intervention, McGarvey et al (2010) had outcomes at 3 months post 
intervention, Taggart et al (2009) measured outcomes 2-4 weeks post intervention 
and Salonen et al (2011) two weeks after intervention. However, it is possible that 2-
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4 weeks post intervention is not long enough to determine whether the intervention 
is effective in the long term.  
 
2.4.6 Outcome measures 
Of the six quantitative studies, a variety of body image, appearance satisfaction and 
quality of life (QOL) measures were used, assessing a variety of components 
including psychological distress, physical appearance satisfaction, self-acceptance, 
avoidance behaviours, appearance-related distress in social situations, feeling 
misjudged due to appearance, and importance of hair. One study reported on 
measures designed specifically for hair loss (McGarvey et al, 2010) and 2 used 
measures designed particularly for cancer patients (Salonen et al, 2010; Roberts et al, 
1997). Nolte et al (2006) designed their own body image measure specifically for 
gynaecological patients. The remaining studies used a variety of widely-used 
measures (for example State-Trait Anxiety Inventory, Profile of Moods Status) to 
assess psychosocial outcomes in addition to body image or QOL. 
The measures were well described in most cases but the detail about their 
psychometric properties was inconsistent and generally weak. Therefore, it is 
difficult to determine whether they actually assess the constructs that the researchers 
were interested in. The majority of studies reported reliability data (except for 
Taggart et al, 2009) but none reported the specific content, face and predictive 
validity of measures and only Roberts et al (1997) commented on validity, 
acknowledging that without a control group there was a possible threat to internal 
validity. 
 
2.4.7 Methods of data collection and analysis 
Data collection and analysis were well reported and appropriate for the design of 
most studies. The majority that used comparison groups (apart from Nolte et al, 
2006) tested for differences in baseline demographics, and Salonen et al (2011) also 
tested for baseline differences in treatment variables between the intervention and 
control group.  When positive effects were found, only McGarvey et al (2010) and 
Willemsen et al (2011) reported effect sizes. Roberts et al acknowledged that not 
having a control group was a limitation of their study.  
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Of the two qualitative studies, Zaninni et al (2012) used Interpretative 
Phenomenological Analysis (IPA) to analyse their interviews and highlighted a 
number of limitations of their study: three different researchers were involved and 
interviews were conducted by the individuals who designed the aesthetic care 
program, which could have led to a reporting bias. Amiel et al (2009) failed to state 
the specific approach they used to analyse their interviews and observations, stating 
that ‘conventional methods’ were used (Amiel et al 2009; p.840).   
 
2.4.8 Conclusions and considerations of adverse effects 
All of the studies provided a clear summary of their findings which were justifiable 
and discussed in relation to past evidence. However, very few had used theory from 
the body image and psychological literature, despite hair loss being highlighted as 
having an impact on self-reported distress and body image. The majority of studies 
highlighted limitations, discussed their implications and suggested how these may be 
rectified in future research. None of the studies reported negative effects from 
participating in the intervention or comparison group. 
 
2.4.9 Generalisability of findings (external validity) 
Most studies addressed external validity but only when discussing the study’s 
limitations. The majority of authors acknowledge that biased, opportunistic 
sampling, lack of a control group and small sample sizes (which resulted in data with 
low statistical power) limited the generalisability of their findings. 
Small sample sizes are typical of research exploring sensitive topics such as hair loss 
and its impact on psychosocial outcomes. However, published studies often fail to 
discuss their recruitment strategies, making it difficult for other researchers to know 
which strategies are effective and which are not (i.e. Jennings et al, 2014). Some of 
the current studies highlighted recruitment as being difficult, with total sample sizes 
as low as 14 (Roberts et al, 1997), and as a result it is difficult to be confident that 
the effectiveness of the intervention has been tested. Exceptions include Nolte et al 
(2006) (68 intervention group, 68 control group) and Salonen et al (2010) (112 
intervention group, 92 control group) which had relatively large sample sizes in their 
intervention and comparison groups, allowing for effectiveness to be evaluated. 
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Moreover, Amiel et al (2009) had a rather large sample size (77) for their qualitative 
study. Within qualitative research, a researcher generally collects data until 
saturation has been reached (O’Reilly & Parker, 2013). It has been argued that the 
more similar (homogeneous) participants are in a sample with regard to their 
experiences, the sooner saturation will be reached (Guest, Bunce & Johnson, 2006). 
Guest et al (2006) postulates that a larger sample size is often required if a sample is 
heterogeneous, the quality of the data is poor and the research questions are vague. 
As the participants in Amiel et al’s (2009) study were a combination of service 
users, service providers and health professionals, a larger sample size would be 
expected due to the heterogeneity of participants. 
Three studies excluded individuals on the basis of issues of mental health or due to 
physical co-morbidities (McGarvey et al, 2010; Nolte et al, 2006; Willemsen et al, 
2011). McGarvey et al (2010) and Nolte et al (2006) excluded those with prior 
experience of cancer or alopecia. Nolte et al (2006) also excluded individuals who 
had a history of disfiguring surgery, drugs, disease or radiotherapy. Willemsen et al 
(2011) excluded those who had received local Alopecia Areata (AA) treatment in the 
preceding four weeks, systematic AA treatment in the preceding six months or 
psychopharmacological treatment or psychological counselling in the previous six 
months. Despite the fact that many authors reported that they refined inclusion 
criteria to reduce confounding factors, they failed to acknowledge the limited 
generalisability of their findings to the many individuals who do not meet the 
inclusion criteria.   
 
2.4.10 Which interventions work, how well, for whom and in what settings? 
The effectiveness of the eight different interventions was mixed. A noteworthy point 
is that given the small sample sizes of some studies, the effectiveness of the 
interventions cannot be accurately tested.  Four showed improvements in either all or 
some of their measures, two studies found only a very small improvement in body 
image (Nolte et al, 2006) or distress over hair loss (Salonen et al, 2011). In the 
qualitative studies, Zaninni et al (2012) and Amiel et al (2010) both reported that the 
majority of participants found the beauty and aesthetic care to be beneficial. 
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Zaninni et al’s (2012) aesthetic care intervention and Amiel et al’s (2009) beauty 
care intervention will be addressed first. Zaninni et al (2012) explored the perceived 
effects of an aesthetic care program for Italian women affected by chemotherapy-
induced alopecia. Using IPA of semi-structured interviews it was found that wigs 
were perceived positively due to their ability to camouflage hair loss and reduce the 
‘sick aspect’ of women affected by chemotherapy-induced alopecia. Amiel et al’s 
(2009) intervention of beauty care in hospitals found that physicians and nurses were 
unable to distinguish between beauty care and socio-aesthetics. The beauty care was 
found to be a ‘morale booster’ and was a good learning experience.  
The quantitative evaluations found small improvements: Nolte et al’s (2006) single 
session videotape intervention targeting patients with gynaecological cancer and 
established hair loss had only a small significant change in body image after the third 
course of chemotherapy, but no interaction effect between intervention and time. In 
Salonen et al’s (2011) individual face-to-face intervention for breast cancer patients, 
a small clinical difference was found between groups in terms of sexual functioning 
and distress associated with hair loss. However, there was no follow-up in these two 
studies, so they were unable to determine their benefits in the longer term. 
McGarvey et al’s (2010) computer-imaging program found a significant decline in 
hair loss-related distress in both groups from baseline, and this distress continued to 
decrease in the intervention group at 3 month follow-up. However, no significant 
interaction was found between intervention and time. In Taggart et al’s (2009) study 
of ‘Look Good Feel Better’ workshops, a significant improvement in self-image was 
found immediately after the workshop but not long-term. A significant improvement 
was also found in self-consciousness, anxiety, fatigue, confusion and total mood in 
Roberts et al’s (1997) group support intervention.  
Willemsen et al’s (2011) ten session hypnosis intervention over a six month period 
found improvements at the end of hypnosis and at follow-up compared to baseline 
on the symptom checklist-90 (SCL-90), with significant decreases on the anxiety, 
depression and sensitivity subscales. Improvement in psychological well-being 
persisted six months after the intervention. Significant improvements were also 
found on the Skindex-17 (a dermatology specific health related quality of life 
measure), particularly on the physical and mental health QOL subscales. 
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Furthermore, participants continued to report better QOL 6 months after the 
intervention.  
To summarise, it remains difficult to establish which elements of the interventions 
were beneficial in terms of psychosocial outcomes to the individuals experiencing 
hair loss. A summary of the key features of these interventions can be found in table 
3. Specifically, they were delivered immediately or soon after hair loss/or cancer 
diagnosis and included hypnosis, promoting and providing information around the 
use of head wear and make up to camouflage hair loss, information provision, a 
trained professional delivering the intervention, individual intervention, and an 
opportunity for individuals to express their concerns.  
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Table 3. Summary of the key features of the interventions included in the Systematic Review  
Citation Timing Sessions Setting Mode of  
Delivered by 
& Content 
Intervention 
components 
        delivery to whom   improvements found 
McGarvey 
et al 
(2010) 
Immediately 
after 
diagnosis 
1 Hospital One-to-
one 
Clinical nurse 
specialist, also 
a cancer 
survivor 
Computer takes 
pts photo, optional 
images are 
available for pts 
to choose i.e. 
bald head, diff 
wigs/hair styles 
Less hair loss distress 
after intervention. 
        
Willemsen 
et al 
(2011) 
Newly 
referred to 
Dermatology 
Clinic 
 
10 Outpatient 
clinic 
One-to-
one 
Research team 
to patients with 
AA 
referred to 
clinic 
1.Discussion on 
family or work 
stress, quality of 
sleep, feeling 
ashamed, low 
self-esteem. 
 
2. Hypnosis 
sessions: 
learning hypnotic  
relaxation, 
learning 
hypnosis sessions. 
 
3. Variety of 
suggestions 
to improve self- 
esteem. 
Significant 
improvements in 
psychological 
well-being. 
 
Better QOL reported 
6 months post hypnosis 
intervention. 
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4. Pts asked to  
perform self- 
hypnosis twice 
a week 
               
Nolte et al 
(2006) 
Immediately 
after hair loss 
has 
been 
established 
 
1 Clinic One-to-
one 
Gynaecological 
oncology 
staff 
 
1.Video 
presenting make-
up techniques 
and suggestions 
for hair and head 
pieces 
 
2. Info provision 
Small but significant 
change in body image 
after the fourth 
course of chemo 
               
Taggart et 
al (2009) 
Median time 
since 
diagnosis 
7.5 months 
  
No 
details 
provided 
Hospital One-to-
one 
Look Good 
Feel Better 
team to 
cancer patients 
Cosmeticians and 
hair specialists 
teach pts 
about skin care, 
make-up 
techniques and 
wig and hair 
alternatives 
Significant 
improvements to self-
image post intervention, 
reduction in 
self-consciousness 
and sig reduction in 
anxiety score. 
  
   
   
 
 
   
   
Roberts et 
al (1997)  
11pts less 
than 2yrs 
since 
diagnosis, 3 
pts 
more than 2 
6 Clinic Group Oncology 
social workers 
to cancer 
patients 
 
1. Psychological 
Support 
 
2. 
Psychoeducational 
techniques 
Overall improvement on 
mood scores. 
 
Overall helpfulness of 
program identified 
for universality of shared  
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yrs 
since 
diagnosis 
including info 
provision, 
problem solving, 
stress 
management 
 
3. Discussion on 
anxiety 
about health, loss 
of  physical 
wellbeing, 
concerns about 
children, 
problems in 
relationships, 
financial and 
vocational 
concerns, feelings 
of 
unattractiveness 
experiences, therapeutic 
group support &  
receiving information. 
               
Salonen et 
al (2011) 
6 months 
after breast 
cancer 
surgery. 
 
1 Clinic One-to-
one 
Trained nurse 
and 
physiotherapist 
to 
patients 
admitted 
to Oncology 
Clinic 
for treatment 
and/ 
1. Teaching and 
providing info 
about illness. 
 
2. Giving 
instructions for 
home exercises. 
 
3. Offering 
concrete support 
87% of women reported 
the intervention to be 
beneficial to them. 
 
83% felt the individual 
support had helped them. 
 
85% felt the opportunity 
to talk had helped them.  
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or follow up 
who  
had breast 
cancer 
surgery 6 
months ago. 
and counselling in 
physical 
functioning and 
providing 
guidance about 
how to 
use upper limbs. 
 
4. Giving general 
health education. 
 
5. Counselling on 
stress related 
problems. 
 
6. Giving women 
a chance to talk 
about their 
feelings and a 
chance to ask  
questions. 
 
7. Providing info 
about 
rehabilitation and 
support 
groups in area. 
 
Women in the 
intervention group were 
more upset by 
hair loss than those in 
the control group- 
however half pts in both 
groups did not 
answer this question. 
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Zannini et 
al (2012) 
Active 
chemotherapy 
& follow-up 
1 Hospital One-to-
one 
Oncologist, 
social workers, 
sociologists, 
hairdressers to 
patients 
suffering 
from 
treatment- 
related hair 
loss 
1. Perceived 
effects of aesthetic 
care program. 
 
2. What cultural 
factors 
influenced 
women's 
choice of 
camouflage. 
Wigs considered best 
way to camouflage 
baldness & make 
women feel stronger.  
 
Wigs worn mainly for  
others or for women 
themselves.  
 
Hair re-growth presents 
visualisation of recovery 
               
Amiel et 
al (2009) 
No details 1 Hospital One-to-
one 
Sociologist & 
clinical 
psychologist to 
professional 
service 
providers, 
health 
professionals 
& patient users 
treated for 
cancer 
 
Evaluated: 1. 
Simple beauty 
care 
delivered by 
cosmetician 
in hospital 
 
2. Beauty care 
provided 
by socio-
aesthetician 
 
3. Image advice 
 
4. Image advice 
and socio-
aesthetics service 
Ability to ask questions 
to socio-aesthetician 
they could not ask  
usual hairdresser. 
 
Beauty sessions as a 
distraction from 
treatment. Helped pts 
accept side effects of 
treatment. 
 
Beauty care as form 
of advice & 
psychological support 
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2.5 Discussion 
2.5.1 Summary of main results  
The overall efficacy of the interventions in this review was poor; if they were 
evaluated in an adequately powered way then the research and conclusions that can 
be drawn from it would be stronger. Most interventions were of short term duration 
and evaluation follow-up, with the longest follow-up being six months. Therefore, 
their effectiveness in the longer term is unknown. One indication of the effectiveness 
of an intervention would be to include long term outcomes. This is particularly 
important, given the duration of hair loss. Despite their limitations, some of the 
positive aspects include the benefits of the interventions being delivered immediately 
or soon after clinical hair loss, providing an opportunity to express emotions, 
delivery by a trained professional and on an individual basis. 
Combinations of the elements of the EPHPP tool and the consort statement provided 
criteria for assessing the quality of the studies. Most followed the guidelines for 
presenting and including criteria to indicate methodological rigour i.e. most reported 
on selection procedures, demographic characteristics, recruitment responses and 
attrition rates. The interventions were generally described in detail, including 
information about who delivered the intervention and where.  
 
2.5.2 Internal validity  
Internal validity refers to how well a study was conducted (i.e. research design, how 
the variables were measured) (Huitt, Hummel & Kaeck, 1999). Studies lacked 
details of the training that individuals delivering the interventions received, but they 
did evaluate their success in doing so according to the research protocol. It is 
important that interventions are manualised, so that interventions delivery can be 
standardised and improved which is particularly important if interventions are to be 
implemented into practice (Orford, 2008).  
Three of the studies (Nolte et al, 2006; McGarvey et al, 2010; Salonen et al, 2011) 
increased internal validity by comparing the intervention with control groups. A 
number of studies incorporated several components within a complex intervention 
and did not include a method for determining which elements were successful and 
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which were not, which is essential if the intervention is to be incorporated into 
routine care for patients. In order to improve the effectiveness of interventions, it is 
important to know ‘what it is that works’, i.e. whether it is specific active ingredients 
or the intervention techniques themselves (Abraham & Michie, 2008). The effect of 
the interventions may have been diluted by the inclusion of participants without 
disturbance in body image or appearance concerns, as evidenced by data from pre-
intervention baseline measures. This is supported in the literature, whereby some 
individuals are proud of their bald heads (Boehmke & Dickerson, 2005) and are 
happy to show them in public by engaging in ‘banalisation’ (Rosman, 2004). 
 
2.5.3 External validity  
External validity refers to the extent to which a study’s findings can be applied to 
other people or settings (Huitt et al., 1999). A number of the studies did not 
adequately consider the influences of selection biases on the generalisability of 
findings, and those that included participants undergoing (or who had completed) a 
variety of treatments did not consider their subsequent cumulative impact on 
appearance as an independent variable. The one study that did consider age as an 
independent variable (i.e. Salonen et al, 2011) found that younger participants were 
more dissatisfied with their body image than older participants, supporting Avis et 
al’s (2004) research that younger women diagnosed with breast cancer have more 
difficulty adjusting than older women. Identification of the characteristics of those 
dropping out of studies would provide important information for researchers and 
health care professionals about the characteristics of those patients who are likely to 
use the intervention and those who are not. A noticeable and unreported selection 
bias across all studies was the predominant recruitment of white/Caucasian 
participants.  
Immediacy of intervention delivery appeared to be a feature of success, which may 
reflect that body image and appearance concerns are a priority for individuals 
experiencing hair loss and therefore need to be addressed during the early stages of 
treatment. However, longitudinal designs are important in order to assess whether 
any benefits of help with negative emotional repercussions of hair loss persist after 
hair has begun to re-grow (Borsellino & Young, 2011; Münstedt et al., 1997). 
Chapter Two: Review 
 
72 
 
2.6 Conclusions 
This review has applied a systematic strategy that identified only a small number of 
evaluated psychosocial interventions for individuals experiencing hair loss. The aim 
of the review was to comment on the current state of the research in this area, its 
scientific quality and areas of success that might inform future intervention design 
and evaluation. While the number of interventions included was small, this does not 
reflect the total number of interventions and sources of support that are available. 
This is demonstrated by the studies which were identified but did not meet the 
systematic review inclusion criteria. The quality of the small amount of research in 
this area is mixed, with some good research of reasonable scientific quality but some 
poor, with significant methodological limitations. Despite promising indications of 
key features that might benefit participants (namely the importance of early 
intervention and opportunities to express feelings and concerns), at present no 
definitive conclusions can be made.  
 
2.7 Implications for future provision of care 
It is essential that as part of routine care, breast cancer patients are aware of and have 
access to support, to help them to manage their treatment-related hair loss. It is 
imperative that health care professionals are aware of interventions which are 
currently available, so they can signpost patients who are affected by treatment-
related hair loss to the relevant services and support organisations. However, before 
promoting services and interventions to breast cancer patients, it is important that 
they are evaluated in order to ascertain whether they offer any benefit to patients. 
 
2.8 Implications for future research 
It is essential that authors are clear about which are the most relevant outcomes in 
this area, as it would help to guide the selection of well-validated measures, 
intervention design and evaluation. Future interventions should recruit participants 
who are clinically homogenous i.e. similar disease severity or duration or both, so 
clinically meaningful outcomes can be used to direct clinical practice. Identifying 
patients in need of psychosocial interventions by screening for appearance and body 
image concerns could increase intervention effect, and large scale longitudinal 
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studies are required that allow for evaluation of small effects and the possibility that 
body image distress fluctuates over time. Furthermore, prospective studies need 
larger sample sizes to be statistically powerful, and should include usual care control 
groups as the efficacy of the current psychosocial interventions for hair loss remains 
uncertain. A noteworthy point is that during the systematic review process a number 
of interventions which focused on camouflage and covering hair loss (i.e. 
behavioural strategies) were identified, however they had not been evaluated and so 
were not eligible for inclusion within this review, demonstrating that a systematic 
review can be limiting. Since a number of interventions currently available for breast 
cancer patients have not yet been evaluated, it is unknown whether they offer any 
benefit to patients or not.  
Whilst the PICO search strategy tool is regarded as a fundamental tool and has been 
widely used in quantitative systematic reviews, even being adopted by the Cochrane 
Collaboration (O’Connor, Green & Higgins, 2008), research has started to question 
its suitability as a strategy for qualitative evidence synthesis (Cooke, Smith & Booth, 
2012). Specifically, ‘Comparison’ is not usually part of a qualitative research 
questions and combining ‘Population’ and ‘Intervention’ as specified by PICO are 
more likely to retrieve quantitative studies. A suggestion for future mixed method 
systematic reviews would be to consider using an additional search strategy tool to 
PICO, such as SPICE (Setting, Perspective, Intervention, Comparison and 
Evaluation) (Booth, 2006) or SPIDER (Sample, Phenomenon of interest, Design, 
Evaluation and Research type) (Cooke et al, 2012) which would increase the chances 
of retrieving qualitative studies. 
The findings of this systematic review were used to inform the further studies within 
this thesis, including an evaluation of Breast Cancer Care’s existing HeadStrong 
service. HeadStrong is currently freely available to breast cancer patients, but has not 
yet been evaluated and so it is not known what benefit the service offers. The next 
stage of this program of research therefore sought to gain an insight into patients’ 
experiences of HeadStrong and to evaluate the service. 
 
 
 
Chapter Two: Review 
 
74 
 
2.9 Summary of the key points in this chapter:  
 This is the first systematic review to examine the evidence of the 
effectiveness of psychosocial interventions to support people affected by hair 
loss.  
 Aspects of the effective interventions in the review included: being delivered 
immediately or soon after hair loss had begun, offering an opportunity to 
express emotions, being delivered on an individual basis and by a trained 
professional. 
 The quality of research in this area is mixed, with some research of 
reasonable scientific quality but some poor, with methodological limitations.  
 Implications of the review include the need for researchers to be clear about 
which outcomes are relevant, in order to help guide the selection of well 
validated measures. Prospective future studies need to include a control 
group and adequate sample sizes to provide statistical power to detect any 
effect of interventions. A number of interventions currently available have 
not been evaluated and as a result were not eligible for inclusion in the 
Systematic Review. 
 
2.10 The next stage of the research 
The next chapter discusses the methodology and methods employed in this program 
of research. A challenge throughout has been around recruitment. The challenges 
faced are discussed in the following chapter, along with the steps taken in attempt to 
overcome them. A key aspect in this research has been patient and public 
involvement (PPI) input. 
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Chapter Three 
Methodology 
3.1 Introduction 
The aims of this thesis were to explore and evaluate current psychosocial 
interventions for breast cancer patients who are experiencing treatment-related hair 
loss and to inform the provision of psychosocial support for this patient group in the 
future. This chapter begins with a discussion of the MRC framework for the 
development and evaluation of complex interventions followed by a justification for 
the selection of methods used, describing the debate surrounding qualitative versus 
quantitative approaches (deemed the ‘paradigm wars’ (Bryman, 2006)), in order to 
appreciate the epistemological and methodological issues involved in designing and 
conducting health psychology research. ‘Paradigm peace’ (Bryman, 2006) and the 
emergence of mixed methods are then discussed. Finally, the chapter discusses the 
importance of service user involvement in research, including how it has been a key 
aspect throughout the thesis. 
 
3.1.1 The use of the MRC framework for complex interventions in this thesis 
Guidelines set out by the Medical Research Council (MRC, 2000; 2008), which 
guide researchers through a process of developing, evaluating and implementing 
complex interventions, was adopted for this research. An advantage of following a 
framework is that it helps with the selection of appropriate research methods to 
develop and evaluate the effectiveness of complex interventions (Evans, Stone, 
Manthorpe & Higginson, 2013). The 2008 MRC framework highlights four phases 
of intervention development: development, feasibility/piloting, evaluation, and 
implementation (De Silva et al, 2014). It acknowledges that the process of moving 
through each of the four stages may not always be linear, and although RCT designs 
are the most robust method to reduce bias, the MRC (2008) guidance argues that it is 
important to use the best and most appropriate methods to fit the particular research 
area under consideration. This may result in an evaluation of an existing service 
being conducted before an RCT (Evans et al, 2013). A pragmatic approach to the 
choice of evaluation methods is encouraged by the framework (Craig & Petticrew, 
2013). To date, the MRC framework has been widely used by researchers to inform 
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study designs evaluating the effectiveness of complex interventions for a variety of 
health conditions (i.e. Barley, Haddad, Simmonds, Fortune, Walters., et al, 2012; 
Dugdale, Elison, Davies, Ward & Dalton, 2016; Eveleigh, Blencowe, Mills & 
Blazeby, 2011; Lakshman, Griffin, Hardeman, Schiff & Ong, 2012; Murchiea, 
Hannaforda, Wykeb, Nicolsonc & Campbell, 2007). 
 
Although the initial 2000 MRC framework has been found to be highly influential, a 
number of limitations have been highlighted, one being that it is based on similar 
phases which are used to evaluate new drugs (MRC, 2008). Also, there is a lack of 
guidance regarding how to evaluate complex interventions, this is a key limitation as 
it is important that researchers understand how and why interventions have a 
particular effect and which part has the greatest impact on outcomes (De Silva et al, 
2014). While the 2000 MRC framework recognises that healthcare evaluations 
consist of a number of complex interacting components, it does not consider the 
context in which the intervention is delivered. For example, it is important to 
consider the social and geographical context in which an intervention is delivered, as 
an intervention may be beneficial in one setting and not in another (Craig et al. 
2008). Acknowledging these limitations, the revised MRC (2008) guidance placed 
more emphasis on the development phase, in order to better understand the research 
area, the context and the components of the intervention, and the link between the 
research areas and outcomes (Evans et al, 2013). In this thesis, and in an attempt to 
minimise any limitations of this research, the revised 2008 MRC framework was 
used in conjunction with the ARC framework which has been discussed in chapter 1.  
 
The first stage (development) of the MRC framework involves reviewing previous 
research to identify whether an intervention may have a desired effect, and providing 
evidence for its possible success (MRC, 2008). The development stage also includes 
identifying the components of the intervention, typically by employing qualitative 
methods such as interviews (Blackwood et al, 2010). During the feasibility/piloting 
stage, the information gathered in the development stage is used to develop the 
intervention and study design, and to explore the feasibility of the intervention and 
its acceptability to participants (MRC, 2008). In the evaluation stage, any possible 
barriers or problems with the randomised controlled trial can be highlighted, before 
the intervention is implemented into practice (Evans et al, 2013). 
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Within this program of research an exploration of psychosocial interventions to 
support patients affected by hair loss was conducted through a systematic review 
(the development stage of the framework; see chapter 2), followed by feedback from 
women who had accessed an existing service (the development stage) (see chapters 4 
and 5). This information helped to design a feasibility study of an RCT 
(feasibility/piloting stage) to explore the feasibility and acceptability of an 
expressive writing intervention that has not previously been used with this patient 
group (see chapter 6). 
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Figure 5. The guiding MRC framework (Craig, Dieppe, Macintyre, Mitchie, Nazareth & Petticrew, 2008). (First produced by the 
British Medical Journal (2008), 25(337): 980. Reproduced with copyright permission from the BMJ Publishing Group). 
Development 
Identifying the evidence base 
Identifying or developing theory 
Modelling process and outcomes 
 
(Systematic Review & HeadStrong studies) 
Feasibility and piloting 
Testing procedures 
Estimating recruitment and retention 
Determining sample size 
 
(Expressive Writing study) 
Evaluation 
Assessing effectiveness 
Understanding change process 
Assessing cost effectiveness 
Implementation 
Dissemination 
Surveillance and monitoring 
Long term follow-up 
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3.2 Epistemology and choice of methods in this thesis 
It has been argued that the choice of methods used should predominantly be 
influenced by each study’s research questions and not by methodological and 
epistemological considerations alone (Kelle, 2006). The research questions 
highlighted in chapter one are best answered by both quantitative and qualitative 
methods. The paradigms and world views that underlie both approaches to research 
are reflected in different origins about the nature of reality (ontology) and knowledge 
(epistemology) (Gelo, Braakmann & Benetka, 2008), as well as in terms of the 
methods used to collect and analyse the data (Chamberlain, 2000). Quantitative data 
analysis requires the transformation of data into a numerical form, while qualitative 
data involves interpretation of the meaning of data collected (Hayes, 2000; Smith, 
2003). Also, qualitative approaches tend to be more inductive than quantitative 
(Hayes, 2000; Pope & Mays, 1995).  
 
3.3 ‘Paradigm war’ 
The term ‘paradigm war’ has been coined in the literature to refer to the debate about 
quantitative and qualitative research at the epistemological level, specifically from a 
perception of these being distinct and competing paradigms (Bryman, 2006). Both 
approaches have a number of weaknesses; qualitative methods’ weaknesses include 
the findings not being generalisable as they are unique to the participant group being 
studied, and since the research is subjective in nature the findings can be influenced 
by the researcher’s personal biases (Johnson & Onwuegbuzie, 2004). The 
weaknesses of quantitative methods include its rigidity of focusing on hypothesis or 
theory testing as opposed to generation, which can result in the researcher missing 
out on important aspects of the phenomenon being studied (Johnson & 
Onwuegbuzie, 2004).  
 
Psychology has traditionally been led by a positivist paradigm believing in a single 
reality and objective research (Stevenson and Cooper, 1997). This ‘scientific’ 
approach is underpinned by experimentation with a reliance on quantitative research 
methods seeking to prove or disprove hypotheses. According to quantitative 
approaches, social and psychological phenomena have an objective reality, whereas 
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qualitative methods consider reality as socially and psychologically constructed 
(Gelo et al, 2008). Whilst the scientific principles such as measurement and 
hypothesis testing are suitable in many instances, they fail to consider social 
processes and the influence of the researcher on the research process (Murray & 
Chamberlain, 1998). These limitations have led to the acceptance of qualitative 
research methods, which recognise that knowledge is a result of an interaction 
between the data being generated and the researcher (Pidgeon, 1996). In recent 
years, the National Health Service (NHS) in the UK has placed increasing emphasis 
on the provision of care that considers and is informed by the needs and experiences 
of patients (Department of Health, 2006a).  This requires different research questions 
being asked and, as a result, the value of qualitative methods has been increasingly 
recognised within health research. 
When deciding which methods to employ, an important consideration is who the 
stakeholders are and the types of data they would value. In this case the key 
stakeholders are breast cancer patients affected by treatment-related hair loss 
(service users), who have taken part in the research with an understanding that the 
findings could potentially inform service provision; research funders (e.g. Breast 
Cancer Campaign); and the range of health professionals involved in service 
delivery. Healthcare organisations operate with limited resources and as a 
consequence the focus is often on addressing the needs of the majority of a given 
population, rather than concentrating resources on an individual level, therefore 
quantitative research is favoured over qualitative research as it allows the researcher 
to generalise the findings to a specific population.  
Despite qualitative research helping to provide detailed understandings of a topic 
that has previously not been researched, it does not set out to be generalisable. In 
contrast, quantitative research uses large samples to enable generalisation of research 
findings. Within mainstream psychology, quantitative methods are the dominant 
method (Alise & Teddlie, 2010); however, over the years there has been increased 
recognition of the limitations of the positivist paradigm (Murray & Chamberlain, 
1998; Silverman, 2000). The phrase ‘paradigm peace’ has been coined in the 
literature to refer to quantitative and qualitative research no longer being regarded as 
incompatible and to promote the use of mixed-methods research (Bryman, 2006). 
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Johnson and Onwuebbuzie (2004) have argued that “mixing methods frequently 
results in superior research” (p.14) as it incorporates both the strengths of qualitative 
and quantitative research methods. 
 
3.4 Mixed methods 
Mixed methods research has been defined as “the type of research in which a 
researcher or team of researchers combines elements of qualitative and quantitative 
research approaches for the broad purposes of breadth and depth of understanding 
and corroboration” (Johnson, Onwuegbuzie & Turner, 2007, p. 123). The past 
decade has seen a rapid increase in health research using mixed methods (Tariq & 
Woodman, 2010; Yardley & Bishop, 2015; O’Cathain, Murphy & Nicholl, 2007), 
identified as the employment of both qualitative and quantitative methods (Brannen, 
2005).  
The current research was primarily ‘bottom up’ as it began with the questions that 
needed investigating. Given the applied nature of those questions, the mixed 
methods literature with its emphasis on real world enquiry was appealing and 
considered in detail before deciding to use this approach throughout the thesis. The 
value of mixed methods or the ‘third paradigm’, as it has been coined, has received 
increasing attention and is now viewed by some to be on an equal level with 
quantitative and qualitative research (Daigneault & Jacob, 20014; Small, 2011). A 
common rationale for conducting mixed methods research is the idea of generating 
complementarity data in order to reveal different dimensions of a phenomenon and 
to enrich understandings of the multi-faceted, complex nature of the social world 
(Moran-Ellis et al., 2006). The term ‘complementarity’ is used to describe the 
process and outcome when different data sets are used to address different but 
complementary aspects of a research project (Brannen, 2004). An important aspect 
of mixed methods research is the integration of the two methods during analysis and 
interpretation (Tariq & Woodman, 2010). 
Denscombe (2008) has outlined four key characteristics of mixed methods; 
qualitative and quantitative methods are used within the same research, the research 
design outlines the sequencing and priority given to the qualitative and quantitative 
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aspects of data collection and analysis, an account is given of the way in which 
qualitative and quantitative aspects of the research relate, with an emphasis on the 
way in which triangulation is used, and finally, pragmatism is the philosophical 
underpinning for the research.  
This thesis takes the view that quantitative and qualitative approaches provide 
complementary information in order to offer a more comprehensive understanding of 
breast cancer patients’ experiences of treatment-related hair loss and their 
psychosocial support needs. Qualitative and quantitative methods address 
fundamentally different research questions, however, mixed methods research can 
overcome the weaknesses of qualitative and quantitative methods by complementing 
the strengths of each other and provide a synthesis, whereby the outcomes of 
different studies lead to an integrated understanding of the phenomenon being 
explored (Fetters, Curry & Creswell, 2013; Lee & Rowlands, 2015).  
 
It is important to highlight the philosophical challenges around mixed methods 
research; given the epistemological differences between quantitative and qualitative 
approaches, an essential element of mixed methods research is that the integrity of 
each component is maintained (Bishop, 2015; Morse, 2003). Pragmatism is viewed 
as “the philosophical partner to mixed methods research” (Denscombe, 2008, p.273) 
which offers a way of approaching the challenges associated with mixed methods 
(Bishop, 2015; Bryman, 2006; Dures, Rumsey, Morris & Gleeson, 2011; Morgan, 
2014). Pragmatic approaches acknowledge that there are fundamental 
epistemological differences between quantitative and qualitative approaches; 
however, these methods are seen as complimentary (Bishop, 2015). Working with a 
pragmatic approach “does not ignore the relevance of epistemology but it does reject 
the ‘top down’ favouring of ontological assumptions at the expense of conducting 
practical and useful research” (Morgan, 2007, p.68). Maxcy (2003) argued that 
pragmatists focus on achieving richer experience, gaining functional knowledge and 
considering the impact of research on practise.  
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3.5 Designs for mixed methods research 
It is important that the design for mixed methods research is driven by the research 
questions (Tashakkori & Teddlie, 2010). When trying to answer the question 
regarding how and when to combine quantitative and qualitative methods, a popular 
approach is develop typologies of mixed methods designs (Bishop, 2015); to date, 
more than 15 designs have been published (Creswell & Plano Clark, 2011). 
Although the names of these designs differ, they can be characterised according to 
whether they merge the qualitative and quantitative data in a concurrent way, or have 
the qualitative or quantitative data build on or extend the other type of data in a 
sequential way (Creswell, Plano Clark & Garrett, 2008).  
Creswell and Plano Clark (2011) propose six designs for mixed methods research: 
explanatory, exploratory sequential, convergent parallel, transformative, multiphase 
and embedded designs. Both explanatory and exploratory designs are sequential, 
with the first component being completed before the second is started; within 
exploratory designs, the qualitative component is usually completed first, whereas 
the quantitative component is completed first in explanatory designs. Embedded 
designs are concurrent, as the quantitative and qualitative components are carried out 
at the same time (Creswell & Plano Clark, 2011). According to Bishop (2015) the 
transformative design is where one of the designs discussed above are selected and 
are enclosed within a transformative framework. For example, quantitative data is 
collected and analysed, followed up with quantitative data collection and analysis, 
whereas an example of a multiphase design is where a qualitative study informs a 
quantitative study which then informs a mixed methods study. The convergent 
parallel design (also known as the triangulation design) is well used within mixed 
methods research (Kettles, Creswell & Zhang, 2011), whereby different but 
complimentary data is obtained on the same topic (Morse, 1991). A concurrent 
triangulation design was adopted for the research as it was the most appropriate in 
answering the research questions. For example, for the HeadStrong studies (study 2 
and 3), in order to answer two overarching research questions, it was deemed 
necessary to conduct two simultaneous but independent studies with different 
samples, the data was then triangulated. Additionally, to explore the feasibility and 
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acceptability of an expressive writing intervention (study 4), quantitative and 
qualitative data was obtained. 
Morse (1991) highlighted the relationship between the various components in a 
mixed methods study by using capital letters for the principal method and lowercase 
for the complementary method. The sequence of the methods is depicted by an arrow 
(e.g. qual      QUANT represents an initial qualitative study guiding a primarily 
quantitative study). A criticism of the priority-sequence model is that it neglects the 
option of attributing equal priority to both methods and using them simultaneously 
rather than sequentially. Morse (1991) highlighted the concurrent use of both 
methods by using a plus sign (e.g. QUAL+quant depicts a quantitative study 
conducted alongside the priority qualitative study). This is an evolving field and 
Johnson and Onwucgbuzie (2004) recognised the possibility of new and alternative 
combinations emerging in the future.  
There are strengths and limitations of sequential and concurrent designs. 
Specifically, with sequential designs it is easier to maintain the integrity of each 
method and to evaluate each method as one study is completed before the next 
begins, whereas concurrent designs encourage the researcher to mix qualitative and 
quantitative more closely, making it difficult to bear in mind the fundamental 
assumptions, strengths and limitations of each approach (Bishop, 2015). However, 
concurrent designs may be more appealing to researchers as they may find it easier 
to make strong links between qualitative and quantitative components than in 
sequential designs (Bishop, 2015). Study 2 and 3 are two independent studies which 
both explore the HeadStrong study at the same time but with two different samples. 
Figure 6 demonstrates the concurrent triangulation design for the HeadStrong 
evaluation (studies 2 and 3), demonstrating that equal priority was applied to both 
qualitative and quantitative data, study 2 used qualitative data collection and 
analysis, whereas study 3 used both quantitative and qualitative data collection and 
analysis. The findings for both studies, were collected and analysed simultaneously 
(see chapters 4 and 5) before the results were combined for interpretation. 
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Figure 6. Visualisation of the concurrent triangulation design for the HeadStrong 
study 
 
There are at least 4 phases in the research process in which quantitative and 
qualitative components of mixed methods research might be integrated; sampling, 
data collection, data analysis, and interpretation (Yardley & Bishop, 2015). 
Creswell, Plano Clark, Gutmann and Hanson (2003) postulate that, when conducting 
mixed methods research, it is important that researchers consider 4 particular 
aspects; the sequence of methods, priority given to the methods, integration and 
theoretical perspective. 
The following section discusses how these four points were addressed in relation to 
this thesis:  
1) The sequence of methods 
The first stage of the research in this thesis involved conducting a systematic review, 
the second stage included studies using qualitative (semi-structured interviews) and 
quantitative (questionnaires) methods, while the third stage utilised quantitative and 
qualitative data (a QUANT + qual study). In stage 2, inductive qualitative and 
deductive quantitative methods were used in the evaluation of HeadStrong (a service 
QUAL QUAN 
           
                                   Study 2 
           QUAL                                      QUAL 
     Data Collection                         Data Analysis          
                          
                                   Study 3                                   Combined data interpretation 
     QUANT + qual                       QUANT + qual 
     Data Collection                      Data Analysis 
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for cancer patients affected by hair loss). Individuals’ qualitative accounts of their 
experiences of chemotherapy-induced hair loss and of the HeadStrong service were 
analysed alongside quantitative data from questionnaires that were developed to 
explore how common these experiences were amongst a larger sample. The main 
research question at this stage was ‘What are individuals’ experiences of the 
HeadStrong service which aim to support them with their hair loss? And are any 
further interventions needed?’ Quantitative measures were best suited for this as it 
maximised the study’s internal validity. Since the findings of these studies indicated 
a need for additional, alternative interventions in this area, a feasibility study of an 
expressive writing study was carried out. This was primarily quantitative, but with a 
qualitative aspect via open ended questions, which were included to obtain 
acceptability data alongside feasibility data, that would inform future decisions about 
any further development and evaluation of an expressive writing intervention with 
this patient group.  
A particular consideration when designing this research was that some participants in 
the quantitative HeadStrong study and expressive writing study may want to reflect 
on their personal experiences and may feel that ticking boxes on a questionnaire does 
not fully represent their unique experience. To address this, the questionnaires 
included open questions so that participants could expand on issues raised and 
provide any further information, if they wished. 
Full details of recruitment for each study can be found in the relevant chapters later 
in this thesis.  
 2) Priority given to each method 
While some researchers have argued that a mixed methods approach can mean that 
qualitative research becomes secondary to quantitative (Denzin & Lincoln, 2005), 
others highlight that qualitative research can be highly prominent within a mixed 
methods research project, to the extent that a project can be qualitatively driven 
(Creswell et al., 2003). Therefore, in order to ensure this thesis was grounded in 
breast cancer patients’ actual experience, semi-structured interviews were chosen as 
this qualitative method is particularly well equipped to gain rich accounts of people’s 
individual experiences.   
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Questionnaires were used during the HeadStrong service evaluation and for the 
expressive writing study, to allow for a focused examination of specific variables 
enabling comparisons within and across data sets (specific details of the methods 
used are included in the individual study chapters). 
 3) Integration 
A main concern with mixed methods is that there is often insufficient detail 
regarding how methods are mixed (Bryman, 2006). One way to integrate the 
quantitative and qualitative findings in any mixed methods study is to analyse the 
two data sets separately and to then compare, contrast and combine the data and 
findings during a second stage of analysis (O’Cathain et al, 2007). There are two 
points at which qualitative and quantitative data are integrated in this thesis. First, 
the qualitative and quantitative findings from the HeadStrong service evaluation 
through semi-structured interviews and questionnaires were analysed in parallel, 
which is common in health research (Őstlund, Kidd, Wengström, & Rowa-Dewar, 
2011). The results were then reported simultaneously. Second, findings from across 
the thesis are synthesised in the final chapter of this thesis.   
 
The findings were triangulated using a composite analysis technique (Yardley & 
Bishop, 2007), the data was collected and analysed using either qualitative or 
quantitative methods, to preserve the integrity and unique contribution of each 
methodological approach. Wagner et al. (2012) argue that the aim of triangulation in 
mixed methods is to seek agreement across quantitative and qualitative methods, so 
that the conclusions can verify each other. A challenge is that the findings from 
different methods can sometimes appear to contradict each other. However, Creswell 
et al (2008) suggest this can actually result in a deeper understanding of a complex 
phenomenon, and contradictory findings using a concurrent design may even be 
viewed as uncovering new theories.   
The first point of integration was the analysis of interviews of women’s experiences 
of hair loss and the HeadStrong service and the identification of areas to take 
forward in the expressive writing study. Analysis needed to be flexible to be able to 
capture the detail of participants’ experiences which could be expected to be highly 
variable, reflecting the variability of the impact of treatment-related hair loss. A 
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number of methods of analyses were considered for the qualitative aspect of study 2; 
thematic analysis was selected as the most appropriate method as it can provide a 
rich and detailed description of the data (Braun & Clarke, 2006). Themes can be 
generated either inductively (i.e. are data driven) or deductively (i.e. are driven by 
theory) (Braun & Clarke, 2006). The thematic analysis employed in this research 
was primarily inductive. Thematic analysis aims to remain close to the data and is 
therefore grounded in the experience and words of those who participate in the 
research. Also, it can summarise key features, including similarities and differences 
of a large data set (Hayes, 2000), which is useful in this case when a main aim of the 
research was to gain an insight into participants’ experiences of the HeadStrong 
service and their support needs (further details can be found in the following 
qualitative HeadStrong chapter). Thematic analysis uses constant comparative 
analysis processes and each interview was analysed using the six stages of thematic 
analysis as outlined by Braun and Clarke (2006) (see chapter 4 for details).  
The analytic process generated a detailed and rich description of each interview 
transcript which led to the identification of the key aspects of individuals’ 
experiences of treatment-related hair loss and their psychosocial support needs. 
These key aspects informed the decision to explore the feasibility of an expressive 
writing intervention. The ARC framework, along with the findings from the 
systematic review, the qualitative and quantitative HeadStrong evaluation, and the 
existing hair loss and expressive writing literatures informed the choice of 
standardised psychological measures and open ended questions that were used in the 
expressive writing intervention feasibility study.  
4) Theoretical perspective 
Only recently has theoretical perspective been discussed in the mixed methods 
research design literature (Creswell et al., 2003; Greene, 2008). The theoretical 
perspective reflects the researcher’s belief that knowledge is both constructed and 
based on the reality of the world we experience and live in (Morgan, 2007). It also 
reflects the researcher’s personal stance towards the topic they are studying 
(Creswell et al., 2003), which for the purposes of this thesis is breast cancer patients’ 
experiences of treatment-related hair loss and their psychosocial support needs. A 
pragmatic approach was taken as the researcher believed that despite there being 
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fundamental epistemological differences between quantitative and qualitative 
approaches, these methods can be complementary when used together to gain an 
insight into a particular phenomenon (Bishop, 2015). In line with Creswell and 
Plano-Clarke, a pragmatic approach was deemed to be appropriate when solving 
practical problems in the ‘real world’ (Creswell & Plano Clark, 2007, p. 20-28). A 
critique of mixed methods research can be found in section 7.6.1. 
 
3.6 Recruitment challenges in psycho-oncology research 
This section discusses recruitment challenges often faced by researchers working in 
psycho-oncology and psychosocial interventions, including the challenges of 
Randomised Controlled Trials (RCTs), the role of healthcare professionals and 
possible ways of overcoming barriers to recruitment. These were considered, at 
length, in the planning of each study.  The specific recruitment challenges for each 
individual study, and the steps taken in an attempt to overcome them, are discussed 
in the subsequent chapters. 
 
3.6.1 Barriers to recruitment  
There are numerous barriers to recruitment, some of which include fear of the 
unknown regarding taking part in research and concerns around the potential costs 
including those associated with travel (Redmond, 2014). Age has been highlighted 
as a consistent barrier to recruitment, with older patients frequently being 
underreported in psycho-oncology studies (Jennings et al., 2014). A common barrier 
to recruitment of RCTs is patient preferences for a specific condition and not 
wanting to be randomised with the chance of receiving the alternative condition 
(Kaur et al., 2013). Recruitment to psycho-oncology research may be hindered by 
the prospect of discussion of a sensitive topic (Jennings et al, 2014) or by stigma 
surrounding mental health (Schain, 1994). However, there is limited research 
regarding barriers to recruitment and alternative strategies specifically in psycho-
oncology (Jennings et al, 2014; Northouse et al., 2006). Jennings et al (2014) 
conducted a clinical trial of a sexual health intervention for female anal and rectal 
cancer survivors. Despite targeted recruitment, 53% of the eligible individuals 
approached declined to participate. Under-recruiting can question the study’s 
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feasibility, which can hinder advancing knowledge and improving care (Jennings et 
al, 2014). It can also limit the statistical power of the study to detect an effect (Baum, 
2002), which may result in clinically relevant differences being reported as 
statistically non-significant, possibly resulting in an intervention being abandoned 
before its true value has been established (Treweek et al, 2013). Also, the external 
validity may be threatened as the sample may be less representative of the population 
(Brown, Fouad, Basen-Engquist & Tortolero-Luna, 2000).  
 
3.6.2 Specific challenges in Randomised Controlled Trials (RCTs)  
Recruitment to trials within cancer research continues to be a particular challenge. 
The annual recruitment of cancer patients to the NIHR Clinical Research Network 
portfolio of cancer studies highlights that adult participation is around 18.3% of 
cancer cases in the UK (NIHR Cancer Research Network, 2013). A study of 114 
multicentre trials found that less than a third achieved their original target (n=38; 
31%), and more than half had to be extended (n=65; 53%) (McDonald et al., 2006). 
Randomised controlled trials (RCTs) are highly regarded as the most powerful 
research method when evaluating health interventions (Feneck, 2009; Ross et al., 
1999; Rothwell, 2005). Random allocation aims to ensure that participants have 
similar baseline characteristics, demonstrating that differences following an 
intervention can be attributed to the intervention and not to an unknown factor 
(Blackwood et al, 2010). Therefore, a RCT design was deemed appropriate to test 
the effectiveness of an expressive writing intervention, however, it was important to 
test the feasibility and acceptability of the design and intervention before any attempt 
was made to conduct a large RCT (see chapter 6).  
RCTs are not an appropriate method for use in all research situations, especially 
those investigating psychosocial aspects of health, as they may create a self-selecting 
sample bias. Individuals may be motivated toward one particular treatment 
condition, and therefore, not want to take part in research which could potentially 
result in them being randomised to receive an alternative treatment and opposing 
condition (Kienle, Glockmann, Schink, & Kiene, 2009; Town, Abbass, & Hardy, 
2011).  
Chapter Three: Methodology  
 
 
91 
 
Several systematic reviews have highlighted a number of issues which RCTs need to 
address in order to successfully recruit a sufficient number of participants; they must 
aim to answer a research question with a clear protocol and low impact data 
collection (Campbell et al., 2007; Ross et al., 1999), employ dedicated research staff 
(Campbell et al., 2007; Ross et al., 1999) and use proven effective recruitment 
strategies (Treweek et al., 2010). Many difficulties with recruitment have been 
reported, including a lack of interest in the study purpose, the patient’s degree of 
illness or fatigue, lack of patient’s perceived benefit from the study, insufficient 
time, the complexity of the study, unwillingness to be randomised into the 
experimental versus control group, demographic and socio-demographic factors, or 
competing trials (Northouse et al., 2006). Yet, these issues are not unique to cancer 
studies. There are also organisational challenges within hospital settings including 
the need to allocate health professionals to help with recruitment and there being 
fewer eligible patients than expected (Donovan et al., 2014). 
 
3.6.3 Influence of healthcare professionals on recruitment 
Very few studies have considered how the process of recruitment occurs, or the 
potential influence that recruiters can have on recruitment (Donovan et al., 2014). 
For example, how patients are informed about a RCT and how health professionals 
present study information to them is pivotal. Donovan et al (2014) highlighted that 
doctors reported difficulty in relation to their joint role as clinician and recruiter; 
some felt that patients may not really be suitable for participation despite meeting 
eligibility criteria and, as a result, were uncomfortable recruiting them. Nurses felt 
conflicted between their roles as carers, patient advocates and recruiters/researchers, 
expressing discomfort about bothering patients with information about RCTs or 
making their own clinical judgements about a patient’s suitability for research. This 
meant that many patients were not told about the study or given the opportunity to 
participate (Donovan et al., 2014). Lemieux et al. (2014) reviewed 985 cancer trials 
from a single breast cancer-specialised institution and found that at least one cancer 
trial was only proposed to 33.1% of all eligible patients. One of the suggested 
reasons for this is that health professionals may believe participation in a clinical 
trial or therapy may be too risky based on a patient’s age, especially if they are an 
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older adult (Daugherty, Ratain, Grochowski et al., 1995). Training health 
professionals and researchers to ensure they have a thorough understanding of the 
RCT design and how to randomise patients fairly could help recruitment (Donovan 
et al., 2014).  
 
3.6.4 Challenges of recruitment into psychosocial intervention studies 
It is not always possible to find out why patients do not take part in studies for which 
they are eligible. Sears et al (2003) found that the majority of individuals who chose 
not to take part in their study did so through passive refusal; individuals were either 
unreachable after multiple call attempts or did not return baseline questionnaires 
after multiple reminders. Boonzaier et al., (2010) explored recruitment issues 
specific to psychotherapy and advanced cancer when evaluating a couples’ 
intervention for women with metastatic breast cancer and their partners. The 
majority of women were contacted by letter because of the significant time gaps 
between appointments but only 9 out of the 88 couples who were sent letters 
expressed an interest in taking part. Recruitment also took place through the 
treatment team and community support agencies, which led to four women 
registering interest in the study, two couples consenting and taking part in the initial 
interview and one couple completing the whole study. Reasons for declining 
included not needing the study; being unwell; too busy and unable to travel to take 
part.  
Psychotherapy studies with higher consent rates have recruited from multiple 
hospital sites, over a number of years, using multiple recruitment methods. For 
example Kissane et al (2006) recruited from seven hospital sites over a 6 year period, 
for their family focused grief intervention, suggesting that resource-intensive 
processes and a potentially long period of time is required to recruit sufficient 
sample sizes.  However, clinical services often do not have sufficient research 
resources available to enable them to recruit participants this way without significant 
research funding. Also, many people diagnosed with cancer adjust to their diagnosis 
over time without an intervention (Stommel, Kurtz, Kurtz, Given & Given, 2006), so 
patients invited to participate in psychosocial intervention studies may not feel it is 
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enough of a priority for them to spend time and energy taking part (Schofield et al., 
2008).  
Boonzaier et al (2010) suggest that patients with cancer might not take part in 
research because the intervention offered may not be what they want. Sherman et al 
(2007) found that cancer patients cited medical information and health promotion as 
their most prominent motivations for attending an intervention, whereas only a small 
percentage identified emotional support as a motivator. It can be difficult to 
encourage people diagnosed with cancer to access psychological support services if 
they have not had previous exposure and understanding of such services (Redman, 
Turner & Davis, 2003). An additional factor to consider is that individuals who have 
received a cancer diagnosis and cancer treatment may experience a lack of 
confidence in seeking support (Foster et al., 2015), this may be due to the side 
effects of cancer treatment and the impact which it has on an individual’s 
appearance, which may lead to a negative influence on their confidence and self-
esteem (Helms et al, 2008). Boonzaier et al (2010) suggest that future studies need to 
consider how to approach patients about the value of psychological services, prior to 
attempting recruitment to a specific intervention. This highlights the importance of 
involving patients through PPI in setting agendas for what research is actually 
conducted (considered in more detail later in this chapter). 
Gatekeeping by health professionals has previously been identified as a recurring 
issue amongst psychosocial studies (Duncan & Cumbia, 1987; Schofield et al, 2008). 
Educating health professionals regarding the value of the intervention and ensuring 
recruitment is broader than just clinical referrals appear to be the main strategies for 
overcoming this difficulty (Boonzaier et al, 2010). Also, patients may attend a large 
number of medical appointments and treatment can be burdensome, and they may 
therefore consider the additional commitment of taking part in research to be too 
much (Boonzaier et al, 2010). However, taking part in intervention-based research 
does not necessarily involve additional appointments.  
It has been proposed that future research may benefit from collecting information 
about why women do or do not participate and what types of support they would 
like, for example through qualitative research using focus groups or screening 
patients using questionnaires to identify specific unmet needs (Boonzaier et al, 
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2010). One of the aims of this research program was to highlight any unmet needs 
that women with breast cancer may be experiencing in relation to their treatment-
related hair loss. For example, the interview schedule for the HeadStrong study 
asked participants about any unmet needs and recommendations for how the 
HeadStrong service could be improved. A discussion around identifying unmet 
needs can be found in chapter 7. 
 
3.6.4.1 Attrition 
It is also important to consider the issues around keeping participants engaged in 
studies once they have consented. Attrition due to illness is an important factor 
(Northouse et al., 2006). All longitudinal studies experience attrition, however, 
significant attrition over the course of a study may result in biased findings and can 
increase study costs (Neumark, Stommel, Given & Given, 2001). Previous research 
has highlighted that attrition in longitudinal studies can vary from 16% to 50%, 
depending on the population studied (McMillan & Weitzner, 2003). Reasons for 
attrition may include death of the participant, the demands of the illness and 
treatments, the requirements or duration of the study, lack of time, loss of interest, 
participant frustration at not being randomised into the desired group and lack of 
contact with the research team (Cooley et al., 2003; Pruitt & Privette, 2001).  
 
3.7 Methods to enhance recruitment and reduce attrition 
It remains relatively unclear why some studies recruit better than others, however, 
ways to enhance recruitment and reduce attrition have been suggested including 
prior consideration of enrolment strategies and reasons for potential decline, the way 
in which sensitive topics are presented by the research staff and including health 
professionals in recruitment (Jennings et al, 2014). Also, conducting pilot and 
feasibility studies is useful in confirming the effectiveness of one’s recruitment 
strategy (Cope, 2015; Loscalzo, 2009). Jennings et al (2014) propose two strategies 
that could help to improve the feasibility of psycho-oncology clinical trials: the 
researcher having greater knowledge of participant interest and consistent reporting 
of recruitment strategies and barriers encountered. These strategies were adopted for 
the expressive writing study in this thesis, where the recruitment strategy involved 
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the researcher attending the breast clinics in order to speak to eligible patients 
directly about the research. Also, the health professionals and charities who helped 
with recruitment fed back information from patients regarding their reasons for not 
wanting to participate in the study. These strategies were advantageous and they 
enabled the researcher to identify barriers to recruitment, make changes as 
appropriate and comment on the suitability of recruitment strategies employed. 
Additional methods to improve recruitment and reduce attrition include telephone 
reminders (McDaid, Hodges, Fayter, Stirk & Eastwood, 2006; Nystuen & Hagen, 
2004), incentives including financial ones (Free, Hoile, Robertson & Knight, 2010; 
McDaid et al., 2006), newsletters and mail-shots to encourage non-respondents 
(Campbell et al, 2007). Yet, despite telephone reminders and financial incentives 
both being used and accepted by many researchers as a legitimate recruitment tool, 
some may consider them a form of coercion (Treweek et al, 2013). Jennings et al 
(2014) suggest that allowing extra time to provide information and build rapport 
with patients could potentially increase willingness to participate. They found that 
individuals were more willing to consider participation when health professionals 
broached the study with them prior to being approached by the researcher, or were 
approached in the privacy of a clinic room. Considerably more women consented 
when approached in clinic, as opposed to by letter, since approaching patients in a 
clinical setting provides the opportunity to build rapport and address directly any 
concerns they may have (Jennings et al., 2014). Sending participants an introductory 
letter under the letterhead of the physician showing their support of the research has 
also been found to promote recruitment (Sears et al., 2003). Additionally, an 
important factor is maintaining healthcare professionals’ engagement with the 
recruitment process. Enrolment can increase rapidly when the researchers contact 
referring physicians to get renewed commitment to the study (McNees, Dow & 
Loerzel, 2005), send monthly enrolment reports to referring physicians and research 
staff and make weekly visits to the site where recruitment is taking place (Sears et 
al., 2003).  
Initiatives such as ‘It’s Ok to Ask’ (National Cancer Research Network, 2015) 
encourage patients to request research participation since evidence suggests 
involvement can improve health outcomes, which may influence recruitment. 
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However, this puts the onus on the patient to contact the researcher during a time 
which can be extremely distressing for the patient, for example close to diagnosis 
and/or treatment decision making and treatment, and when they may already feel 
overloaded, such that the thought of taking part in research could be too much. 
Additionally, if patients have little experience or understanding of research or 
psychology then they may fear the unknown, demonstrating the importance of 
researchers taking the time to explain what would be involved in participating in the 
research and directing them to further information (e.g. including the following link 
in participant information sheets: http://www.nbt.nhs.uk/research-and-
innovation/our-research/take-part-research). Moreover, it is important to actively 
recruit patients after they have agreed to be contacted or expressed a willingness to 
consider participating, since patients do not actively seek information about research 
(Puts et al. 2009; Townsley et al, 2006). This further demonstrates that researchers 
need to be active rather than relying on patients taking the lead in making contact 
with them. 
 
3.7.1 Patient and public involvement (PPI)  
In the UK, researchers (particularly those conducting NHS research) are increasingly 
being encouraged to involve service-users and patients in their research (Cotterell et 
al, 2010; Department of Health, 2006a). PPI refers to those who use, have used, or 
are eligible to use health and social care services (Beresford, 2005). Service users 
can offer a unique perspective based on their own experiences of living with illness 
which is different from that of clinicians and academics (DoH, 2005). There is an 
increasing emphasis on the importance of users of health and social care 
participating in decisions regarding their care (Maslin-Prothero, 2003; Rise et al., 
2013) and it is logical that this extends to their involvement in determining research 
agendas and priorities.  
The National Health Service (NHS) Research and Development established 
INVOLVE in order to promote service user involvement in research and evaluation 
(Beresford, 2007). Research has highlighted that including service users can generate 
new knowledge, resulting in a change to the research design and/or the way it is 
carried out (Cotterell et al., 2010). Specifically, including service users in the initial 
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stages of research is critical as they have the freedom to influence the aims and 
methods (Brett, Staniszewska, Mockford et al, 2010), including helping with the 
wording of questionnaires, and the content, face validity and appropriateness of 
measurement tools (Brett et al., 2010; Oliver & Buchanan, 1997).  
The Cancer Reform Strategy highlighted user involvement as an implicit component 
of good cancer service commissioning and delivery (Department of Health, 2007). 
Cancer network partnership groups are regional organisations in the UK, consisting 
of cancer patients and health professionals working together to help improve cancer 
care (Attree, Morris, Clifton, Hinder & Vaughan, 2009). An evaluation of the work 
of these cancer networks highlighted that the service users involved had influenced 
cancer care in a number of different ways, for example the assessment, 
implementation and review of surgical services for upper gastro-intestinal patients 
(Attree et al., 2009). Moreover, user engagement has been found to be essential in 
maintaining ethical standards and the welfare of participants in research (Wright, 
Corner, Hopkinson & Foster, 2007). 
Despite there being an emphasis on involving service users in cancer services and 
research, little research has actually focused on the impact which involvement has on 
the service users themselves (Cotterell et al., 2010) and there is a need for more 
structured approaches to reviewing the investments made in supporting the 
involvement of service users in research (Morrow, Ross, Grocott & Bennett, 2010). 
A study by Cotterell et al (2010) found that service users feel positive about being 
involved in influencing services or research and it has also been reported that service 
users can benefit from therapeutic gains, improved self-esteem and confidence from 
the research process (INVOLVE, 2012).  
There is a general assumption that the effects of service user involvement are 
beneficial, however, concerns include financing service user time, issues with 
service user benefits and payments, and a need for training and support (Beresford, 
2013; Brett et al., 2012; Pollard & Evans, 2013). Also, previous research has 
highlighted that people affected by cancer can hear distressing things when engaged 
in work with cancer professionals (Cotterell et al, 2010; Gray, Fitch, Greenberg, & 
Shapiro, 1995) and may lack objectivity (Wright et al., 2007) which can be a 
limitation of including PPI in research. Moreover, as service users might not be 
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familiar with the complexity of the research process, such as ethics, they may have 
unrealistic expectations regarding what can be achieved and how long research takes 
(Wright et al., 2007).  This could slow down the research process and may be very 
frustrating and stressful for the service user; however, it is possible to overcome this 
limitation with appropriate support i.e. from the research team by explaining the 
different stages and timescales involved in research (Stevens, Wilde, Hunt & 
Ahmedzai, 2003).   
 
3.7.2 Patient and public involvement (PPI) in this thesis 
There are a number of different ways that patients and members of the public can 
become involved with different stages of the research cycle (see figure 7), for 
example, they can help to develop research questions, review research materials, join 
advisory groups and help to disseminate research findings (INVOLVE, 2012). 
Throughout this program of research, there have been two sources of PPI; a novice 
patient user representative from the Network Breast Site Specific Group of the Avon, 
Somerset and Wiltshire Cancer Network (ASWCN) and a number of advisors from 
Breast Cancer Care. An advantage of using a novice user representative is that, over 
time, users can become ‘professionalised’ which can weaken their representativeness 
(Wright et al., 2007). A user representative from ASWCN, who has personal 
experience of breast cancer and treatment-related hair loss, was able to bring her 
own unique perspective to this research. Following INVOLVE (2012) guidance, the 
research team met with the user representative to talk about the research and explore 
each party’s expectations and understanding of service user involvement in it. The 
researcher met with the user representative regularly throughout the program of 
research in a setting of her choice which was easily accessible for her. She was 
consulted during the planning stages of the research and played an active role in ‘the 
designing and managing’ aspect of the research cycle (see figure 7) which involved 
reviewing the written materials (i.e. invitation letters, information sheets, consent 
forms, questionnaires, debrief sheets) used in studies 2 (chapters 4 and 5) and 3 
(chapter 6), which has previously been highlighted as a benefit of engaging service 
users in research (Brett et al., 2012). 
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Figure 7. Diagram taken from INVOLVE (2012), depicting service user 
involvement at the designing and managing stage of the research cycle. (First 
produced by INVOLVE (2012), p.31. Reproduced with copyright permission from 
INVOLVE).  
 
In order to prevent some of the negative aspects of including service users in 
research highlighted above, Department of Health (2006b) policy and guidelines on 
reimbursement and payment for service users were followed. The user representative 
was happy to be contacted via email and was sent paper copies of any materials to 
read ahead of face-to-face meetings to discuss her feedback. INVOLVE (2012) 
advise that it is good practice to offer payment to user representatives involved in 
research. Payment for the user representative’s time was included within the PhD 
research budget and this was discussed before the user representative agreed to take 
on the role. The user representative was paid for the time she spent reading and 
providing feedback on the materials for each of the studies, she was reimbursed for 
her travel expenses, and refreshments were provided at each meeting. Previous 
research has found that receiving payment and being treated hospitably can help 
users feel valued, which is associated with a sense of empowerment (Hanley, 2005). 
Designing and 
managing 
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The researcher ensured that the information and details given to the user 
representative were appropriate for a lay person and that the research process 
involved in each of the individual studies was clearly outlined. Since user 
representatives may find the experience of PPI potentially distressing, the user 
representative was asked if she was still happy to act as a user representative prior to 
each meeting and was informed that she could withdraw at any time if she no longer 
wanted to be involved.  She was also provided with a list of support charities that she 
could contact if needed. 
Breast Cancer Care’s advisory group ‘Voices’ (www.breastcancercare.org.uk/get-
involved/volunteer-us/become-breast-cancer-voice), consists of hundreds of people 
from around the UK with experience and expertise of being diagnosed and treated 
for breast cancer. Prior to involving Voices, approval was granted from Breast 
Cancer Care. Working with Voices involved liaising with members through Breast 
Cancer Care staff and corresponding via email rather than speaking to them 
personally. Members of Voices were also involved in the ‘designing and managing’ 
stage of the ‘research cycle’ where they provided in-depth written feedback on the 
materials for studies 2 and 3. 
 
3.8 Summary 
A mixed methods research design was adopted for this research, as both qualitative 
and quantitative methods were used to answer the research questions. A mixed 
methods approach is frequently utilised within health psychology research due to its 
flexibility and appeal to a variety of stakeholders. In order to answer the research 
questions outlined in chapter one, the separate analyses from the different stages of 
the research were integrated. A detailed discussion of the different epistemological 
approaches has been provided in this chapter, including a justification for using a 
pragmatic approach.  
Discussions of the challenges to recruitment, particularly within psycho-oncology 
research have been provided. In order to enhance recruitment for this research, an in-
depth literature search was carried out to explore methods which have been 
successfully implemented in previous research. Also, service user involvement was 
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incorporated throughout the different stages of the research (further details of service 
user involvement for each study can be found in the subsequent chapters).  
 3.9 Summary of the key points in this chapter:  
 The MRC framework for the development and evaluation of complex 
interventions was used in this research; it stresses the importance of rigorous 
reviews, of establishing the need for any new intervention and careful 
acceptability and feasibility work before trials are conducted to evaluate their 
effectiveness.   
 Given the applied nature of the research questions a mixed methods approach 
was adopted within this thesis. 
 A concurrent triangulation design was adopted for the HeadStrong service 
evaluation; equal priority was given to the qualitative and quantitative studies 
which were conducted simultaneously.  
 An embedded design was adopted for the expressive writing study, as the 
quantitative and qualitative components were carried out at the same time. 
 PPI was important throughout this research program and a patient 
representative from the Breast Site Specific Group of the Avon, Somerset 
and Wiltshire Cancer Network (ASWCN) and a number of advisors from 
Breast Cancer Care’s Voices patient group were involved throughout.  
 
3.10 The next stage of the research 
The following chapter discusses the findings from an evaluation of one of the most 
widely available nationwide support services for those affected by hair loss in the 
UK. It is the first study to be conducted of HeadStrong which is a freely accessible 
service offering information and support around scalp care and in the use of 
headwear (scarves etc) to camouflage hair loss.  
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Chapter Four   
A Camouflage Based Support Service 
 
4.1 Background 
Support services currently available for breast cancer patients who are affected by 
treatment-related hair loss tend to focus on information and advice around scalp care 
and behavioural-based camouflage techniques such as the use of wigs and 
headscarves. However, many of these interventions have not yet been evaluated and 
as a result were not included in the systematic review earlier in this thesis (chapter 
2). One of the most widely available nationwide support services for those affected 
by hair loss in the UK is HeadStrong (www.breastcancercare.org.uk/HeadStrong), 
which is a freely accessible service offering information and support around scalp 
care and in the use of headwear (scarves etc.) as an alternative to wigs to camouflage 
hair loss. It is important to acknowledge that additional services do exist (a 
discussion of these services can be found in chapter 1). However, Look Good Feel 
Better (LGFB) and HeadStrong are the only two services which are widely available 
in the UK. As discussed in chapter 2, LGFB has already been evaluated (see Taggart, 
2009). However, to the best of the researcher’s knowledge, to date, HeadStrong has 
not been evaluated.  
HeadStrong is funded by the charity Breast Cancer Care and is provided through 
volunteers across the UK at 24 different centres. HeadStrong centres normally offer 
appointments one day per week, but appointment availability varies across sites. A 
HeadStrong session is usually provided as an hour-long, one-to-one session, but 
patients are welcome to bring a family member or friend along to the session. Most 
patients only attend one HeadStrong session but they can attend more than once, if 
they wish. 
Breast Cancer Care has developed their own brief questionnaire which they ask 
individuals to complete after attending a HeadStrong session. According to the 
charity, this has indicated high levels of patient satisfaction with the service. 
However, this is a satisfaction survey which is useful for audit purposes rather than a 
rigorous research evaluation, and, to date, these findings have not been published. It 
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remains unclear how successful HeadStrong is in helping women manage their 
distress in relation to treatment-related hair loss. It is important that services such as 
HeadStrong are evaluated so that health professionals can signpost breast cancer 
patients to services that they are confident will be beneficial. In conclusion, there is 
still a need for rigorously evaluated psychosocial interventions to support patients 
facing the challenges and emotional impact of treatment-related hair loss. As 
HeadStrong is a freely accessible national service for breast cancer patients, it was 
considered important to explore patients’ experiences of the service and to see if it 
offers benefits in helping them to manage their feelings towards hair loss.  
Specifically, the study aimed to address the following research questions: 
 What are individuals’ experiences of the HeadStrong service which aims to 
support them with their hair loss? 
 Are any further interventions needed? 
 
4.2 Aim 
The aim of the service evaluation was to explore users’ experiences of the 
HeadStrong service and its effectiveness, specifically its impact on appearance-
related distress, concern about hair loss, psychological well-being and confidence in 
managing the personal impact of the situation. 
 
4.3 Method 
4.3.1 PPI involvement 
As outlined in chapter 3, a patient user representative from the Network Breast Site 
Specific Group of the Avon, Somerset and Wiltshire Cancer Network (ASWCN) 
who was an advisor throughout this research, read over the participant information 
sheet, consent form and semi-structured interview schedule and questionnaires to 
check that the materials were appropriate for breast cancer patients, and provided 
suggestions on how the materials could be improved to make them more accessible 
for patients (see appendices 2, 3, 4). 
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4.3.2 Design 
 
This evaluation of a current intervention was driven equally by quantitative and 
qualitative methodology. As there is no known research that concentrates 
specifically on the HeadStrong service, it was important that this research 
highlighted which aspects of psychosocial support for chemotherapy-induced hair 
loss are important to individuals (see figure 8). It was important to use mixed 
methods research to overcome the weaknesses of qualitative and quantitative 
methods (as discussed in chapter 3) by complementing the strengths of each other 
and providing a synthesis, whereby the outcomes of the qualitative and quantitative 
studies would lead to an integrated understanding of the participants’ experiences of 
the HeadStrong service.  
 
 
 
 
 
 
 
 
 
 
Figure 8.  HeadStrong service evaluation  
 
Whilst the aim of the qualitative study was to explore patients’ experiences of the 
HeadStrong service, the quantitative element evaluated its effectiveness. Different 
participants were included in the qualitative and quantitative studies, so that the 
study did not become burdensome and time consuming for participants. Also, 
Qualitative data 
analysis 
Combined data 
interpretation 
Qualitative data 
collection 
Quantitative & 
qualitative data 
collection 
Quantitative & 
qualitative data 
analysis 
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participants in the quantitative study were women, who were accessing HeadStrong 
at the time, this was important so that the study could follow participants over a three 
month period, through their hair loss journey. Whereas participants in the qualitative 
study, were women who had experienced hair loss, who had used HeadStrong in the 
past and were able to reflect on their experiences of hair loss and of the HeadStrong 
service. The quantitative study was informed by the ARC (2009) framework 
(previously outlined in chapter 1), which demonstrates the importance of pre-
disposing factors (demographic variables, hair loss status, treatment history) and 
moderating factors (importance placed on appearance, self-esteem and fear of 
negative evaluation) in determining psychosocial adjustment to treatment-related 
hair loss as indicated by relevant outcomes (QOL, appearance-related distress, 
anxiety, depression, confidence in managing hair loss). 
The following section will discuss the qualitative study which explored breast cancer 
patients’ experiences of treatment-related hair loss and a camouflage based support 
service. 
 
4.4 Research questions: 
 What were service users’ experiences of hair loss? 
 What were service users’ experiences of the HeadStrong service? 
 
4.5 Method  
The current study used telephone interviews to explore women’s experiences of 
treatment-related hair loss and of the HeadStrong service. The interviews lasted 
between 20 and 90 minutes. Although telephone interviews may have a number of 
limitations including restricted development of rapport and being a less natural 
encounter (Gillham, 2005; Shuy, 2003), they have been shown to be useful when 
conducting research into sensitive topics. Participants have been found to be more 
confident and open when speaking over the telephone, as opposed to being face-to-
face with the interviewer (Trier-Bieniek, 2012). Also, telephone interviews are 
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advantageous when looking to recruit participants from wider geographical locations 
(Irvine, 2011), which was the case in the current study. 
 
4.5.1 Recruitment strategy 
Purposive sampling was most appropriate given that a specific population, i.e. 
individuals who had attended HeadStrong within the last 6 months, were the focus of 
the research. Recruitment was through the charity Breast Cancer Care, who posted 
out 50 letters (see appendix 5) to a selection of people across the country who had 
attended a HeadStrong session in the previous 6 months, and had indicated that they 
would be happy to be contacted regarding future research. 50 letters were posted in 
the first instance and depending on the response rate, more letters would have been 
posted had saturation not been reached from the 25 interviews which were 
conducted. This 6 month time period was selected as a longer period of time can 
effect an individual’s accuracy when reflecting on their experiences. The selection 
process included a member of staff from Breast Cancer Care randomly selecting 
every 5th person from their database, which included a list of individuals who had 
attended HeadStrong in the previous 6 months. The researcher designed the study in 
discussion with Breast Cancer Care and it was agreed that the charity would contact 
potential participants in order to adhere to ethical guidance and data protection. The 
charity also promoted the study to its Body Image Advisory Group, which consists 
of patients, health professionals and body image experts who are campaigning for 
the provision of care for breast cancer patients to include support for body image and 
intimacy concerns. Three of the participants were patient representatives on the 
Body Image Advisory Group. It is important to acknowledge the possible 
implications of including participants from the Body Image Advisory Group. In 
particular, women who are sufficiently motivated to become involved with a group 
aiming to improve care around appearance-related issues for women with breast 
cancer may have particularly strong views on the subject which may differ to those 
who are not motivated to join such a group. This was not a problem, given that a 
qualitative approach was being used so the aim was not to involve a representative 
sample, but rather to gather views from women with a range of experiences and who 
were all in a position to discuss the topic from their own, individual perspective.  
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The letters included an information sheet, a consent form and a pre-paid envelope for 
individuals to return their consent form to the researcher if they wished to be 
interviewed about their experiences. If individuals had any questions or queries 
about the study they could contact the researcher via telephone or email before 
deciding whether or not to consent to take part in the study. The researcher then 
contacted those who wanted to take part, to arrange a convenient date and time for 
the interview to take place. 
 
4.5.2 Sample characteristics 
Twenty five women elected to participate – a sample size appropriate for thematic 
analysis (Guest et al, 2006). In this study, cases were compared at the individual 
level. Names of participants have been changed for confidentiality. Mean age of 
participants was 51 (range = 34-68 years) and all of the participants described 
themselves as White. The interviews were conducted during April and May 2013, 
with participants being between 4 and 13 months post diagnosis (mean 8 months) at 
the time of the interview. All of the participants had received or were currently 
undergoing chemotherapy at the time of the interview and had experienced or were 
currently experiencing hair loss. Participants were from a variety of geographical 
locations across the country (see table 4 for participants’ demographic details). The 
inclusion criteria for the study was that participants were over the age of 18, had 
received a breast cancer diagnosis, were receiving curative cancer treatment and had 
attended a HeadStrong session within the last 6 months. The exclusion criteria 
included individuals under the age of 18, who were receiving palliative care and who 
could not speak fluent English.  
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Pseudonym Age Ethnicity Date of 
Diagnosis 
Type of treatment 
received 
Experience of  
hair loss 
Employment  Location  Marital status 
Emma 50 White Oct-12 Chemotherapy & 
Surgery 
Yes Full time work England Partner 
Sophie 56 White Sep-12 Chemotherapy, 
Lumpectomy, 
Mastectomy 
Yes Full time work Wales Married 
Claire 64 White Dec-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Retired Edinburgh Divorced 
Emily 55 White Aug-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Starting new job 
soon 
On the Wirral Married 
Debbie 43 White Mar-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Part time work England Engaged 
Penny 48 White Sep-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Full time work England Married 
Katie 50 White Aug-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Full time work Newcastle Partner 
Nicola 61 White Sep-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Retired Merseyside Married 
Polly 60 White Nov-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Working full time Liverpool Married 
Stephanie 40 White Sep-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Working full time England Divorced/live 
with partner 
Helen 48 White Aug-12 Chemotherapy & 
Surgery 
Yes Working part time Nottinghamshire Married 
Kathryn 54 White Nov-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Working part time Yorkshire Married 
Iris 57 White Aug-12 Chemotherapy & 
Radiotherapy 
Yes Working full time Scotland Divorced 
Eila 57 White Jul-12 Chemotherapy & 
Surgery 
Yes Working full time England Married 
Lauren 68 White Nov-12 Chemotherapy, 
Surgery & Tablets 
Yes Retired Doncaster Married 
Julia 44 White Sep-12 Chemotherapy & 
Radiotherapy 
Yes Working full time Wales Divorced 
Cecile 59 White Dec-12 Chemotherapy Yes Working full time Chester Married 
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Table 4. Participants’ demographic details
Juliette 35 White Nov-12 Chemotherapy & 
Surgery 
Yes Student Leicester Partner/ co-
habiting 
Dawn 44 White Aug-12 Chemotherapy & 
Radiotherapy 
Yes Other On the Wirral Married 
Debra 55 White Aug-12 Chemotherapy, 
Radiotherapy, 
Surgery, Other 
Yes Self-employed full 
time 
England Married 
Sienna 34 White Dec-12 Chemotherapy, 
Radiotherapy, 
Surgery, Other 
Yes Working full time Birmingham Married 
Mercedes 44 White Aug-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Working part time  Essex Married 
Chenade 60 White Nov-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Returning to work  Halifax Married 
Poppy 47 White Jan-13 Chemotherapy Yes Working full time England Married 
Whitney 59 White Aug-12 Chemotherapy, 
Radiotherapy, Surgery 
Yes Working part time Halifax Partner 
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4.5.3 Ethical approval 
As the study was classed as service evaluation, approval from NHS Research Ethics 
(IRAS) was not required (see appendix 6). Approval from the University of the West 
of England Research Ethics Committee was obtained (appendix 7). The research was 
conducted in accordance with British Psychological Society (BPS) guidelines 
(British Psychological Society, 2009).  
The interview required active involvement from the participant, which may have 
produced an aspect of self-reflection which could stimulate thoughts and feelings in 
the participants which they may not have experienced before. This may have had a 
positive therapeutic effect but it could also have led the interviewee to recall 
distressing experiences, bringing negative emotions to light (Harber & Pennebaker, 
1992; Pennebaker, 1989). The information sheet given to participants therefore 
contained contact details for support services should the participants wish to seek 
support. 
 
4.5.4 Data collection 
Following advice from staff at Breast Cancer Care and PPI, participants were given 
the option to have either a face-to-face or telephone interview (see appendix 4 for a 
copy of the interview schedule). All participants chose a telephone interview which 
followed a semi-structured format. The interview schedule was developed by the 
researcher and reviewed by three members of the research team and the patient-user 
representative. It was important to gain an insight into pre-disposing factors which 
included questions around demographics, hair loss status and what treatment 
participants had undergone. The semi-structured interview schedule also included 
questions relating to participants’ experiences of the HeadStrong service and other 
support they had accessed or wished they had received. 
 
4.5.5 Data analysis 
The interviews were transcribed verbatim by an external, qualified audio typist and 
subjected to inductive Thematic Analysis (TA) - a method of systematically 
identifying, organising and offering insight into patterns of meaning across a data set 
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(Braun & Clarke, 2006). Braun and Clarke’s (2006) thematic analysis is a widely 
used “method for identifying, analysing and reporting patterns (themes) within data” 
(Braun & Clarke, 2006, p79). Advantages of thematic analysis include it being 
theoretically flexible, meaning that it can be used within a variety of frameworks, 
including the pragmatic approach and exploratory nature of this research. In terms of 
level of analysis too, there is flexibility with both descriptive and more interpretative 
levels being acceptable (Braun & Clarke, 2006). Themes can be generated 
inductively (i.e. data driven) or deductively (i.e. theory driven); an inductive 
approach was employed for the qualitative HeadStrong evaluation because this was 
exploratory in nature rather than being theoretically driven. While thematic analysis 
remains grounded in individual experiences, it is able to summarise features of a 
dataset and highlight the similarities and differences within individual accounts 
(Boyatzis, 1998; Braun & Clarke, 2006). 
 
The software NVivo (http://www.qsrinternational.com/products_nvivo.aspx) was 
used to analyse the data, alongside analysing the interview transcripts by hand. 
Following recommended stages of thematic analysis (Braun & Clarke, 2006), 
analysis started with becoming familiar with the interview data (phase 1) by reading 
and re-reading each transcript whilst noting down initial ideas. The second phase 
involved coding interesting aspects, all the codes were gathered and organised into 
potential themes (stage 3). The themes were then reviewed and refined ensuring that 
the sub-themes were relevant to each main theme and a thematic ‘map’ was 
produced (stage 4). The themes were then named ensuring that they captured the true 
meaning of the themes (stage 5). Details of the analytic process can be found in 
appendices 8, 9 and 10.  
Demonstrating quality in qualitative research is essential (Mays & Pope, 2000; 
Meyrick, 2006). It is important for the researcher to immerse themselves in the data 
both during data collection and analysis, demonstrating in-depth engagement 
(Yardley, 2000). Rigour and transparency are essential (Davies & Dodd, 2002; 
Morse, 2015; Yardley, 2000; Moravcsik, 2014), requiring the findings, particularly 
the codes and themes, to be verified by an impartial researcher and provided in a 
clear account that demonstrates how the themes were generated from the data. In this 
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study, a reviewer was asked to check five transcripts along with the codes and 
themes that had been produced. No disagreements came to light. Furthermore, the 
lead researcher kept a reflective diary throughout the interview process, to record 
thoughts and feelings before and after each interview. Reflective diaries help to 
make the process of data analysis as visible and transparent as possible 
(MacNaughton, 2001; Morse, 2015). An account of the researcher’s reflection can be 
found in section 7.5.  
 
4.6 Results 
Thematic analysis of the 25 semi-structured interviews identified three main themes: 
facing the challenges of hair loss, receiving support for treatment-related hair loss 
and meeting unmet needs. Underpinning these three main themes were nine sub-
themes. These are presented in Figure 9. The themes were chosen, in accordance 
with the guidelines for thematic analysis, on the basis of their prevalence and the 
emphasis placed on them by the participants. The themes are described below. 
Pseudonyms are used throughout; some of the participants chose their own, whereas 
others were happy to be given one 
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 Figure 9. Thematic map of interview themes and sub-themes for the qualitative HeadStrong service evaluation 
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4.6.1 Theme 1: Facing the challenges of hair loss 
During the interviews many participants referred to their breast cancer as a ‘journey’. 
All the women had experienced treatment-related hair loss which they described as 
being extremely distressing. Hair loss-related distress typically began from the 
moment the possibility of chemotherapy was first discussed with them. The 
challenges in relation to hair loss, started when they anticipated hair loss, through to 
hair re-growth and beyond. 
Cecile, Eila and Whitney spoke about their hair loss being the most distressing thing 
about being diagnosed with breast cancer. The fact that Cecile’s first priority was 
that if she died, she wanted to ensure she has a wig on, shows the importance women 
placed on their hair and the extent of the impact which losing it could have. Cecile 
acknowledged that to have that thought seemed ‘really mad’ which could suggest 
that she was surprised at the extent the impact of losing her hair had on her:  
 “I said to her [the breast care nurse]... what worries me the most is if I die 
 I want to make sure I've got a wig on…she said, you're not  going to die.  
 And I said, no but I need to tell my husband if I die he needs to put my wig on 
 - I don't want to be in a coffin with no hair!...And it did seem a really mad 
 thought to have, but it came into my head”(Cecile) 
 
 
Eila demonstrated that the distress she felt as a result of losing her hair was not due 
to her being vain but because hair loss has such a large impact on an individual. Hair 
loss brought with it a number of challenges, including its impact on participants’ 
lives, confidence, relationships and others’ reactions.  
 
 “I lost all my vanity through cancer, you know.  I'm not vain in any way, 
 shape or ... that doesn't mean to say I don't want to look good but I'm not 
 vain anymore” (Eila) 
 
Whitney spoke about the importance of her hair to her and the impact which losing it 
has had on her, including the extreme distress she has felt. For Whitney, losing her 
hair was worse than cancer itself: 
 
 “Hair loss was worse than the cancer.  Mind you..if I'd been diagnosed with 
 terminal I don't think losing your hair would ... wouldn't be anywhere as 
 bad”(Whitney) 
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Whitney was very proud of her hair, it was very important to her. She had invested a 
lot of money and time, ensuring that her hair looked the best that it could. Now that 
Whitney’s hair had started to re-grow different to how it was before, it was a 
continuing source of distress for Whitney: 
 
  “I've prided myself in my hair,... I don't ever wash my own hair unless we're 
 on holiday, I go to the hairdressers once a week.  It's always looked 
 immaculate and... well, it's just the worse thing ever…it's not just losing your 
 hair, I mean, it's coming back quite thick now but it's coming back grey and I 
 look at myself and I don't even recognise ... I don't even look like I used to 
 look like…everybody says you will eventually get back to it - it's  not them 
 going through it and I could still cry now…if I'd have had a pound for every 
 blinking tear I've cried when my hair started falling out” (Whitney) 
 
Once participants started to lose their hair, they found it extremely distressing and 
mourned its loss. For some, the distress they felt continued throughout the course of 
their hair loss and extended to concerns over whether it would grow back the way it 
was before: 
 “You're actually mourning a loss that you think means something to you and 
 I'm thinking am I going to get my hair back the way I want it?” (Cecile)  
Participants described how their hair loss was all consuming and feeling like they 
were alone, with hair loss constantly in their thoughts.  
 “It’s like being in this little world of your own where all you’re thinking 
 about is hair” (Emily) 
Emma demonstrates how distressing losing her hair was and, as a result, she isolated 
herself so that she did not have to see anyone. Hair loss was a process, it did not 
happen straight away. Emma, like many participants, took steps to minimise the 
impact of the loss, including cutting her hair shorter before it started to fall out. Once 
participants’ hair started to fall out, it was often a very quick process, which was 
incredibly distressing for participants: 
 “I couldn't face anybody…I literally did fall apart the day after the haircut 
 and then 10 days later ... it started literally within a couple of days… I was in 
 the bath and I was washing it and what was left was just coming out in 
 absolutely massive handfuls.  It was really, really upsetting” (Emma) 
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Cecile demonstrates how shocking and upsetting it was for her to see her altered 
appearance: 
 “Wearing the scarf is like a statement - you are a cancer patient... you look 
 in the mirror - I don't do it now but when it first happened…I felt I was 
 like that painting the scream - my mouth just opens just aghast and I would 
 weep buckets of tears.  Terrible.  And I'm just like that painting the scream 
 and then I think why am I looking at it, cover it up, cover it up” (Cecile) 
 
Whitney discussed the impact hair loss had on her self-esteem. The experience was 
so profound for her, that she described it as the worst thing that could have happened 
to her since she had always placed a great deal of importance on her appearance. To 
help her to try to cope, she goes to the hairdressers regularly, to try to maintain some 
‘normality’: 
 “ I'm trying to be realistic about how I feel and I know I should be glad I'm    
 still here and I am glad I'm here but.. I'm very proud of the way I look and 
 how I  dress.  I'm a very vain person and…I've found it very hard - I'm sort 
 of getting used to it now.  Believe it or not, for my own self-esteem, I still go 
 once a week to the hairdressers, put my wig  on and she tickles it up a bit and 
 I've just kept that going.  I don't know ... it's a really emotional, difficult thing 
 for me to have lost.  I've not bothered about my boob because she's done an 
 absolutely fantastic job on that, my fingernails I can cope with - I can cope 
 with that…Worst thing that probably could've happened to me other than 
 losing my life” (Whitney) 
 
The prospect of hair loss was significant for many of the participants and they 
wanted to prepare for it the best they could. Sienna describes below that, as she had 
been told in advance that she would lose her hair through chemotherapy, she felt that 
this enabled her to prepare and she was glad that she had prior warning. Also, there 
is an element of downward social comparison, for example, Sienna compared herself 
to other women who have lost their hair and she felt that they had been affected 
more by their hair loss than she had: 
 “I think because I was mentally prepared that it was going to happen ... I 
 have seen some women ... I have known some women where it does 
 affect them worse.  I think, actually, I got off quite lightly because I was 
 expecting it” (Sienna) 
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Women spoke about how shaving their hair off before it fell out was a way of 
gaining a sense of control over the situation. Many of them had asked someone close 
to them to shave their hair off when they felt the time was right, however, it was 
difficult situation for the family especially the person who was asked to shave the 
participant’s head. However, as Emma illustrates, although there are some things 
that participants felt they could re-gain control of, controlling how they would react 
once they lost their hair was not one of those things: 
 “It's nice to think that there's something that you have got control over 
 because…once you get the diagnosis you just feel like you've no control over 
 anything so little things like buying scarves, like organising your wig, you 
 know, being able to get your hair cut at the right time, are just little things 
 that you've got some control over.  But what, unfortunately, you don't have 
 any control over is the way you react when your hair goes because, 
 obviously, nobody can prepare you for that.  They can tell you it's going to 
 happen but nobody can tell you how you are going to feel about it 
 personally”(Emma) 
Mercedes talked about feeling like she resembled a baby chick once her husband had 
shaved her head but she felt that shaving her head not only helped herself but also 
her family reach a level of acceptance even though she did not want to do it: 
 “I did get my husband to shave my head.  Not baldy, baldy shave, but where I 
 had lots of little bits of hair... I did look like a chick - you know when 
 they're first born they've got little bits sticking up so I did ask him and he 
 really, really didn't want to do it... but I suppose…I think that helped then.  I 
 think it helped the family as well”. (Mercedes) 
For many participants, humour was a coping strategy which they used:  
 “I said my hair isn't who I am and I realised that very quickly…in  terms of 
 how I felt, yeah it was a shock to see myself with no hair and my husband ... 
 has been fantastic throughout but then he has made a joke about it all along 
 and he ... the series Kung Fu on the television, and there's a bald Buddhist 
 Monk called Grasshopper, so he started calling me Grasshopper!  So, you've 
 got to have humour in these things... I think it's how other  people treat you 
 and my husband hasn't baulked at the fact I've no hair.  He says it'll grow 
 back” (Eila) 
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Some of the challenges for participants were practical challenges, including deciding 
whether to dye their hair. Also, there is an element of comparisons here as 
participants’ re-grown hair was often different to how their hair was prior to losing 
it: 
 “Now I'm thinking Oh bloody hell, do I dye my hair?!  Even though it's only 
 sort of ... oh I don't know, not even half an inch thick, probably a quarter ... I 
 don't know it's just dead, dead short but I can see it's coming back sort of 
 grey and dark where my hair over the years got lighter and lighter...  So my 
 next worry is how quick it's going to grow and how quickly can I  colour it!  
 All these things to contend with!” (Cecile) 
Some participants’ hair did not grow back as quickly as they were advised it would, 
or had hoped for. Managing personal expectations around the rate at which their hair 
would re-grow was a further source of distress for participants. Claire and Stephanie 
spoke about their disappointment and frustration at how slow their hair was re-
growing and the fact that no one had told them how long it would take: 
 “No it was ... about 16 months since I've lost my hair and most people it's 3-6 
 months - might not have much but they've a full head of hair and I still don't 
 have a full head of hair” (Claire) 
 “ It's beginning to recover ... nobody told me how long it would take and it's 
 been six or seven weeks and it's still really bald and nobody talks to 
 you about that - nobody says it's going to take a long time, or be patient” 
 (Stephanie) 
Also, whilst some participants found hair loss a real problem, some managed it more 
easily. Being told in advance that they would lose their hair was a factor which 
helped participants to cope. 
 “And, to be fair I didn't have ... I've been very fortunate, I haven't had a 
 really big issue with it, to be honest.  I felt that, from the beginning really, I 
 was told quite clearly that I would lose my hair” (Sophie) 
  
 “I think because I was mentally prepared that it was going to happen ... I 
 have seen some women ... I have known some women where it does affect 
 them worse.  I think, actually, I got off quite lightly because I was expecting 
 it” (Sienna) 
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However, for some participants hair loss was not as distressing as they anticipated. 
For example, Debra prefers her wig, to her own hair as it is easier to manage: 
 “It's a bit strange really, because I didn't actually like my hair!  So, in some 
 respects I wasn't traumatised by it, although when it did start coming out in 
 big clumps, it was sort of more the physical aspects of that that was…sort of 
 a bit freaky…you're washing your hair and it's all coming out, but ... you 
 know, in that respect I wasn't too bothered and I've got ... a lovely wig which 
 is so much nicer than my original hair! it's just frizz and, you know, so ... it's 
 ... a lot of people envied me because it was curly... but it's just very hard to 
 manage…I used to spend ages blow-drying and suddenly I could just stick 
 this perfect head of hair on my head so I've actually ... I have enjoyed having 
 the wig!” (Debra) 
 
4.6.1.1 Loss of identity 
Some participants felt that losing their hair impacted on their sense of self and their 
identity which was very challenging. Many participants greatly valued their hair, as 
evidenced below by Cecile who saw losing their hair as losing a part of her identity: 
 “This woman came in with a scarf on and I  turned  to my husband and I 
 went, I could no more come to the hospital  wearing one of them scarves 
 than fly to the moon.  He goes, yeah, but you're not that sort of person, you're 
 not even dressed like them are you?  I've sort of got my clothes on, got my 
 wig on, got my make-up on. I’m just thinking it's like a statement - I'm 
 thinking does my hair look ... I've put on a wig now  and I'm thinking is my 
 hair looking alright!  Do you know what I mean because I just  ... your 
 hair is your identity ... it's what makes you.  So I mean, some people 
 aren't hair people, are they?” (Cecile) 
 
Mercedes dyed her hair before having her mastectomy to ensure that it would be 
looking its best and uses the term ‘how pathetic’ when speaking about her decision 
to prevent her roots being visible when going into hospital for surgery. This 
demonstrates how important Mercedes’ hair was to her and how it formed an integral 
part of her identity, so hair loss changed her sense of self: 
 “I am someone that always colours my hair and always has styles - and at 
 the time, when I was diagnosed, it was very blonde and I went ... before I 
 went in for the mastectomy, I went and had it dyed brown so that it wouldn't 
 have roots while I was in hospital, that's how pathetic” (Mercedes) 
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Hair loss was not just confined to one’s head. Participants also lost their eyebrows 
and eyelashes, which some felt altered their appearance and their sense of self, more 
than the loss of hair on their head. This changed participants’ self-image.  Emma 
spoke about the distress of losing the hair from the top of her head and, when she 
thought it could not get much worse, she then had to adjust to losing her facial hair 
too: 
 “You think that's sort of, the rock bottom but then your eyelashes and your 
 eyebrows go and you realise that actually yes it still can get worse in terms 
 of  your appearance, yeah” (Emma) 
In Debra’s case it was these changes to her appearance that made her see herself as 
someone with cancer: 
 “The loss of the eyebrows that's, I think ... even though I'm sort of mousey 
 blonde, they weren't very dark anyway, but it's obvious that they're not there, 
 if you see what I mean, and the eyelashes as well.  I think, in some respects 
 that's been harder because they do make you look different, the loss of the 
 eyebrows. You know, you can put a wig on your head…I think perhaps... I've 
 missed those more than my hair I think really... once the eyebrows have gone 
 you think yes I do look like I've got cancer” (Debra)  
 
Even when participants used false eyelashes to camouflage their hair loss, this still 
affected their appearance. 
 “Because, even when you put false eyelashes on it just gives a whole different 
 appearance to your eyes” (Julia) 
When describing how she felt about her hair loss, Cecile compared herself to Jews in 
concentration camps who’s heads were shaved to remove their identity.  Cecile 
spoke powerfully about feeling humiliated as a result of losing her hair and felt that 
part of her identity had been taken away from her: 
  “I tell you what my first emotion or my first thought was ... the people, the 
 Jews when they were taken in the concentration camp all had their heads 
 shaved and that wasn't for hygiene purposes, that was for humiliation, so I 
 actually felt humiliated” (Cecile) 
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Several participants spoke about losing their pubic hair and how this made them feel 
like a child rather than a woman. Kathryn spoke about feeling defeminised both as a 
result of losing half her breast and her hair. Although Kathryn’s hair may re-grow 
she is aware that she will need hormonal treatment in the future and that the bodily 
changes they may cause are yet another threat to her femininity. 
 “As a woman ... because you don't feel like a woman ... when you've only 
 got, you know like I've got one and a half breasts now and a bald head and ... 
 the alopecia, of course, isn't just on your head, you know, it's your pubic 
 areas ...even when you look down there, you don't look like a woman 
 anymore, you  look like a child.  And it all feeds back into you that you are a 
 woman and, you know, you're still a woman even though you've got this 
 disease and you've had these treatments that sort of defeminise you a little 
 bit”  (Kathryn) 
 
Polly and Sienna also spoke about the importance to them of feeling feminine, and 
Sienna also described her body not feeling like it was her own by referring to it as 
‘an alien’. This again demonstrates the role of hair in an individual’s identity. 
 “Well obviously I wanted to look feminine, I didn't want to look ... I'm a 
 positive person, I didn't want to feel kind of not feminine”(Polly) 
 
 “ I did feel a little bit like an alien for a time ... sounds a bit odd saying it out 
 loud but it's because you're completely hairless and, you know, your body 
 hair doesn't grown and ... yeah.  I mean, I used to joke it was great, I haven't 
 got to shave my legs ... no, so it was a sort of bittersweet thing really”  
 (Sienna). 
 
The impact of identity keeps shifting; the future is a constant worry for participants, 
for instance at the beginning, the future possibility of hair loss, then later on the 
possibility of further changes: 
And then of course you've got the endocrine treatments to come, your 
tamoxifen and  things so, again, sort of defeminising you” (Kathryn) 
The majority of participants spoke about the impact that hair loss had on their 
appearance and how they had tried to manage this, often by trying to keep their 
appearance as ‘normal’ as possible: 
 “That wasn't what I wanted, I wanted to ... I needed things to be as normal as 
 possible and that included my appearance” (Eila) 
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 “Like I'm wearing a skinhead now, you know! Not the most attractive look 
 but ...!” (Helen) 
Participants were surprised by the impact that hair loss had on their identity. Some 
participants were not expecting their hair loss to have as much of an impact as it did, 
some spoke about the impact it had on their confidence and appearance, particularly 
around socialising.  
 “No, confidence in my appearance.  I can still deal with day to day situations 
 and things like that but ... that's not a problem, it's confidence in my 
 appearance” (Polly) 
 
 “I did think that it was going to be a problem but I had no idea just how 
 much of an impact it was going to have.  I certainly…never realised that it 
 would actually have a knock-on effect into, sort of, all areas, my confidence 
 in all areas” (Emma) 
Sienna describes how she had been brought up to be a very confident person and 
enjoyed singing in pubs and bars but because of her hair loss she felt unable to 
continue to perform in public: 
 “I'm one of the most confident people I know.  I've got three brothers and I 
 was brought up to be very confident and I'm a singer in a band, and I do 
 that as a sort of ... in pubs and bars and things, and it took away my 
 confidence to do that for a while” (Sienna) 
The following quote suggested that Whitney could be depressed. In response, the 
researcher asked Whitney if she had spoken to someone about her feelings and she 
replied that she had spoken with her doctor. The researcher recommended some 
charities that Whitney could contact if she would like further support and someone 
to speak to.  
 “I've lost a lot of my bounce.  I feel ... I feel dead inside, I'm not interested in 
 things  and I've talked to the hairdresser and she thinks that maybe when my 
 hair comes back ……..I'll probably be more myself again…. I've not 
 stopped going out, I don't go as many places” (Whitney) 
 
4.6.1.2 Responding to the reactions of other people 
The participants spoke about both the reactions of other people to their hair loss 
(such as staring, asking questions) and engaging in certain behaviours because of 
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this. Some positive aspects included feeling like they were being treated nicer than 
they normally would. For example, Poppy described the ‘head scarf effect’, which 
was evident when she spoke about her daughter’s orthodontist being 
uncharacteristically nice to both of them. However, Poppy cannot be sure it was due 
to her headscarf but this is an example of how she was interpreting the reactions of 
the others around her:  
 “My daughter's got braces and she goes to this orthodontist and he's ...really 
 quite ...well, if you carry on doing this I'm not going to do this again ... so I 
 went oh well you never know, maybe he might be a bit nicer to you this time 
 ... and we went in and he was nice as pie ....he was just really, really nice and 
 we just came out and laughed our heads off because it was just like ... oh so 
 there you go, the headscarf effect, it does ... and his whole attitude totally 
 changed in a positive way” (Poppy) 
 
Some people’s reactions were perceived as caring, as Poppy demonstrates below:  
 “I forget that I've got a headscarf on and I'll come out of a shop and I'm 
 thinking ... they were nice ... and I'm thinking .. oh, that's why!” (Poppy) 
 
However, there were some negative reactions from other people. Penny and 
Stephanie all spoke about some of the reactions they had received from members of 
the public. Penny explained that she had expected children may ask questions about 
her hair loss, but was surprised by the reactions of adults. Stephanie spoke about the 
change in people’s behaviour once they found out that she had cancer, which made 
her reluctant to go out in public, and fearful of being judged:  
 “I do find there are a lot of people who stare though. I was very surprised at 
 how many adults.  I was expecting a small child might go "mummy, 
 mummy why hasn't that lady got any hair?", which if they'd asked me I'd 
 have told them that "Well I've been poorly and the medicine I've had's made 
 my hair fall out, but it will come back", which is what you do, but you 
 can't do that with adults can you?” (Penny) 
 “You know, "I like your hat, love" and we had a joke and then he went "You 
 haven't got cancer have you?" and I went yeah and then of course he sat next 
 to me "I'm so sorry" ... people stare at you everywhere you go, people stare 
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 at you and not in a cruel way in a "Oh has that poor girl got cancer?".  And 
 it's not ... it makes you feel uncomfortable out socially” (Stephanie) 
Emily embraced her hair loss and described it as a liberating experience, but felt that 
other people were shocked and reacted more negatively to it than she did:  
 “To be honest, I found it [hair loss] quite liberating!... I thought I'd be 
 bothered about it but I really haven't and I find it's more confronting for 
 other people, you know, because I'm bald most of the time  - I only put a hat 
 on if I'm cold…I've probably got about half an inch of hair now which, you 
 know, opening the door to the postman or delivery man and you can see them 
 taking a step backwards and getting quite ... So I've found other people have 
 been more confronted by it than me”. (Emily) 
 
Participants spoke about the impact which their hair loss had on family members and 
their reactions. Some participants reported negative reactions, not only from 
strangers but from family members. For example, Sabrina spoke about the 
insensitive comments and reaction she received from her husband: 
 
 “I was having conflict with my husband at the time, we've since divorced, 
 and one of his very first comments about my hair loss was that I should wear 
 a scarf in the kitchen because he didn't want my hair in his food.  That was 
 the most degrading comment anyone made” (Sabrina) 
A number of participants spoke about the stigma attached to both headscarves and 
very short hair, and how people assume that someone in a headscarf has cancer. As a 
result participants did not like to wear headscarves as they felt it was an external 
symbolism of their cancer and would make people aware that they had cancer, as 
Whitney and Sienna illustrate below: 
 “It's a stigma ... I'm not bothered about cancer but it's the look and your face 
 looks fatter, you've no hair... I feel I've got this stigma about me that if I go 
 out looking like this, my hair looks like it ... my face  looks fatter so ... yeah.  
 Well that's it she's ... you know?  Or, the other side of the coin is nobody'd 
 surely have their hair cut like that!  And I have got a sense of humour, you 
 know, but I find it difficult because of my vanity, I suppose” (Whitney) 
 
Sienna considered the experience of being in social situations with people that she 
knows well, compared to being with strangers where she feels less comfortable. 
Again, this demonstrates participants’ feelings that short hair is an external symbol 
of their cancer.  
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 “I went to a wedding when my hair was still very short and I do feel very 
 self-conscious…I was fine at work and going around with a buzz cut … when 
 it was already short - I'm fine with that because everyone knew me, but I 
 think if I had to go on social situations I found it a bit more difficult.. I just 
 feel very, very self-conscious because people who see you with short hair, I 
 don't know, I think they tend to look at me and they go oh cancer patient, you 
 know.  And you don't want to feel like someone unique” (Sienna) 
 
Penny discussed how society has changed over recent years and as a result people 
have become more accepting and understanding compared to the 1980’s. 
“It's not something that personally bothers me - I just feel sorry for them... 
they obviously just don't comprehend coz you'd think in this day and age with 
people knowing a lot more about treatment that people would understand... I 
mean, when my mother was diagnosed with cancer in the 1980's you didn't 
discuss it. ..And if you did lose your hair ladies definitely wore a wig and 
wouldn't be seen out in a hat or a scarf.  In fact they wouldn't leave the house 
for 6 months while they had no hair because it was considered a taboo thing” 
(Penny) 
 
Some participants spoke about engaging in behaviours such as wearing headgear to 
hide their hair loss, or not doing so if that drew more attention to them or upset other 
people, as shown in the quotes from Dawn below: 
 “My niece just said to me you look funny Auntie [xxx] and I thought oh right 
 ... that's it, I need to do something now.  It was ... of course ... and she didn't 
 mean any harm by it but it upset my Mum because she was there at the time.  
 It didn't upset me particularly, I just thought she didn't mean any harm by it” 
 (Dawn) 
Helen spoke about wanting to try to keep her hair until after Christmas as that was 
her son’s wish: 
 I sort of held onto my hair right until Christmas coz my youngest son 
 said "Mum, I hope you get to keep your hair  'til Christmas" and how it 
 hung onto my head for Christmas ... because on Boxing Day I washed it 
 and it just matted on my head ... it was all dead ” (Helen) 
 
Lauren described how she had scalp cooling whilst receiving her chemotherapy 
treatment in an attempt to prevent or reduce hair loss, because her grandchild did not 
like her wearing a wig – this is another example of the steps that participants had 
taken to protect the feelings of others: 
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 “I'm glad that I did the scalp cooling, mainly because my youngest 
 grandchild who's only four - she doesn't like wigs.  She doesn't like me when 
 I'm wearing the wig... I mean the others don't mind…the others have my wig 
 on and all sorts but she's very much ... she'll say take wig off Nanna” 
 (Lauren) 
For some participants, treatment-related hair loss had altered how they felt about 
themselves and as a result had impacted on their relationships with others including 
their partners, in particular their intimacy. Participants spoke about the negative 
impact hair loss had on their intimate relationships with their partners; in particular 
they felt it took away any aspect of spontaneity as they always wanted to make sure 
they had hidden their baldness and felt confident in how they looked. 
 “And you feel ugly and it affects your relationship.  Because you don't have 
 much confidence in yourself and your partner. He thinks I'm beautiful and 
 adores me and told me all the right things - he's been amazing - but it 
 doesn't matter because it's how YOU feel about yourself” (Stephanie) 
 “Well me and my partner have only been together for three years so we're 
 really quite new and still very loving and, you know, and we haven't sort of 
 settled down into that mundane thing.  We're very full-on sexually and stuff 
 like that.  We like to bath together and things like that and it's really, sort of 
 ... it's ... um ... have to have something on my head to go in the bath and it 
 just ... everything feels sort of awkward and has to be planned, nothing's 
 spontaneous anymore” (Katie) 
 
 
4.6.1.3 Adjusting to a new sense of self 
Participants spoke about adjusting to their hair loss and getting used to seeing 
themselves differently. Several participants spoke about not recognising themselves 
anymore as a result of their hair loss:  
 “You look in the mirror and you're not there anymore… like it's just a 
 complete, sort of, stranger and you don't like, you know, what you're seeing 
 looking back at you”. (Emma) 
 
Helen spoke about losing her hair as being a time of anxiety and describes a process 
of adjusting to a new appearance and new identity: 
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 “When I went from having long hair to …having it cut short that was really 
 upsetting, you know, because, I've never had short hair and never thought I 
 liked short hair, or wanted it... so that was awful.  And then after that it's just 
 a slow transition and I think, you know, one day you've got hair that's quite 
 thick, the next day you've got hair that's a little less thick and then  you're 
 sorting of looking at it, seeing what you can do and you just learn to see 
 yourself differently” (Helen) 
 
Over time participants started to adjust to a new self, as Debra, Helen and Chenade 
highlight below: 
 “I was saying I didn't like my hair, initially, when you see yourself in the 
 mirror  sometimes it was a shock and it did take a little bit of time to get used 
 to it,  just the first couple of minutes you're thinking oh no, I look terrible but 
 once you'd got used to it ... but it did give you a real idea of what it could 
 look like” (Debra) 
 “But, you know, it's getting used to yourself looking different.  And the 
 difference of having no hair under a scarf or a fringe under a scarf makes 
 you look less 'cancer victim'” (Helen) 
  “At the beginning I never ... I wouldn't stand in the window, you know, 
 without a head covering on.  Now I'm more prone to bobbing outside to the 
 car for things without anything on.  I am aware of ... sometimes' of people's 
 ... you know, sort of a double-take look but I'm more confident in myself now” 
 (Chenade) 
 
Once participants’ hair started to grow back, this presented another set of issues for 
their identity. Even though they were grateful that they now had some hair, there 
were still a number of challenges that they had to comprehend. Whitney, Claire and 
Stephanie spoke about adjusting to their new appearance. In particular, Whitney 
spoke about the excitement of adjusting to her new self: 
 “When it first started growing and my partner ... I mean, I've stopped 
 wearing little hats in bed and everything now ... it is quite exciting watching 
 your hair come back.  It's not the same but it is quite exciting” (Whitney)   
Kathryn demonstrates that it is not only the women themselves that had to adjust to a 
new self but also family member. She spoke about how her daughters reacted when 
she wore a wig, and how upsetting it was for her to hear their comments that she 
‘was not mum’ anymore. As a result, she had not worn the wig since. 
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 “I didn't like the wig, I found it uncomfortable to wear and when I put it on at 
 home ... I've got two daughters and the expression on their face, it was quite 
 ... quite devastating. They looked at me and they said you're not Mum with 
 that wig on.  And I'm afraid the wig has been destined to a lonely life in a 
 cupboard” (Kathryn) 
 
4.6.2 Theme 2: Experiences of receiving support for treatment-related hair loss 
Participants spoke about receiving their cancer diagnosis in terms of shock, suddenly 
having numerous medical appointments to attend and the different strategies they 
had used to cope with their hair loss. These included attending support services such 
as HeadStrong, where they received advice and information which gave them a sense 
that they were better placed to cope by trying to re-gain control of the situation. 
Participants also reflected on their experiences of using the NHS wig service and 
also attending a Look Good Feel Better session.  
Participants heard about HeadStrong through a number of avenues including from 
various health professionals, cancer support groups and through friends who had 
attended HeadStrong: 
 “I think I had…like a number of leaflets from a breast care nurse and it was 
 among…you know, the leaflet about it [HeadStrong] was among there” 
 (Katie) 
 
There were a variety of reasons why participants attended a HeadStrong session, the 
main reason being for help with the practical and emotional sides of hair loss. Most 
participants wanted advice around how to take care of their scalp and around the 
different head camouflage available: 
 “I went along because I know they do give you a free headscarf, so I thought 
 oh well that's a bonus and I thought it might be quite interesting.  I think, um, 
 some of the techniques to tie the scarf ... I mean it was quite detailed and it 
 was quite hard to remember that, but they do give you some information and, 
 yeah, I just found it quite nice really.  It was before, you know, I got into all 
 the treatment properly so it was just a way of me preparing myself really”
 (Sienna) 
 
One of the main advantages of HeadStrong was that it enables participants to 
visualise what they would look like without their hair, and for those who had 
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attended before they had lost their hair, this helped them to come to terms with the 
prospect of losing it: 
 
 “I think one of the things that was very useful was that they put, you know, 
 like a little stocking on your head, so it actually showed you what you'd look 
 like with no hair ... you know, gave you a bit of an idea… once they'd done 
 that I felt a bit, sort of, happier about the whole thing.  And, obviously, they 
 had things to, you know ... they showed you the scarves and I bought some 
 little hats that I actually preferred to the scarves, so they introduced me to 
 the products that were available” (Debra) 
 
 “The two ladies that did it were lovely, you know, funny and ... I mean, I still 
 had my hair when I went but they kind of put this stocking thing on my head 
 and I thought it was the first time I'd get an idea what I would look like 
 without it [hair] and I ... you know, we had a good laugh about it so it was ... 
 you know, it was light hearted, that's what I'm trying to say really” (Katie) 
Some participants particularly liked that the HeadStrong volunteers were able to 
tailor the tone of the session to their needs, for example, some felt that the session 
was light hearted which is what they wanted: 
 “I'm fairly irreverent about the whole thing and they [HeadStrong 
 volunteers] were happy to banter with me and some of the scarves they put 
 on looked absolutely ridiculous and my daughter was there and she was, you 
 know, she was like "no, no, take it off" and we were all falling about laughing 
 so it was a really funny, bantering-type session…I think that the staff there 
 gauged how I cope with stuff and worked…with that so ... I found that 
 really  good because some of the other services I felt you have to be a victim 
 almost” (Emily) 
  
In particular, HeadStrong provided a welcomed break from medical appointments.  
Participants spoke very highly of the service and particularly liked that it was 
informal and feminine: 
  “The thing that was really nice… was that it was something that was light-
 hearted ... it was probably about six weeks after my diagnosis ... I  was 
 really, really freaked out by it and, you know, I was having all these medical 
 appointments, kind of, really out of the blue ... this horrible diagnosis ... and 
 I'm quite young, so it nice to have something that was just a bit girlie and, 
 sort of, light-hearted” (Juliette) 
 “Out of all the services, HeadStrong is head and shoulders above the rest” 
 (Helen) 
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HeadStrong showed participants that there were alternative camouflage options 
available to wigs. During the sessions, participants had been able to try on a variety 
of headscarves and hats and were shown different ways in which they could be 
styled. Eila talks about how HeadStrong showed her that she could still look good 
without having to wear a wig, and both the quotes below suggest that participants 
still placed importance on how they looked and how this could boost their sense of 
wellbeing. 
 
 “And I think at that time, that's what I really needed.  It was better than any 
 counselling session I could have asked for” (Julia) 
 “I found going to buy a wig totally ... the most distressing, uncomfortable 
 experience and I actually have never ever, EVER, worn my wig. But, I went 
 to Headstrong and they showed me that, in actual fact, I could still look good 
 without wearing a wig” (Eila) 
 
HeadStrong enabled women to talk about their hair loss without feeling a sense of 
guilt. Many participants had felt they should be grateful that they were receiving 
chemotherapy and worried that they would feel guilty and considered vain if they 
told health professionals or family and friends about their distress over losing their 
hair. In contrast, HeadStrong enabled them to voice their emotions, without feeling 
guilty.  
 “It was like giving you permission to talk about something which other 
 people could have seen as a little bit of self- obsession and it was lovely to 
 have that permission to sort of self-indulge and that they were quite happy 
 for you to self-indulge and ... I mean, they empathised and sympathised, but it 
 was like permission to grieve a little bit, as well, even though it hadn't 
 actually happened” (Kathryn) 
 
A number of participants indicated how they enjoyed being able to talk to someone 
who understood what they were going through and how they were feeling.  
HeadStrong gave them this opportunity and a chance to talk freely about their 
concerns about hair loss.  
 “My own friends are wonderful but sometimes, you know, you don't want to 
 sort of like moan on all the time about what's this and that's wrong with you 
 and what's bugging you this time - you try to keep it sort of off the subject 
 when you're with your friends, so ... it was nice to have someone who 
 understood really” (Katie) 
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 “I just didn't realise what a devastation cancer is on an individual and on a 
 family.  But ... and it's why people like Headstrong are so needed.  Because 
 sometimes you actually need someone who isn't a member of the family that 
 you can grieve with and who aren't going to judge and perhaps roll their 
 eyes or think God is she self-obsessed with this illness.  But they're quite 
 happy to let you rant on about it or ... and without judging you” (Kathryn) 
 
Participants spoke about the benefits that learning from the volunteers at HeadStrong 
had on enabling them to cope with their hair loss, and the range of worries and 
concerns they had. For example, in the quote below, Sophie describes learning more 
about the possible consequences of losing all her hair. 
 “Generally being able to talk to other people (the HeadStrong volunteers) 
 who had gone through the same so they know how you're feeling and 
 how you're dealing with thing” (Nicola) 
 “Which, in fact, nobody HAD told me and I was sort of thinking, oh gosh, am 
 I starting with a cold, but she (HeadStrong volunteer) was explaining to me 
 that that had happened to her, that her nose was just running all the time, 
 simply because you lose hair in the nostrils as well!” (Sophie) 
 
4.6.2.1 Timing 
Many participants worked either full-time or part-time whilst receiving treatment, 
which left them very little time for anything else, including accessing and attending 
support services. Also, as demonstrated by Juliette below, participants felt that there 
was limited time available for support in the NHS: 
 “I think it's difficult when you're getting your own treatment because you do 
 tend to get a bit busy as well ... like you're going to appointments yourself all 
 the time” (Sienna) 
“I'm always just a little bit aware that, you know, you get an appointment 
and I don't like to feel like I'm wasting their time and I'll write down 
questions but then, you know, won't remember everything I want to ask them 
or …I'll ask a question but then not go into it in as much detail as I'd like 
because... I always feel rushed with the NHS and maybe that's partly me 
rushing myself” (Juliette) 
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Participants spoke about the timing of when they chose to attend a HeadStrong 
session. Some went prior to losing their hair as this helped them to prepare, whereas 
others waited until they had started to lose it.  
 “I think I'd started to lose little bits…I think the appointment was something 
 like 3 weeks I think maybe ...  2, maybe 3 weeks into the chemotherapy 
 session and they knew it was going to happen pretty soon so the appointment 
 came before that so I was prepared beforehand” (Polly) 
 “I'm not sure some women might like to go once they've lost their hair, 
 because the headscarves fit differently when you haven't got any hair, so they 
 did advise me of that, they did say “oh you know it'll be a bit different when 
 you haven't got any hair” but ... I think for me personally it did work to  go 
 then, yeah” (Sienna) 
However, with hindsight, others would have preferred to use HeadStrong once they 
had lost their hair and were able to see and use headscarves on their bald (or balding) 
head rather than on a full head of hair. Overall, 20 participants attended HeadStrong 
prior to hair loss, whereas five waited until they experienced hair loss before they 
attended HeadStrong: 
 “I think I would've probably been better, or I would have benefitted from 
 waiting... when you've got a head full of hair nothing looks the same.  Until 
 you're faced with the reality of it, you know ... I don't know whether I should 
 have just waited ... or had a second session maybe, do you know what I
 mean?” (Eila). 
 
4.6.2.2 Information provision from HeadStrong 
Participants described HeadStrong as a great source of advice and information 
regarding coping with hair loss, including scalp care and where to purchase hair 
products. This helped them to manage the stress of the situation, by increasing 
feelings of control. 
 “HeadStrong was the most informative in terms of support services” 
 (Sienna) 
 “I would definitely recommend them just for the general advice I got and ... 
 just talking about it really, especially as I'd not lost my hair at that point, it 
Chapter Four: A Camouflage Based Support Service   
 
 
 
133 
 
 did reassure me a bit that it wasn't as scary as ... because it's just the fear of 
 the unknown really” (Debra) 
 “I thought it's a good chance to buy some nice scarves and things but, I 
 mean,  they went on to give advice on different ways to tie them, they went on 
 to give advice ... they gave advice on head care…they give tips (Kathryn) 
 
4.6.2.3 Confidence boost 
Anticipating hair loss was a daunting prospect and it was a time of great uncertainty. 
Participants were unsure about how they should take care of their scalps and use the 
various products (wigs, headscarves etc.) that could disguise their hair loss. 
HeadStrong was found to help participants with these questions and as a result 
increased their confidence around social interactions and meeting other people.   
 “As a woman with a full head of hair you suddenly think oh I don't know 
 whether I'm supposed to put certain creams on or do certain things and 
 actually I don't know how to tie a headscarf and ... so things like that, so I 
 thought it was easier to do it before rather than after so that was it.  Just a 
 preparation to give myself a bit more confidence I suppose” (Poppy) 
 “I think it gave me a bit more confidence, you know, that when I started to 
 lose my hair I would have something for it, you know, I wouldn't frighten the 
 postman, you  know, that sort of thing” (Chenade)  
 
4.6.2.4 Group v individual support 
A number of participants mentioned that they had known very little about 
HeadStrong or what to expect from their session, prior to attending. Participants had 
different views about the way in which it was delivered. Some were glad that it was 
provided on a one-to-one basis since this allowed them to feel more relaxed and to 
ask their individual questions. 
 “When I got there I was half expecting it to be a group session but I was 
really pleased then when it was just like me because there were questions 
that I wanted to ask and because it was focused on one person it wasn't a 
generalised chat” (Polly) 
 
 “I think it needs a one-to-one contact.  I don't think I would have had the 
 confidence to go into a room full of people and chat about losing my hair 
Chapter Four: A Camouflage Based Support Service   
 
 
 
134 
 
 before I'd lost my hair.  After you've lost your hair it sort of becomes ... I 
 don't know, I suppose it's like after you've had a child and maybe you're more 
 self-conscious about your body but I think it would have been too personal to 
 talk about before I'd been through it” (Julia) 
 
However, some were feeling alone with their hair loss and would have liked it to 
have been a group session so that they could have met others going through a similar 
experience, to reassure them that they are not alone. 
 
 “And all this one-to-one, well ... maybe they should start with, say even two 
or three people together where you actually felt that you were not alone in 
this hair loss thing” (Cecile) 
 
4.6.3 Theme 3: Meeting unmet needs 
Although most participants talked positively about HeadStrong and the practical 
support it provided, a number of participants suggested ways in which the service 
could be developed in order to address their need for more emotional support. Cecile 
demonstrates that HeadStrong was not beneficial to her as she did not want to use 
head scarves: 
 
 “One of the things she [HeadStrong volunteer] said to me as I walked in, 
 what's your expectations for today?  I said how to cope with hair loss.  And 
 she was oh yeah, we've got loads of things here and then just pulled out big 
 baskets of scarves, and I'm thinking, I don't even like scarves.  I hate scarves.  
 That's what was going through my head - why's she showing me scarves, I 
 don't like scarves” (Cecile)   
 
4.6.3.1 Lack of emotional support 
Many participants spoke about experiencing a number of emotions through their 
cancer journey, which they felt unprepared for. Some felt that the emotional support 
that they received from their oncology service was limited and, as a result, they had 
actively sought emotional support elsewhere but found this extremely difficult to 
access and thought it should be offered routinely. 
 
 “No-one see’s to your needs” (Poppy) 
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Stephanie and Cecile both felt that the emotional support they received was 
insufficient and they wished they had been offered more support, including the 
opportunity to speak to a counsellor. Cecile spoke about her distress at having to 
wait 16 weeks to speak to a counsellor, when she needed to speak to somebody 
immediately after receiving her diagnosis, so she could discuss her feelings about 
hair loss at that stage rather than feeling alone for several weeks: 
 “It's a whole new world when you've been diagnosed with cancer - it opens a 
 whole new world and people say "Oh you'll be over it soon, it'll be over 
 soon".  It'll never be over, never.  Not for anyone who's experienced cancer, 
 it will be a part of their lives for the rest of their lives and, sort of, took me a 
 long time to figure that out and it was an emotional time and counselling 
 could've really helped there”(Stephanie) 
 
 “Counselling straightaway.  No use waiting 16 weeks when your hair's 
 dropped out…you've gone through every emotion under the sun.  From the 
 word go, from the hospital, right, you've got a problem with your hair loss, 
 we've got a counsellor, whether it be a breast care nurse, but somebody 
 trained in that particular field that you can go and speak to who understands 
 what you're trying to say and what you're going through” (Cecile) 
Participants spoke about feeling abandoned at times and wanting more contact with 
health professionals with expertise in psychosocial issues, yet appreciated that they 
are extremely busy with other patients, as Sienna highlights below:  
 
 “I know it's impossible there are so many patients and they've got new ones 
 coming in, but I felt a little bit abandoned psychologically” (Sienna) 
Not all participants felt the same way, as some were able to manage the situation 
themselves. For example, Eila described how camouflage helped her to manage her 
hair loss and lessen its impact on her. This demonstrates that women’s experiences 
and needs are varied, so there needs to be a range of options and means of support 
available in order to meet individual needs. 
 “I was more ... it very quickly became a non-issue to me and I just made sure 
 that, as I say, I wore nice headwear so it wasn't ... I wasn't psychologically 
 affected ... I didn't feel psychologically affected by it at all” (Eila)  
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4.6.3.2 Areas for improvement 
Participants still felt that the care provided by both the oncology service and 
HeadStrong could be improved, so that psychosocial support is provided throughout 
the hair loss journey, and highlighted some criticisms and limitations of HeadStrong. 
Cecile and Juliette both felt that the service could benefit from being run by 
professional employees rather than volunteers, since they did not know whether the 
information provided by the volunteers was correct or not:  
 “I just think it wants really, really revamping, and right the way through 
 from when you know you're going to lose your hair, how you deal with losing 
 your hair, then when you've lost your hair and your scalp is sore and you're 
 not sure what to do with it, that you can go and ask this person on a 
 professional level and know that the information they give you is correct” 
 (Cecile) 
 “I didn't think it was as good as I was hoping... I know it's volunteer run and 
 I know that things that involve volunteers depend an awful lot on goodwill 
 and you don't have as much control over what's going on as maybe you 
 would with an employee” (Juliette) 
  
Some participants felt that HeadStrong was too prescribed and structured, and would 
have preferred it to be tailored more to the individual. Juliette describes below how 
she went to HeadStrong hoping to receive information about scalp care but she felt 
disappointed as she was given a leaflet rather than someone talking to her about her 
concerns and providing advice on products that she could use. 
 
 “I did find it helpful but I sort of felt they stuck a little bit to a kind of routine 
 that they did... and when…I wanted to know was about care of my head once 
 my hair was going…they just sort of gave me a leaflet about that, they did not 
 really talk through that at all and they sort of said oh we can't recommend 
 products and ... I thought well ... I don't need you to tell me to go and buy this 
 product but it would be quite good to just have an idea” (Juliette) 
 “But, I mean, they don't go ... it's like they're reading a script” (Whitney) 
 “HeadStrong is a good service but it could be enriched by, you know, if we 
 could donate so that, if a lady comes in ... you know, who can't afford to [buy 
 a head camouflage], they could say, well look, these have been donated
 ..feel free to take it” (Eila) 
Chapter Four: A Camouflage Based Support Service   
 
 
 
137 
 
 
Some participants spoke about the difficulties of attending a HeadStrong session. For 
some it was difficult finding the time to attend an appointment at the hospital on top 
of all their existing medical appointments, reinforcing the importance of time as 
discussed earlier in the chapter. Others found it hard to travel to HeadStrong as they 
had to rely on someone else to take them. Some were unable to attend a session 
when they would have liked to, due to being ill and, as a result, had already lost their 
hair by the time they were able to attend HeadStrong. 
 
 “I was in the hospital at least once a day for a scan or an appointment of 
 some sort or another, it was a very busy period and attending HeadStrong 
 meant ... another visit to the hospital” (Poppy) 
 
  “It's not really fair, to him, to have him take me, you know, to places like 
 that [HeadStrong]” (Whitney) 
 
 “I had to cancel two [HeadStrong] appointments because I was 
 poorly……unfortunately, with not being able to get to them 'til after 
 Christmas I had used my own scarves but  they kept slipping off and ... 
 because they weren't really the right thing” (Dawn) 
 
Participants also spoke about actively seeking out different sorts of support and 
taking up every opportunity available to them, further demonstrating participants 
want and need support. However, as Helen demonstrates below, time was an issue 
for many of the participants. Participants spoke about needing support which is 
easier to access, reinforcing the importance of timing as discussed above. 
  “Well I’ve got this to do, I’ve got that to do, I could really do without 
 another hour or so down there and, as much as it would’ve been nice...I 
 think if I’d have worked through  it I would’ve tapped into it all (support 
 services)” (Helen) 
An important issue for participants was where the HeadStrong session was held, 
with comments about the room needing to be bigger, and many preferring it to have 
taken place somewhere separate from the hospital or the Oncology department since 
this environment was a distressing reminder of their cancer diagnosis. 
 
 “I never thought, I never dreamt that I would be going down, turning down   
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 that department so I think to have to turn down that department again, I think 
 ... yes, I suppose, that would have been the one thing I would have changed,  
 was a different setting really” (Chenade) 
 
 “I don't know where else I would suggest that they held these services, it was 
 in the middle of a busy hospital, a private room, but I just sat while I was 
 waiting for my appointment and I just sat there and I thought thank God I'm 
 not coming to this to be treated because I would have run a mile.  So I don't 
 know whether there's a better environment ... that whether they should use 
 something like ... something less threatening than the hospital environment, 
 where you end up spending so much time anyway, I don't know whether a 
 Health Centre room or whatever” (Eila) 
 
Participants spoke about using online forums and Facebook as a way of trying to re-
gain control and seeking support and reassurance from other people, as it offered 
them the opportunity to speak to other’s in a similar situation and offered peer 
support which they did not feel that HeadStrong offered:  
 “Oh look my hair's starting to come out, and then you'll get lots of comments 
 back of kind of, ‘oh but you know you look really beautiful’ and,’ it 
 just shows how beautiful your face is’... so I think…the impression I get is 
 that women who really feel ashamed of it and hide it, maybe don't deal with it 
 quite as well as women who sort of grasp it and  say, you know, this is me 
 and ... to be able to share that with some people and to have some positive 
 supportive comments” (Juliette) 
 “It's [online support] good and bad in that you get lots of support but you 
 also ... it can scare you a little as well just because, you know, people die on 
 it. And people have worse experiences ...  You can find yourself becoming 
 too involved in the world of cancer if you're not careful” (Stephanie) 
 
Although some participants found online support helpful, others would prefer to 
speak to someone face to face who has been through a similar experience. Eila 
suggests that a ‘buddy system’ could be implemented, were women could speak to 
someone who is not a family member and who has been through a similar experience 
of hair loss:  
 
 “There should be a 'buddy system'... I know you can go on-line on these 
 chatrooms and things but, quite frankly, the  dead of night when people are 
 on ... I don't want to be on ... you know, I want to speak to somebody like 
 I'm speaking to you now.. you need somebody… who's actually been there, 
 done that and got the t-shirt…you need somebody who knows what thoughts 
 you have and what concerns…who's not going to sit there and cry”. (Eila) 
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4.7 Discussion 
The aim of the study was to explore women’s experiences of treatment-related hair 
loss and of the HeadStrong service. It was evident that many of the participants were 
experiencing appearance-related distress and hair loss had negatively impacted on 
their quality of life. Whilst HeadStrong often helped to an extent, the accounts from 
those women who felt it had not met all their needs suggested that greater access to 
alternative interventions offering individually tailored support is needed. 
Three main themes were identified.  The first ‘Facing the challenges of hair loss’ 
focuses on the impact which hair loss had on an individual’s sense of self, which 
often began before they had lost their hair since the anticipation could be a stressor 
in itself. Uncertainty continued as hair began to re-grow, supporting previous 
research whereby individuals have continued to perceive themselves as different, 
despite their outward appearance returning to ‘normal’ (Münstedt et al., 1997).  
A range of individual differences were apparent. Some managed the impact of hair 
loss well, whereas others found it very distressing. Alopecia affected participants in 
a variety of ways, including their confidence and relationships with close partners 
and family members. Participants also viewed the general public as being more 
aware of their diagnosis because of their altered appearance. This supports previous 
research that has highlighted the negative impact of breast cancer and its treatment-
related side effects (Sheppard, 2008; Shapiro et al., 2001). Participants not only lost 
their hair from the top of their head but also their eyelashes and eyebrows. Their 
accounts illustrated how hair loss not only affected their appearance but also their 
overall sense of self.  
Hair loss had impacted on a variety of aspects of participants’ lives including their 
identity, relationships and confidence – stopping some participants from engaging in 
activities that they had once enjoyed. This supports previous research whereby 
chemotherapy-induced hair loss has been found to cause anxiety, depression, 
negative body image, lowered self-esteem, and a reduced sense of well-being 
(Hesketh et al., 2004; Lemieux et al., 2008). Participants reported not wanting their 
partners to see their bald heads which, for some, impacted on their intimate 
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relationships as there was no longer an aspect of spontaneity. Münstedt et al (1997) 
previously reported that 13% of women with gynaecological malignancies believed 
they would be rejected by their partner once treatment-related hair loss occurred; 
therefore it is possible that women used head camouflage to conceal their hair loss 
from their partners out of fear of being rejected.  
Once participants’ hair had started to fall out they described how they mourned the 
loss of their hair, with some participants describing their distress and feelings of 
humiliation and comparing themselves with others who have had their heads shaved 
in traumatic circumstances.  
The majority of participants spoke about how they had been informed by health 
professionals that they would lose their hair before starting chemotherapy. For many, 
this gave them time to mentally prepare and to attend a HeadStrong session so that 
they could learn different ways to tie headscarves and look after their scalp before 
they started to lose their hair. This supports Batchelor (2001) who argued that during 
the anticipation phase, there is a need to deal with the anxiety and uncertainty 
associated with hair loss, to provide accurate expectations about the physical 
changes that might take place, and to prepare patients for the psychological and 
social challenges they may experience.  
The women in the current study discussed both the distress caused by other people’s 
reactions to their hair loss and the lengths they went to in order to protect other 
people’s feelings. These are consistent with previous research (Hilton et al., 2008). 
Even though they were given practical advice around scalp care and using wigs and 
headscarves, they were not prepared for other people’s reactions to their altered 
appearance. As well as exposing them as a ‘cancer patient’ (see above), participants 
also felt that they were being stared at because their altered appearance went against 
social norms for what is considered to be an acceptable and expected way for women 
to look. Participants spoke about using scalp cooling to try to preserve their hair or 
covering their hair loss as they did not want their loved ones to see them with a bald 
head as this was a reminder of their cancer.   
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Many participants spoke about the impact hair loss had on their sense of self and 
identity. Traditionally, an individual’s sense of self is seen as stable, however, over 
time it has now become to be seen as adaptable (Pilarska, 2016). An individual’s 
sense of self is also linked to their sense of identity. Experiencing a traumatic event 
such as receiving a cancer diagnosis and experiencing treatment-related hair loss can 
affect the reaction that an individual receives from others which can have a negative 
impact on their identity. As a result an individual may view themselves as 
unattractive and may avoid socialising with other people for fear of rejection 
(Horowitz, 2015). This was supported by the current research whereby a number of 
participants spoke about avoiding social situations as a result of their hair loss, in 
fear that they would be judged. 
The impact of hair loss on identity is an issue which has been acknowledged in the 
literature but little is known about the process for how this occurs. Embodying 
identity is defined as “the way in which a person changes how they view their self 
(mind, body, and spirit) in an effort to reconcile physical or body alterations” 
(Koszalinski & Williams, 2012, p. 116). It is argued that individuals undergo a 
process whereby they experience feelings of “it’s not me” and gradually progress to 
recognising themselves with an altered appearance (“but, it’s me”), before reaching 
the final stage of acceptance, where an individual incorporates their altered 
appearance into their sense of self (“it’s me”) (Koszalinski & Williams, 2012).  This 
is the process participants described in the current study. Many women spoke about 
not recognising themselves when they first lost their hair and progressing through a 
process of gradual acceptance, whereby they started to incorporate the physical 
changes into their new sense of self. According to Koszalinski and Williams (2012) 
embodying identity proposes a framework to help ensure that individuals are 
supported through the process of coming to terms with their altered appearance, 
especially when their self-esteem is negatively affected and there are visible 
reminders of their cancer such as hair loss.  
Women spoke about their hair loss signifying their loss of control, including control 
over whether or not to tell people about their diagnosis, which led to a transition 
from an initial private experience (shared with family and friends) to a publicly 
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visible indication of their cancer. This supports previous research that has 
highlighted how hair loss exposes an individual as a ‘cancer patient’ (Harcourt & 
Frith, 2008; Hilton et al., 2008). Once hair loss had begun, the majority of 
participants made the decision to shave their heads, to spare them from having to 
watch their hair fall out. Previous research by Hilton et al (2008) found that patients 
initially cut their hair shorter, followed by shaving their head, usually soon after their 
hair loss became noticeable. People’s reasons for doing this ranged from 
practicalities such as to avoid having to clear up shed hair, physical discomfort 
caused by hair loss, aesthetic concerns, or wanting to take back some control (Hilton 
et al., 2008).   
Previous research highlights that patients are eager for their hair to re-grow once 
they have finished treatment (Hesketh et al., 2004). Yet hair regrowth can bring even 
more challenges, as patients must decide when to stop using wigs, hats or 
headscarves. Some participants had unrealistic expectations regarding their hair 
regrowth and expected it to re-grow just as quickly as it fell out. Once hair starts to 
re-grow, if it is different to how it used to be, it can be very distressing for 
individuals especially if they are not prepared for this (Rumsey & Harcourt, 2005).  
The theme ‘Experiences of receiving support for treatment-related hair loss’ focuses 
on participants’ experiences of the HeadStrong service. It was clearly a great source 
of advice, including information around scalp care and different types of headscarves 
and hats available to camouflage hair loss. Information about cancer treatment side 
effects has previously been shown to improve understanding, satisfaction, treatment 
compliance, emotional distress, anxiety and depression (Fallowfield, 1992; Whelan 
et al., 1998). Some participants in the current study were happy with the amount of 
information they received from HeadStrong, whereas others would have liked more. 
In a previous evaluation of a skin camouflage clinic, all participants highlighted their 
appreciation of having written information to take away from their appointment 
(McConochie & Pearson, 2006), however, information provision is a complex issue; 
individual preferences for information vary greatly and timing is an important issue, 
as individuals’ information needs change over time. It was evident from the 
interviews that timing was an important issue. Specifically, finding the appropriate 
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time to attend HeadStrong, whether this was prior to hair loss or once it had started 
to fall out.  This was an individual preference.  Some participants found it difficult to 
find time to attend a HeadStrong session whilst also attending numerous hospital 
appointments, and juggling day-to-day responsibilities such as work and home life. 
Psychosocial needs relate to a desire for help or support that underlies a person’s 
emotional and psychological wellbeing (Watson et al., 2012; Swash, Hulbert-
Williams & Bramwell, 2014). An unmet need is characterised by the gap between a 
patient’s experience of a service and the actual service they required (Carr & Wolfe, 
1976). The third theme ‘Meeting unmet needs’ highlights that HeadStrong had not 
met all participants’ needs and areas that could be improved were identified, 
including the possibility of providing both one-to-one and group sessions, offering 
more flexibility to meet individuals’ specific needs. Some felt HeadStrong was not 
sufficiently tailored to the individual and should be delivered on a more professional 
level. However, individual needs are subjective and vary greatly, which can make it 
extremely difficult for service providers to ensure that their service is suitable for all. 
To further emphasise the importance of individual differences, Wiggins, Moore-
Millar and Thomson (2014) highlighted the complex consequences around alopecia 
patients’ use of camouflage, including modifying their behaviour in social situations 
to conceal their use of a wig, demonstrating that camouflage is a starting point but 
not a remedy for all the distress associated with hair loss.  
 
There was a consensus from participants in the current study that very little 
emotional support is available specific to hair loss, which supports previous research 
related to hair loss and the impact of cancer more broadly (Armes et al., 2009; 
Shapiro, Wiseman & Liu, 2000). In a survey with 606 cancer patients, 58% of 
participants felt their emotional needs received less attention than physical issues 
(Macmillan Cancer Support, 2006). Support services which are currently available 
for patients affected by hair loss tend to focus around offering practical advice 
around scalp care and the use of hats and headscarves rather than emotional support. 
A few participants reported feeling let down by the lack of psychological support 
they received from their oncology service and felt that they would have benefited 
from being offered a counsellor to talk to. HeadStrong does not currently aim to 
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offer psychological support, but a recommendation would be to try to bridge the gap 
so that those who attend HeadStrong and discuss wanting psychological support, 
could then be signposted to the appropriate service. However the volunteers 
delivering HeadStrong would need to feel confident in doing so.  
It became apparent through the interviews that a number of participants were unclear 
about what HeadStrong entailed prior to attending a session. Therefore, it is 
important that HeadStrong is publicised, including a description of the service.  
A number of participants in the current study found it distressing to attend a 
HeadStrong session in the hospital setting which was so strongly associated with 
their cancer diagnosis and/or treatment. This supports ongoing literature about the 
link between environment, health and wellbeing (Weiss & Lonnquist, 2000). 
Edvardsson, Sandman and Rasmussen (2014) found that patients felt that being at 
the Oncology Centre meant being forced into a world of cancer, which included the 
loss of dignity and control. The present study also supports previous research 
highlighting patients’ difficulties around travelling to appointments due to feeling 
unwell or because of a lack services closer to home (Shapiro et al, 2000). However, 
it is important to note that the systematic review (chapter 2) found that interventions 
delivered in hospitals/clinics were advantageous. Therefore, this further emphasises 
individual differences and preferences for where and how an intervention is 
delivered, highlighting the importance of flexible intervention delivery. 
 
4.7.1 Methodological considerations 
A strength of the current study is that recruitment was nationwide, allowing the 
inclusion of participants with experience of HeadStrong sessions from a variety of 
different geographical locations. However, a possible limitation is that the charity 
providing the service was key to the recruitment process, therefore leading to the 
possibility of sampling bias. Steps were taken to minimise this, including random 
selection of individuals who had attended a HeadStrong rather than purposeful 
sampling of individuals who had attended specific centres.   
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All the women invited to take part in the study were experts in their own 
experiences. Being a qualitative study with 25 White, English-speaking women who 
had undergone chemotherapy following a diagnosis of breast cancer, it would be 
wrong to assume that the themes identified above are necessarily applicable to breast 
cancer patients from other ethnic backgrounds, nor to men or women with other 
cancer diagnoses. People from other ethnic backgrounds might experience hair loss 
differently since hair conveys extensive symbolism across cultures (Etcoff, 1999). It 
is also important to highlight that the findings from this study cannot be generalised 
to all breast cancer patients who have attended a HeadStrong session. 
 
4.7.2 Conclusion 
 
This qualitative study suggests that the HeadStrong service can be an important and 
helpful intervention for breast cancer patients affected by hair loss, but it also 
indicates that it is not necessarily meeting all their needs. Some participants reported 
not finding hair loss as distressing as they had anticipated it would be, and managed 
the situation and their feelings well. As Tierney, Taylor and Closs (1992) suggest, it 
may be “unhelpful to assume that all patients will be concerned by the prospect or 
devastated by its occurrence” (p.79). However, many participants found treatment-
related hair loss to be a very distressing experience. This variation again emphasises 
the importance of individual differences and how no two people are the same 
regarding their specific experiences and support needs (Independent Cancer 
Taskforce, 2015).  
The wider appearance literature has demonstrated the importance of interventions to 
reduce avoidance and social anxiety by equipping individuals with effective social 
skills to manage everyday situations (Clarke, 1998; Thompson & Kent, 2001), rather 
than relying solely on camouflage-based approaches. Therefore, these interventions 
might usefully be offered to breast cancer patients whose appearance-related 
concerns around hair loss are having a detrimental effect on their daily lives. 
Since support needs are likely to vary between individuals and over time, it is 
important that patients are equipped with a toolbox of strategies to help them to 
manage all aspects of hair loss, rather than relying on one strategy, i.e. camouflage. 
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Additional support and interventions that are readily and easily accessible are needed 
so that HeadStrong volunteers and health professionals alike can signpost patients to 
further sources of support as necessary. 
 
As a mixed methods approach was taken, with the qualitative and quantitative 
(Chapter 5) HeadStrong studies conducted in parallel, a synthesis of the findings 
from both these studies can be found in section 5.4.2, together with 
recommendations for changes to practice which were presented to Breast Cancer 
Care on the basis of these findings. 
 
4.7.3 Summary of the key points in this chapter: 
 This is the first study of the national HeadStrong service which focuses on 
providing information and support around scalp care and the use of hats and 
headscarves to camouflage hair loss. 
 The qualitative study aimed to answer the following research questions; what 
were service users’ experiences of hair loss and of the HeadStrong service? 
 Twenty five women participated in semi-structured interviews. Three main 
themes were identified: facing the challenges of hair loss, experiences of 
receiving support for treatment-related hair loss and meeting unmet needs.  
 Hair loss brought with it a number of challenges, including an impact on 
women’s lives, their identity, confidence and relationships, and having to 
deal with the reactions of other people.  
 A key contribution from this study is that it is the first qualitative study of 
women’s experiences of the national HeadStrong service. A key contribution 
to knowledge is that whilst the HeadStrong service offers practical support 
around camouflaging hair loss, it does not completely address women’s 
distress or provide the emotional support that some need.   
 
4.8 The next stage of the research 
Although this qualitative study has given insight into women’s experiences of 
HeadStrong, it is still unknown whether or not it offers measurable improvements to 
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their distress around hair loss. The following chapter therefore presents a 
quantitative study conducted with breast cancer patients who had made an 
appointment to attend a session. The focus was to assess whether HeadStrong 
reduces women’s distress around hair loss, and improves their confidence in 
managing the consequences of hair loss, the reactions of others and the use of 
headwear, and whether any improvements are maintained in the longer term.
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Chapter Five 
A Quantitative Study Exploring the Impact of Breast Cancer Care’s 
HeadStrong Service  
 
5.1 Introduction  
This study aimed to evaluate the HeadStrong service, specifically its impact on 
appearance-related distress, concern about hair loss, psychological well-being and 
confidence in managing the personal impact of the situation. The ARC (2009) 
framework helped to inform the development of the questionnaires; it was important 
to gain an insight into pre-disposing factors which included questions around 
demographics, hair loss status and what treatment participants had undergone. Also, 
it was important to gain an understanding of participants’ thought processes, 
including the value they placed on their appearance, and in determining their 
adjustment to their altered appearance, whether it has affected their quality of life 
and whether they had experienced any appearance-related distress. 
 
5.1.1 Research questions:- 
 
1. Does attending a HeadStrong session improve participants’ 
confidence in managing the consequences of hair loss, the reactions 
of others and use of headwear?   
2. Are any improvements as a result of attending a HeadStrong session, 
maintained over time? 
3. As a result of attending a HeadStrong session, are there any changes 
in the value placed on appearance, self-esteem, quality of life, fear of 
negative evaluation, appearance-related distress, anxiety and 
depression over time? 
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5.2 Method 
5.2.1 Design  
This was a multi centred study which took a quantitative approach using a pre-
intervention questionnaire (see appendix 11) to evaluate the HeadStrong service, 
with a 2 week (see appendix 12) and 3 month follow-up to examine its short and 
longer-term impact. A 3-month follow-up (see appendix 13) was included on the 
basis that participants’ hair might not have grown back fully in this time and they 
might still be facing the challenges of hair loss.  
A randomised controlled trial (e.g. Bottomley, 1997) would have been an alternative 
design, with women allocated to either receive the HeadStrong service (intervention) 
or control group (an in-depth discussion of the suitability of RCTs has been 
presented in chapter 3). However, it was considered unethical to deny individuals 
access to the existing HeadStrong service by randomising them to the control group, 
at a time at which they could benefit from the intervention. Moreover, those who 
were distressed by their hair loss may have been unlikely to consent to join a study 
in which they only had a 50:50 chance of receiving an intervention that may benefit 
them, especially knowing that they could access the service directly if they chose not 
to agree to randomisation (Kaur et al., 2013). This highlights the need to conduct this 
study in a way that would enable a rigorous evaluation of the service, whilst 
accurately reflecting the circumstances in which the program would be delivered 
beyond the evaluation period. Therefore, a pre and follow-up evaluation was deemed 
the most appropriate way of conducting a reliable, ecologically valid assessment of 
the HeadStrong service, that would reflect most closely the way in which it is 
implemented in its everyday setting within the current provision of care for breast 
cancer patients.  
 
5.2.2 Developing the questionnaires 
The content of the questionnaires was informed by the ARC framework (see 
appendix 11, 12, 13 for the HeadStrong questionnaires). Relevant standardised 
measures were selected, with additional self-constructed items being included if 
suitable standardised measures were not available. Advice was sought from the 
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supervisory team, Breast Cancer Care’s user representative group (Voices) and a 
user representative from ASWCN, during the development of the questionnaires to 
assess its suitability (further details regarding PPI involvement in this thesis can be 
found in Chapter 3). 
The questionnaires were piloted on ten women of various ages (all over 18 years) 
who were not familiar with the research area, to see how long they took to complete. 
This indicated that each questionnaire booklet would take no longer than 30 minutes 
to complete, which the PPI representative agreed would be acceptable. The 
questionnaires were made available to participants as paper versions or online (using 
Qualtrics software), giving them a choice as to how they took part in the study. They 
were provided online in the hope that this would increase participation (Sax, 
Gilmartin & Bryant, 2003) and make the study more accessible for participants.  
The questionnaires comprised of sections covering the components of the ARC 
framework (see figure 10). 
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Figure 10. The guiding theoretical framework for the HeadStrong evaluation. 
Guided by the ARC (2009) framework, in Clarke, Thompson, Jenkinson, Rumsey 
and Newell. (2013). CBT for Appearance Anxiety: Psychosocial Interventions for 
Anxiety due to Visible Difference. Figure 3.5, p. 35. (Reproduced with copyright 
permission from Wiley-Blackwell).  
 
The rationale for the choice of measures is discussed below. Figure 11 summarises 
which measures were included at each data collection point.  
 
 
 
 
Stage One 
(Predisposing Factors) 
Demographic 
information 
Breast cancer 
information 
Use of HeadStrong 
Stage Two (Intervening 
Cognitive Processes) 
Value placed on 
appearance (ASI-R) 
Self-esteem (Rosenberg 
self-esteem scale) 
Social acceptance (FNE) 
Stage Three 
(Outcomes) 
Psychosocial impact 
of hair loss 
 
Appearance-related 
distress (DAS-24) 
 
Quality of life 
(FACT-G) 
 
Psychological 
functioning (HADS) 
 
Confidence in 
managing the 
consequences of 
hair loss 
 
Confidence in 
managing the 
reactions of others 
 
Confidence in using 
headwear 
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Figure 11. The measures contained within the questionnaires at each data collection 
point. 
 
5.2.2.1 Stage One: Predisposing Factors 
5.2.2.1.1 Demographic details  
Information including sex, age, ethnicity, educational background, employment 
status and residential area were obtained at baseline (Pre-HeadStrong questionnaire).  
 
5.2.2.1.2 Breast cancer information  
Details including type of cancer (this was to ensure that only breast cancer patients’ 
data was included within the analysis, to prevent patients with a different type of 
Pre- HeadStrong 
questionnaire 
Demographic 
information 
Breast cancer 
information 
Hair loss status 
Use of HeadStrong 
Psychosocial impact of 
hair loss 
ASI-R 
DAS-24 
Self-esteem 
QOL 
FNE 
HADS 
 
 
 
2 week follow-up 
questionnaire 
Hair loss status 
Use of HeadStrong 
Psychosocial impact of 
hair loss 
ASI-R 
DAS-24 
Self-esteem 
QOL 
FNE 
HADS 
 
 
 
 
3 month follow-up 
questionnaire 
Hair loss status 
Use of HeadStrong 
Psychosocial impact of 
hair loss 
ASI-R 
DAS-24 
Self-esteem 
QOL 
FNE 
HADS 
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cancer mistakenly been given the questionnaire), time since diagnosis and treatment 
received, were obtained at baseline (Pre-HeadStrong questionnaire). Using a VAS 
scale, participants were asked about their hair loss status (i.e. whether the participant 
had already lost hair or was anticipating doing so) at baseline and at each follow-up 
data collection point. The scale ranged from 0-10 with 0 indicating no hair loss and 
10 indicating complete hair loss. 
 
5.2.2.1.3 Use of HeadStrong  
Information was gathered regarding participants’ use of the HeadStrong service, 
including number of sessions received, and how they knew about the service. 
Participants were also asked their reason(s) for attending HeadStrong, expectations 
of it and, at follow-up, the extent to which their expectations were or were not met, 
whether they would recommend it to others and whether they thought the 
information and techniques learnt at the session would help them in the future.  
 
5.2.2.2 Stage Two: Intervening cognitive processes 
5.2.2.2.1 Value placed on appearance 
The Appearance Schemas Inventory-Revised (ASI-R) (Cash, 2003) measures the 
importance, meaning and impact of appearance on one’s life.  It consists of 20-items, 
based on a 5-point Likert scale ranging from 1 (strongly disagree) to 4 (strongly 
agree). The 20-items are split into two scales; the self-evaluative salience scale is a 
12-item measure of the degree to which one’s appearance is considered important to 
self-worth, the motivational salience scale is an 8-item measure of the degree of 
motivation that a person has to maintain or improve his/her appearance. When 
scoring the ASI-R, a composite score is the mean of the 20 ASI-R items.  
 
The internal consistency (as measured by Cronbach’s alpha; Cronbach, 1951) for the 
self-evaluative salience is (α = 0.86) and (α = 0.83) for motivational salience. There 
are different aspects of value placed on appearance, with body investment being one 
of them. The ASI-R (Cash, 2003; Cash et al., 2004) has been widely used in studies 
of body image investment in breast cancer survivors (Chua, DeSantis, Teo & 
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Fingeret, 2015; Moreira, Silva & Canavarro, 2010). Importantly, high motivational 
salience has been found to be associated with better body image outcomes, whereas 
high self-evaluative salience has been found to be associated with negative outcomes 
in relation to appearance satisfaction following breast cancer treatment (Moreira et 
al, 2010).  
Other validated measures of body image in breast cancer patients were considered 
but not used in this study. Specifically, the Body Image after Breast Cancer 
Questionnaire (BIBCQ; Baxter, 1998) and the Body Image Scale (BIS; Hopwood, 
Fletcher, Lee & Al Ghazal, 2001) are both widely used and highly reliable (Baxter et 
al,. 2006; Chen et al., 2010; Metcalfe, Esplen, Goel & Narod, 2004; Moreira et al., 
2009; Zhang, Liu & Jin, 2011). However, they include questions about surgery 
which was not a focus of this study. Also, as the ASI-R was being used to measure 
the value placed on appearance and the DAS24 to measure appearance-related 
distress (outlined below), an additional body image measure was not deemed 
necessary. Furthermore, it was considered important for the questionnaire not to 
appear repetitive and to monitor the length of the questionnaire so as not to deter 
participants from completing it.  
 
5.2.2.2.2 Self-esteem  
The Rosenberg Self-Esteem Scale (Rosenberg, 1965), a 10-item measure of 
respondents’ general feeling towards themselves, was included at each time point. 
Items are scored from 4 (‘strongly agree’) to 1 (‘strongly disagree’), where higher 
scores denote higher levels of self-esteem. It is a reliable and valid measure of global 
self-worth (Rosenberg, 1965). It has received more psychometric analysis and 
empirical evidence than any other self-esteem measure and has been widely used in 
the breast cancer literature (e.g. den Heijer et al., 2011; Fernandez-Taylor & Bloom, 
2011; Gómez-Campelo, Bragado-Álvarez & Hernández-Lloreda, 2014; Musanti, 
2012; Park et al., 2015; Pauwels, De Bourdeaudhuij, Charlier, Lechner & Van Hoof,  
2012).  
Two alternatives to the Rosenberg Self-Esteem scale were considered: The Texas 
Social Behavioural Inventory (TSBI) (Helmreich, Strapp & Ervin, 1974) is a 32-item 
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measure which was developed to assess feelings of self-worth in terms of 
interpersonal interaction in the four domains of social confidence, dominance, social 
competence and relations to authority figures, however, the TSBI is not a global 
measure of self-esteem. The Feelings of Inadequacy Scale (FIS; Janis & Field, 1959) 
is a 23-item measure of self-esteem, which asks participants to indicate how bad they 
feel about themselves. Low scores indicate high feelings of inadequacy (low self-
esteem) and high scores indicate high self-esteem. 
The Rosenberg Self-Esteem scale was considered most appropriate for the current 
study as it is widely used in the breast cancer literature (Ates et al., 2016; Fernandez, 
Gregorio, Mas & Rodriquez, 2012; Kovačič & Kovačič, 2011; Musanti, 2012; Wang 
et al., 2014). It is a global measure of self-esteem, unlike the TSBI, and has 10-items 
compared to the FIS which has 23-items. So, in order to keep the questionnaire 
concise and ensure it was not too time consuming and burdensome for participants, 
the Rosenberg Self-Esteem scale was used. 
 
5.2.2.2.3 Social acceptance  
The brief version of the Fear of Negative Evaluation Scale (FNE, Leary, 1983) is a 
12-item measure which examines the extent to which an individual is concerned 
about other people's opinions of them. Participants score each statement from 1 (not 
at all characteristic of me) to 5 (extremely characteristic of me). Scores range from 
12-60 with high scores indicating a greater fear of negative evaluation. The FNE has 
a high level of internal consistency (α = 0.90). The Social Avoidance and Distress 
Scale (SAD; Watson & Friend, 1969), a 28-item measure of social anxiety, was 
considered but the brief version of the FNE was chosen as it has 12-items as opposed 
to the SAD’s 28-items.  
5.2.2.3 Stage Three: Outcomes 
5.2.2.3.1 Psychosocial impact of hair loss  
Participants were asked about their confidence in managing the consequences of hair 
loss, confidence in managing the reactions of others and confidence in using the 
techniques learnt at HeadStrong. For each of these three questions, participants’ 
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confidence was measured on a VAS scale from 0-10, with 0 relating to ‘no 
confidence’ and 10 meaning ‘complete confidence’. 
 
5.2.2.3.2 Appearance-related distress  
The Derriford Appearance Scale (DAS24; Carr, Moss & Harris, 2005) is a 24-item 
measure used to assess appearance concern in clinical and research settings (Moss, 
2005). Items relate to participants’ behaviours and concerns surrounding an area of 
their body they are self-conscious about. Items are scored from ‘not at 
all’/’never’/’almost never’ (with a non-applicable option) to ‘extremely’/’almost 
always’. High scores indicate high levels of distress. The DAS24 is psychometrically 
robust and has been found to discriminate well between clinical and non-clinical 
populations and within the general population between those concerned and those 
not concerned about their appearance (Carr et al, 2005). 
The DAS24 has been widely used in appearance-related studies, including some 
breast cancer research (i.e. Nozawa et al., 2015; Moreira & Canavarro, 2012). Total 
scores range from 11-96 with lower scores representing lower levels of social 
anxiety and social avoidance. Internal consistency is high (α = 0.92). The DAS24 
has good construct validity, which has been found in both patients and members of 
the general population concerned and not concerned about their appearance and in 
correlations with a range of established scales. 
 
5.2.2.3.3 Quality of life  
The Functional Assessment of Cancer Therapy - General (Version 4; FACT-G; Cella 
et al, 1993) consists of 27 items, based on a 5-point Likert scale ranging from 0 (not 
at all) to 4 (very much). There are 4 sub-scales: physical well-being (7 items), 
social/family well-being (7 items), emotional well-being (6 items) and functional 
well-being (7 items). Each sub-scale can be summed to give an overall quality of life 
score; the higher the score, the better the quality of life. Internal consistency of the 
sub-scales is as follows: physical well-being (α = 0.88), social/family well-being (α 
= 0.87), emotional well-being (α = 0.76) and functional well-being (α = 0.90).  
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The FACT-G and the European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire (EORTC QLQ-C30; Aaronson et al., 1993) and its 
breast cancer specific questionnaire (EORTC QLQ-BR23; Sprangers et al., 1996), 
are the most widely used instruments to measure quality of life in breast cancer 
patients (Montazeri, 2008). While the FACT-G and EORTC QLQ-30 include similar 
items, the FACT-G is shorter, especially if the EORTC QLQ BR23 is included 
(comprising of 53 items compared to 27 or 37 items with the FACT-G or FACT-B, 
respectively). The FACT-B includes an additional breast cancer subscale (10 items), 
which focuses on appearance. Since this was explored in detail in another section of 
the questionnaire (appearance concerns), in order to avoid repetition of similar items, 
the FACT-G was chosen as opposed to the FACT-B.  
 
5.2.2.3.4 Psychological functioning  
Psychological measures including the Hospital Anxiety and Depression Scale 
(HADS; (Zigmond & Snaith, 1983), Beck Depression Inventory (BDI; Beck, 1961) 
and the Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) 
have been widely used and validated in cancer patients (Alexander, Palmer & Stone, 
2010; Carver & Antoni, 2004; Land et al., 2006; Mitchell, Meader & Symonds, 
2010; Montazeri, 2008). Other instruments such as the Profile of Mood States 
(POMS; McNair, Lorr & Droppleman, 1971) and the Mental Adjustment to Cancer 
scale (MAC; Watson et al, 1988) have been used to measure psychological 
functioning in cancer patients. These measures were considered for the present 
study, however, the HADS was felt to be most appropriate due to it being shorter 
(having 14-items as opposed to the other measures; BDI – 21 items, CES-D – 20 
items, POMS short form – 37 items and MAC short form – 29 items). Also, the 
HADS covers both depression and anxiety, whereas the BDI and CES-D scales 
measure depression only.  
The Hospital Anxiety and Depression Scale (Zigmond & Snaith 1983) has been 
widely used in psycho-oncology including breast cancer research (i.e. Alexander et 
al., 2010; Bidstrup et al., 2015; Saboonchi, Petersson, Wennman-Larsen, 
Alexanderson, Brännström & Vaez, 2014; Love, Kissane, Bloch & Clarke, 2002; 
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Osborne, Elsworth, Sprangers, Oort, & Hopper, 2004; Rodgers, Martin, Morse, 
Kendell & Verrill, 2005; Sheppard, Harper, Davis, Hirpa & Makambi, 2014; 
Vahdaninia, Omidvari & Montazeri, 2010). Seven of the 14-items assess levels of 
depressive symptoms and seven measure anxiety, each are rated on a 4-point Likert-
type scale ranging from 0 to 3. The items of the sub-scales can be summed to give an 
overall score (scores range from 0-21 for each sub-scale). Internal consistency of the 
sub-scales is: anxiety (α = 0.84) and depression (α = 0.83). Zigmond and Snaith 
(1983) have determined cut off values to indicate clinical levels of depression and 
anxiety; scores between 0-7 are regarded as being in the ‘normal’ range, 8 – 10 are 
considered to denote ‘borderline’ distress and scores of 11 or more are regarded as 
‘case’ level, indicating severe levels of distress.  
 
5.2.2.4 Open ended questions 
At the end of each of the questionnaires, there was a box where participants could 
insert any comments if they wished. 
 
5.2.3 Ethical and R&D approvals  
Ethical approval was obtained from the Faculty of Health and Applied Sciences 
Research Ethics Committee at the University of the West of England (UWE), Bristol 
(see appendix 14). Also, Breast Cancer Care gave their permission and full support 
for their HeadStrong service to be evaluated. 
R&D approval was sought from 6 HeadStrong centres; Liverpool, North Wales, St. 
John’s (Scotland), Chester, London and Southend. These sites were selected on the 
basis of having the highest attendance rates (see appendix 15 for information 
regarding the number of patients seen at each centre per annum). Confirmation was 
obtained that NHS ethics approval was not needed (see appendix 6) since this was 
deemed service evaluation of current care, rather than introducing a new 
intervention, and no randomisation was involved (Health Research Authority, 2013).  
Approval was granted from Research and Development (R&D) at the two 
HeadStrong centres in Chester and Southend. However, there were some barriers to 
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the set-up of the study and recruitment at some sites, where R&D departments 
thought that NHS ethics should have been obtained (despite having confirmation that 
the study was service evaluation), or insisted that the researcher should be an NHS 
staff member and that all questionnaires should be provided in Welsh (resources 
were not available for translation). Therefore, despite careful planning and 
discussions with Breast Cancer Care from the outset, the study could only take place 
at HeadStrong centres in Chester and Southend, both of which have above-average 
throughput of patients (as indicated by data provided by Breast Cancer Care, see 
appendix 14).  
 
5.2.4 Eligibility criteria 
5.2.4.1 Inclusion criteria 
Women aged 18 and over, who had received a breast cancer diagnosis and were 
planning to attend a HeadStrong appointment in the next month. 
 
5.2.4.2 Exclusion criteria 
Women who were unable to read or speak fluent English were excluded from the 
study as resources were not available to translate the questionnaires, and the 
HeadStrong centres in this evaluation only deliver the service in English (it can be 
delivered in Welsh, if patients in Wales prefer). Moreover, the psychometric 
properties of the measures may be affected if translated into a different language as 
the meanings of items within the measures may change (Villagran & Lucke, 2005). 
 
5.2.5 Sample size 
A minimum sample size of 72 was needed, based on a priori power calculation using 
the primary outcome variable, the Derriford Appearance Scale (DAS-24). In order to 
allow for possible non-completion due to the unpredictable nature of breast cancer 
and side effects of treatment, which means participants may become increasingly 
unwell and unable to complete the questionnaires at all three time points, a sample of 
84 was the target in order to allow for attrition. Recruitment took place over a 10 
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month period but unfortunately only 22 participants were recruited during this time, 
of which only 16 met the inclusion criteria as 6 had ovarian cancer. 
 
5.2.6 Intervention delivery 
The HeadStrong session was provided as usual. The way in which patients access the 
HeadStrong service varies from centre to centre. In Chester, patients either make an 
appointment in person or over the telephone. Letters confirming appointments are 
then posted out. The head of the HeadStrong centre in Chester agreed to post out 
study evaluation packs (containing an information sheet, consent form and baseline 
questionnaire) along with these letters. However, the Southend site does not send out 
appointment letters, so evaluation packs were handed out to patients when they 
attended their HeadStrong appointment.  
Potential participants at each site were asked to read the information they had been 
given and to complete the baseline questionnaire if they wanted to take part.  These 
were either returned to the researcher using a stamped addressed envelope provided 
with the letter, or taken to their appointment and given to HeadStrong staff who 
returned them to the researcher. It was important for the researcher to build strong 
links with the HeadStrong staff. This involved face-to-face or telephone meetings 
before recruitment for the study started and once recruitment started, the researcher 
rang each site every week to check on recruitment and address any queries that the 
staff may have.  
 
5.2.7 Data collection 
The questionnaire pack contained an information sheet (appendix 16), consent form 
(appendix 17), the pre-HeadStrong questionnaire and a pre-paid, stamped, address 
envelope for the participants to return the consent form and questionnaire. 
Participants were asked to provide either a postal or email address, so that the 
researcher could send them the subsequent follow-up questionnaires, either in the 
post or via email with a link to the online questionnaires. 
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5.3 Results 
5.3.1 Data analysis 
Data was analysed using the statistical program IBM SPSS. In order to conduct 
parametric tests, certain assumptions were tested by checking the distribution of 
variables. The Kolmogorov-Smirnov scores were examined for each of the measures 
to test for normality; they were all found to be normally distributed except for self-
esteem at 3 month follow-up, the physical well-being (PWB) QOL subscale at 2 
week follow-up, the functional well-being (FWB) subscale at baseline, the anxiety 
subscale at 3 month follow-up and the depression subscale at baseline, suggesting a 
violation of the assumption of normality. However, parametric tests are often robust 
and therefore unaffected by violations of assumptions (Norman, 2010).   
The data was also checked for outliers, using histograms and boxplots. At baseline 
there was one outlier for QOL and two for FWB. At 2 week follow-up there were 
two outliers for PWB, four for EWB, one for FWB and three for depression. At 3 
month follow-up there was one outlier for the ASI-R measure. However, given that 
the values are not too different from the remaining distribution; these cases were 
retained in the data set (Pallant, 2010). Therefore, parametric tests were justified. 
Content analysis was used to analyse responses to the open ended questions. This is 
deemed appropriate within health research as it allows the researcher to examine the 
data in a systematic and objective way by identifying key concepts which can then 
be quantified and analysed using statistics (Hsieh & Shannon, 2005). A deductive 
approach was taken, so that the coding of the data was guided by the findings from 
the previous literature review, systematic review and qualitative HeadStrong 
evaluation.   
5.3.2 Demographic information 
Sixteen female breast cancer patients took part in the evaluation. This was the first 
time they had been to HeadStrong. Their ages ranged from 41-64 years (M = 52.93, 
SD = 7.29). Five (31.25%) had already experienced hair loss prior to attending 
HeadStrong, with four participants having started to lose their hair 14 days after 
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starting chemotherapy. See table 5 for further demographic and breast cancer 
information. 
Table 5. Participants’ demographic and breast cancer information. 
 
 Participants (n = 16) 
Age 
Mean (SD) (range) in years   
 
52.93 (7.29) (41-64) 
Ethnicity 
White 
n(%) 
16 (100) 
Employment status 
Working full-time 
Working part-time 
Retired 
In education 
Unemployed 
n (%) 
8 (50) 
3 (18.75) 
2 (12.5) 
1 (6.25) 
2 (12.5) 
Residence       
England                                                   
Wales 
n (%) 
15 (93.75) 
1 (6.25) 
Cancer type    
Breast                                                     
n (%) 
16 (100) 
Time since diagnosis  
Mean (range) in months 
 
1.9 (1-5) 
Treatment received (note a)    
Mastectomy                                               
Lumpectomy                                             
Chemotherapy                                          
Radiotherapy                                             
Herceptin                                                  
Tamoxifen 
n (%) 
9 (56.25) 
6 (37.5) 
10 (62.5) 
6 (37.5) 
1 (6.25) 
1(6.25) 
Experience of hair loss (note b) 
Yes                                                            
No 
n(%) 
5 (31.25) 
11 (68.75) 
Time to hair loss (note c) 
Mean (range) in days 
 
14 (4-21) 
Extent of hair loss at baseline (note d)    
Mean (range) 
 
6.2 ( 3-9) 
Notes: (a) Figures do not necessarily equal 100 as some participants received more 
than one type of treatment. (b) Experience of hair loss relates to whether participants 
had lost any of their hair. (c) Time to hair loss is how long after starting 
chemotherapy participants started to lose their hair. (d) Extent of hair loss relates to 
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the amount of hair loss participants had experienced at baseline, rated on a VAS 
scale from no hair loss to complete hair loss (0-10). 
 
5.3.3 Follow-up recruitment data   
Ten women completed the 2 week follow-up questionnaire (38% dropout). Seven of 
these participants had experienced hair loss at this time. Four attended HeadStrong at 
the Chester site, 5 in Southend and one did not state where they attended their 
session. Nine participants completed the 3 month follow-up questionnaire (44% 
dropout rate from baseline, 10% dropout rate from the 2 week follow up); all 
participants had experienced hair loss at this time point. 
 
5.3.4 Accessing HeadStrong 
Participants found out about the HeadStrong service through a number of avenues 
including their breast cancer nurse (44%), Macmillan (19%), the chemotherapy day 
unit (13%), chemotherapy nurse (6%), the internet (6%) or Breast Cancer Care 
website (6%). One participant did not answer this question.   
Women gave a number of reasons for attending HeadStrong, with some indicating 
more than one reason. The most common reasons were to prepare for hair loss and to 
learn how to use scarves, see table 6 for details. 
When asked about their expectations of HeadStrong, participants’ hoped that the 
volunteers would be sympathetic, would be able to provide support, information and 
advice on where to buy headscarves, guidance on how to take care of their scalp, and 
that the session would boost their confidence. Participants’ hoped that the volunteers 
had been through the same experience themselves. Two women reported that they 
did not have any expectations, as they did not know what HeadStrong was going to 
entail. At 2 week follow up, 6 participants indicated that their expectations were 
partially met; three indicated that they were completely met and one participant did 
not answer the question.  
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Table 6. Participants’ reasons for attending HeadStrong 
Reason           n (%) 
For advice concerning scalp care  
 
          6 (37.50) 
To find the best way to deal with the process           2 (12.5) 
To help prepare for hair loss           7 (43.75) 
To learn how to use scarves            7 (43.75) 
Find out about where to purchase head scarves           1 (6.25) 
To boost confidence           4 (25) 
To meet someone in the same circumstances  
 
          2 (12.5) 
Psychological support                                                                 2 (12.5)  
Note. The figures do not equal 100% as some participants stated more than one 
reason. 
 
5.3.5 Comparing completers with non-completers 
The demographic and cancer variables were compared between the 9 participants 
who completed all three questionnaires (completers) and the 7 who only completed 
the baseline questionnaire (including the one participant who completed the baseline 
and 2 week follow-up questionnaire) (non-completers). The only significant 
difference was age (˂ .05), with the completers being younger than the non-
completers (mean ages of 51 and 55, respectively). 
 A Mann-Whitney U test was carried out to compare scores on standardised 
measures from the completers and non-completers. A significant difference was 
found in functional well-being (FWB) scores of completers (Md = 18.00, n = 9) and 
non-completers (Md = 20.50, n = 7), U = 26.00, z = -2.62, p = .007. No statistically 
significant findings were found for any of the other standardised measures.  
An independent-samples t-test was then conducted to compare FWB scores for 
completers and non-completers. There was a significant difference in scores for 
completers (M= 16.10, SD= 4.63) and non-completers (M= 20.67, SD= 1.21; t (14) = 
-2.34, p = .04, two-tailed). The magnitude of the difference in the means (mean 
difference = -4.57, 95% Cl: -8.76 to -.38) was large (eta squared = .17). No 
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significant findings were found for the other measures. These findings from the 
parametric test support those from the non-parametric tests, to show that no 
differences were found between completers and non-completers on any of the 
variables except the functional well-being subscale. However, caution is needed as 
parametric tests assume that the population from which the samples are taken are 
normally distributed and as discussed earlier in section 5.3.1, a number of variables 
including FWB violated this assumption of normality. Moreover, it is important to 
note that due to a small sample size, it is possible that a non-significant result may be 
found due to insufficient power.  
See table 7 for the means and standard deviations (SDs) for each of the non-
standardised (VAS) measures and table 8 for the standardised measures. 
 
Table 7. Descriptive statistics for each of the VAS measures at each time point. 
 Baseline  
Mean (SD) 
2 week follow 
up 
Mean (SD) 
3 month follow-
up Mean (SD) 
Confidence in managing 
the consequences of hair 
loss 
4.25 (2.52) 7.80 (1.32) 7.00 (1.73) 
Confidence in managing 
the reactions of others 
3.88 (2.53) 6.70 (2.41) 5.44 (3.00) 
Confidence in using head 
scarves and other head 
wear 
3.87 (3.10) 7.70 (1.77) 7.67 (2.00) 
Note. The above variables were measured on a Visual Analogue Scales (VAS) from 
0 (zero confidence) to 10 (complete confidence). 
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Table 8. Descriptive statistics for the standardised measures at each time point. 
Measure Baseline  
Mean (SD)                  
2 week  
follow up 
Mean (SD) 
3 month  
follow-up 
Mean (SD) 
Composite Appearance 
Schemas Inventory- Revised 
(ASI-R) 
 
Self-evaluative 
salience (ASI-R) 
 
Motivational                              
salience (ASI-R) 
3.15 (.51) 
 
 
2.81 (.54) 
 
3.68 (.48) 
2.91 (.39) 
 
 
2.79 (.51) 
 
3.65 (.41) 
3.19 (.51) 
 
 
2.96 (.62) 
 
3.63 (.47) 
Self-esteem 21.06 (4.06) 20.00 (3.09)  20.25 (3.77) 
QOL (FACT G) 
 
Physical wellbeing (PWB)  
Social wellbeing (SWB) 
Emotional wellbeing (EWB) 
Functional wellbeing (FWB) 
76.31 (12.94)  
19.88 (5.32) 
23.63 (3.48)  
15.00 (4.73) 
17.81 (4.31) 
70.80 (14.05) 
17.10 (6.77)  
20.50 (3.72)  
18.30 (2.91)  
14.90 (5.34)  
58.25 (13.88) 
13.00  (5.86) 
18.63 (3.34) 
15.00 (3.66) 
11.62 (5.15) 
Fear of negative evaluation 
(FNE) 
34.50 (8.63) 33.60 (13.15)  30.63 (11.48) 
Anxiety (HADS) 
Depression (HADS)  
8.13 (3.88) 
7.81 (3.75) 
6.70 (6.09)  
8.80 (3.97) 
7.50 (4.72) 
10.38 (3.58) 
Derriford appearance scale 
(DAS-24) 
31.69 (10.41) 37.10 (11.21)  41.78 (11.12) 
Note. The composite ASI-R score is the mean of the 20 ASI-R items. Self-
Evaluative Salience is the mean of 12 of the ASI-R items. Motivational Salience is 
the mean of 8 of the ASI-R items. 
 
 
5.3.6 Inferential statistics 
5.3.6.1 Pearson’s correlations 
The relationship between demographic and treatment variables (age and extent of 
hair loss) and standardised measures were investigated using Pearson product-
moment correlation coefficient. Preliminary analyses were performed to ensure no 
violation of the assumptions of normality, linearity and homoscedasticity.  
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5.3.7 Research questions 1 and 2: does attending a HeadStrong session improve 
participants’ confidence in managing the consequences of hair loss, the 
reactions of others and use of headwear? Are any improvements as a result of 
attending a HeadStrong session maintained over time? 
The Friedman Test indicated a statistically significant difference in participants’ self-
reported confidence in managing the consequences of hair loss across the three time 
points; ᵪ² (2) = 13.88, p = .001 ˂ .05. There was an increase in median scores for 
confidence from pre-intervention (5.00) to 2 week follow-up (7.00) which remained 
stable at 3 month follow-up (7.00). In support of this a Wilcoxon Signed Rank Test 
revealed a statistically significant increase in confidence in managing the 
consequences of hair loss from pre-intervention to 2 week follow-up, z = -2.53, p = 
.011, and pre-intervention to 3 month follow-up, z = -2.57, p = .010.  
A statistically significant difference in self-reported confidence in managing the 
reactions of others was found across the three time points; ᵪ² (2) = 10.08, p = .006 ˂ 
.05. Median scores increased from pre-intervention (5.00) to 2 week follow up (7.00) 
but then decreased at 3 month follow-up (5.00). Moreover, a Wilcoxon Signed Rank 
Test revealed a statistically significant increase in confidence from pre-intervention 
to 2 week follow up, z = -2.56, p = .011.  
There was a statistically significant difference in reported confidence in using 
headwear to camouflage hair loss across the three time points; ᵪ² (2) = 6.07, p = .048 
˂ .05. Inspection of the median values showed an increase in confidence from pre-
intervention (1.00) to 2 week follow up (9.00) which remained stable 3 months later 
(9.00). A Wilcoxon Signed Rank Test revealed a statistically significant increase in 
confidence in using headwear from pre-intervention to 2 week follow up, z = -2.32, p 
= .02 and from pre-intervention to 3 month follow-up, z = -2.36, p = .018.  
All participants who completed the 2 week and 3 month follow-up questionnaires 
said that they would recommend HeadStrong to someone who is concerned about 
treatment-related hair loss, and felt confident that the techniques they learnt at 
HeadStrong would help them in the future. 
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5.3.8 Research question 3: as a result of attending a HeadStrong session, are    
there any changes in the value placed on appearance, self-esteem, quality of life 
fear of negative evaluation, appearance-related distress, anxiety and depression 
over time? 
The Friedman Test indicated a statistically significant difference in ASI-R total 
scores, quality of life (QOL), social wellbeing (SWB), emotional wellbeing (EWB), 
fear of negative evaluation (FNE), depression and appearance-related distress (DAS-
24) across the three time points, see table 9 for further details.  
 
Table 9. Median and p-values for each standardised measure on the Friedman test 
 Baseline 2 week follow 
up 
3 month 
follow-up 
p value 
ASI-R 63.00 59.00 64.00 .04* 
QOL 
   SWB 
   EWB 
   FWB 
   PWB 
74.00 
22.50 
14.00 
17.00 
21.00 
76.50 
20.50 
18.50 
16.00 
18.50 
59.00 
19.00 
13.50 
11.00 
11.50 
.02* 
.04* 
.03* 
.11 
.13 
FNE 40.00 32.50 30.50 .04* 
Depression 8.00 9.00 10.00 .04* 
Anxiety 8.50 7.00 5.00 .97 
DAS-24 35.00 38.00 41.00 .03* 
Self-esteem 20.00 20.00 20.50 .70 
* p < .05 
Moreover, a Wilcoxon Signed Rank Test revealed a statistically significant decrease 
in quality of life from 2 week to 3 month follow-up, z = -2.52, p = .012. A significant 
decrease in social well-being from pre-HeadStrong to 3 month follow-up, z = -2.38, 
p = .018 and a significant decrease in emotional well-being from 2 week to 3 month 
follow-up, z = -2.37, p = .018.  There was a statistically significant decrease in fear 
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of negative evaluation from pre-intervention to 3 month follow-up, z = -2.31, p = 
.021.  
A paired-samples t-test showed a statistically significant increase in appearance-
related distress (DAS-24) (t (7) = -3.01, p ≤ .01) and depression t (7) = -2.49, p ˂ .05 
between baseline and 3 month follow-up. A significant decrease was found in social 
wellbeing (SWB) (t (7) = 3.38, p ˂ .05), physical wellbeing (PWB) (t (7) = 2.70, p ˂ 
.05) and fear of negative evaluation (FNE) t (7) = 4.00, p ˂ .01 from baseline to 
follow-up, see table 10 for further details.  
 
Table 10. Means and p-values for each standardised measure for the paired samples 
t-test 
 Baseline 
Mean (SD) 
3 month follow-
up Mean (SD) 
p value 
ASI-R 62.56 (7.16) 63.89 (10.23) .61 
QOL 
   SWB 
   EWB 
   FWB 
   PWB 
71.63 (15.46) 
22.13 (3.94) 
14.88 (5.67) 
15.25 (4.77) 
19.38 (5.42) 
58.25 (13.88) 
18.63 (3.34) 
15.00 (3.66) 
11.62 (5.15) 
13.00 (5.86) 
.06 
.01* 
.93 
.13 
.03* 
Self-esteem 19.75 (2.71) 20.25 (3.77) .69 
DAS-24 33.11 (12.05) 41.78 (11.12) .01* 
FNE 37.13 (10.45) 30.63 (11.48) .01* 
Depression 8.75 (3.24) 10.38 (3.58) .04* 
Anxiety 8.25 (4.33) 7.50 (4.72) .40 
*p < .05 
Note. The figures in the above table are different to those in table 8, as only the data 
for the completers (i.e. those who completed both the baseline and follow-up 
questionnaires) are included in the analysis. 
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5.3.8.1 Partially overlapping samples 
As the data set has a combination of independent and paired data (those 9 
participants who completed all three questionnaires compared to the 7 participants 
who only completed the baseline and 2 week follow-up questionnaire), a standard 
approach would be to perform a paired samples t-test (as discussed above), which is 
acceptable if the number of discarded data was relatively ‘small’ and the samples 
were still relatively ‘large’. However, this would result in half of the data being 
discarded and the power of the test being reduced. An alternative approach is to use 
the corrected Z-test, formulated by Looney and Jones (2003), which makes use of all 
the available data and accounts for the fact that there is a combination of paired and 
independent samples. The corrected Z-test combines the paired and independent Z-
tests for comparing means together, this method has previously been found to 
provide adequate control of type 1 error and generally has equal power to that of the 
usual two-sample t-test (Looney & Jones, 2003), see appendix 18 for a copy of the 
test statistic. 
When using the corrected Z-test at the 5% significance level there was a significant 
difference between the mean scores pre and 3 month follow-up on the DAS-24 [Z = 
-7.24, p < .001], physical wellbeing (PWB) [Z = 3.12, p < .01], social wellbeing 
(SWB) [Z = 4.94, p < .001], functional wellbeing (FWB)  [Z = 1.12, p ≤ .001], total 
quality of life (QOL) [Z = 3.63, p < .001] and depression [Z = - 2.32, p < .05]. 
Therefore, there is statistically significant evidence that the mean scores on these 
measures are different between baseline and 3 month follow-up, see table 11 for 
further details. 
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Table 11. Comparison of the paired samples t-test and corrected Z p-values for each 
of the standardised measures.     
 
                                      Paired samples t-test  
      (discard unpaired)  
                 p- value             
           Corrected Z p-value 
 
 
DAS-24                  0.012* 
 
                               0.000*** 
Self-esteem                  0.692                                0.583 
 
Total QOL          0.056 
   PWB                      0.031*  
   SWB                                 0.012*    
   EWB                      0.933  
   FWB                      0.12      
                               0.000*** 
                               0.002** 
                    0.000*** 
                               1.000 
                               0.001** 
FNE                   0.005**
    
                                0.154 
 
Anxiety                  0.402
     
                                0.611 
Depression                  0.042*
     
                                0.022* 
ASI-R                   0.611
  
Self-evaluative                     0.222 
Motivational salience          0.793                                                
                                0.838 
                                0.457 
                                0.848 
***p < .001; ** p < .01; < p < .05 
 
As a non-parametric alternative to the corrected Z-test is currently unavailable, for 
triangulation purposes a Wilcoxon Signed Rank Test was conducted (see table 12).  
This revealed a statistically significant increase in appearance-related distress (DAS-
24) (z = - 2.19, p < .05, with a medium effect .45) and depression (z = - 1.98, p < 
.05, with a medium effect .40) over time. Whereas, a significant decrease was found 
for quality of life (QOL) (z = - 2.90, p < .05, with a large effect .59), social 
wellbeing (SWB) (z = - 2.38, p < .05, with a medium effect .49) and fear of negative 
evaluation (FNE) (z = - 2.31, p < .05, with a medium effect .47).  
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Table 12. Median and p-values for each standardised measure for the Wilcoxon 
Signed Rank Test 
 Baseline 3 month follow-up p-value 
ASI-R 63.00 64.00 .67 
QOL 
   PWB 
   SWB 
   EWB 
   FWB 
74.00 
21.00 
22.50 
14.00 
17.00 
59.00 
11.50 
19.00 
13.50 
11.00 
.03* 
.06 
.02* 
.75 
.12 
FNE 40.00 30.50 .02* 
Self-esteem 20.00 20.50 .60 
DAS-24 35.00 41.00 .03* 
Anxiety 8.50 5.00 .40 
Depression 8.00 10.00 .05* 
*p ≤ .05 
 
5.3.9 Participants’ experiences of hair loss and of the HeadStrong service 
At the end of each of the three questionnaires, there was a box for participants’ 
comments. At baseline, a number of participants commented on their feelings of 
apprehension and uncertainty towards their imminent hair loss: 
 “I am due to undergo chemotherapy very soon so……I am dreading it” 
 (Angela). 
 “At present I have not suffered any hair loss…..I think I know how I am 
 going to handle it, but it may be very different when reality hits” (Eva). 
The majority of participants were feeling positive and took steps, including attending 
HeadStrong and cutting their hair, in order to re-gain a sense of control:  
 “I have booked HeadStrong and a wig fitting appointment for before my 
 treatment/hair loss- taking control! I also intend to have my hair shaved 
 before it all  falls and have cut my hair considerably shorter since my 
 diagnosis. Although I am feeling positive and strong and welcome treatment, 
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 I anticipate more negative emotions once treatment starts and the effects 
 show” (Freya). 
 “all my family and myself are positive about the forth coming treatment” 
 (Erica). 
 “4 days until 2nd cycle of treatment. Shaved hair off (not completely- number 
 1 razor) day of first treatment as couldn't bear the thought of hair falling out 
 in clumps. As yet there are not patches although my nurse told me before my 
 treatment that it would have completely gone by cycle 2 on AC chemo. I have 
 always changed my hair style. I colour my hair frequently and was not as 
 fazed by the 'skin head' as I thought I would  be” (Freya). 
Participants spoke about the difficulties around staying positive when contending 
with cancer treatment and the side-effects of treatment: 
“At the time I was diagnosed with breast cancer, I was being treated for a 
 clinical depressive…this funnily enough made me quite accepting of the 
 diagnosis. However, as I move through the different stages, surgery, 
 treatment, treatment-side effects, it makes it harder to be positive” (Ronnie). 
 “I feel very positive and strong. It will be interesting to see how my thoughts 
 and feelings compare in 3 months, after another 3 cycles. Fingers crossed I'll 
 feel the same :)” (Jan). 
Freya spoke about her main concern being how others would perceive her, 
particularly worrying that she will look ‘ill’ due to her hair loss: 
 “Throughout this experience I feel my main concern has been/is with the 
 thoughts and  perceptions of others rather than feeling bad about myself. 
 My main insecurity is worrying that I look 'ill' not the hair loss. I have been 
 lucky enough to keep my eyebrows and eyelashes- so far. This has helped 
 with such insecurities” (Freya). 
 
5.4 Discussion 
The findings from this study demonstrate the effect of the HeadStrong service on 
breast cancer patients’ distress in relation to their hair loss. The majority of 
participants attended HeadStrong to learn more about how to use headscarves and to 
prepare for the process of hair loss. Previous research (i.e. Harcourt & Frith, 2008; 
Hilton et al., 2008; Rumsey & Harcourt, 2005) has highlighted that hair loss can 
render an individual visible as a ‘cancer patient’. Some participants wanted to attend 
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HeadStrong to regain some control over this situation and hoped that feeling more 
confident about using headwear to disguise their hair loss would help them manage 
the reactions of other people and keep their cancer diagnosis more private.   
Participants who completed all questionnaires were younger than those who did not. 
Previous research has highlighted that younger women with breast cancer report a 
lower quality of life than older women, as younger women are at a different stage in 
their life than older women and are thought to experience greater distress (Knobf, 
2007). Side effects of breast cancer treatment tend to be more prominent in younger 
women including the onset of early menopause (Baucom, Porter, Kirby, Gremore & 
Keefe, 2006). It is, therefore, possible that the younger women may have completed 
all questionnaires as they felt more in need of support.   
The findings show that HeadStrong significantly improved participants’ confidence 
in managing their hair loss, the reactions of others to it and using the headwear to 
camouflage it. The benefits of the practical advice and information that they were 
given at HeadStrong was also evident in the qualitative study (chapter 4). Previous 
research has highlighted the benefits of information provision and advice 
(Fallowfield, 1992; McConochie & Pearson, 2006). The increase in confidence 
around managing hair loss and using headwear was maintained at 3 month follow-
up, however confidence in managing the reactions of others dropped over this time. 
This may be because the HeadStrong session focused on making hair loss less 
obvious, rather than managing their feelings about how other people reacted to their 
altered appearance. Previous research has highlighted that, despite being told how to 
prepare for the changes to one’s body as a consequence of chemotherapy, it is 
difficult to prepare for the reactions of other people (Hilton et al., 2008). The current 
study suggests HeadStrong may go some way to increase patients’ confidence 
around hair loss and use of headwear but camouflage alone is not sufficient to 
manage all the challenges facing patients who have lost their hair. Patients may need 
access to more support in managing the emotions they are feeling and coping with 
the reactions of others in ways other than camouflage. 
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Quality of life scores were found to reduce from baseline to 2 week follow-up and to 
3 month follow-up. Specifically a decrease in emotional well-being was found 
between 2 week and 3 month follow-up. However, it is not possible to determine 
whether this decrease in reported quality of life is due to hair loss alone, other side 
effects of cancer treatment or other things going on in participants’ lives (Cancer 
Research UK, 2014). A number of factors can impact on an individual’s quality of 
life, including age, treatment received, hair loss status and psychosocial factors 
including value placed on appearance, support received and health care experience, 
all of which are supported within the breast cancer literature (Helms et al, 2008; 
Knobf, 2007; Shapiro et al., 2001).  
 
A decrease in fear of negative evaluation, whereby participants are less concerned 
with how they think others will judge them, was found from baseline to 3 month 
follow-up. This may be because patients’ needs and priorities change as they 
progress through their cancer journey (Vogel, Bengel & Helmes, 2008), possibly 
becoming less concerned about what other people may think of them. Also, the 
increased confidence that participants reported at 3 month follow-up around 
managing their hair loss and using head wear may have positively influenced any 
fear of negative evaluation.  
 
Appearance-related distress, depression and quality of life scores (including 
physical, social and functional well-being) were all poorer at 3 month follow-up 
compared to baseline. This may be due to participants having lost all their hair by 3 
month follow-up and, along with the potential impact of other treatments (including 
weight gain and early onset menopause), may still be adjusting to an altered 
appearance, experiencing poor body image, loss of libido and an impact on intimate 
relationships (Fobair et al., 2006; Pauwels et al., 2012). This would suggest that 
despite HeadStrong going some way to help participants with some aspects of the 
side effects of their treatment, it did not buffer them against all aspects of 
appearance-related and other psychological distress, or help to maintain their quality 
of life.  
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Compared to other evaluations of camouflage-based interventions, these findings 
were similar to those of McGarvey et al (2010) who found that the education 
information provided alongside a computer imaging service was useful. Also, Nolte 
et al’s (2006) Best Look Forward intervention found a small but significant change 
in body image and all participants said they would recommend the camouflage based 
videotape intervention to others experiencing hair loss, however, some participants 
did find some aspects of the intervention unhelpful which is similar to the findings 
from the HeadStrong service evaluation. Similar to the current findings, Taggart et 
al’s (2009) Look Good Feel Better intervention was found to significantly improve 
self-image post intervention but these benefits were not maintained in the long term. 
Also, a significant reduction in self-consciousness was found. These findings suggest 
that camouflage based support services can go some way to support patients who are 
affected by treatment-related hair loss, however, additional interventions are required 
to meet individual support needs. 
It is important to acknowledge that the ARC framework has not been tested in full in 
the current study due to the small sample size. The suitability of the ARC framework 
is considered in chapter 7. Also, if there had been a larger sample size, it would have 
been possible to compare normative data for each of the measures.  
 
5.4.1 Limitations 
This was a quantitative study with only 16 participants at baseline, 10 at 2 week 
follow up and 9 at 3 month follow-up, all of whom were English speaking. The 
findings cannot therefore be generalised to other patients who have attended the 
HeadStrong service. Even though there were open ended questions in each of the 
questionnaires, participants only included comments at the end of the baseline 
questionnaires, therefore it was not possible to make narrative comparisons across all 
three time points. Recruitment may have been low due to the nature of the 
evaluation; some patients may not have liked the idea of filling out numerous 
questionnaires and may have preferred to take part in an interview or focus group, 
where they may have felt they had more of a voice (Cornwall, 2008). Additionally, 
the timing may not have been appropriate as potential participants already had a lot 
to contend with including receiving treatment and attending hospital appointments. 
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As a result they may not have wanted, nor had the time, to take part in research.  
Similarly, some women wanted to take part but chose not to, or consented and 
subsequently dropped out, because the side effects of treatment meant they were too 
unwell. Additionally, although the researcher maintained regular contact with the 
managers of the HeadStrong centres in order to oversee the process by which service 
users were invited to take part, it was not possible to determine whether everyone 
who attended a HeadStrong session received a questionnaire. A suggestion for future 
research would be for the researcher to speak to potential participants in person; 
however this may not be practical if geographically diverse HeadStrong sites are 
involved. Staggering recruitment from different sites might be effective and more 
feasible.   
Recruitment for the current study only took place at two HeadStrong sites, which 
may not be representative of other sites. However, HeadStrong is intended to be 
delivered in the same way in every centre since the volunteers all receive 
standardised training. Therefore, it is possible that similar findings would still be 
found if participants had been recruited from other HeadStrong sites. 
 
As stated above, due to the small sample size it was not possible to test the 
predictive ability of the ARC framework in full, particularly the role of the 
predisposing and intervening variables as mediators or moderators of the outcomes. 
This makes it difficult to comment on the suitability of the ARC framework in this 
context. If the sample size had permitted, a hierarchical stepwise regression analysis 
would have been conducted to assess the predictive ability of the predisposing and 
cognitive processing variables on the outcome variables.  
 
5.4.2 Synthesis of results 
 
The findings from the qualitative and quantitative HeadStrong studies have found a 
number of similar findings; participants wanted to attend HeadStrong in order to 
regain some control over their hair loss, they found the information and practical 
advice they received to be particularly helpful, and they found it difficult to deal with 
the reactions of others to their hair loss. Yet, although they found HeadStrong 
beneficial to an extent (e.g. increasing their confidence around managing their hair 
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loss and using headwear), participants still reported a number of unmet needs 
including emotional support. Therefore, the findings from the qualitative and 
quantitative studies suggest that HeadStrong was potentially beneficial, but could not 
address all participants’ needs alone. 
 
5.4.3 Clinical implications of the qualitative and quantitative HeadStrong 
studies 
The qualitative and quantitative HeadStrong studies support previous research 
demonstrating that hair loss is a very distressing side effect of treatment for many 
breast cancer patients. Whilst the findings cannot be generalised without caution, 
nevertheless they provide an insight into women’s experiences of a particular 
camouflage-based intervention that aims to support women across the UK who are in 
this difficult situation. The following recommendations could improve the provision 
of care to support this patient group: firstly, it is important that patients have a 
clearer understanding of what a HeadStrong session will involve, so they can be 
better prepared for it. Whilst some participants were satisfied with the amount of 
practical advice and information they received from HeadStrong, others would have 
liked more, indicating that the level of information given may vary from one centre 
to another and that participants’ information needs vary. Through the qualitative and 
quantitative studies, it became apparent that participants’ expectations were beyond 
the remit of HeadStrong. For example, some participants thought that the service 
would be delivered in a group setting or that it would offer emotional support, thus 
demonstrating the importance of patients talking through their expectations with the 
HeadStrong volunteers at the start of the session. Ideally, the service would be 
tailored more to the individual, so that participants start the session by discussing 
with the volunteer what they hope to get out of it, in order that the volunteer can 
tailor the session to the individual. However, this would require volunteers feeling 
confident in doing this and may require additional training.  
Secondly, the qualitative and quantitative HeadStrong studies highlighted that 
participants had been seeking emotional support, but this was not necessarily 
provided by the NHS. It is important that health professionals working with this 
patient group are aware of the potential emotional impact of receiving a cancer 
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diagnosis and experiencing treatment-related hair loss, and are confident in 
signposting patients towards emotional support, if needed. It is important that 
Oncology services ensure that people in their team (e.g. specialist nurses) are 
experienced and available to discuss hair loss with patients in order to assess the 
importance of hair to them, and their possible response to its loss. Such 
understanding is important for the provision of interventions that are meaningful to 
individual patients. It is acknowledged that many teams including specialist nurses 
do already go to great lengths to support patients well. A screening assessment could 
ensure patients are referred to appropriate sources of support such as other health 
professionals (including psychosocial specialists), support programs or self-help 
groups. For example, the Patient Concerns Inventory (PCI) (Rogers, El-Sheikha & 
Lowe, 2009) (www.patient-concerns-inventory.co.uk) may be useful to identify each 
patient’s concerns (a discussion of the PCI can be found in section 7.4.1). 
Further evaluation of HeadStrong is still warranted on a larger scale, as recruitment 
was a challenge for the current study. Some suggestions to aid future research 
include the researcher being on site to speak to potential participants as this has been 
found to benefit recruitment elsewhere (Jennings et al, 2014), and finding ways to 
establish the reasons why individuals do not want to participate. Evaluation of other, 
similar services (such as Head Start which is held at the Bristol Haematology and 
Oncology Centre (BHOC) and ‘My New Hair’ (http://www.mynewhair.org/for-
hairdressers/) are needed. Both of these services focus on head wear to camouflage 
hair loss, similar to HeadStrong. The Head Start service is based solely at BHOC, 
whereas, the ‘My New Hair’ service is available through salons throughout the UK. 
‘My New Hair’ is an organisation set up by Trevor Sorbie, a British celebrity 
hairdresser and offers a two stage, nurse and expert-led education program for 
hairdressers, in communication skills training and being able to style wigs. Also, 
Nicky Clarke, a celebrity hair dresser, also delivers training courses for hair stylists 
to learn how to cut wigs. 
Despite the limitations outlined above, the findings from the current study might still 
help to inform future research and indicate a number of recommendations for the 
provision of care. It is important that health professionals are able to signpost 
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patients to available services such as HeadStrong, but are also aware that patients 
might have other needs that a service like this is unable to address. Additional, 
alternative interventions need to be freely available and easily accessible for patients; 
especially bearing in mind that time was a constraining factor for many of the 
participants in the qualitative study.  
 
5.4.4 Disseminating the research findings 
Once the researcher had completed both the qualitative and quantitative HeadStrong 
evaluation, she attended a meeting at Breast Cancer Care’s Head Office, to present 
the study findings to the Director of Services and Engagement, along with BCC 
Heads at each of the NHS sites which host the HeadStrong Service. The researcher 
was also able to discuss the recommendations on how the service could be improved. 
As a result of the study findings, along with the feedback that Breast Cancer Care 
had received directly from their own ongoing feedback questionnaires, the 
HeadStrong service has been changed so that it is tailored more to individuals’ 
needs. As a result, HeadStrong volunteers receive additional training so that, at the 
start of a session, they discuss with the patient what they hope to gain from 
HeadStrong, and then tailor the session to the individual’s needs. Also, patients are 
provided with more information about the HeadStrong service prior to attending a 
session. A summary of the research findings were also shared with the HeadStrong 
volunteers, the participants from the qualitative and quantitative studies, BCC 
Cancer Voices and the member of ASWCN, who had been advisors for the study.  
 
5.5 Conclusion 
In conclusion, these qualitative and quantitative studies suggest that the HeadStrong 
service can be a helpful intervention for breast cancer patients affected by hair loss 
in terms of improving confidence in managing hair loss, particularly around using 
head camouflage. As highlighted previously (chapter 4) support needs vary between 
individuals and throughout their cancer journey; not all patients want the same 
support with hair loss. For some, their concerns centre around managing the 
reactions of others, whilst others focus on appearance concerns or practical issues 
such as having a cold scalp. Therefore, individuals warrant different support 
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depending on their specific concerns and efforts should be taken to ensure that each 
patient’s individual needs are identified and addressed. It is imperative that patients 
are equipped with strategies to help them to manage all aspects of hair loss, rather 
than relying on one strategy, such as camouflage.   
In summary, HeadStrong may be a valuable intervention for some patients but it will 
not necessarily provide all the support they require and it will not appeal to all 
patients. There is still potential to develop the range of interventions available for 
this patient group. The following chapter therefore considers the feasibility of an 
alternative intervention (expressive writing) to support breast cancer patients who 
are affected by treatment-related hair loss.   
 
5.6 Summary of the key points in this chapter: 
 The findings of this study provide an insight into women’s experiences of 
one particular intervention.  
 Benefits of HeadStrong included improvements in self-reports of confidence 
in managing hair loss, using headwear to camouflage hair loss and handling 
the reactions of others.  
 Participants’ reported quality of life, emotional well-being and fear of 
negative evaluation were found to reduce over time, but appearance-related 
distress and depression were all poorer at 3 month follow-up.  
 The research has led to the development of a number of recommendations for 
the provision of care, including the HeadStrong session being tailored to 
individuals’ needs. 
 It is evident that HeadStrong maybe appropriate for some individuals, but 
additional interventions are required to address patients’ unmet needs and to 
offer a broader, more holistic approach to supporting those who are affected 
by hair loss. 
 
5.7 The next stage of the research 
Although HeadStrong has been found to be beneficial for some people, a number of 
participants in the qualitative and quantitative HeadStrong studies highlighted a 
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number of unmet needs, mainly around emotional and psychological support. A 
sizeable body of research has demonstrated that expressive writing can offer benefits 
in physical health and psychological wellbeing (Pennebaker et al, 1997), which is 
important for this patient group given that breast cancer patients can experience an 
increase in appearance-related distress and decrease in QOL over time, as found in 
the quantitative HeadStrong service evaluation. To date, the potential benefits of an 
expressive writing intervention have not been explored with breast cancer patients 
who are affected by treatment-related hair loss. The following chapter therefore 
explores the feasibility and acceptability of an expressive writing intervention. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Six: An Expressive Writing Intervention  
 
 
 
183 
 
Chapter Six 
Feasibility of an Expressive Writing Intervention to Support Breast 
Cancer Patients Affected by Treatment-Related Hair Loss 
 
6.1 Introduction 
The findings from the systematic review discussed in chapter 2 highlighted that there 
is relatively little evaluated, specialist support available to help breast cancer patients 
manage the challenges and emotional distress associated with hair loss. These 
findings, along with those from the HeadStrong service evaluation in chapters 4 and 
5 which showed that despite the positive findings including helping them with the 
practical side of hair loss, women felt that not all their emotional and psychological 
needs were met, helped to inform the final study in this program of research: the 
feasibility of an expressive intervention to support breast cancer patients affected by 
treatment-related hair loss. Rather than conducting a full RCT of HeadStrong, after 
careful consideration, it was decided it would be more advantageous to conduct a 
scoping study of expressive writing interventions and to adapt an existing expressive 
writing intervention, to explore its acceptability and feasibility with a new patient 
group. As the participants in the HeadStrong evaluation highlighted a number of 
unmet needs, once these findings had been fed back to Breast Cancer Care, it was 
thought to be more advantageous to explore a different intervention with this patient 
group. Also, recent research has highlighted a need for interventions which utilise 
novel approaches such as writing activities, to address body image distress in breast 
cancer patients (Fingeret, Teo & Epner, 2014). 
This chapter begins by providing an overview of what expressive writing is; the 
findings from a scoping study are then presented, followed by a justification of why 
an existing intervention was selected, by discussing the origin of this approach and 
outlining different theories which have been proposed to explain its benefits. 
Specifically, its use in previous research with breast cancer patients is then discussed 
before the feasibility study is presented. A noteworthy point is that the phrases 
‘expressive writing’ and ‘emotional disclosure’ are used interchangeably as they are 
both used within the literature to denote essentially the same intervention. 
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6.2 Pennebaker and Beall’s expressive writing paradigm 
For a number of years research has investigated the health benefits of expressive 
writing using a paradigm developed by Pennebaker and Beall (1986), were 
participants are required to write about their deepest thoughts and emotions about a 
stressful or traumatic life experience, typically for 15 to 20 minutes on three or four 
consecutive days. Pennebaker (1993) argues that the process of making sense of an 
event, of gaining insight about a trauma, and of organising and interpreting an 
upsetting experience into one’s self-schema is the mechanism by which expressive 
writing is helpful. This supports Piaget’s cognitive development theory, where 
individuals can either assimilate the experience into their existing schema or 
accommodate their schema to the new experience (Poon & Danoff-Burg, 2011). 
Therefore, the benefits of emotional disclosure include the ability to disclose 
information which enables individuals to free their mind of unwanted thoughts, help 
them to make sense of upsetting events and teach them to regulate their emotions in 
a more beneficial manner. 
Pennebaker’s expressive writing paradigm is attractive to researchers, care providers 
and funders due to it being low-cost and requiring minimal time to implement (Lee 
& Cohn, 2010). Expressive writing can be carried out at any time and venue which 
suits the participant, making it potentially well suited for patients (Ashley, O’Connor 
& Jones, 2011). Since chronic illnesses including breast cancer are expensive to treat 
and manage, low-cost and easily administered interventions are particularly 
appealing to help control treatment costs while improving patients’ quality of life 
(Broderick, Stone, Symth & Kaell, 2004). Self-administered interventions offer 
particular benefits, such as decreased need for direct health professional assistance 
and the potential for broad delivery (e.g. to target poorly served rural areas) (Smyth 
& L’Abaté, 2000).  
 
6.3 Effectiveness of expressive writing studies 
Despite emotional disclosure generally being considered beneficial, some 
researchers have begun to question its effectiveness due to the inability to replicate 
the effects. A number of meta-analyses have been conducted (Smyth, 1998; Frisina, 
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Borod & Lepore, 2004; Frattaroli, 2006; Harris, 2006; Mogk, Otte, Reinhold-Hurley 
& Kroner-Herwig, 2006; Zhou, Wu, An & Li, 2015). Overall, these meta-analyses 
showed expressive writing to work, with small significant effect sizes of .230 
(Smyth, 1998) and .101 (Frisina et al., 2004). Zhou et al (2015) stated that a 
significant effect was found with expressive writing studies reducing somatic 
symptoms for breast cancer patients.  Moreover, the results from a meta-analysis by 
Frattaroli (2006) confirm that experimental disclosure does have small but beneficial 
effects for participants with an overall r-effect of .075. This effect size is smaller 
than that found in the previous two meta-analyses, possibly because Frattaroli (2006) 
included a large number of unpublished studies. Frattaroli’s (2006) meta-analysis 
highlighted that effect sizes tended to be larger when studies only included 
participants with physical health problems and/or a history of trauma or stressors, 
and were not college students. Furthermore, studies involved disclosure at home, 
with sessions of at least 15 minutes, and participants were instructed to discuss 
previously undisclosed topics and to write about recent events.  
In contrast, Harris (2006) found expressive writing to be effective in healthy people 
but not in people who had received a medical diagnosis. Mogk et al (2006) found 
that expressive writing had either minor or no effects. It is important to acknowledge 
that the diversity of populations included and the heterogeneity of the meta-analyses 
may be accountable for the discrepancy in findings (Zhou et al, 2015). Recent 
research has argued that even small effects of expressive writing in subgroups of 
patients could still be clinically relevant (Zachariae & O’Toole, 2015). 
 
6.4 Theories to explain why expressive writing is beneficial 
A number of theories have been proposed as possible explanations for why 
expressive writing can be beneficial, the next section will provide an overview and 
critique of these theories. 
 
6.4.1 Inhibition theory  
Rather than inhibiting thought and feelings, it has been found that expression of 
thoughts and feelings about an upsetting event is beneficial, leading to a reduction in 
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stress and improvements in psychological and physical health (Frattaroli, 2006). 
Early emotional disclosure studies encouraged people to write about events which 
they had not previously discussed with anyone (Frattaroli, 2006). This suggests that 
those who naturally hold back and keep things to themselves would benefit the most 
from expressive writing. However, Francis and Pennebaker (1992) found that 
participants who were low in dispositional constraint benefited most from an 
experimental disclosure intervention, whereas those who were high in dispositional 
constraint benefited less. Moreover, the results from Frattaroli’s (2006) meta-
analysis provide very little support for inhibition theory, since there was some 
evidence that studies that instructed participants to discuss undisclosed trauma were 
only marginally better than studies that lacked this instruction.  
 
In contrast there is evidence to suggest that writing about a stressful/traumatic event 
that one has previously discussed with others is as likely to produce beneficial health 
outcomes as writing about a stressful/traumatic event that has not been discussed 
previously (Greenberg & Stone, 1992). This may be because there is an important 
distinction between describing traumatic experiences and disclosing deep emotions 
and thoughts related to these experiences (Sloan & Marx, 2004). In summary, the 
inhibition theory has received mixed support as an underlying mechanism for the 
written disclosure paradigm.  
 
6.4.2 Cognitive-processing   
Another theory thought to explain the benefits of expressive writing is cognitive-
processing theory. Pennebaker, Colder and Sharp (1990) asked participants who had 
reported benefiting from the expressive writing process why they thought they had 
benefited; most felt that writing allowed them to gain insight into what had happened 
to them. By using a computerised text-analysis program to examine the words used 
during the writing exercises, Pennebaker, Francis and Booth  (2001) found that 
participants who had benefited most from emotional disclosure in previous studies 
demonstrated an increase in the use of causation words (such as because, effect, 
hence) and insight words (for example consider, know, think) during their writing 
Chapter Six: An Expressive Writing Intervention  
 
 
 
187 
 
session. In contrast, those who did not benefit from disclosure did not increase their 
use of these types of words.  
The cognitive-processing theory has proven difficult to evaluate empirically, as it is 
difficult to measure cognitive changes (Sloan & Marx, 2004). Also, research has 
provided very little support for this theory as cognitive-processing instructions were 
not significantly related to higher effect sizes (Frattaroli 2006). The evidence 
supporting the cognitive theory is correlational and it is possible that the changes 
observed in the language used to describe and discuss traumatic and stressful events 
may be associated with some other mechanism of change (Sloan & Marx, 2004).  
 
6.4.3 Self-affirmation  
Self-affirmation helps to explain why certain individuals are more negatively 
affected by certain situations than others. “A strong self is a self-affirmed self, a self 
that is able to deal with threatening events and information by drawing resources 
from itself” (Stapel & Van der Linde, 2011, p. 34). Individuals with greater self-
resources (i.e. social status, personal characteristics) have been found to recover 
more quickly from negative events and experience greater well-being (Hobfall, 
1989). There are two types of self-affirmation techniques; value affirmation and 
attribute affirmation. An example of value affirmation is where participants are 
asked to rank a number of values and personal characteristics (e.g. relations with 
friends, artistic skills) in order of personal importance. Participants are then asked to 
indicate their most important value and to write an essay describing why this value is 
important to them (Sherman et al, 2000). Whereas in attribute affirmation studies, 
participants are provided with positive feedback about their personality with an aim 
to increase the cognitive accessibility of positive self-definitions, an example of 
positive feedback is “although you may feel you have a number of personality 
weaknesses, your personality is fundamentally strong” and “You are very social”  
(Koole & van Knippenberg, 2007, p.673). 
Value affirmation increases self-clarity by affirming an individual’s core beliefs and 
through this process individuals are reminded of who they are, what they deem 
important and what they stand for, whereas attribute affirmation increases self-
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esteem as an individual affirms positive self-descriptions, positive self-images are 
made salient, which is likely to temporarily increase one’s feelings of self-worth 
(Stapel & Van der Linde, 2011). Creswell et al., (2007) found that self-affirmation 
mediated the relationship between emotional expression and benefit writing on 
early-stage breast cancer patients’ physical symptoms at 3-month follow-up. Their 
study suggests that self-affirmation can help buffer the stress associated with writing 
about difficult cancer-related thoughts and feelings.  
 
6.4.4 Self-regulation theory 
Experimental disclosure allows individuals to observe themselves expressing and 
controlling their emotions, which is thought to give people a new or stronger sense 
of self-efficacy for emotional regulation (Lepore, Greenberg, Bruno & Smyth, 
2002). A self-regulation writing exercise found that when students described 
problems they encountered in college and came up with ways to resolve them, this 
produced the same benefit as expressive writing (Cameron & Nicholls, 1998). King 
(2001) found that writing about one’s ‘best possible self’ produced health benefits, 
including a reduction in visits to the doctor, similar to those found from writing 
expressively about a trauma. It is believed that people experience emotion as a result 
of the status of their goals, as a feedback system which tells them whether they are 
on the right track or are moving away from the path that will lead them to goal 
attainment. Therefore, emotional disclosure allows an individual to make sense of 
the event, explore sources of emotion, clarify goals and get the self-regulation 
feedback system back on track (King, 2002).  
If self-regulation is the mechanism by which experimental disclosure works, writing 
about a positive event should produce the same benefits as writing about the 
negative. The self-regulation theory has received support; particularly for reducing 
symptoms of depression, however, to date there are few studies (Frattaroli, 2006).  
6.4.5 Exposure theory 
Exposure theory argues that the expression of thoughts and feelings about an 
upsetting event is similar to exposure therapy and learning theory (Sloan & Marx, 
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2004). Research has suggested that the written disclosure paradigm may allow an 
individual to be exposed to aversive stimuli that had been previously avoided, and 
that the repetition of confronting and describing their thoughts and feelings about 
their traumatic experience, should lead to these thoughts and feelings being 
eliminated (Lepore & Smyth, 2002; Sloan & Marx, 2004).  
A number of studies have explored changes in intrusive thoughts and avoidance as 
outcome measures of the written disclosure paradigm, but findings have been mixed. 
Whilst some studies indicated reductions in intrusive thoughts (Klein & Boals, 2001; 
Schoutrop, Lange, Hanewald, Davidovich & Salomen, 2002) others found no effects 
(De Moor et al., 2002; Lepore, 1997; Stroebe, Strobe, Scut, Zech & van den Bout, 
2002). A number of explanations may account for these mixed results; some studies 
have used small sample sizes (e.g. Gidron, Peri Connolly & Shaley, 1996; Walker, 
Nail & Croyle, 1999) which may not be surprising as the attrition rate for exposure 
therapy is relatively high at 80-90%; and some studies used only a single writing 
session (Lepore, 1997; Smyth, True & Souto, 2001), which may have not been long 
enough to clear negative emotional thoughts. Furthermore, studies have varied in 
their length of follow-up period which may account for the difference in efficacy. To 
date, the evidence provides inconsistent support for exposure theory. 
Several theories have been discussed above, although there is some data to support 
them, there is contradictory evidence for each theory, suggesting that a single theory 
may not fully account for the effects of written emotional disclosure. Sloan and 
Marx (2004) suggest that it may be possible that one mechanism accounts for the 
initial changes in health and psychological status while another mechanism accounts 
for the maintenance of changes. However, regardless of the underlying mechanisms, 
evidence shows that expressive writing is malleable to differing situations and 
participants (Smyth & Pennebaker, 2008), making it a promising intervention for use 
with patient groups going through difficult and varied health-related experiences.  
 
6.5 A scoping study of expressive writing studies 
Scoping studies enable a researcher to “map the key concepts underpinning a 
research area and to highlight the main sources and types of evidence available” 
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(Mays, Roberts & Popay, 2001, p. 194). An advantage of a scoping study is the 
ability to explore the range and nature of studies in a research area and to identify 
any gaps in the literature. As there are no set procedures for scoping the literature, a 
scoping study using Arksey and O’Malley’s (2005) framework which includes five 
stages was conducted to explore the available expressive writing studies. The 
scoping study started by identifying the research question, which was ‘What is 
known from the existing literature about the availability and effectiveness of 
expressive writing studies?’.  
To provide a comprehensive review of the available expressive writing studies, no 
date limits were set and in 2014 electronic searches were conducted on the following 
databases: Allied and Complimentary Medicine Database (AMED), Applied Social 
Sciences Index and Abstracts (ASSIA), British Nursing Index (BNI), Campbell 
Collaboration, Cumulative Index to Nursing and Allied Health Literature 
(CINAHL), Cochrane Library, PsychINFO, Science Direct. For each database 
specific MeSH terms were identified for the broad term; expressive 
writing/emotional disclosure. Inclusion criteria consisted of studies published in 
English, which focused on the health benefits of expressive writing, however, to 
maintain an inclusive approach, the studies included were not restricted to a clinical 
population. Hand searches were also conduced of key journals, in case any studies 
were missed from the database searches. The researcher also contacted experts in the 
field, to explore any unpublished expressive writing/emotional disclosure studies. 
Study data was then entered onto a ‘data charting form’ using Microsoft Excel, 
information included; the author(s), year of publication, intervention type, study 
population, methodology and results (see Appendix 19 for a list of the expressive 
writing studies identified). A noteworthy point is that a scoping study is not as 
rigorous as a systematic review, it provides a narrative account of the existing 
literature, it does not aim to assess the quality of evidence unlike a systematic review 
(Arksey & O’ Malley, 2005). A narrative account of the findings from the scoping 
study is presented below, comparisons across the studies are provided and gaps in 
research are highlighted. 
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6.6 Expressive writing studies 
Through the scoping study, twenty nine expressive writing studies were found. A 
critique of research on emotional disclosure studies is that they were conducted with 
healthy college/university students (Baum & Rude, 2013; Knowles, Wearing & 
Campos, 2011; Lepore, 1997; O’Connor & Ashley, 2008; O’Connor et al., 2010; 
Poon & Danoff-Burg, 2011; Sloan, Feinstein & Marx, 2009). Participants were 
required to go to a laboratory for three to five sessions of 15-20 minutes each, during 
which they were randomly assigned to either write expressively about a 
stressful/traumatic experience or write without emotion about a neutral topic 
(Frattaroli, 2006). Some of the benefits of emotional disclosure studies include 
improvements in immune function (Pennebaker, Kiecolt-Glaser & Glaser, 1988), 
reduction in health centre visits (Pennebaker et al., 1990), reduction in absenteeism 
rates from work (Francis & Pennebaker, 1992) and decrease in self-reported upper 
respiratory problems (Greenberg, Wortman & Stone, 1996). Moreover, although 
most people find experimental disclosure to be a positive experience, some 
individuals do report that they find the experience to be unenjoyable or unhelpful 
(Frattaroli, 2006). 
Disclosure studies soon progressed from college/university samples to community 
members, including those with rheumatoid arthritis, asthma and migraine headaches. 
The first study of this kind was published by Kelley, Lumley and Leisen (1997) who 
explored the effects of experimental disclosure on arthritis-related problems in 
rheumatoid arthritis patients. Those who wrote expressively about traumas compared 
with non-writing controls reported less physical dysfunction in the weeks following 
writing. Research findings with medical patients include a reduction in cancer-
related doctor visits for breast cancer patients assigned to an experimental disclosure 
group (Stanton et al, 2002). Emotional disclosure has more recently been used with 
individuals with psychiatric and psychological problems, the results from which are 
mixed; Russ (1992) found that disclosure improved psychological and physical 
health for college students who had a history of anxiety. Moreover, some studies 
have found null effects for disclosure, such as studies with former psychological 
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patients (Bird, 1992), participants with negative body image (Earnhardt, Martz, 
Ballard & Curtin, 2002) and those with suicidal tendencies (Kavoc & Range, 2002).  
Imrie and Troop (2012) carried out a pilot study involving a self-compassion 
instruction in an expression task to identify the possible effect on psychological 
outcomes using participants from a day hospice. All participants in the experimental 
group reported an increase in self-soothing, at one week follow-up, whereby they 
were able to help themselves to reduce negative feelings and promote positive 
feelings, whereas those in the control group reported a decrease in self-soothing. 
However, there were a number of limitations of the study which include a small 
sample size, so there were not enough participants to carry out meaningful inferential 
statistical analysis. The study demonstrates that a simple modification to standard 
expressive writing instructions can improve self-soothing and self-esteem. 
 
6.6.1 Expressive writing studies with breast cancer patients 
A number of expressive writing studies have been conducted with breast cancer 
patients (Craft, Davis & Paulson, 2013; Gellaitry, Peters, Bloomfield & Home, 2010; 
Gripsrud, Brassil, Summers, Søiland, Kronowitz, & Lode, 2016; Laccetti, 2007; 
Low, Stanton & Danoff-Burg, 2006; Low, Stanton, Bower & Gyllenhammer, 2010; 
Stanton et al., 2000; Stanton et al., 2002; Przezdziecki, Alcorso & Sherman, 2016; 
Przezdziecki & Sherman, 2016). Merz, Fox and Malcarne (2014) conducted a 
systematic review of experimental trials of cancer patients who participated in an 
expressive writing intervention, nine of the thirteen studies included in the review 
were with breast cancer patients. Several main effects for expressive writing were 
found, including sleep, pain and general physical and psychological symptoms. 
Stanton et al. (2002) asked breast cancer patients to either write about their deepest 
thoughts and feelings regarding breast cancer (expressive writing group), positive 
thoughts and feelings regarding breast cancer care (benefit finding group) or a 
control group. It was found that both the emotional expression group and the benefit 
finding group made significantly fewer medical visits for cancer-related illness at a 
three month follow-up than the control group. Moreover, female participants 
commented that expressive writing was helpful to them personally. Przezdziecki and 
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Sherman (2016) found that a self-compassionate writing intervention led to reduced 
levels of negative affect and an increase in a self-compassion in breast cancer 
survivors with body image-related issues. Furthermore, Craft et al (2012) found that 
early breast cancer survivors who wrote about the trauma of their diagnosis or facts 
about their disease showed greater improvement in their quality of life than those 
who did not write or those who wrote about a self-selected traumatic event. 
However, the generalisability of the findings of this study are limited because it was 
conducted with a convenience sample.  
Extensive research has demonstrated that social support is important for positive 
adjustment and decreased psychological distress, specifically, the perceived 
match/mismatch between wanted and perceived support is crucial with ‘mismatch’ 
being related to poorer psychosocial adjustment (Reynolds & Perrin, 2004). A study 
by Gellaitry et al (2010) found significant effects of an expressive writing 
intervention on perceptions of social support in a cohort of women who had recently 
completed treatment for early stage breast cancer. Women who wrote about their 
experiences of having breast cancer were more satisfied with the support that they 
were receiving from significant people in their lives compared to those in the control 
group. Recent research found that a self-compassion based writing activity was 
found to be acceptable by breast cancer survivors and health professionals 
(Przezdziecki et al, 2016). 
Low et al (2010) explored the effects of a home-based expressive writing 
intervention among metastatic breast cancer patients. The findings are inconsistent 
with previous trials conducted with early stage breast cancer patients and no main 
effects were found. However, this is the first randomised control trial to examine the 
effects of expressive writing with metastatic breast cancer patients.  
 
6.7 Health benefits of expressive writing 
Expressive writing studies have found physical improvements in clinically relevant 
outcomes including reduction in blood pressure in those whose blood pressure is 
elevated (Beckwith McGuire, Greenberg & Gevirtz, 2005), improved immune 
function (Esterling, Antoni, Fletcher & Margulies, 1994; Pennebaker et al., 1988; 
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Petrie, Booth, Pennebaker & Davidson, 1995), faster wound healing following 
biopsy (Weinsman, Ebrecht, Scott, Walburn, & Dyson, 2008), improvements in 
patients with severe asthma or rheumatoid arthritis (Broderick et al, 2004) and 
reduced health problems (Greenberg & Stone, 1992; Pennebaker & Beall, 1986). 
Moreover, King and Miner (2000) highlight that writing about the benefits of a 
traumatic event was just as beneficial in reducing illness-related doctor’s visits as the 
more traditional disclosure paradigm. With regards to the effects of expressive 
writing on psychological health, it has been found that some patient groups reported 
improvements in well-being (Broderick, Junghaenel & Schwartz, 2005), increased 
positive affect (Normal, Lumley, Dooley & Diamond, 2002), and reductions in 
depressive symptoms (Bodor, 2002). 
It is believed that the traditional writing paradigm has become less effective, 
possibly because the idea of writing about stress and worries has become a common 
activity, particularly in western countries, alongside a cultural shift towards being 
more open and emotionally expressive (Smyth & Pennebaker, 2008). For example, 
social networking sites are now common and provide ‘normal’ opportunities for 
written forms of emotional disclosure.  
 
6.8 Analysis of the use of language in expressive writing  
The cognitive-processing theory has been outlined above in section 6.4.2.  It has also 
been suggested that the use of cognitive mechanism words in describing an event 
may indicate a process of reappraisal, suggesting participants are changing from not 
processing to actively processing an event. Using a computerised text analysis 
program, Linguistic Inquiry and Word Count (LIWC) (Pennebaker et al., 2001), 
researchers have found that increasing use of cognitive mechanism words (e.g. 
causal words such as ‘because’ or ‘cause’ and insight words such as ‘think’ or 
‘consider’) is linked to greater health improvements (Pennebaker & Francis, 1996; 
Pennebaker, Mayne & Francis, 1997). Increases in cognitive mechanism words have 
also been associated with improvements in posttraumatic psychological growth 
(Ullrich & Lutgendorf, 2002), improved immune function (Petrie et al., 1995), and 
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fewer negative changes brought about by being HIV + (Rivkin, Gustafson, 
Weingarten & Chin, 2006).  
A study by Lee and Cohn (2010) used Pennebaker’s LIWC program to gain an 
insight into the coping strategies of participants in their expressive writing 
intervention. It was found that participants who used proportionally more insight-
related words in their writing samples scored lower than other participants on two of 
the three scales assessing emotion-focused coping. These findings provide tentative 
support that emotion-focused coping inhibits the use of insight when adults think 
about stressful experiences. Also, participants who used more essay words denoting 
negative emotion displayed a tendency to score lower on the problem-focused 
coping scale derived from COPE. This provides support that problem-focused 
coping inhibits the use of negative emotion words when thinking about stressful 
experiences. Moreover, Laccetti (2007) explored the relationship between patterns of 
word use in expressive writing and QOL scores at baseline and at three month 
follow-up in women with metastatic breast cancer. It was found that women who 
used more positive-affect words demonstrated higher scores on the emotional well-
being subscale three months after the writing intervention compared to those who 
used more negative-affect words.  
 
6.9 Factors used in expressive writing studies 
This section discusses the factors that have been included in previous expressive 
writing studies. 
 
6.9.1 Moderators and mediators  
6.9.1.1 Alexithymia  
Alexithymia is a personality construct which has been highlighted as potential 
moderator of the health benefits of expressive writing (Baikie, 2008). Although 
individuals with alexithymia are not characterised by an absence of emotional 
experience, they do find it difficult to identify and label their feelings (Taylor, Bagby 
& Parker, 1997) and express them verbally (Ashley et al., 2011). Engaging in 
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expressive writing requires an individual to be able to identify and express their 
feelings linguistically. The majority of studies have found that individuals lower in 
alexithymia derive greater benefits from expressive writing (Lumley, 2004). 
However, some studies have found that higher alexithymia scores are associated 
with better disclosure outcomes (Solano, Donati, Pecci, Persichetti & Colaci, 2003). 
Ashley et al (2011) found no main effects of a writing intervention on depressive or 
anxious symptoms but did find that alexithymia moderated the efficacy of expressive 
writing, as lower scores on alexithymia were associated with improved depressive 
and anxiety symptoms at follow-up in the positive and control writing conditions but 
not in a stress writing condition.  
 
6.9.1.2 Individual differences 
Individual differences among participants may account for some of the differences in 
the effect of emotional disclosure. Western culture typically discourages men from 
expressing emotion, therefore men may benefit more because this paradigm provides 
them with a context to express themselves that they normally would not have 
(Frattaroli, 2006). This can also be extended to ethnic groups who have a less 
expressive culture and to those who have an emotionally inhibited personality.  
The effectiveness of expressive writing has been found to vary according to coping 
style. Cameron and Nicholls (1998) proposed that pessimists may use expressive 
writing as a means of ruminating on a problem and avoiding the pursuit of effective 
coping strategies, whilst optimists may use it as a means of gaining insight into a 
problem and developing effective coping strategies. A study of breast cancer patients 
supports the claim that individual differences influence the efficacy of expressive 
writing interventions. Stanton et al, (2002) assess the coping style of each participant 
using three subscales on the COPE measure and found that participants who 
displayed a non-avoidant coping style benefited more from the expressive writing 
intervention than did those who displayed an avoidant coping style. However, Miller 
and Cohen (2001) found that individuals with avoidant coping styles may benefit 
more than other participants from expressive writing.  
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In summary, research suggests that individuals who have difficulty feeling or 
expressing their emotions to others are more likely to benefit from writing, however 
to date there is no clear picture of whether personality or individual difference 
dimensions may moderate expressive writing (Smyth & Pennebaker, 2008). 
 
6.9.2 Outcome variables 
A number of studies (i.e. Pennebaker & Francis, 1996; Sloan & Marx, 2004) have 
relied on GP visits as the dependent variable, but many individuals do not visit a GP 
even when they are unwell. The exclusion of additional outcome measures limits 
researchers’ ability to determine whether physical health complaints and visits to a 
GP may actually be an indication of depression or perhaps a history of trauma, 
therefore, it is imperative that studies employ psychometrically sound self-report 
measures of psychological functioning as well as a measure of physical functioning 
(Sloan & Marx, 2004). 
 
6.9.3 Writing instructions 
The instructions developed by Pennebaker and Beall (1986) allow participants to 
choose their writing topic, whereas some studies have directed the participant to 
write about particular issues. Smyth’s (1998) meta-analysis of the available literature 
indicated that the instructions to write about current traumas resulted in a higher 
mean effect size for outcome than instructions to write about past traumas. 
 
6.9.4 Number and duration of writing sessions 
Typically, studies include three writing sessions (Batten, Follette, Hall & Palm, 
2002; Esterling et al., 1994; Richards, Beal, Seagal & Pennebaker, 2000; Smyth, 
Stone, Hurewitz & Kaell, 1999), however some have used one (Greenberg et al., 
1996; Lepore, 1997), four (Greenberg & Stone, 1992; Park & Blumberg, 2002; 
Pennebaker & Beal, 1986; Pennebaker et al., 1988), five (Schoutrop et al., 2002; 
Spera, Buhrfeind & Pennebaker, 1994) or seven sessions (Stroebe et al., 2002).  
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There has been recent debate over how long one should write in order to benefit 
from it. The majority of expressive writing studies ask participants to write for 15-20 
minutes a day for 2 or 3 consecutive days, but this time period has been driven by 
convention rather than empirical evidence and few studies have sought to identify 
the minimum writing period required to benefit. Although the original session by 
Pennebaker and Beall (1986) used a 15-minute session, most studies have used 20-
minute sessions and some have even used 30 (Greenberg et al, 1996) or 45-minute 
sessions (Schoutrop, Lange, Brosschot & Everaerd, 1997). A study by Burton and 
King (2008) instructed participants to write for two minutes each day for two days. 
Participants were found to gain health benefits from the two minutes of writing but 
this meant they were often cut off in the middle of thought. The first meta-analysis 
on expressive writing by Smyth (1998) found that duration was unrelated to writing 
benefits. Frattaroli’s (2006) meta-analysis found that writing sessions longer than 15 
minutes tended to show a larger effect than sessions less than 15 minutes. However, 
the meta-analysis employed studies which included physically and psychologically 
healthy participants. Consistent with both the cognitive and exposure theories of 
expressive writing, the number and duration of the writing sessions may be 
important, as only a few sessions that are short in duration may not be adequate for 
cognitive reframing and/or elimination of negative emotions.  
 
6.9.5 Time between writing sessions 
The spacing between writing sessions also seems to be flexible; research has found 
that 1 hour of intensive writing produced similar physical health benefits to the 
traditional 3-days, although students perceived the writing as less helpful in this 
shortened duration (Symth & Pennebaker, 2008). The meta-analysis by Smyth, 
Hockemeyer and Tulloch (2008) suggests that if the days where people engaged in 
expressive writing were spread out then the effects may be stronger, however 
research has failed to support this idea (Sheese, Brown & Graziano, 2004). A 
number of studies have conducted the writing sessions on consecutive days, although 
a few studies have spaced out the sessions over one (Esterling et al, 1994, de Moor, 
2002), two (Schoutrop et al, 1997) or three weeks (Stanton et al, 2002). Smyth’s 
(1998) meta-analysis indicated that studies that used a longer period of time between 
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sessions were associated with a higher effect size. However, this finding was based 
on a limited number of studies, making the interpretations of this data tentative. 
Therefore, there does not appear to be a clear indication that a longer time period 
between sessions is associated with greater benefits than writing sessions conducted 
on consecutive days. 
 
6.9.6 Follow-up  
Researchers have varied the time to follow-up such that they range from 
immediately following the last writing session to 6 months later. The variation of the 
follow-up period may explain some null findings (Batten et al., 2002; Stroebe et al, 
2002) as it may be the case that any beneficial effect obtained through written 
disclosure may disperse after a few months (Sloan & Marx, 2004). A number of 
studies have included multiple follow-ups; however all of these studies have 
collapsed the multiple follow-up visits in order to compute a single follow-up visit 
score used in subsequent analyses (de Moor et al, 2002; Smyth, True & Souton, 
2001; Walker et al., 1999). This approach does not allow for an examination of 
whether the beneficial effects of expressive writing are sustained. It is important to 
note that that some studies find increases in negative outcomes in the short term 
before the beneficial effects emerge in the medium to longer term. 
This section has highlighted the different factors which previous expressive writing 
interventions have included. Expressive writing studies can vary with regards to their 
design, including the length of the writing sessions, the time between writing 
sessions. The following sections will discuss the feasibility and acceptability of an 
adapted expressive writing intervention for breast cancer patients affected by 
treatment-related hair loss.  
 
6.10 Justification for the use of an expressive writing intervention to support 
breast cancer patients affected by treatment-related hair loss 
As outlined above, a sizeable body of research has shown expressive writing can 
offer benefits in physical health and psychological wellbeing (Pennebaker et al, 
1997), which is important for this patient group given that breast cancer patients can 
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experience an increase in appearance-related distress and decrease in QOL over 
time, as found in the quantitative HeadStrong service evaluation (chapter 5) and 
previous published literature (see chapter 1). Self-administered interventions offer a 
number of benefits not only to patients but to healthcare providers, as highlighted 
above. A study by Gripsrud et al (2016) highlighted the appropriateness of an 
expressive writing intervention for breast cancer patients, as it enables individuals to 
process their feelings and release cognitive and emotional worries. Whilst expressive 
writing interventions have been used effectively with breast cancer patients, 
including their ability to address body image issues in breast cancer survivors 
(Przezdziecki & Sherman, 2016), they have not been used with a specific focus on 
hair loss. Given the complexity of the personal impact of a cancer diagnosis and 
treatment, it is important to consider specific stressors (e.g. hair loss) and explore 
ways of helping patients (see chapters 1 and 4 for an in-depth discussion of the 
personal impact of a breast cancer diagnosis and the side effects of treatment).  
The systematic review and HeadStrong service evaluation highlighted the 
importance of interventions being delivered soon after a cancer diagnosis and prior 
or soon after individuals have started to lose their hair. The systematic review also 
highlighted the importance of enabling participants to express their concerns (see 
section 2.4.10). A number of participants in the qualitative study (chapter 4) spoke 
about how time and travel were constraining factors on their attendance at support 
groups, and others stated that they preferred interventions that are one-to-one rather 
than with other people, which supports the same finding from the systematic review. 
Also, the quantitative HeadStrong study (chapter 5) highlighted the importance of re-
gaining a sense of control. Whilst the HeadStrong service was found to go some way 
to increase patients’ confidence around hair loss and the use of headwear, 
camouflage alone was found to be insufficient in helping patients to manage all the 
challenges they face. As previously highlighted in chapters 4 and 5, individuals want 
different support depending on the specific concerns they are facing at any particular 
point in time. It is imperative that patients are equipped with a range of strategies to 
help them to manage all aspects of hair loss, rather than relying solely on one 
strategy, i.e. camouflage. Therefore, Pennebaker’s expressive writing intervention 
was deemed appropriate in response to what participants said they wanted in the 
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previous studies, in order to help support breast cancer patients with their thoughts 
and feelings in relation to treatment-related hair loss.  
During the planning stages of the research, the researcher attended several meetings 
at the Bristol Haematology and Oncology Centre (BHOC). These included separate 
meetings with three of the Breast Consultants, the Head of the Clinical Trials Unit, a 
Clinical Psychologist and the Head of the Chemotherapy Unit. The researcher also 
presented the proposed study at a research forum at BHOC and gathered feedback 
from the health care professionals in attendance, all of which was invaluable in 
helping to guide the present study. Additionally, the researcher attended various 
international and national conferences throughout the program of research, providing 
the opportunity to discuss the plans for the expressive writing study with different 
audiences and to receive invaluable feedback (see appendix 20 for a comprehensive 
list of where the research has been discussed).  
 
6.10.1 Justification for a feasibility study 
As highlighted in section 3.1.1, the MRC framework guided this research. The 
framework highlights that once the need for an intervention has been established, it 
is important to design and evaluate the effectiveness and feasibility of an 
intervention prior to its wider implementation. The term ‘feasible’ has been used to 
describe whether an intervention is capable of being carried out (Hagen, Biondo, 
Brasher & Stiles, 2011). An important aim of a feasibility study is to determine 
important parameters for a larger main study and to test whether a larger study is 
likely to be successful in testing the intervention (Hagen et al., 2011; Arain, 
Campbell, Cooper & Lancaster, 2010). Therefore, it was important to conduct a 
feasibility study of an expressive writing intervention for breast cancer patients who 
are affected by treatment-related hair loss, to establish factors including whether 
patients were willing to be randomised, willingness of health professionals to recruit 
patients and to determine response rates (Arain et al., 2010). 
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6.11 Research questions: 
This study set out to answer the following questions: 
 Is an adapted expressive writing intervention feasible for breast cancer 
patients with treatment-related hair loss?  
o Is the timing of the intervention (i.e. for patients newly referred for 
chemotherapy) feasible? 
o What is the attrition rate? 
o Did patients take up the offer to take part in the study? 
o Did participants find the writing task useful? 
 Are the measures which have been informed by previous literature and the 
ARC framework appropriate to detect changes and are they suitable for use 
in a larger RCT study? 
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6.12 Method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Flow chart highlighting the development of the expressive writing study 
A series of meetings were held with health professionals from the 
Bristol Haematology & Oncology Centre (BHOC) to discuss the 
expressive writing study. 
A meeting was held with the patient user representative to discuss the 
initial idea of adapting an expressive writing intervention for breast 
cancer patients who are affected by treatment-related hair loss. 
An in-depth literature search of existing expressive writing studies 
was conducted, focusing on study design, theory and details of the 
intervention.  
Research protocol 
developed. 
Research protocol presented to health professionals including 
the Head of the Clinical Trials unit at BHOC.   
Additional meetings were held with breast oncologists, 
chemotherapy nurses, a clinical psychologist, and breast care 
nurses to discuss the research protocol and study design. 
The researcher met with the patient user representative to 
discuss the research protocol and expressive writing 
intervention, and gather feedback on the research materials. 
Study materials were disseminated to Breast Cancer Care 
Voices, who provided feedback. 
Feedback from health 
professionals, Breast 
Cancer Care Voices and the 
user representative, along 
with the literature search 
informed the revised 
research protocol and study 
design. 
Study submitted for ethical 
review. Then, recruitment 
commenced. 
Regular meetings held with the oncologists, 
clinical psychologist, breast care nurses, 
clinical trials manager and chemotherapy 
nurses during recruitment.   
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6.12.1 Design  
This study was a two group comparison with participants randomly allocated to 
either an intervention or control condition. Measures were taken pre-intervention and 
again at 2 week, 1 month and 3 month follow-up. This 2 x 4 mixed design ranks 
highly in design hierarchy and permits unbiased comparisons for treatment effect 
and a direct assessment of short-term and long-term changes within the intervention 
group. 
As discussed in section 3.6.2, it is acknowledged that RCTs are not without 
limitations, including the possibility that they can lead to self-selecting samples and 
underpowered studies (Campbell et al., 2007; McDonald et al, 2006; Page & Persch, 
2013). Also, RCTs have been criticised for “being unable to uncover what is really 
happening underneath the surface of events and enable findings to be translated to 
‘real’ practice” (Blackwood et al, 2010, p. 512) which reduces the generalisability of 
their findings. Despite these limitations, an RCT design was deemed appropriate for 
this study, primarily because they help protect against selection bias (Odgaard-
Jensen et al., 2011). It is important to conduct studies that are appealing to the key 
audience if the research is to have impact – in this instance, policy makers and health 
professionals who might be in a position to implement any findings from a study of 
an expressive writing intervention. It is likely that these groups are more familiar 
with RCTs than with other designs, so might take more notice or put more 
significance on the findings from a study using this design.  
Participants were block randomised to a writing condition using the Sealed Envelope 
tool (Sealed Envelope Ltd, 2015) which generated a randomisation list using block 
sizes of 2, 4, and 6; so that the researcher could not predict which group the 
participants would be randomised to. Random sampling is regarded as the gold 
standard in sampling methodology (Williamson, 2003). It was a single-blind trial, 
whereby the participants were blinded to which condition they were in. Block 
randomisation is commonly used in trials as it reduces bias and confounding since 
participants have equal probability of being assigned to either the intervention or 
control group, ensuring an equal number of participants are in each condition (Efird, 
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2011). The researchers were not blind to randomisation because participants had to 
be sent the specific writing instructions for their allocated condition.  
 
6.12.2 Questionnaires 
Similarly to the previous studies in this thesis, this study was informed by the ARC 
(2009) framework, demonstrating the importance of a theoretical framework of pre-
disposing factors (demographic information, breast cancer information including hair 
loss status, information and support received) and moderating factors (importance 
placed on appearance, self-esteem and fear of negative evaluation, alexithymia) in 
determining psychosocial adjustment to treatment-related hair loss as indicated by 
relevant outcomes (appearance-related distress, QOL, psychological functioning). 
 
 
 
 
 
 
 
 
Figure 13. The guiding theoretical framework for the expressive writing study based 
on the ARC (2009) framework, in Clarke, Thompson, Jenkinson, Rumsey, and 
Newell. (2013). CBT for Appearance Anxiety: Psychosocial Interventions for 
Anxiety due to Visible Difference. Figure 3.5, p. 35. (Reproduced with copyright 
permission from Wiley-Blackwell).  
 
The findings of the previous studies in this thesis and the review of previous 
expressive writing studies, above, informed the choice of standardised measures, 
with additional self-constructed items being included if standardised measures were 
not available. The standardised measures used in the quantitative HeadStrong study 
Stage One 
(Predisposing Factors) 
Demographic 
information 
Breast cancer 
information 
Information and 
support received 
 
Stage Two (Intervening 
Cognitive Processes) 
Value placed on 
appearance (ASI-R) 
Self-esteem (Rosenberg 
self-esteem scale) 
Social acceptance (FNE) 
Toronto Alexithymia 
Scale (TAS-20) 
 
Stage Three  
(Outcomes) 
Appearance-related 
distress (DAS-24) 
 
QOL (FACT-G) 
 
Psychological 
functioning (HADS) 
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(chapter 5) were found to be acceptable which helped to inform the decision to use 
them for this study.  
The questionnaires were piloted on 10 women who were over the age 18 and not 
familiar with the research area. Although it took this healthy group no longer than 30 
minutes to complete the measures, it was expected that some breast cancer patients 
who have had at least one cycle of chemotherapy may take slightly longer to 
complete them if they are affected by chemotherapy-related cognitive impairments 
(Boykoff, Moieni & Subramanian, 2009; Collins, Mackenzie, Stewart, Bielajew & 
Verma, 2009; Myers, 2009; Wefel, Lenzi, Theriault, Davis & Meyers, 2004). The 
questionnaires were available online using Qualtrics, in the hope that it would 
increase participation, as they can be convenient and easy for respondents to 
complete (Brindle, Douglas, van Teijlingen & Hundley, 2005; Hunter, 2012; Jones, 
Murphy, Edwards & James, 2008; Katz, Fernandez, Chang, Benoit & Butler, 2008). 
 
6.12.3 Demographic information  
Details including sex, age, ethnicity, educational background, employment status 
were obtained at baseline (questionnaire 1). 
 
6.12.4 Breast cancer information  
Breast cancer information including type of cancer, time since diagnosis and types of 
surgical and adjuvant treatment(s) received were obtained at baseline (questionnaire 
1). 
Questions were included at each time point about participants’ hair loss status (i.e. 
whether they had already lost their hair or were anticipating doing so); whether they 
were receiving any other practical or emotional support such as counselling, and 
whether they were keeping a diary. It was important to know if people were 
receiving support or keeping a diary as this may affect the efficacy of the expressive 
writing intervention (Smyth & Pennebaker, 2008).  
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6.12.5 Information and support  
Participants were asked whether they were happy with the level of information and 
support that they had received from their GP, consultant, breast care nurse and other 
support organisations, since perceived satisfaction with support received has been 
found to impact on psychosocial outcomes (Reynolds & Perrin, 2004). 
 
6.12.6 Standardised measures  
The measures used for this study were those used in the quantitative HeadStrong 
study (see section 5.2 for a justification of their use), with the addition of the 
Toronto Alexithymia Scale (see below). The same measures were used as they were 
relevant to both studies, and this would allow direct comparisons of the evaluations 
of these two very different interventions, if the expressive writing intervention was 
deemed feasible and subsequently tested. 
The measures included in this study were, therefore:- 
 Appearance Schemas Inventory - Revised (ASI-R) 
 Rosenberg Self-Esteem Scale (RSE) 
 Derriford Appearance Scale (DAS24) 
 Functional Assessment of Cancer Therapy - General (FACT-G) 
 Brief Version of the Fear of Negative Evaluation Scale (FNE) 
 Hospital Anxiety and Depression Scale (HADS)  
 Toronto Alexithymia Scale (TAS-20) 
 
Alexithymia  
The Toronto Alexithymia Scale (TAS-20) (Bagby, Parker & Taylor, 1994; Bagby, 
Taylor & Parker, 1994) is a 20-item self-report scale. Each item is rated on a 5-point 
likert scale ranging from 1 (strongly disagree) to 5 (strongly agree), with scores 
ranging from 20 to 100. Higher scores indicate higher levels of alexithymia. TAS-20 
assesses three dimensions of alexithymia; difficulty identifying feelings (DIF), 
difficulty describing feelings (DDF) and externally orientated thinking (EOT). The 
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three factor structure has been replicated in a number of studies both with clinical 
and non-clinical samples (i.e. Parker, Taylor & Bagby, 2003; Tsaousis et al., 2010). 
Good internal consistency and test-retest reliability have been reported in a range of 
samples (Erni, Lotscher & Modestin, 1997; Loas, Otmani, Verrier, Fremaux & 
Marchand, 1996; Pandey, Mandal, Taylor & Parker, 1996). It has been widely used 
within expressive writing studies (i.e. Ashley et al., 2011; Baikie, 2008; O’Connor & 
Ashley, 2008) and is a reliable and valid measure of the alexithymia construct 
(Taylor, Bagby & parker, 2003).  
 
6.12.7 User involvement 
As previously discussed in chapters 3, 4, 5 and mentioned above, user involvement 
was included throughout this program of research. In preparation for this study, both 
the patient representative and members of Breast Cancer Care’s Voices reviewed the 
information sheet, consent form, questionnaires and debrief sheet to check for 
understanding, clarity and length of the questionnaires. Their feedback enabled the 
researcher to shorten the length of the questionnaire as it was felt that it was initially 
too long and to alter the information so that it was tailored to the lay person.  
 
6.12.8 Feasibility data 
In order to know whether it would be feasible to conduct a full RCT, study-specific 
questions included in the 3 follow-up questionnaires enquired as to where 
participants completed the writing task, their thoughts about it, the extent to which 
they found it useful and whether they had continued to write since completing the 
task (see section 6.11 for an outline of the specific questions). Moreover, any 
feasibility data such as the length of the writing exercise, the writing topic that the 
participants reported to the researcher regarding the intervention and questionnaires 
was noted. Feasibility data was also collected from breast consultants, breast care 
nurses and chemotherapy day unit nurses who helped with recruitment. This 
included records of the number of women invited to take part and informal feedback 
from these health professionals. Also, at the end of each questionnaire there was a 
space for participants to write any comments that they would like to add. 
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6.12.9 Recruitment  
Recruitment took place at the chemotherapy day unit, breast clinics, new patient 
talks and through poster advertisement (see appendix 21) in waiting rooms at the 
Bristol Haematology & Oncology Centre (BHOC).  
Meetings with several breast consultants prior to commencing the study confirmed 
that more than 300 early stage breast cancer patients who would meet the study 
inclusion criteria detailed below receive curative chemotherapy at BHOC each year 
(25 new patients per month). Recruitment was through a single NHS site as the 
researcher wanted to be available on site to speak to potential participants face-to-
face about the study, which previous research has highlighted as being advantageous 
in recruitment (Jennings et al., 2014). Meetings were held with chemotherapy 
nurses, breast care nurses and consultants to build and maintain rapport and regular 
contact was maintained with them throughout the recruitment period, which is 
deemed essential when asking health care professionals to identify eligible research 
participants (McNees et al., 2005; Sears et al., 2003). 
In order to increase recruitment, the study was also promoted through a number of 
alternative routes. Specifically, two support organisations (Breast Cancer Care (who 
advertised the study on their website and in their quarterly bulletin) and The Haven 
(who promoted the study at 3 of their counselling centres), the Call for Participants 
website (www.callforparticipants.com), Mumsnet, Twitter and media coverage 
following a press release (see appendix 22) and a radio interview (figure 14 includes 
full recruitment details).  
Unfortunately, uptake to the intervention was slower than anticipated; therefore, in 
addition to the various recruitment strategies outlined above, recruitment was 
extended from the initially planned 6 months to 12 months. The recruitment 
challenges faced in this study are discussed fully in the discussion of this chapter 
(section 6.13) and chapter 7. 
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6.12.10 Participants 
6.12.10.1 Inclusion criteria 
Women over 18 years of age, who had received a diagnosis of breast cancer, had 
received at least one cycle of curative chemotherapy and as a result were 
experiencing hair loss (current and or/expected hair loss) were eligible to take part. 
 
6.12.10.2 Exclusion criteria 
Individuals who were unable to complete a written intervention and the 
questionnaires in English, or were unable to physically write by hand or word 
processor, for a 20-minute period were not eligible to take part. Women who were 
receiving palliative care or who were currently participating in another psychosocial 
intervention study were also excluded. 
 
6.12.10.3 Sample size 
Since this was a feasibility study, the intention was not to look for effectiveness of 
the intervention. However, it was still considered useful to explore the possible 
effectiveness of the intervention at this preliminary stage. A statistician at the 
University of the West of England (Dr Paul White) therefore helped to develop the 
sample size calculations. Based on a priori calculation using the Derriford 
Appearance Scale (DAS-24), a sample size of n = 50 per group would ensure at least 
90% power for detecting a medium sized interaction effect and would have in excess 
of 90% power for a within group investigation of change using the paired samples t-
test for detecting a clinically relevant medium sized effect (Cohen’s d = 0.5) using 
contemporary levels of significance (alpha = .05) in a two-sided test. 
 
6.12.11 Approvals 
NHS ethics approval was obtained from the NRES Committee South West – 
Frenchay (see appendix 23). R&D approval was also obtained from University 
Hospitals Bristol and ethical approval from the Faculty of Health and Applied 
Sciences Research Ethics Committee at the University of the West of England 
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(UWE), Bristol (see appendix 24). Also, the study was adopted onto the NIHR 
Clinical Research Network (NIHR CRN) portfolio. 
 
6.12.12 Data collection 
Potential participants were identified by breast consultants, chemotherapy day unit 
nurses and breast cancer nurses from the Bristol Haematology & Oncology Centre 
(BHOC) who handed them a questionnaire pack that included an information sheet 
(see appendix 25) along with the study invitation letter (appendix 26) which was 
signed by the consultants, a consent form and the baseline questionnaire 
(questionnaire 1). Alternatively, health professionals identified and initially spoke to 
eligible patients about the study, before introducing them to the researcher who was 
available in clinic to discuss the study and answer any questions they may have. 
Potential participants who wished to take part were asked to complete and return the 
consent form (appendix 27) and baseline questionnaire using the prepaid envelope 
provided. The information sheet included the researcher’s details as a point of 
contact for any queries. The questionnaires were also available online (using the 
secure online data collection site Qualtrics) if participants preferred to complete 
them in this way (see figure 14 for a flow chart of the data collection process). 
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Procedure                                             Data Collection & Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.  Flow chart of the data collection process for the expressive writing study 
Patient is sent letter about the study with an 
information sheet, consent form and baseline 
questionnaire (questionnaire 1). 
Patient returns consent form 
and baseline questionnaire 
(questionnaire 1) to the 
researcher in pre-paid 
envelope provided, if they are 
interested in taking part. 
Participant is sent the writing instructions 
which correspond to the group which they 
have been randomised to. 
Participant writes for 20 minutes, for 4 
consecutive days on the topic which they have 
been instructed to write about. 
Participants, who are happy to do 
so, send their writing samples to 
the researcher for analysis. 
Participant is given the post questionnaire 
(questionnaire 2) to complete either in paper 
form or online two weeks after they have 
engaged in the writing study. 
Participant returns post 
questionnaire (questionnaire 2) to 
the researcher in pre-paid 
envelope provided. 
Participant is given the 1 month follow-up 
questionnaire (questionnaire 3) either in paper 
form or online to complete 1 month after 
engaging in the writing study. 
Participant returns 1 month 
follow-up questionnaire 
(questionnaire 3) to the 
researcher in pre-paid envelope 
provided. 
Data analysis 
Potential participant is identified by NHS staff at 
the Bristol Haematology & Oncology Centre, or 
contacts the researcher in response to an advert 
for the study. 
Participant is given the 3 month follow-up 
questionnaire (questionnaire 4) either in paper 
form or online to complete 3 months after 
engaging in the writing study. 
 
Participant returns 3 month 
follow-up questionnaire 
(questionnaire 4) to the researcher 
in pre-paid envelope provided. 
 
Once participants complete and return their 
baseline questionnaire (questionnaire 1), they 
will be block randomised by the researcher into 
either an expressive writing intervention or 
control group. 
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Women who consented to take part and completed the baseline questionnaire 
(appendix 28) were block randomised by the researcher using the Sealed Envelope 
(2015) tool, as discussed above in section 6.12.1, into one of two conditions; 
intervention or control group. Once participants completed and returned 
questionnaire 1 to the researcher they were sent the relevant writing instructions, 
either by post or email, depending on their preference indicated on the consent form. 
Participants were encouraged to write in the week prior to their next cycle of 
chemotherapy, this was based on advice received from the health professionals at 
BHOC, including consultant oncologists who had extensive experience of working 
with breast cancer patients. The initial information sheet and consent form gave them 
the option of sharing their writing with the research team, in order for it to be read 
and analysed. Participants were invited to send what they had written to the 
researcher for two reasons; first, to check they had adhered to the writing 
instructions and second, to see what they had written about. Participants who gave 
consent for this posted their writing to the researcher using the prepaid envelope 
which was provided.  
Participants were asked to indicate on the consent form whether they would prefer to 
receive the writing instructions and follow-up questionnaires (see appendix 29 for a 
copy of the 2 week follow-up expressive writing questionnaire, appendix 30 for the 1 
month follow-up questionnaire and appendix 31 for the 3 month follow-up 
questionnaire) by post or email and were subsequently sent a pre-paid envelope or an 
email with a link to the online questionnaires, as appropriate. 
 
6.12.13 The intervention 
The intervention (expressive writing) group were instructed to write about their 
thoughts and feelings around hair loss for a period of 20 minutes for four 
consecutive days, since this has been the optimum timing favoured by many 
previous expressive writing studies. In line with the expressive writing intervention 
developed by Pennebaker, participants were instructed to let go, not to worry about 
grammar or sentence structure and to explore their deepest thoughts and emotions. 
Specifically, participants randomised to this group were asked to write about any 
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aspect of their experience of treatment-related hair loss which they found difficult to 
share with others, as previous discussed in section 6.4.1. Expression of thoughts and 
feelings about an upsetting event has been found to be beneficial including 
improvements in both psychological and physical health (Frattaroli, 2006). The 
present expressive writing intervention was adapted, so that participants were asked 
to write about their hair loss in relation to other parts of their lives, including how it 
related to their family life, relationships with their partner, children, parents and 
friends, daily activities, hobbies or work, and how they had tried to manage the 
situation and their feelings about it (see appendix 32). It was important to adapt the 
present expressive writing intervention as the focus of the study was to explore 
whether an expressive writing intervention is suitable for breast cancer patients who 
are affected by treatment-related hair loss, therefore, it was important that the writing 
topics were around hair loss. For each of the four days, participants were instructed 
to focus on a different aspect of hair loss: 
 
 Day one- deepest thoughts and feelings about hair loss 
 Day two- hair loss in relation to appearance 
 Day three- hair loss in relation to life 
 Day four- managing treatment-related hair loss.  
 
A few expressive writing studies have used a no writing control group (i.e. Craft et 
al., 2013). However, to stay in line with Pennebaker’s traditional expressive writing 
paradigm and other expressive writing studies with breast cancer patients, a writing 
control group was used. Careful consideration was given to deciding on a suitable 
control topic. Previous expressive writing studies with cancer patients have used 
what were deemed to be a variety of neutral control topics including what they had 
done the previous day (Mosher, Johnson,  Dickler, Norton, Massie & DuHamel, 
2013), facts about cancer and treatment (Low et al., 2006; Stanton et al., 2002) or 
daily activities (Zakowski, Ramati, Morton, Johnson & Flanigan, 2004). Additional 
control topics used by previous expressive writing studies with non-cancer 
populations include time management (Arigo & Smyth, 2012; Gortner, Rude & 
Pennebaker, 2006; O’Connor et al, 2010; O'Connor, Allen & Kaszniak, 2005; Sloan 
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et al, 2009), describing their home (Danoff-Burg, Mosher, Seawell & Agee, 2010) or 
describing landscapes pictures (Ashley et al., 2011). However, despite previous 
expressive writing studies with cancer patients often focusing on time management, 
discussions with the supervisory time including a clinical psychologist with 
extensive experience of working with breast cancer patients and advice from the 
patient representative for this program of study indicated that time management was 
not a ‘neutral’ topic for cancer patients who’s time typically revolves around 
multiple clinic and treatment appointments. Therefore, a purely descriptive topic was 
deemed appropriate for the control group and they were instructed to write for 20 
minutes a day for four consecutive days about a neutral topic without any emotional 
expression (See Appendix 33). Specifically, they were asked to describe a different 
topic each day: 
 Day one – their home 
 Day two – the neighbourhood/area they live in 
 Day three – their town/city 
 Day four –a place they have recently been to 
 
Once participants had completed the study, they were sent a debrief sheet outlining 
the aims of the study and explaining the two different writing groups (see appendix 
34 for a copy of the debrief sheet). 
 
 
6.12.14 Analysis 
As this was a feasibility study the data and analysis primarily included information 
about recruitment, response rates and qualitative feedback from patients and health 
professionals. Secondly, the numerical data collected through the baseline, 2 week 
follow-up, 1 month follow-up and 3 month follow-up questionnaires was analysed 
using the statistical program SPSS. The data from the open-ended questions was also 
examined. 
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6.13 Results 
Recruitment and retention 
As mentioned previously, the expressive writing study was promoted through a 
number of avenues; figure 14 includes the recruitment details. The majority of 
patients identified and assessed for eligibility were through the Bristol Haematology 
and Oncology Centre (BHOC) (N = 43). Call for Participants and Twitter were 
particularly advantageous in promoting the study, with 741 study page views on Call 
for Participants and 395 views on Twitter. Patients who heard about the study 
through an alternative avenue to BHOC informed the researcher of how they heard 
about it, allowing the researcher to collate this information. Ten participants 
consented to take part in the study, nine completed the baseline questionnaire. Of 
these nine participants, five completed the writing exercise and four completed the 2 
week, 1 month and 3 month follow-up questionnaires. 
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6.13.1 Summary of the recruitment strategy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Summary of recruitment and  
study design 
 
Patients identified and assessed for 
eligibility at BHOC   N = 43 
by breast consultants (n = 12) 
by chemotherapy day unit nurses (n = 
28) 
by breast care nurses (n = 3) 
 
 Completed baseline questionnaire   
N = 9 
Completed the 2 week, 1 month and 3 
month follow-up questionnaires N = 4  
Breast Cancer Care 
4 participants consented to take part 
 
The Haven Centres 
1 participant consented  
Twitter: 395 clicks on study link 
No participants recruited  
 
 
Press release: No participants 
recruited 
Local radio interview  
No participants recruited 
Completed writing exercise N = 5 
 
Refusals N = 44 
Eligible from BHOC but did not 
consent N = 40 
Contacted researcher to express 
interest in the study but did not 
consent N = 4 
 
Dropout rates 
After consenting N = 1 
After baseline N = 4 
After writing exercise N = 1 
Note. two participants who consented and completed the 
baseline questionnaires emailed the researcher to say 
they had been unwell and not yet able to complete the 
writing task but hoped to do so in the near future. 
 
 
Consented to take part in the study   
N = 10 
 3 participants were randomised to 
the intervention group and 2 to the 
control group 
Call for Participants website: 
741 clicks to view study page 
5 asked for more information  
1 participant consented  
 
Poster advertisement in the breast 
clinic waiting room 
No participants recruited 
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Note. It was not possible to assess the eligibility of the individuals who clicked on 
the study link on Twitter and Call for Participants if they did not contact the 
researcher for further information 
 
6.13.2 Demographic information at baseline 
Nine female breast cancer patients completed the baseline questionnaire. All were 
within the age range 34-55 years (M = 44.89, SD = 7.82). Eight (88.89%) had 
already experienced hair loss at baseline, with most participants starting to lose their 
hair 2 weeks after starting chemotherapy. Table 13 presents further demographic 
information. Four (44.44%) participants reported being very upset by their hair loss. 
Three (33.33%) were receiving support from their breast cancer nurse or the Penny 
Brohn Centre. Four participants reported keeping a diary, the reasons for which 
included: 
 to monitor the side effects of chemotherapy  
 to record the physical and emotional impact of each chemotherapy session 
so as to report the impact of treatment to oncologists  
 a friend suggested it 
 to enhance motivation and positive thinking 
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Table 13. Demographic Information 
 
Notes: Figures do not always equal 100 as some participants received more than one 
type of treatment.  
*Experience of hair loss relates to whether participants had lost any of their hair.  
$Time to hair loss is how long after starting chemotherapy participants started to 
lose their hair.  
~Extent of hair loss relates to the amount of hair loss participants had experienced, 
rated on a likert scale from 0 (no hair loss) to 10 (complete hair loss).   
#The mean time since diagnosis has been increased as one participant received their 
breast cancer diagnosis 15 years and 11 months ago, compared with the majority of 
                                   Participants  
(n = 9) 
Age 
Mean (SD) (range) in years                 
 
44.89(7.82) (34-55) 
Ethnicity   
White 
White-Caribbean                                                                                              
n (%) 
8 (88.89) 
1(11.11)
Employment status     
Working full-time                                    
Working part-time                                                                                     
Housewife   
Self-employed                                          
Unemployed                                            
n (%) 
3 (33.33) 
1 (11.11) 
2 (22.22) 
1 (11.11) 
2 (22.22) 
Cancer type   
Breast                                                     
n (%) 
9 (100) 
#Time since diagnosis 
Mean (range) in months                     
 
30.02 (1.5 months-15 years 11 months) 
Treatment received    
Chemotherapy 
Surgery 
Radiotherapy                                             
Hormone therapy                                                                                         
n (%) 
9 (100) 
7 (77.78) 
3 (33.33) 
1 (11.11) 
 
*Experience of hair loss  
Yes                                                            
No                                                            
n (%) 
8 (88.89) 
1 (11.11) 
$Time to hair loss  
Mean (range) in days                              
 
19 (5-49) 
~Extent of hair loss     
Mean (range)                         
 
6.78 (0-10) 
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participants receiving their diagnosis between 1.5 months and 4 months prior to 
completing the baseline questionnaire (M= 30.02). 
 
6.13.3 Two week, 1 month and 3 month follow-up  
Only four participants completed the 2 week, 1 month and 3 month follow-up 
questionnaires (55.6% dropout rate). Three had been randomised into the 
intervention and one into the control group. All four participants reported that they 
had completed their writing at home. Although they had all lost their hair, one was 
not upset by it, two were a little upset and one reported feeling very upset. 
Participants’ satisfaction with the information and support they received from their 
GP, consultant, breast care nurse and support organisations varied, with satisfaction 
generally decreasing from 2 week follow-up to 3 month follow-up for the four 
participants who complete the 3 month follow-up questionnaire (see table 14).  
One participant who was randomised into the expressive writing group had received 
support from a number of sources including financial support and nutritional advice 
from Macmillan, and had attended a living with cancer course. This participant also 
stated that she was receiving ongoing psychotherapy which she started before 
receiving her cancer diagnosis and found that it was helpful in providing emotional 
support not only with cancer but other aspects of her life. This has a number of 
implications which are discussed in detail in section 6.14.2.   
Unfortunately, the very small sample size was insufficient to conduct statistical 
analysis on the patient reported outcome measures. Small sample sizes are a 
limitation and acknowledged characteristic of feasibility studies, resulting in the 
inability to determine statistical significance of the effectiveness of an intervention 
(Cope, 2015). 
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Table 14. Participants’ satisfaction with level of information and support received. 
  2 week 
follow-
up 
(n =  4) 
   1 month 
follow-up 
(n = 4) 
   3 month 
follow-
up 
(n = 4) 
  
          
 
 
Not 
at 
all 
  A little A lot Extremely  
 
Not 
at all 
  A  
little 
A lot Extremely Not at    
all 
A little A 
lot 
Extremely 
Are you happy with  
the level of information  
and support you have  
received from your GP? 
   2 2  1          3      2   2        
Are you happy with the                                       
level of information and  
support you have received  
from your Consultant?  
        1  1 2  2          2     2    2         
Are you happy with the          
level of information and  
support you have received  
from your Breast Care  
Nurse? 
   1        1                2       2            2     2    2         
Are you happy with the           
level of information and  
support you have received  
from support 
organisations? 
        1  2          1       1  2          2     1                   1 2         
Chapter Six: An Expressive Writing Intervention  
 
 
 
222 
 
6.13.4 Acceptability data 
6.13.4.1 Participants’ experiences of the writing task 
As can be seen in figure 14, five participants completed the writing task (four in the 
intervention group and one from the control group), of whom four completed the 2 
week, 1 month and 3 month follow-up questionnaires (three from the intervention 
group and one from the control group). Of the three participants who had been 
randomised to the intervention group, one participant reported that she did not find 
the writing task useful, whilst one did.   
At 2 week follow up, Sally described the writing task as being difficult because she 
did not know what to write about: 
  “Hard work, I didn't really feel I had that much to write about!” (Sally).   
At 1 month follow-up, she indicated that she did not feel particularly affected by 
losing her hair: 
  “I'm not that bothered about losing my hair, it will  grow back” (Sally) 
At 3 month follow-up, Sally added: 
  “I found it quite hard work, and don't like to dwell on it” (Sally) 
In contrast, at two weeks follow-up, Audrey and Cally both found the writing task 
helpful as it provided an opportunity for them to reflect on their hair loss: 
 “It really made me stop and think and reflect on my feelings and thoughts 
 about the hair loss specifically and I had not really done that up until that 
 point and might not otherwise have done so either” (Audrey) 
 “Makes you think deeply about hair loss instead of just accepting it” (Cally) 
At 1 month follow-up, Audrey found it helpful to explore her thoughts in relation to 
her hair loss which she thought she would not have done if it was not for the study:  
 “It was a way of exploring what I thought and felt about losing my hair and I 
 don't think I would have done that if I'd not been writing about it” (Audrey)
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Writing also helped Cally to think about her diagnosis and treatment and to realise 
how well she had come to terms with what she had been through: 
 “Made me really think about what had happened - and I realised I was ok 
 with it, which was less scary. It helped to process thoughts - and look back 
 and realise how well I have come to terms with diagnosis” (Cally) 
At 3 month follow-up, Audrey and Cally both described how writing about their hair 
loss had helped them: 
 “Helped to explore deeper, inner feelings about hair loss and treatment and 
 in fact  the business of having cancer” (Audrey) 
 “good way to express thoughts - and useful to look back on, to realise how I 
 have adapted” (Cally) 
 
Also, Cally commented that she had enjoyed taking part in the research and had 
found it beneficial: 
 “I have found it really helpful taking part in this study - helped me recognise 
 how I  am feeling about e.g. hair loss” (Cally) 
 
At all three time points, Lucy who was randomised into the control group did not see 
the relevance of the control writing topic:  
 “I do not understand the relevance of writing about my surroundings” (Lucy) 
 
Unfortunately, one participant who completed the writing did not complete any of 
the follow up questionnaires, so their feedback on the intervention is not available.  
Three participants had continued to write after completing the writing task by 
keeping a diary; one participant did not give a reason for why she had kept a diary, 
one woman did so because a friend recommended it, whilst the other participant 
reported keeping separate diaries for the physical and emotional impact of their 
treatment:  
“I keep two diaries; one to track the chemo, what I ate, activity I've done, 
drugs taken, energy levels and the second diary is to report streams of 
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consciousness in the mornings, about anything I'm thinking about or feeling 
at that point” (Audrey). 
 
The feedback from these women supports the acceptability of the intervention 
condition of the expressive writing study, although Smyth and Pennebaker (2008) 
express concern that keeping diaries may alter the effects of expressive writing 
interventions. However, as demonstrated above, some patients prefer to write about 
the wider challenges of cancer diagnosis and the impact of cancer treatment, rather 
than being restricted to write about a specific aspect. Feedback from the participant 
in the control condition indicates that this was not acceptable, suggesting a need for 
an alternative topic for the control group in any further study or the use of an 
alternative design without an active control condition. However, it must be 
remembered that only one woman completed and fed back on the control condition, 
a response rate which itself indicates the need for caution over the acceptability of 
this condition.   
Three participants sent their writing to the researcher, two from the intervention 
group and one from the control group. Participants’ writing was not analysed but it 
was checked to ensure that they had adhered to the writing instructions, which they 
had done. Interestingly, there was a substantial difference in the quantity of writing 
received from the two participants from the intervention group; one woman had 
written half an A4 side of paper each day, whereas the other participant had written 2 
sides of A4 paper and documented the time that started and finished writing, 
demonstrating that she had written for precisely 20 minutes, as instructed. This is 
further evidence to suggest that expressive writing is not necessarily suitable for 
everyone, but for some women expressive writing could be a beneficial and 
enjoyable intervention. 
 
6.13.4.2 Feedback from health professionals and patients 
Feedback was received from both the nurses at the Chemotherapy Day Unit and the 
three consultants who helped to identify eligible patients. The nurses confirmed that 
6 patients had declined to take part because they wanted to focus on their 
chemotherapy treatment without taking part in research at the same time and two 
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patients had difficulty writing. The consultants identified 5 patients who felt they did 
not have time to take part.  
A noteworthy point is that as well as identifying patients for the current study, breast 
cancer nurses were also trying to identify patients to participate in a drugs trial, 
alongside trying to provide emotional support to breast cancer patients. Therefore, 
understandably, the time they could allocate to identifying eligible patients for the 
expressive writing study was limited and is likely to have contributed to the low 
uptake to the current study.  
Timing was an important barrier to uptake. As noted in figure 14, two participants 
consented to participate and completed the baseline questionnaire but had been 
unwell due to the side effects of chemotherapy treatment yet still wanted to complete 
the writing task as soon as they felt well enough. Unfortunately these participants 
had still not felt well enough or did not have the chance to complete the writing task 
several weeks later. One patient who the researcher spoke to at a new patient session 
was interested in taking part but felt they would not have time to participate due to 
the concurrent demands of being a carer and having to rely on public transport to 
regularly attend hospital appointments. 
 
6.14 Discussion  
Based on the feasibility data received, it is concluded that the expressive writing 
intervention and evaluation is not feasible for breast cancer patients newly referred 
for chemotherapy in its current form. This could be due to aspects of the intervention 
and/or aspects of the study design. 
Owing to the small sample size, it was not possible to comment on the suitability of 
the measures. However, participants did not report any problems with any of them 
and there was no missing data in the questionnaires that were returned, suggesting 
this small group of participants found the measures to be acceptable. 
As described above, despite using a number of approaches to recruitment based on a 
review of the challenges of recruitment previously reported in the psycho-oncology 
and RCT literatures (see chapter 3), this was still a major challenge for this study. 
Chapter Six: An Expressive Writing Intervention  
 
 
 
226 
 
Before designing the study in terms of deciding what to ask participants to write 
about, a thorough review of the expressive writing literature found that very few 
studies in this area provided a detailed description of their recruitment strategy. This 
is an additional reason why PPI was included to help ensure that the materials and 
design were acceptable to participants. This supports previous research highlighting 
a paucity of published literature in psycho-oncology regarding recruitment strategies, 
specifically in studies regarding sensitive or stigmatized issues (Jennings et al, 
2014). It has been proposed that many researchers consider recruitment to be an 
implementation problem that may not warrant analysis and discussion in their 
research (McNees et al, 2005). However, better reporting of recruitment information 
is critical because it remains unclear whether interventions are viable if it is not 
possible to easily recruit patients for evaluation studies (Boonzaier et al, 2010; Cope, 
2015). 
Only one expressive writing study with early stage breast cancer patients (Stanton et 
al, 2002) reported that participants declined or terminated participation without 
giving a reason and, when a reason was given, these included being too busy to 
commit to the study. The current study also found that women dropped out or 
refused to consent due to being unwell or too busy with their cancer treatment. 
However, two expressive writing studies with metastatic breast cancer patients have 
reported recruitment difficulties; Laccetti (2007) reported reducing their study’s 
power as a result of recruiting 68 participants as opposed to their original target of 
100 women and Low et al (2010) reported that patients dropped out due to being too 
ill. However, once again a lack of information regarding the recruitment strategy was 
provided.  
A low uptake to home-based expressive writing interventions has been reported in 
three studies; two with arthritis patients (Broderick et al, 2004; Wetherell et al., 
2005) and one with early stage breast cancer patients (Gellaitry et al., 2010). These 
studies reinforce the need to consider the possible burden of research on patients 
who are managing serious and/or chronic health conditions and to consider each 
study and patient group on an individual basis.   
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The few authors who have provided recruitment details in their study write-ups 
include Baum and Rude (2013) who reported high attrition, which they attributed to 
the study being online. The authors believed that lack of face-to-face personal 
interaction with the researcher might have reduced participants’ commitment to 
completing the study. However, in an attempt to avoid this from happening in the 
present study, the researcher attended the BHOC on a daily basis to speak to eligible 
participants and maintained regular contact with those who had consented in order to 
check their progress with the study. Jennings et al (2014) suggest that allowing extra 
time to provide information and build rapport with potential participants, medical 
staff briefly mentioning the study to patients prior to being approached by the 
researcher, and approaching potential participants in the privacy of a clinic room all 
increase willingness to take part. All these recommendations were followed in the 
current study, as highlighted above. Sending participants an introductory letter under 
the letterhead of the physician shows their support of the research and can promote 
recruitment (Sears et al., 2003). A letter was therefore printed on the hospital’s 
headed paper, naming the hospital consultants who supported the study and the 
charity that funded it. This letter was included in the questionnaire pack, with the 
hope that this would add to the credibility of the study and make it more inviting to 
potential participants. 
Once it became apparent that recruitment was much slower than anticipated, the 
literature was searched for guidance on additional ways to improve recruitment. A 
number of studies have found that a financial incentive can help to improve 
recruitment (Free et al., 2010; McDaid et al., 2006). It was therefore decided to offer 
participants a £20 Marks and Spencer voucher as a gesture of gratitude for 
completing the study. An amendment to the study’s ethics application was submitted 
to the University of the West of England (UWE) and approved, so that new 
participants and women who had already consented to take part before this 
amendment were all sent a voucher. However, introducing an incentive did not 
appear to make any difference to recruitment. 
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6.14.1 Limitations 
In addition to the limitations resulting from the low levels of recruitment discussed 
above, it is possible that the study attracted a self-selecting sample, whereby those 
that might most need and want support did not participate as they did not want to 
risk being randomised to the control group. Furthermore, individuals may not feel 
they have the emotional or cognitive capacity to take on more commitments, such as 
research, whilst going through treatment. An additional limitation is that the 
researcher was not blinded to which condition the participants were randomised to, 
which could have led to experimenter bias, where the researcher’s expectations of 
how a participant would perform based on the condition they were randomised to 
may have affected the study. 
 
6.14.2 Implications 
As discussed at the start of this chapter, the current intervention and study design 
was informed by previous expressive writing studies, including the few that have 
been conducted with early stage breast cancer patients. Without conducting further 
research it is impossible to draw specific conclusions, but it appears that the timing 
of the current intervention was not appropriate since most patients had recently 
received a breast cancer diagnosis and were starting cancer treatment. Future 
research may benefit from conducting a longitudinal exploratory study to follow 
individuals from their initial diagnosis up to two years post primary treatment, to 
provide an insight into how breast cancer patients adjust to their hair loss in the 
longer term including hair re-growth. This would enable researchers to gain an 
understanding of when would be an appropriate time to implement interventions to 
support breast cancer patients. The enthusiasm of one woman to take part several 
years after treatment adds to the suggestion that it may be more appropriate to offer 
the intervention to women who have completed their treatment but are still 
struggling with hair loss issues. Also, the study appealed to one patient who had tried 
several sources of support and may have taken part in the present study as she felt in 
need of the support. However, if a full trial was to be conducted, including patients 
who were receiving additional sources of support, this could lead to a contamination 
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effect, as it would be difficult to know whether it was the expressive writing 
intervention or other interventions that was effective. In order to know whether a full 
expressive writing study is effective, patients would have to be excluded if they were 
receiving support elsewhere.  
Furthermore, the expressive writing intervention was not attractive to everyone. 
Previous research has found that individuals have different preferences for 
interventions, sources of support and involvement in research (for example, see 
Frith, Harcourt & Fussell, 2007 who found that some breast cancer patients were 
very keen to take part in a photo elicitation study of their experiences of 
chemotherapy, whilst several others did not find this appealing). It is imperative that 
a variety of interventions are available in order to accommodate individual 
preferences for support. Therefore, future research in this area may benefit from 
including a needs assessment to identify patients who are distressed by their hair loss 
and in need of support.  It is important to not only know what patients’ needs are but 
also to know how they can be supported and how to refer patients for support.  
In hindsight, rather than employing an RCT design, it may have been more 
beneficial to conduct a single arm exploratory study, whereby all participants receive 
the expressive writing intervention. This may have encouraged more patients to 
participate, on the assumption they chose not to take part as they did not want to be 
randomised to the control condition, also this would mean that a smaller sample size 
would be required. If this design was considered feasible and in line with the MRC 
framework, a definitive trial (but not using an RCT design) could then be conducted 
and the long term implementation explored. 
 
6.15 Summary of the key points from this chapter: 
 This is the first study to adapt Pennebaker and Beall’s expressive writing 
intervention for breast cancer patients who are affected by treatment-related 
hair loss.  
 The aim of the study was to explore the feasibility of an RCT to evaluate an 
expressive writing intervention for breast cancer patients with treatment-
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related hair loss and to investigate whether the timing of the intervention and 
the recruitment strategy is appropriate. 
 Participants were either randomised to an intervention group, where they 
write about their thoughts in relation to their hair loss or a control group 
where they took part in a descriptive writing task. 
 Nine female breast cancer patients completed the baseline questionnaire. 
Four participants completed all follow-up questionnaires, three of which had 
been randomised into the intervention group and one into the control group.  
 Reasons for declining to participate included; wanting to focus on their 
treatment, two patients reported having difficulty writing, not having time to 
take part. 
 The expressive writing intervention and evaluation is not feasible for patients 
newly referred for chemotherapy in its current form. This could be due to 
aspects of the intervention and/or aspects of the study design. 
 
6.16 Next stage of the research 
The following chapter presents the main findings from this program of research and 
highlights their contribution to knowledge, including the contribution it has made to 
current knowledge around the psychosocial impact of hair loss due to chemotherapy 
and the provision of supportive interventions for those affected.  
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Chapter Seven 
Discussion  
 
7.1 Introduction 
This chapter discusses and synthesises the key findings from this program of 
research, including the contribution it has made to current knowledge around the 
psychosocial impact of hair loss due to chemotherapy and the provision of 
supportive interventions for those affected. The studies in this thesis are considered 
in the order in which they were conducted and presented earlier. This chapter 
discusses the research findings in relation to current NHS policies on the provision 
of cancer care and implications for future research and practice. Limitations of the 
research are then outlined ahead of a reflection on the methodologies employed, the 
use of PPI and the research process as a whole. 
The purpose of this research was to explore psychosocial interventions to support 
breast cancer patients affected by treatment-related hair loss. The studies in this 
thesis have revealed a number of interesting findings relating to this issue. 
 
7.2 Synthesis of the research findings and contribution to knowledge 
Previous research has highlighted the need for rigorous evaluations of interventions 
to support patients affected by treatment-related hair loss (Lemieux et al., 2008). The 
systematic review discussed in chapter two was the first review of this sort to date to 
explore the effectiveness of psychosocial interventions for patients experiencing hair 
loss. The aims of the review were to identify existing research into current 
psychosocial interventions, to comment on the scientific quality of those studies and 
identify aspects of effective interventions in order to inform future intervention 
design and evaluation. 
Of the 5,182 potentially relevant papers identified, only 8 articles met the inclusion 
criteria; 4 focused on behavioural techniques to camouflage hair loss, 3 provided 
psychological support and one was based on hypnosis. The interventions were 
delivered face-to-face in an individual or group setting, or online. The review 
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concluded that the scientific quality of research in this area is mixed. Whilst some 
research was of reasonable quality, the overall quality of the design of the 
evaluations was poor since they were underpowered and were limited to short term 
follow-up, so it is unknown if any benefits were maintained in the longer term. Few 
interventions had been manualised, therefore making it difficult for other 
researchers/health professionals to replicate them. Only one study provided reasons 
for attrition, making it difficult for researchers/health professionals to identify for 
whom the interventions may or may not be suitable. All interventions were delivered 
in a hospital/clinic setting and only 3 studies included a control group. Lack of 
details regarding the training of researchers and health professionals delivering the 
interventions makes them difficult to replicate. 
 
The effectiveness of the 8 different interventions was mixed; 6 showed 
improvements in either all or some of their outcome measures, yet 2 of these only 
found a very small improvement in body image (Nolte et al, 2006) or upset with hair 
loss (Salonen et al, 2011).  The two qualitative studies (Amiel et al, 2009; Zaninni et 
al, 2012) reported women’s experiences of beauty-based interventions and concluded 
that the majority of participants found them to be beneficial. Key aspects of the 
successful interventions included the immediacy of the intervention, the inclusion of 
information provision and an opportunity to express emotions and concerns. 
However, many currently available interventions were not included in the review as 
they did not meet the inclusion criteria.  
The findings from the systematic review highlighted that few interventions for 
individuals affected by hair loss had been evaluated, this informed two further 
studies: an evaluation of Breast Cancer Care’s HeadStrong service and a feasibility 
study of an expressive writing intervention. Chapters four and five presented the first 
evaluation of Breast Cancer Care’s HeadStrong service. The HeadStrong service 
evaluation used a mixed methods approach, consisting of interviews with 25 women 
who were an average of 8 months post-diagnosis and a pre-post- and 3 month 
follow-up survey with 16 women who were an average of 1.9 months post-diagnosis 
at baseline.  Nine women completed all follow-up data collection points. 
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The qualitative study revealed three main themes; challenges of hair loss, 
experiences of receiving support for treatment-related hair loss and meeting unmet 
needs. The challenges women faced as a consequence of hair loss began at diagnosis 
when they were advised that they would lose their hair as a side effect of 
chemotherapy, and continued until and after their hair had started to re-grow. 
Women in both the qualitative and quantitative studies indicated that their hair loss 
had impacted negatively on their lives, including the impact on their confidence, 
relationships with close family and friends and also the general public. Some women 
were able to manage the consequences of their hair loss relatively well whilst others 
could not. Timing was a significant factor in their use and the perceived usefulness 
of HeadStrong; some participants felt it was important to attend a session prior to 
losing their hair, but it was difficult for many to find the time to attend due to 
managing work commitments and hospital appointments. Preference for individual 
versus group sessions was mixed, reinforcing the different individual support needs 
and suggesting the need for a patient-focused individual needs assessment. Whilst 
HeadStrong enabled participants to re-gain a sense of control through the practical 
advice and information they received, which was evident from both the qualitative 
and quantitative HeadStong studies, it did not necessarily address their emotional 
support needs. Additional suggestions for improvement included tailoring the service 
to each individual’s needs.  
Some participants reported that wearing headscarves and/or having short hair 
signified a ‘cancer look’ that made other people aware of their diagnosis, and that 
using these to hide their hair loss did not therefore remedy all the distress they had 
been experiencing. In contrast, some women felt more confident in using headwear 
and managing the physical consequences of their hair loss, including the reaction of 
others after attending HeadStrong. However, the quantitative HeadStrong study 
highlighted that participants’ confidence in managing the reactions of others was not 
maintained at follow-up. Quality of life and emotional well-being reduced 
significantly from post-HeadStrong to 3 month follow-up, whilst social well-being 
and fear of negative evaluation decreased significantly between the pre-HeadStrong 
and 3 month follow-up. These findings suggest that the HeadStrong service may not 
help to improve individuals’ quality of life in the longer term. However, due to the 
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small sample size the findings cannot be generalised and should be interpreted with 
caution.  
In view of the need to develop additional interventions to meet the needs of patients 
experiencing alopecia, the feasibility of an expressive writing intervention was 
explored with 9 breast cancer patients who had lost their hair, or were expecting to 
do so, due to curative chemotherapy treatment. This was the first study to explore the 
feasibility and acceptability of Pennebaker and Beall’s expressive writing 
intervention with breast cancer patients who are affected by treatment-related hair 
loss. The main finding of this study was that the expressive writing intervention 
and/or the design of the evaluation, as used in this study, was not feasible for this 
patient group.  Recruitment was very difficult and the response rate was low, whilst 
the attrition rate of those that consented to take part was high. This may be because 
patients had recently received their diagnosis and may not want to take part in 
research during this difficult and distressing time. Also, some people may not have 
found the intervention appealing or perhaps did not want to risk being randomised 
into the control group. Amongst those that did take part, feedback on the expressive 
writing was mixed, with some participants reporting that they found it useful and 
very interesting participating in the study, whilst others commented that they found 
the writing task difficult as they did not feel they had enough to write about. Also, 
one participant queried the relevance of the control group topic. This suggests that 
expressive writing may be appealing to some patients and it is possible that some 
may benefit from the intervention but, based on the small sample size of the current 
research, no definitive conclusions can be made and careful consideration would be 
necessary before conducting a further feasibility study of an adapted intervention or 
design, or a larger trial.  
The findings from this program of research have provided an important insight into 
the psychosocial interventions available for individuals affected by hair loss, 
women’s experiences of a particular type of intervention (HeadStrong) and of an 
expressive writing intervention. On the basis of this original research, the following 
recommendations are made if attempts are to be made to continually improve the 
provision of care to support this patient group: 
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 Women need to be provided with a tool box of strategies to help them 
manage their treatment-related hair loss. 
 It is important that a needs assessment is conducted, so that patients are 
informed of the appropriate services available to them and what they 
incorporate. 
 Available interventions need be tailored to individual’s needs, including 
interventions which provide emotional support and do not solely focus on 
camouflaging hair loss. 
 It is important that health professionals are able to signpost patients to 
available services like HeadStrong but are also aware that patients might 
have other issues or concerns that a service like HeadStrong is unable to 
address.  
 
7.3 Implications of the current research  
This section discusses the implications of these studies for future research and 
practice. Throughout the studies it was apparent there was a great diversity in the 
psychosocial impact and consequences of treatment-related hair loss for breast 
cancer patients. Some women seemed relatively unaffected by the experience, 
whereas others had been and continued to be very distressed and were enduring 
adverse consequences both during treatment and in the longer-term, once treatment 
had ended. This supports previous research (Batchelor, 2001; DoH, Macmillan 
Cancer Support & NHS improvement, 2013; Lemieux et al., 2008; Rosman, 2004). 
Specifically, the interviews in the qualitative part of the HeadStrong service 
evaluation (chapter 4) highlighted women’s experiences of emotional, physical and 
social difficulties including appearance concerns, psychological distress and impacts 
on work, socialising and personal relationships around the time of diagnosis, during 
and after treatment had finished.  Indeed, some were still distressed by their hair loss 
at the time of interview, demonstrating the need for psychological support 
throughout the cancer journey (Department of Health et al, 2013; NICE, 2014). The 
following sections offer recommendations for the provision of appropriate support 
for breast cancer patients affected by treatment-related hair loss in the future, and 
consider areas for further research. 
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7.3.1 Support for hair loss distress 
NICE guidelines state the need for breast cancer patients to be offered access to 
specialist psychological support, yet highlight that the quality and provision of 
psychological support currently offered to breast cancer patients varies significantly 
(NICE, 2014). A recent report has highlighted that 30% of patients were bothered by 
hair loss one year after diagnosis and, interestingly, this rate improved at two and 
three years but returned to 29% at 5 years (DoH, 2012). This corresponds with 
findings from the qualitative HeadStrong service evaluation, whereby some women 
were still affected by their hair loss several months after finishing treatment. It has 
been reported that 49% of breast cancer patients reported having difficulty with their 
appearance/body image (DoH, 2012), which is reinforced by the current research.  
Women’s concerns were diverse and not only confined to their hair loss.  
Cancer patients often report greater satisfaction with their healthcare professional 
and the extent to which their needs are met when they have discussed the emotional 
impact of cancer with them, despite having no recollection of a direct conversation 
regarding their emotional needs (Bonito, Horowitz, McCorkle & Chagpar, 2013). 
Health professionals are pivotal in providing information and signposting people 
towards emotional support if required.  Health professionals may not appreciate the 
importance of addressing appearance concerns with patients or perhaps are unsure of 
how to broach the topic with patients (Cadogan, 2012). Research has demonstrated 
the benefits of communication skills training includes improving skills and 
confidence in recognising patient concerns and can improve health professionals’ 
attitudes towards psychosocial care (Razavi et al., 2003). However, many healthcare 
professionals, including breast care nurses, are often over stretched and under 
resourced to be able to determine the level of information and support individuals 
want and are unable to signpost them to the relevant resources (Macmillan, 2014). It 
has been suggested that patients may be more likely to discuss psychological health 
with patients if they know psychological support is available (Cadogan, 2012). 
Therefore, it is imperative that interventions are available which patients can self-
refer to. However, in order to do this, a variety of interventions need to be available 
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to meet individual needs, and patients need to know what types of interventions 
exist, and how to access them.  
 
7.3.1.1 Information provision 
Macmillan (2014) highlighted the variation in the level of information and support 
that cancer patients in the UK receive, with a third of outpatients reporting they had 
not received sufficient emotional support. In addition, the latest national Cancer 
Patient Experience Survey (CPES) (Quality Health, 2014) reported that 17% of 
patients did not receive information about support or self-help groups when they had 
wanted or needed it. This supports the findings from the qualitative HeadStrong 
study where some women were happy with the information and support they 
received, whilst others wanted more specific information and support.  
Many oncology departments now include an area, often run by Macmillan, where 
information leaflets are available and a number of breast cancer charities include 
information on their websites. Also, both in the literature and in the HeadStrong 
qualitative study, patients report discussion forums as being an important source of 
information.  However, some patients are cautious of relying on discussion forums 
for information as they do not know how credible it is. This demonstrates that 
although lots of information is available, perhaps patients do not know how to access 
it or perhaps they find the amount of information available overwhelming or do not 
know which sources of information are credible and which are not, especially if they 
read conflicting information. Therefore, it is imperative that information is accessible 
and streamlined for patients, to ensure they do not receive conflicting information 
(Carpenter, Geryk, Chen, Nagler, Dieckmann & Han, 2015). It is acknowledged that 
this is a difficult task as individual information needs vary greatly. Further 
suggestions on how to improve information provision are discussed in section 7.4.2. 
 
7.3.2 Meeting unmet needs 
The need for pathways and services that address individuals’ needs efficiently and 
effectively has been documented (DoH et al, 2013; Macmillan, 2014). Both the 
current research and previous studies (e.g. Armes et al, 2009) have suggested that 
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many cancer survivors have unmet needs, including those struggling with the 
consequences of treatment (Santin, Mills, Treanor & Donnelly, 2012), and the one-
size-fits-all follow-up approach adopted by the NHS has been criticised in terms of 
failing to meet individuals’ specific needs (Macmillan, 2014). This thesis further 
supports the need for a patient-centred service which is directed by individual needs, 
as evidenced by the systematic review and HeadStrong service evaluation. The 
National Cancer Survivorship Initiative (NCSI), launched in 2007, aims to develop 
services to support and enable cancer survivors to live as healthy and as good a 
quality of life as possible. The initiative promotes a holistic needs assessment so that 
each individual receives the support they require, for example by being referred to 
appropriate support programs or self-help groups and organisations, leading to 
improved quality of life for the patient in a cost effective way (DoH et al, 2013).  
The NCSI identified five areas in need of improvement in the care and support for 
people living with and beyond cancer, including focusing on health and well-being 
after cancer treatment, support for self-management and tailored support at follow-
up (DoH et al, 2013). It has been highlighted that psychological and emotional 
support are an essential part of patient care (NICE, 2004; NICE, 2012), which was 
evident in the present research particularly during the qualitative HeadStrong service 
evaluation where a number of patients spoke about the importance of psychological 
support during their cancer journey and the difficulties they faced in accessing it. 
NICE (2012) highlights that patients wish to be treated as individuals, so it is 
imperative that services are tailored to each individual’s needs. The researcher met 
with Breast Cancer Care’s Heads of Services to discuss the findings from the 
HeadStrong service evaluation. Based on these findings, along with the feedback 
from their own audit forms given to individuals who have attended a HeadStrong 
session, Breast Cancer Care now intend to tailor their service more to individuals’ 
needs, so that at the start of a HeadStrong session the volunteer delivering the service 
will take time to ask the patient what they hope to gain from the session and what 
they would like help with.  
One-to-one peer support programs have shown to be effective amongst cancer 
patients (Meyer, Coroiu & Korner, 2015). The majority of participants in the 
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HeadStrong evaluation preferred the session to be provided on a one-to-one basis as 
they did not think they would feel confident asking questions in a group session. 
However, some participants would have preferred the session to be group based in 
order to provide peer support. This further emphasises individual preferences for 
patient-centred support and the need to provide easy access to a variety of 
interventions and support services. Self-management is becoming a key aspect of 
tailored care to meet individual needs (DoH et al, 2013), and the internet has been 
highlighted as an effective mode of delivery to support self-management (Murray, 
2012).  
 
7.4 Provision of care and future research 
This program of research has highlighted that there is still room for improvement in 
the provision of support for this patient group. This section highlights areas for 
future care provision and research. 
 
7.4.1 Identifying future research priorities for breast cancer patients 
 
To facilitate the development of a research agenda to support breast cancer patients 
affected by treatment-related hair loss, one suggestion for future research is to 
conduct a Delphi survey of breast cancer patients’ research priorities for support. A 
Delphi survey is a consensus technique widely used in health research (Downing et 
al., 2015; Fearon et al, 2011; Rayner, Price, Hotopf & Higginson, 2011), they are 
particularly useful when there is insufficient information available (Hasson, Keeney 
& McKenna, 2000). A Dephi is a multi stage process, consisting of rounds, to 
combine participants’ opinions into a group consensus on a research question, the 
responses from each round are then summarised and fed back to participants 
(McKenna, 1994). A Delphi survey would provide an insight into women’s priorities 
for research into psychosocial support. 
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7.4.2 Utilising a screening tool to identify patients’ distress related to hair loss 
As discussed above, the impact of treatment-related hair loss varies greatly from one 
patient to another and it is extremely difficult for health professionals to assess 
individuals’ needs due to the time restrictions of out-patient consultations. Also, 
patients can find it difficult to raise concerns related to their appearance, and health 
professionals often underestimate the consequences of hair loss and do not know 
how best to broach appearance concerns with their patients (Clarke & Cooper 2001; 
Randall & Ream 2005). Over the last decade, health policies have focused on 
detecting and meeting the psychosocial needs of cancer patients, including screening 
for emotional distress at key points along the patient pathway (Salmon et al., 2015). 
The main aim of these health policies are to reduce stress amongst cancer patients 
and to ensure they receive the psychological help they need (Holland et al., 2013). 
Evidence suggests that screening can improve clinicians’ and patients’ 
communication regarding psychological needs (Ristevski et al., 2013).  
Research has highlighted the benefits of a Patient Concerns Inventory (PCI) (Rogers, 
El-Sheikha & Lowe, 2009) (www.patient-concerns-inventory.co.uk) which is 
completed prior to out-patient consultations and allows patients to indicate their 
needs and concerns, which can help to promote discussions during out-patient 
consultations, resulting in health professionals being able to signpost patients to the 
support they need. The PCI was originally developed for use in head and neck cancer 
clinics, however, recent research with breast cancer patients has shown that it helped 
them to identify issues including body image, psychological and social functioning 
for discussion with health professionals (Kanatas et al., 2014). Similarly, Question 
Prompt Lists (QPLs) aim to promote patient participation during consultations and 
help them acquire information suited to their needs (Dimoska et al., 2012). QPL 
interventions in oncology settings have been found to increase patient participation 
and improve psychological outcomes including anxiety (Brandes, Linn, Butow & 
van Weert, 2015). Macmillan Cancer Support is currently undertaking a pilot study 
of the role of support workers in a number of NHS sites across the country. Early 
findings indicate that these staff can undertake holistic needs assessments and 
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provide the coordination of care that patients state they need (Independent Cancer 
Taskforce, 2015). 
These interventions might all offer great benefit to breast cancer patients, if rolling 
them out for routine use in breast clinics enables the identification of those who are 
negatively affected by treatment-related hair loss, and helps them to receive the 
support they want, however, before they are offered as part of routine care, more 
research including pilot testing is required to ensure that the screening tools can offer 
benefit to patients.  
 
7.4.3 Stepped care models 
Service provision in the UK generally includes specialist NHS services and support 
offered by charities (Hansen & Clarke, 2009). Healthcare services in the UK are 
developed in accordance with the Department of Health and the National Institute for 
Health and Clinical Excellence (NICE) (Cadogan, 2012). Stepped care models are 
used within the NHS to help organise the provision of services and to help healthcare 
professionals to select the most effective interventions. Patients are offered the least 
intensive intervention first and can then step up or down the pathway depending on 
their needs (NICE, 2011). Stepped care models are particularly appealing as they are 
cost effective; people receive the least intensive interventions for their need (NICE, 
2011). NICE guidelines have led to the development of a stepped care model known 
as Improving Access to Psychological Therapies (IAPT), whereby primary care 
mental health workers deliver psychological interventions.  
There are currently very few services within the UK which offer specialised support 
to those with appearance concerns. ‘Outlook’ is an NHS outpatient specialist service 
for people with appearance concerns, which uses Social Interaction Skills Training 
(SIST), to help patients manage the challenges of social situations (Robinson, 
Rumsey & Partridge, 1996) and Cognitive Behavioural Therapy (CBT) (Cadogan, 
2012). To the best of the researcher’s knowledge, ‘Outlook’ is the only NHS 
outpatient service in the UK specific to patients’ appearance-related concerns. 
Research and support around appearance concerns, such as that provided through 
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Outlook, which is not cancer specific may be beneficial to those affected by hair 
loss.  
Moving forward in supporting breast cancer patients affected by treatment-related 
hair loss, it could be useful to consider the suitability of the Centre for Appearance 
Research (CAR) framework of appearance-related interventions (Rumsey & 
Harcourt, 2012) to inform both research and provision of care. In line with current 
stepped care frameworks (NICE guidelines, 2007, 2009) the CAR framework of 
interventions includes different levels of therapeutic intervention, depending on 
individual needs (Jenkinson, 2012). The CAR framework follows the philosophies of 
similar stepped care models, so that all patients are offered support at levels 1 and 2 
and, if required following an assessment with a trained health professional, may be 
offered more intense therapeutic approaches such as those at level 4 and 5, thus 
aiming to provide cost effective care like other stepped models. 
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Figure 16. The CAR framework of interventions for people with visible differences 
(Rumsey & Harcourt, 2012). (First produced by Professor Nichola Rumsey and 
Professor Diana Harcourt (2012), p. 684, Figure 50.1. Reproduced with copyright 
permission from Oxford University Press). 
 
The CAR framework is a tiered model of interventions. It is important to determine 
what level of intervention a patient might benefit from, by using a needs assessment 
or screening tool, as discussed above. At the societal level (level 0 on the 
framework), public attitudes towards hair loss and breast cancer treatment could be 
explored, with a view to challenging societal messages, including appearance-related 
beliefs. However, it is extremely difficult to bring about societal change. Managing 
other people’s reactions can be particularly difficult for many cancer patients 
affected by hair loss, as found in both the current and previous research (e.g. Hilton 
et al., 2008), so interventions that promote understanding and acceptance of diversity 
in appearance, for example, through the media including poster campaigns, could be 
beneficial for those whose appearance is different. For example, Breast Cancer 
Care’s recent body image campaign (BCC, 2014, 
 
                                                           O: 
General population and societal campaigns 
 
 
  1: 
Information given to all breast cancer patients 
                                                                   2: 
One-to-one advice and information re hair loss (e.g. HeadStrong, online forums) 
service) 
3: 
Self-administered interventions (e.g. Face IT) 
4: 
Face-to-face, online, telephone 
counselling/therapy from a specialist (e.g. 
principles of ACT) 
5: 
Complex, 
specialist-led 
counselling/ 
therapy (e.g. 
CBT) 
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www.breastcancercare.org.uk/body) includes a film of individuals talking about their 
experiences of body image after breast cancer. Also, a number of school based 
interventions promote positive attitudes and behaviours in secondary education 
towards body image. An advantage of these interventions is that children might then 
educate their parents and family members too. However, even if population and 
societal campaigns were to bring about change in some people’s attitudes, they 
would be unlikely to remedy all the concerns that breast cancer patients affected by 
hair loss have. Additional interventions to offer support at an individual level, as 
evidenced in the framework, are still needed. 
For those in need of low level psychological support, written information in the form 
of leaflets and information booklets can offer accessible advice (Jenkinson, 2012). 
Level 1 of the framework would involve all breast cancer patients who are likely to 
be affected by hair loss receiving information in different formats (e.g. written, 
online). Notably, in many cases this is already happening thanks to charities and 
organisations such as Macmillan and Breast Cancer Care who have a wealth of 
information booklets including some specific to hair loss and body changes after 
treatment.  However, some patients do not receive information and are unaware of 
the resources freely available to them (Independent Cancer Taskforce, 2015).  
Providing each patient with the information that meets their individual needs is a 
major challenge. One way of moving forward may be to introduce an online hub, 
whereby one website is promoted by breast cancer charities and health professionals 
and from where patients can be directed to resources and interventions based on their 
needs. This could make information much more accessible for some breast cancer 
patients; however, it is important to acknowledge that online materials are not 
accessible or popular with everyone and a number of participants in the present 
research preferred paper copies of questionnaires rather than online materials. Also, 
breast cancer generally affects older individuals; in the UK between 2010 and 2012, 
24% of breast cancer cases were diagnosed in those over the age of 75 (Cancer 
Research UK, 2015). It is possible that this age group may be less confident in using 
computers, therefore information provision cannot solely be online, even though 
web-based interventions are being used successfully by older people (Yardley & 
Nyman, 2007). 
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One way of fostering peer support (level 2 of the framework) is through discussion 
forums which some charities already run (e.g. Breast Cancer Care), whereby patients 
can talk to peers online. However, patients may read about other patients’ distressing 
experiences which may have a negative effect on their own wellbeing. A number of 
participants in the HeadStrong qualitative study spoke about engaging in online 
discussion forums - some found them to be an easily accessible form of peer support, 
whereas others found them unhelpful.  
 
However, the level of information patients seek varies greatly and some will require 
a higher level of intervention. Patients could attend a HeadStrong session or a similar 
service, for example Look Good Feel Better, which offers advice including scalp 
care, the use of hats and headscarves to camouflage hair loss and make up to disguise 
facial hair loss. As highlighted in the systematic review and HeadStrong service 
evaluation, camouflage-based support services may be exactly what some women 
want and need, but they may not necessarily meet all patients’ needs. Therefore, 
patients warranting further support may benefit from a level 3 intervention.  This 
could include the expressive writing intervention explored in chapter 6, although it is 
not clear from the current research whether this is effective or acceptable for this 
patient group.  
 
As highlighted above, cancer patients report a number of unmet needs during and 
after they have finished active treatment. As a consequence of receiving a cancer 
diagnosis and treatment, individuals may lack confidence and feel vulnerable, which 
is a potential barrier to accessing support (Foster et al., 2015). Many cancer survivors 
believe eHealth interventions could be a valuable addition to follow-up care 
(Lubberding et al., 2015). Future research could explore the development and 
effectiveness of online interventions to specifically support patients troubled by the 
appearance-related impact of their treatment. Online interventions are readily 
available at any time, overcoming some of the problems patients have reported 
around difficulty in accessing support and attending face-to-face interventions (a 
problem that was reported in the HeadStrong evaluation in this thesis). Clinicians 
have advocated the use of remote online interventions as a way to increase access to 
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interventions for patients unable to attend interventions in a hospital setting (Bessell, 
Clarke, Harcourt, Moss & Rumsey, 2010). Also, recent research has highlighted the 
utility of online interventions in aiding patients to self-manage (Murray, 2012). For 
example, Face IT is an online CBT-based intervention specifically to support people 
with appearance-related concerns associated with an altered or unusual appearance.  
It has been found to increase positive adjustment, whilst reducing anxiety, 
depression and appearance concerns in adults with a range of disfigurements 
(Bessell, Brough, Clarke, Harcourt, Moss & Rumsey, 2012). Importantly, findings 
from Face IT compare favourably with a similar intervention delivered face-to-face 
by highly trained health professionals (Bessell, 2009).  
 
Face IT could be beneficial for breast cancer patients who are affected by treatment-
related hair loss as it targets the underlying concepts of body image and appearance 
concerns. Moreover, although the systematic review in chapter 2 highlighted that 
currently evaluated interventions for hair loss are delivered either in a hospital or 
clinic setting, the findings from the HeadStrong study found that patients would 
prefer interventions to be delivered away from the environment they associate with 
their cancer treatment. This further supports the need for varied and flexible 
interventions to meet patient’s individual needs. An online intervention would make 
psychosocial support easily accessible for patients, enabling them to use it at a time 
and location convenient for them, meaning they would not have to travel for the 
intervention (see the HeadStrong evaluation in chapter 4). However, engagement in 
internet-based interventions can be low (Gorlick, Bantum & Owen, 2014). It would 
be imperative to engage users in future research, to understand their experiences and 
needs throughout the development of an intervention of this sort, highlighting the 
importance of including PPI. 
  
Levels 4 and 5 of the CAR framework are the most intense and include interventions 
aimed at the most distressed patients with complex support needs, who would benefit 
from more expert input and specialist therapy such as that available through a 
qualified, experienced psychologist or counsellor. Interventions provided at these 
levels include Cognitive Behavioural Therapy (CBT) and third wave approaches 
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such as Acceptance and Commitment Therapy (ACT) (an in-depth discussion of 
these interventions can be found below in section 7.4.3). Level 4 interventions may 
include brief remote one-to-one or telephone therapy, whereas the level 5 
interventions are for those experiencing the highest levels of psychosocial distress 
and include a one-to-one intervention with a specialist health professional and would 
typically last longer than the level 4 interventions. As highlighted above, rather than 
seeking a one-size-fits-all approach it is imperative, even at this level, to assess 
individual needs since the psychosocial consequences of treatment-related hair loss 
are diverse and cannot be judged on severity of hair loss alone.  
 
7.4.4 Exploring additional interventions  
Within the UK, cancer policy (i.e. Department of Health, 2011) is supportive of the 
use of psychological interventions to improve the patient experience (Hulbert-
Williams, Storey & Wilson, 2015). Literature on interventions developed for long-
term conditions could help advance the support provided to cancer survivors (DoH et 
al, 2013). The suitability and efficacy of alternative interventions to support breast 
cancer patients affected by treatment-related hair loss could usefully be investigated, 
including Cognitive Behavioural Therapy (CBT), Mindfulness, and Acceptance and 
Commitment Therapy (ACT).   
 
7.4.5 Cognitive behavioural therapy (CBT) 
CBT offers a problem-focused approach whereby “dealing with distress, positioning 
it within a medical model and as something abnormal to be corrected or fixed, 
distress cognitions are identified and their impact minimised to improve behaviour 
and outcome” (Hulbert-Williams et al., 2015, p. 17). It is often used within the NHS 
to treat anxiety and depression (Jenkinson, 2012). CBT approaches to appearance 
concerns have received favourable support (Jarry & Ip, 2005). Specifically, CBT has 
been found to be effective in reducing depression and anxiety and improving quality 
of life in cancer patients, with large effect sizes > .9 (Osborn, Demoncada & 
Feuerstein, 2006). It has also been shown to help psycho-sexual adjustment 
(Siddons, Wootten & Costello, 2013; Watson et al., 2013). However, despite the 
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acceptability of CBT from clinicians and researchers, it is important to acknowledge 
that, to date; only a few studies provide good quality evidence to support its use with 
individuals with appearance concerns (Bessell & Moss, 2007; Jenkinson, 2012). 
Also, the longer-term benefits are unclear (Hayes et al., 2004) and CBT interventions 
currently lack a replicable underlying intervention framework (Hulbert-Williams et 
al., 2015). Therefore, a CBT based approach may be beneficial for breast cancer 
patients who are affected by treatment-related hair loss but before definitive 
recommendations can be made, more research is needed to demonstrate its 
effectiveness in supporting this particular patient group. 
 
7.4.6 Mindfulness 
Mindfulness is described as paying complete attention to the experiences occurring, 
in a non-judgemental way (Brown & Ryan, 2003). It is related to alexithymia, as 
they both describe how people handle and process their internal experience. 
Mindfulness requires an acceptance and awareness that adopts a willingness to face 
and accept thoughts and emotions (Brown, Ryan & Creswell, 2007). An individual 
has to assimilate the traumatic experience into their system or alter their schema so 
that the traumatic experience can be accommodated (Sloan & Marx, 2004). Poon and 
Danoff-Burg (2011) examined trait mindfulness as a moderator of the expressive 
writing paradigm, and found that a higher mindfulness score predicted greater 
improvements in physical and psychological symptoms, negative and positive effect, 
and sleep quality. Therefore it is suggested that individuals who are more mindful 
benefit more from disclosing their emotions and thoughts regarding stressful 
experiences than do those who are less mindful.  
There is evidence for the adoption of third wave interventions within cancer care 
including mindfulness-based approaches (Hulbert-Williams et al., 2015). 
Mindfulness training involves encouraging individuals to enter a state of mind where 
they pay active, non-judgemental attention to both positive and negative experiences 
(Hayes & Smith, 2005). There is growing support for mindfulness interventions for 
cancer patients including benefits in reduced fatigue, and improved mood, quality of 
life, sleep and benefit-finding (Casellas-Grau, Font & Vives, 2014; Monti et al., 
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2013; Ott, Norris & Bauer-Wu, 2006; Schroevers & Brandsma, 2010; Smith, 
Richardson, Hoffman & Pilkington, 2004; Lengacher et al., 2015). Mindfulness also 
plays a key role in other third-wave therapeutic approaches including ACT (Hulbert-
Williams et al., 2015). 
Ledesma and Kumano (2009) conducted a meta-analysis that found a mindfulness-
based stress reduction (MBSR) program was effective in improving the well-being 
of breast cancer patients. Due to small sample sizes and as the meta-analysis relied to 
a large extent on data from observational studies, conclusions must be taken with 
caution. Furthermore, mindfulness has gained attention for its ability to improve 
acceptance of symptoms which are impossible or difficult to change (Fjorback, 
Arendt, Ørnbøl, Fink & Walach, 2011), suggesting its potential use to help patients 
affected by chemotherapy reach a level of acceptance of their hair loss.  
 
7.4.7 Acceptance and commitment therapy (ACT) 
To date, few interventions have explored the effectiveness of psychological 
interventions that promote acceptance of the distress which is evident in cancer 
populations (Feros, Lane, Ciarrochi & Blackledge, 2013). ACT is a theory driven 
behavioural approach (Arch & Mitchell, 2015) that “focuses on changing a patient’s 
relationship with their thoughts, rather than changing the content of the thoughts” 
(Feros et al., 2013, p. 459). Patients learn to experience difficult thoughts and 
feelings without being controlled by them.  It promotes forms of coping that predict 
positive psychosocial outcomes, which could include accepting cancer-related 
distress; reducing cancer-related avoidance and committing to behaviour change 
(Stanton, Ravenson & Tennen, 2007).  
ACT aims to develop psychological flexibility to enable a person to act effectively 
with their distressing symptoms through the use of acceptance strategies, 
mindfulness techniques and a range of behavioural approaches to ultimately buffer 
against psychological distress (Feros et al., 2013). Research focused on interventions 
based on the use of ACT demonstrates positive findings (Köhle et al., 2015). 
Research with cancer patients (i.e. Feros et al., 2013; Karekla & Constantinou, 2010; 
Rost, Wilson, Buchanan, Hildebrandt & Mutch, 2012), has shown improved distress, 
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mood disturbance, anxiety, depression and quality of life (Arch & Mitchell, 2015; 
Feros et al., 2013).  
Future research may benefit from exploring the use of mindfulness and ACT-based 
interventions specifically to support breast cancer patients affected by treatment-
related hair loss, at levels 4 and 5 of the framework in figure 16. Following the MRC 
guidance, this included exploring their acceptability and feasibility, before piloting 
the interventions to exploring the recruitment procedure, before rolling out a large 
scale RCT of the interventions to explore if they could offer any benefit to patients. 
 
7.5 Reflection  
 
This section outlines my reflection on the ARC framework, my personal experience 
of the methods used and of conducting mixed methods research. A reflective diary 
was kept throughout, which proved useful at each stage of the research process. A 
summary of the key points from the reflective diary are included below.  
 
I have always had a passion for appearance and body image research. I found the 
process of conducting the research to be extremely challenging at times but I have 
also found it enjoyable and I feel like it has been a steep learning curve. I had no 
experience of conducting a systematic review but fortunately I was able to attend the 
Health Psychology Doctorate lectures on systematic reviews. Once I knew what a 
systematic review involved, I enjoyed conducting the review; however, it was 
tedious at times; especially when checking thousands of study titles. After 
determining the final studies for my review, I found reading and quality checking the 
studies enjoyable. 
I found the qualitative interviews daunting at first, particularly as I was concerned 
that I was inconveniencing the patients at a very difficult time; when they are 
undergoing treatment. As soon as the interviews commenced I relaxed and enjoyed 
listening to women’s experiences. I was honoured when many of the women thanked 
me for listening to their experiences and said that talking about their experiences had 
really helped them. I was initially surprised to find that the women’s experiences of 
treatment-related hair loss were so diverse and at times I was concerned when some 
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women disclosed difficult experiences, however, I had a very supportive supervision 
team which I was able to discuss these concerns with afterwards.  
One of my greatest difficulties has been the NHS ethics process and navigating my 
way through this process. I spoke to several people from my research centre who had 
experience of the NHS process and sought their advice prior to applying for NHS 
ethics, but as the process changes frequently; they were not always able to provide 
any assistance with the process.  
I felt that it was imperative that I invested a considerable amount of time and effort 
in meeting with various gate keepers and health professionals prior to commencing 
each study. In advance of recruiting for the HeadStrong study, I attended a meeting 
with senior staff members from Breast Cancer Care to ascertain information about 
the HeadStrong service and to arrange for me to attend a number of HeadStrong 
sessions; to gain an insight into the service and to meet the volunteers that deliver the 
service. I attended numerous meetings and research forums in order to meet with 
health professionals to inform them of my expressive writing study; to ask them for 
their advice at the planning stage of the research, and for their assistance with 
recruitment. I was quite apprehensive prior to my initial meeting with the health 
professionals as it was crucial that I made a good impression. However, I found that 
all meetings went exceptionally well, with all health professionals being very 
supportive of my research, and my confidence increased as I undertook more 
meetings.  
The research process has increased my awareness of the practicalities and further 
reinforced the importance of conducting applied research. I feel that my confidence 
both as a human being and as a researcher, along with my research skills have grown 
considerably over the course of the research process and it has helped to highlight 
future areas for professional development.  
 
7.5.1 Reflection on the ARC framework 
 
This program of research was informed by the ARC framework (2009) which 
demonstrated the importance of a theoretical framework of pre-disposing factors and 
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moderating factors in determining psychosocial adjustment to treatment-related hair 
loss, further details can be found in section 1.14. This is the first time the ARC 
framework has been used with individuals with breast cancer. It was used as a 
starting point to explore psychosocial interventions to support breast cancer patients 
who are affected by treatment-related hair loss. Specifically, the ARC framework 
informed the development of the questionnaires used in the quantitative evaluation 
of HeadStrong and the expressive writing feasibility study. Utilisation of the ARC 
framework was advantageous in gaining an insight into the pre-disposing factors of 
adjustment to treatment-related hair loss and an understanding of participants’ 
thought processes including the value they placed on their appearance and in 
determining their adjustment to their altered appearance. Unfortunately, it was not 
possible to test the ARC framework in full due to the small sample size in both 
studies, therefore, support for the framework is limited and no definitive conclusions 
about its suitability with this group can be made. If researchers were to consider 
using the ARC framework in the future, a key consideration would be; what are the 
key predisposing factors, intervening cognitive processes and outcomes in adjusting 
to an altered appearance. Although it is difficult to predict what the rate of uptake 
would be to a study, it is important to optimise recruitment and try to overcome any 
foreseeable barriers to recruitment, in order to be able to test the ARC framework to 
the full.  
 
7.5.2 Reflection on the methods used  
 
The widely used MRC (2008) framework also guided this program of applied 
research, which has taken a stepwise mixed methods approach. Following the MRC 
framework, firstly, a systematic review was conducted which allowed a rigorous 
consideration of the quality of evaluations of interventions for people affected by 
hair loss. Secondly, the exploratory nature of qualitative research enabled an in-
depth understanding of women’s experiences of treatment-related hair loss and of the 
HeadStrong service. All participants in the qualitative and quantitative HeadStrong 
study were recruited through the support charity Breast Cancer Care, suggesting they 
either wanted support or to share their experiences in order to be able to help others 
in the future. Interviews used in the qualitative HeadStrong study allowed women to 
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recall their experiences in detail and allowed me to gain an understanding of their 
experiences. Building a rapport is an essential part of the interview process and it 
was relatively easy to build a rapport with the participants; it was important for them 
to feel comfortable and able to talk openly and share their experiences without 
judgement.  
 
As a consequence of having become familiar with the breast cancer literature and 
having observed a few HeadStrong sessions prior to conducting the interviews, it 
was anticipated that participants would have emotional stories to tell and it would be 
important to be mindful of being empathetic to their experiences. The majority of 
women’s stories were extremely positive about the support they had received from 
health professionals, through HeadStrong and from their family and friends. Several 
women commented that they found the interview helpful and appreciated the 
opportunity to speak to someone outside of their immediate family or friends. Every 
woman who consented to participate in the qualitative HeadStrong study was 
interviewed. The low attrition rate may reflect a desire from participants to re-pay 
the HeadStrong volunteers and service providers for their help and support. A 
strength of both the qualitative and quantitative HeadStrong studies was the 
recruitment of individuals from several different HeadStrong centres.  
 
The study helped to understand participants’ experiences of the HeadStrong service, 
allowing an executive summary report to be compiled and given to Breast Cancer 
Care (see appendix 35). As discussed previously in chapter 5, the researcher attended 
a meeting with the Director of Services and Engagement, along with the Heads of 
Services at Breast Cancer Care, to present the findings from the study and to discuss 
the implications for practice, which the charity has now considered whilst reviewing 
its provision of the HeadStrong service. As a result of the study findings, Breast 
Cancer Care has altered the HeadStrong service, so that it is tailored to individuals’ 
needs.  
  
Recruitment was difficult for both the quantitative HeadStrong service evaluation 
and the expressive writing study. On reflection, the timing of the interventions and 
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studies needs careful consideration. Time since participants’ diagnosis in the 
qualitative HeadStrong study was 8 months compared to 1.9 months in the 
quantitative study and 30.02 months in the expressive writing study (however there 
was a very wide range in this study: 1.5 months - 15 years 11 months). Patients 
newly referred for chemotherapy attend numerous hospital appointments and are also 
adjusting to their diagnosis, whereas those further along their cancer journey may 
have had time to make this adjustment and have more time to take part in research as 
the commitment to treatment and check-ups reduces. The side effects of treatment 
may play a role in patients’ uptake of the invitation to participate in research. 
Research has highlighted that more than a quarter (28%) of patients report that their 
arms were swollen or tender to some extent, including difficulties with mobility and 
undertaking usual activities (DoH, 2012). These physical factors could influence 
recruitment into study such as the HeadStrong and expressive writing intervention, 
where participants were asked to complete questionnaires on a number of occasions 
soon after diagnosis or amidst treatment regimes. The question remains as to what 
extent women in these studies are representative of breast cancer patients affected by 
treatment-related hair loss. It is difficult to know whether the women who declined 
to participate would differ from those who took part. However, it has previously 
been noted that any research into a sensitive topic will have an inevitable bias, since 
individuals who are finding a situation stressful may be reluctant to participate 
(Kent, 2000).  
The possible burden that the research may have on participants was the main reason 
why there was input from patients and support organisations in the planning stages 
of the studies (see chapter 3 for a full discussion of the use of PPI) and steps were 
taken to ensure that the research materials would not be overly burdensome. Also, it 
was important to make the materials accessible, in order to hopefully increase 
recruitment. However, research is needed to explore this further, particularly if 
looking to recruit patients at a later stage in their cancer journey who are 
experiencing the ongoing distress of hair loss.   
As previously discussed in chapter 3, RCTs are considered to be the gold standard in 
health research, but they require larger sample sizes than were possible in the current 
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studies. Based on the literature discussed in chapter 3 a number of incentives, 
including financial, were provided to individuals in the hope that it would help 
recruitment; however, this was not the case. The importance of maintaining regular 
contact with participants has been highlighted in the literature (see chapter 3), 
therefore, for both the quantitative and expressive writing studies, the researcher 
regularly contacted both the participant and healthcare professionals who were 
helping to identify eligible participants. This was found to be beneficial, particularly 
for the expressive writing study, where having the researcher present in the oncology 
department served two purposes; firstly, it helped to remind healthcare professionals 
to identify eligible participants. A number of health care professionals commented 
that because they are understandably extremely busy it was good to see the 
researcher as a reminder to identify eligible patients. Secondly, it enabled eligible 
patients to ask the researcher any initial questions that they may have had. Also, for 
both the HeadStrong service evaluation and expressive writing study, building a 
rapport with the researcher may have made both the health professionals and patients 
feel more confident in asking questions regarding the studies.  However, there are 
still barriers to recruitment and it is important to find ways of overcoming the 
challenge of recruiting breast cancer patients for psychosocial interventions.  Future 
researchers run the risk of facing the same challenges and pitfalls which could 
potentially impede future research in this area (Cope, 2015).   
It is important to acknowledge there are some methodological limitations to this 
program of research. Firstly, a problem with applied research of this nature, as 
discussed above, is the need for the researcher to build rapport with health 
professionals in order to obtain access to participants. Yet this could have impacted 
on recruitment if eligible patients were perhaps concerned that the researcher was not 
independent from their medical team. Whilst every effort was made to ensure 
confidentiality in each study, there is a possibility that women who were dissatisfied 
with any aspect of the care they have received might not participate for fear that 
what they say may be reported back to the health professionals or HeadStrong 
volunteers.  
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7.5.3 Reflection on the methodology 
 
There are benefits of combining qualitative and quantitative research methods; some 
researchers have even argued that it results in superior research (Johnson & 
Onwuebbuzie, 2004; Yardley & Bishop, 2015). Mixed methodology was deemed 
most appropriate for addressing the different research questions within this thesis 
(Lee & Rowlands, 2015). A pragmatic approach was taken as the researcher believed 
that despite there being fundamental epistemological differences between 
quantitative and qualitative approaches, these methods are complementary (Bishop, 
2015). Several benefits of using mixed methods included gathering different types of 
data that would be useful to various stakeholders including Breast Cancer Care, 
which was a key consideration related to the utility of the findings. Whilst it may 
have been easier to maintain the integrity of each method using a sequential design, a 
benefit of using a concurrent triangulation design for the HeadStrong study meant 
links were made between the qualitative and quantitative components.  
 
There are limitations to both qualitative and quantitative approaches, including the 
findings from qualitative methods not being generalisable as they are unique to the 
participant group being studied and quantitative methods focusing solely on 
hypothesis testing (Johnson & Onwuegbuzie, 2004) (see chapter 3 for further 
details). The researcher took the view that quantitative and qualitative approaches 
provide complementary information in order to offer a more comprehensive 
understanding of breast cancer patients’ experiences of treatment-related hair loss 
and their psychosocial support needs (Bishop, 2015). It meant that the limitations of 
quantitative methods were compensated by the advantages of qualitative methods, 
and vice versa. However, not all findings were found to be complementary, which is 
a challenge of mixed methods research. The qualitative HeadStrong findings along 
with those from the quantitative HeadStrong study and systematic review helped to 
guide the development of the expressive writing study, specifically the systematic 
review found that hospital interventions were the most beneficial, however, women 
in the HeadStrong study indicated that timing was an issue in attending support 
services at a hospital, which also served as a reminder of their cancer and 
participants wanted more emotional support. Therefore, a remote intervention was 
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deemed more appropriate. Also, the SR and HeadStrong studies identified a need for 
an intervention to help patients express their feelings and emotions, which the 
expressive writing intervention aimed to do. 
 
A challenge of mixed methods research is the integration of the qualitative and 
quantitative methods during analysis and integration (Tariq & Woodman, 2010), 
however, a main reason for using a mixed methods approach was to enable 
triangulation for the HeadStrong study (Howe, 2012), allowing the exploration of 
breast cancer patients’ experiences of treatment-related hair loss and preferences for 
psychosocial support through the use of different perspectives.  Integration meant 
pondering over the findings, checking the fit of each new set of interpretations with 
developing understanding. A complete synthesis was not necessarily the aim of this 
research, therefore, meanings do not necessarily have to be consistent to be valid, 
they can be seen as multi-dimensional (Mason, 2006). Despite a qualitative approach 
being deemed more appropriate in exploring individual experiences of a 
phenomenon, the collection of quantitative data is equally important as it allowed the 
exploration of women’s experiences of the HeadStrong service as they accessed it, 
whereas the qualitative study was asking people to reflect back on their experiences 
which may have been several months earlier. 
 
To summarise, this program of research has demonstrated the usefulness of mixed 
methods research to examine psychosocial interventions to support breast cancer 
patients affected by treatment-related hair loss. The methodologies used in this 
program of research have produced a range of data that have complementary 
applications, permitting different kinds of understanding and knowledge. Whilst the 
feasibility of a quantitative, randomised controlled trial was worthy of consideration 
for the expressive writing study, qualitative methods were necessary to explore 
individuals’ experiences of the HeadStrong service. Having completed this research 
program, the pragmatic approach undertaken is still considered the most appropriate 
for this applied research. 
 
 
 
Chapter Seven: Discussion  
 
 
 
258 
 
7.5.4 Reflection on patient and public involvement (PPI) 
 
Patient involvement has played a vital role within this research. It was used for a 
number of reasons, including the hope of overcoming recruitment challenges (Jones 
et al., 2015). Whilst there are a number of advantages to PPI, which have been 
discussed in chapter 3, there are also limitations. The main limitation is that a PPI 
representative cannot represent the views of every other patient, if they are relying 
on their own experience to inform their views and advice to the research team. This 
is why it was important to not only rely on one patient advisor and why Breast 
Cancer Voices were also consulted both for the HeadStrong evaluation and 
expressive writing study. Also, it must be acknowledged that those who choose to be 
involved in research as PPI volunteers are highly motivated and may differ in this, 
and other ways, to those who choose not to be involved in research but might still be 
the recipients of future interventions and care that result from it.  
 
Moving forward with PPI, it is important that researchers take time to explain each 
step of the research process if patients and service users acting as PPI representatives 
are unfamiliar with it. For example, a particular challenge of using PPI in this 
program of research was that service users did not like the wording used in some of 
the information sheets and instructions on the questionnaires used in the quantitative 
studies. It was therefore important to re-phrase some of the wording so they were 
more user friendly to participants. It is acknowledged that a lack of awareness or 
understanding about the research process can lead to unrealistic expectations (Wright 
et al., 2007), which is why it was important for the researcher to meet with the user 
representative on a regular basis, to build a rapport and to gain an understanding of 
the user representative’s expectations.  
 
 
7.6 Summary of the main findings 
As discussed previously, the first stage of the research was to conduct a systematic 
review of the available evidence of the effectiveness of psychosocial interventions to 
support people affected by hair loss. The systematic review revealed several 
characteristics of the successful interventions; intervention delivery soon after hair 
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loss, information provision, individual based intervention; and an opportunity for 
individuals to express their concerns. The second stage of the research involved 
taking a mixed methods approach to evaluate the HeadStrong service. The findings 
suggest HeadStrong can be an important and helpful intervention for breast cancer 
patients affected by hair loss, but it does not necessarily meet all of their needs. It 
was highlighted that there is still potential to develop a range of interventions for this 
patient group. The third stage in this program of research considered the feasibility 
of an expressive writing intervention to support this patient group. Although the 
expressive writing was found to be appealing to some, based on the small sample 
size no definitive conclusions could be made. Please see appendix 20 for a list of 
conferences and research events were the findings from this program of research 
have been disseminated. 
 
7.7 Conclusions 
This program of research has explored psychosocial interventions to support breast 
cancer patients affected by treatment-related hair loss. It has contributed to the 
limited body of research in this area by highlighting the relevance of this issue to 
those affected, giving an overview of the psychosocial support needs of this 
particular group and of the psychosocial support currently available to them. Also, it 
has considered the acceptability and feasibility of an expressive writing intervention 
which has not previously been tested in this context. Whilst generalisations cannot 
be made due to the small sample sizes in each of the studies, the research provides a 
basis for further research in this area. Moreover, women’s individual psychosocial 
support needs in relation to their hair loss need greater recognition and further 
research is advised to determine the most appropriate means of providing 
individualised, effective support to meet the needs of this patient group.  
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Appendix 1. Outline of the search strategy and search terms used for the systematic 
review 
 
Stage 1. Terminology:- 
Appearance/body image: body image, physical appearance, disfigurement, visible 
difference, alopecia, hair-loss/hair loss 
Psychosocial Interventions: therapeutic interventions, patient teaching, education, 
advice, communication, camps, exercise, social skills training, wigs, headwear, 
scarves, CBT/Cognitive Behavioural Therapy, behavioural therapy, counselling, 
social support, social support networks, group therapy, peer support, hair consultant, 
nurse practitioner, oncology nurse, specialist nurse, cancer resource program, couple 
based interventions, nursing care, psycho-social support, information provision. 
Psychosocial Intervention is defined as any program that incorporates techniques 
that aim to reduce psychosocial distress by reducing anxiety and depression and 
increasing social activities. 
Cancer: oncology, cancer, tumour, chemotherapy 
Stage 2. Identification of databases to search:- 
 AMED – Allied and Complementary Medicine 
 ASSIA – Applied Social Sciences Index and Abstracts 
 BNI – British Nursing Index 
 CAMPBELL COLLABORATION – Systematic reviews of the effects of 
social interventions 
 CINAHL – Cumulative Index to Nursing and Allied Health Literature 
 EMBASE- Psychiatry and Pharmacology 
 MEDLINE – Biomedicine and Health 
 PUBMED – Clinical Science and Biomedicine 
 PSYCHINFO – Psychology 
 SCIENCE DIRECT – Social Sciences 
 SCIENCE CITATION INDEX – Medicine, Psychiatry 
 SOCIAL SCIENCES CITATION INDEX – Psychology 
 UK PUBMED CENTRAL – Biomedical and life sciences 
 
Stage 3. Identification of ‘grey’ literature:- 
 WEB OF KNOWLEDGE – ISI Web of Science and ISI Proceedings 
 ZETOC (BRITISH LIBRARY) – Conference papers/proceedings 
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 CONFERENCE POSTERS – Review of abstract publications, attendance at 
International Psycho-Oncology Conference 
 CONTACTS & EXERTS: –  
- Dr. Clarke 
- Dr. Collins 
 ORGANISATIONS – website search of cancer charities: Breast Cancer 
Campaign, Breast Cancer Care, Breast Cancer UK, Tenovus, Cancer UK 
 HAND SEARCH of Bibliographies – of those studies selected for systematic 
review and those identified as highly relevant during first screening of 
abstracts. 
 
Stage 4. Systematic Consideraion of Concept/MeSH Terminology:- 
To ensure that the chances of capturing all relevant papers are maximised, the first 
search for each database will be conducted with just the two concepts ‘psychosocial 
intervention’ and ‘hair loss’ for each. If the number of articles retrieved is high or if 
the relevance of the articles retrieved is low, the next concept ‘cancer’ will be 
entered with each database MeSH term. 
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The following searches were conducted with no limit on year of publication: 
Database Intervention Hair loss/Appearance 
AMED Psychological intervention$ Hair loss 
(EBSCO) Psychological adj1 intervention$ Alopecia 
Searched 9/2/12 Psychological adj2 intervention$ Bald* 
& 10/2/12 Psychological adj3 intervention$ Appearance* 
 Psycho-social intervention$ Visible difference* 
 Psycho-social adj1 intervention$ Body image* 
 Psycho-social adj2 intervention$ Self-concept 
 Psycho-social adj3 intervention$ Body awareness 
 Psychosocial intervention$ 
 
 Psychosocial adj1 intervention$ 
 
 Psychosocial adj2 intervention$ 
 
 
Psychosocial adj3 intervention$ 
   Therapeutic intervention$   
British Nursing Index Patient teaching 
(Same hair 
loss/Appearance search 
terms as above) 
(ProQuest) Patient adj1 teaching$ 
 Searched 10/2/12 Patient adj2 teaching$ 
 
 
Education 
 
 
Exercise 
 
 
Advice 
 
 
Communication 
 
 
Camp$ 
 
 
Social skill$ training 
 
 
Camouflage 
 
 
Wigs 
   Scarves   
CINAHL Cognitive behavio?ral therapy 
(Same hair 
loss/Appearance search 
terms as above) 
(EBSCO) Behavio?ral therapy 
 Searched 12/2/12 Cognitive therapy 
 & 13/2/12 CBT 
 
 
Counselling 
 
 
Social support 
 
 
Social support networks 
 
 
Group therapy 
 
 
Peer support 
 
 
Outreach program$ 
 
 
Couple-based intervention$ 
 
 
Nursing care 
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Nursing care-plan$ 
 
 
Psychological care 
 
   EMBASE  
 
(OVID) 
(Same search terms used as 
above) 
 Searched 13/2/12 
  
   MEDLINE 
  
(OVID) 
(Same search terms used as 
above) 
 Searched 14/2/12 
  
   
   PSYCHINFO 
  
(EBSCO) 
(Same search terms used as 
above) 
 Searched 14/2/12 
  
   INDEX/SOCIAL 
  
SCIENCES CITATION 
(Same search terms used as 
above) 
 INDEX 
  (WEB OF SCIENCE) 
  Searched 14/2/12 & 15/2/12 
 
   
   ASSIA Psychological intervention$ Alopecia 
Searched 15/2/12 Psychological adj1 intervention$ Hair loss 
 
Psychological adj2 intervention$ Baldness 
 
Psychological adj3 intervention$ Physical appearance 
 
Psycho-social intervention$ Visible difference$ 
 
Psycho-social adj1 intervention$ Disfigure$ 
 
Psycho-social adj2 intervention$ Body image$ 
 
Psycho-social adj3 intervention$ Self-concept 
 
Psychosocial intervention$ Body awareness 
 
Psychosocial adj1 intervention$ 
 
 
Psychosocial adj2 intervention$ 
 
 
Psychosocial adj3 intervention$ 
 
CAMPBELL 
 
Psychological intervention$ Hair loss 
COLLABORATION Psycho-social intervention$ Alopecia 
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Searched 15/2/12 Psychosocial intervention$ Baldness 
 
Therapeutic intervention$ 
 
 
Psychological care 
 
 
Appearance 
 
 
Visible difference$ 
 
 
Disfigure$ 
 
 
Body image$ 
 
   UK PUBMED Psychosocial Hair loss 
CENTRAL Psycho-social Alopecia 
Searched 15/2/12 Appearance Baldness 
 
Visible difference 
       
COCHRANE LIBRARY Psychological intervention$ Hair loss 
Searched 15/2/12 Psychological adj1 intervention$ Alopecia 
 
Psychological adj2 intervention$ Physical appearance 
 
Psychological adj3 intervention$ Physical adj1 appearance 
 
Psycho-social intervention$ Physical adj2 appearance 
 
Psycho-social adj1 intervention$ Physical adj3 appearance 
 
Psycho-social adj2 intervention$ Visible difference$ 
 
Psycho-social adj3 intervention$ Visible adj1 difference 
 
Psychosocial intervention$ Visible adj2 difference 
 
Psychosocial adj1 intervention$ Visible adj3 difference 
 
Psychosocial adj2 intervention$ Body image 
 
Psychosocial adj3 intervention$ Body adj1 image 
 
Therapeutic intervention$ Body adj2 image 
 
Patient teaching Body adj3 image 
 
Patient adj1 teaching$ Baldness 
 
Patient adj2 teaching$ Self-concept 
 
Education Body awareness 
 
Exercise Body adj awareness 
 
Advice Body adj2 awareness 
 
Communication Body adj3 awareness 
 
Camp$ 
 
 
Social skill$ training 
 
 
Camouflage 
 
 
Wigs 
 
 
Scarves 
 
 
Cognitive behavio?ral therapy 
 
 
Behavio?ral therapy 
 
 
Cognitive therapy 
 
 
CBT 
 
 
Counselling 
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Grey Literature Search 
 
WEB OF KNOWLEDGE Psycho* intervention Hair loss 
Searched 14/2/12 Appearance Alopecia 
 
Body image$ Baldness 
 
Visible difference 
 
 
Self-concept 
 
 
Body awareness 
 
 
Disfigure$ 
 
   ZETOC (combined conference and journal 
search) Psycho* Hair loss 
Searched 16/2/12 Appearance Alopecia 
 
Body image Baldness 
 
Visible difference 
 
 
Self-concept 
 
 
Body awareness 
       
 
Search Record: 
Search 1.a Hair Loss and intervention were included in all Ovid databases: AMED, British 
Nursing Index, CINAHL, EMBASE, MEDLINE, PSYCHINFO, Index/Social Science 
Citation Index: 8960 articles found and imported to Refworks. 
Search 1.b ASSIA: Hair loss and intervention search terms run on this database and 463 
articles were found and imported to Refworks. 
Search 1.c UK PUBMED: Hair loss and intervention terms run on this database and13 
articles were found and  imported to Refworks. 
Search 1.d Cochrane Collaboration: Hair loss and intervention run on this database and 
1456 articles found and imported to Refworks. 
 
Social support 
 
 
Social support networks 
 
 
Group therapy 
 
 
Peer support 
 
 
Outreach program$ 
 
 
Couple-based intervention$ 
 
 
Nursing care 
 
 
Nursing care-plan$ 
   Psychological care   
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Search 1.e Web of Knowledge: Hair loss and intervention run on this database and 1183 
articles found and imported to Refworks. 
Search 1.f Zetoc: Hair loss and intervention run on this database and 378 articles found and 
imported to Refworks. 
Once duplicates removed from Refworks: 5182 articles left for first review. 
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Appendix 2. Participant information sheet for the qualitative HeadStrong service 
evaluation 
 
 
 
An evaluation of Breast Cancer Care’s HeadStrong Service: 
Information Sheet 
You are being invited to take part in a study. Please read this information carefully 
and contact us if you have any questions about it. Thank you. 
What is the purpose of the study? 
This study is interested in people’s experiences of hair loss due to cancer treatment 
and their opinions about Breast Cancer Care’s HeadStrong service. The study is 
being carried out by Melissa Pilkington, a PhD researcher from the Centre for 
Appearance Research (CAR) which is based at the University of the West of 
England (UWE), Bristol  
Why have I been chosen? 
You are being invited to take part because you have previously attended a Breast 
Cancer Care HeadStrong session.  Anyone who has previously attended the 
HeadStrong service is eligible to take part. We are looking for a total of 25 people to 
take part 
Do I have to take part? 
No, taking part is voluntary. You do not have to take part if you do not want to and, 
if you do take part, you can withdraw from the study up to a month after taking part. 
Whether or not you take part will not make any difference to your care, now or in the 
future.   
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What will I have to do if I take part? 
If you decide that you would like to take part in the study, you will be interviewed to 
explore your reasons for accessing HeadStrong, what you anticipated HeadStrong 
would provide and whether you think HeadStrong helped you in the long term. 
Interviews will be conducted via telephone. It is anticipated that interviews may last 
up to an hour maximum and we would like to record your interview if you are happy 
for us to do so.  
What are the possible benefits of taking part? 
We do not expect that you will personally benefit from taking part in this study, but 
you might be pleased to think that your feedback will be used to inform HeadStrong 
and other support services for people experiencing hair loss in the future 
Will my identity be protected? 
Yes, your identity will be protected. During the interview you will be asked about 
your diagnosis and hair loss, however, in order to protect your identity only a 
summary of this information will be reported during the write up if the evaluation. 
What will happen with the results of the interview? 
The results of the study will be given to Breast Cancer Care, so that they can use 
them to plan HeadStrong and other support services in the future. Your individual 
answers will not be passed on to Breast Cancer Care, they will only receive a 
summary of the study findings overall 
How will the findings be shared with other people? 
The overall findings will be published in a journal, presented at conference 
presentations and written up as part of a PhD. Also, a summary of the findings will 
be made available to both participants and to Breast Cancer Care for them to present 
at meetings. 
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Who has reviewed the study? 
The study has been approved by the University of the West of England (UWE) 
Research Ethics Committee. It has also been approved by Breast Cancer Care.  The 
study is funded by Breast Cancer Campaign. 
Your right to withdraw from the study 
You have the right to withdraw from the study up to a month after you have taken 
part. If you wish to withdraw from the study, please contact the researcher and your 
interview and all your information will be withdrawn from the study and destroyed. 
What do I do now? 
If you would like to take part in the study, please complete the consent form 
attached. 
 
If you have any further questions, please contact, Melissa Pilkington at:- 
Email:- Melissa.Pilkington@UWE.ac.uk 
Telephone No:- (0117) 3283882 
 
Or you can contact Melissa’s supervisor, Dr Diana Harcourt at:- 
Diana2.Harcourt@uwe.ac.uk  
Telephone No:- (0117) 3283967 
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If you do want any more information about cancer-related hair loss, or would like to 
discuss any concerns you have, you might like to contact any of the following 
organisations that specialise in support for people affected by cancer:- 
 
Breast Cancer Care:-  
www.breastcancercare.org.uk 
Peer Support Team Telephone No:- 0845 0771893  
Peer Support Team Email:- ukpeersupportteam@breastcancercare.org.uk 
Breast Cancer Care’s Free Helpline for one-to-one support:- 0808 800 6000 
 
Maggie’s Centre:- 
http://www.maggiescentres.org/  
To arrange face-to-face support with a support specialist:- 
Email:- enquiriesatmaggiescentres.org  
Telephone No:- 0300 123 1801 
 
Macmillan:- 
www.macmillan.org.uk  
If you have any questions, would like support or someone to talk to:- 
Cancer Support Specialist Telephone No:- 0808 808 00 00 
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Appendix 3. Participant consent form for the qualitative HeadStrong service 
evaluation 
 
 
An evaluation of Breast Cancer Care’s HeadStrong Service: 
Consent Form 
 
This study is interested in patients’ experiences of Breast Cancer Care’s HeadStrong 
service.  Taking part in the study will involve either a face-to-face or telephone 
interview to discuss your experiences of HeadStrong. The interview should take no 
longer than an hour.  
I would like to record the interview, with your permission. In order to protect your 
identity only a summary of the information you provide will be reported during the 
write up if the evaluation. You do not have to take part and you have the right to 
withdraw from the study up to a month after taking part.  
If you give your consent to take part in the study, please sign below and return this 
form using the pre-paid envelope provided. 
Print your name……………………………….     Date…………………….. 
Your Signature................................................   Date................................ 
Contact Telephone Number.............................................................. 
Or 
Email................................................................................ 
Thank you for your time. 
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Appendix 4. Interview schedule for the qualitative HeadStrong service evaluation 
Interview schedule 
Before we start, I would like to remind you that you do not have to answer any 
questions that you don’t want to and if you choose not to answer a question, you 
don’t have to tell me why. Also, you are free to stop the interview anytime if you 
feel you don’t want to continue. The types of questions I ask do not have a right or 
wrong answer. I’m interested in finding out what you think and feel about things. I 
would like you to be open and honest when answering the questions. You will be 
asked to make up a false name for yourself and any information that you give will be 
treated as confidential. Are you happy to start? Do you have any questions before we 
start? 
 Where did you attend your HeadStrong session? 
 Why did you decide to go to a HeadStrong Session? 
 How did you hear about HeadStrong? 
 How many HeadStrong sessions did you attend? 
 Did you attend HeadStrong prior to losing your hair or had you already 
started to lose your hair? (hair loss anticipation, hair loss moment, coping 
with hair loss, hair re-growth?) 
 Did you use any other service to help with your hair loss? 
 Where you offered any other support by your multidisciplinary team? 
 How did losing your hair make you feel?  
 Were some situations more difficult to handle than others? 
      - How did you try to manage the situation and how did you feel? Etc etc. 
 What did you hope HeadStrong would achieve? 
 What were your expectations of HeadStrong?  
     - Were your expectations met? 
 What did you think it would be like at the session? 
 Did HeadStrong help you with certain aspects of your life? 
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- To manage the impact that hair loss had on your overall appearance? Body 
image? Concern about hair loss? Quality of Life? Confidence in managing 
hair loss i.e. use of camouflage? Managing the reactions of other people? 
 Has HeadStrong changed how you feel about hair loss? 
 How do you feel about hair loss since going to the HeadStrong session? 
 Have you used what was covered in the HeadStrong session since?  For how 
long? Can you give me an example of a time or a situation when you’ve used 
it? 
 What did you like about HeadStrong? 
 Would you change the HeadStrong session in any way? If yes, how? 
 Are there any aspects of hair loss that the session hasn’t helped you with? 
 Would you recommend HeadStrong to other people experiencing hair loss? 
Why, or why not? 
 Is there anything else you would like to add? 
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Appendix 5. Invitation letter posted to eligible participants for the qualitative 
HeadStrong service evaluation 
 
Printed on Breast Cancer Care Letter Headed paper 
                                                                        
                                                                   Date: 
 
Dear  
 
Invitation to take part in a study exploring people’s experiences of the 
HeadStrong service. 
 
I am writing to everyone who has attended a HeadStrong session, to tell them about 
a piece of research that is taking place and to invite them to take part. The research is 
investigating the emotional impact of hair loss and in particular people’s experiences 
of the HeadStrong service. It will help us to ensure that Breast Cancer Care provides 
the best possible appropriate support for people affected by hair loss. 
The research is being carried out by Melissa Pilkington, a PhD researcher from the 
Centre for Appearance Research (CAR) which is based at the University of the West 
of England (UWE), Bristol.  
Please read the information sheet that has been sent to you with this letter and decide 
if you would like to take part. If you have any questions about the research, please 
do not hesitate to contact the researcher whose contact details are at the bottom of 
this letter.  
If you do decide that you would like to take part, please note that any information 
that you give to the researcher will be treated as confidential. You are free to 
withdraw from the research up to a month after taking part and you will not be 
required to give a reason for withdrawing.  
If you wish to take part, please read the enclosed information sheet and sign the 
consent form and return to Melissa Pilkington by using the pre-paid envelope 
enclosed. 
If you would like more information please contact Melissa Pilkington:- 
Email: Melissa.Pilkington@uwe.ac.uk 
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Telephone: 0117 3283882.  
The Centre for Appearance Research 
Room 2L13 
University of the West of England, Bristol 
Frenchay Campus 
Coldharbour Lane 
Bristol 
BS16 1QY 
 
Thank you for reading this letter and for considering taking part in the study.  Your 
support is much appreciated.  
 
 
Yours Faithfully, 
 
 
 
Breast Cancer Care 
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Appendix 6. Letter from NRES confirming REC review was not required for the 
HeadStrong service evaluation 
ENQUIRY TO NRES 
Dear Melissa, 
 
Thank you for your email and summary seeking clarity on whether your project should be 
classified as research requiring ethical review.  
As you will be aware, the new harmonised UK-wide edition of the Governance 
Arrangements for Research Ethics Committees (GAfREC) came into effect on 01 September 
2011; detailed changes in the harmonised GAfREC can be found here on the NRES website. 
There two key elements are whether: 
 
i. your project is research? (The leaflet, "Defining Research", will help you to distinguish 
between research, audit or service evaluation and public health surveillance.) OR 
ii. your project is research requiring ethical review? The algorithm, “Does my project require 
review by a Research Ethics Committee?”, is designed to assist researchers, sponsors and 
R&D offices in determining whether a project requires ethical review by a Research Ethics 
Committee under the UK Health Departments. It encompasses the requirements for ethical 
review under both the policy of the UK Health Departments and legislation applying to the 
UK as a whole, or to particular countries of the UK.  
The Supplementary notes section, in particular, outlines the types of research that do not 
normally require review by a REC within the UK Health Departments’ Research Ethics 
Service.  
Advisor’s Comments: 
Based on the information provided I would agree that this evaluation doesn't require REC 
review. 
However, if you are undertaking the project within the NHS, you should check with the 
relevant NHS care organisation(s) what other review arrangements or sources of advice 
apply to projects of this type. Guidance may also be available from the clinical governance 
office.  
Where the Research Governance Framework for Health and Social Care applies, the 
research will continue to require management permission from host care organisations 
(“R&D approval”). Within the Integrated Research Application System (IRAS), it is possible 
to indicate in the Filter that a research project requires review by NHS R&D only. Where a 
project raises potential ethical concerns, NHS organisations may require ethical review and, 
exceptionally, NRES would be willing to undertake this review. For student research, most 
universities will require such a review as part of their normal institutional processes. 
All types of study involving human participants should, however, be conducted in 
accordance with basic ethical principles, such as informed consent and respect for the 
confidentiality of participants. Also, in processing identifiable data there are legal 
requirements under the Data Protection Act 2000. When undertaking an audit or 
service/therapy evaluation, the investigator and his/her team are responsible for 
considering the ethics of their project with advice from within their organisation. 
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This response should not be interpreted as giving a form of ethical approval or any 
endorsement to your project, but it may be provided to a journal or other body as evidence 
that ethical approval is not a requirement. 
Regards  
NRES Queries Line REF 04/26/50 
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Appendix 7. Confirmation of UWE ethical approval for the qualitative HeadStrong 
service evaluation 
 
Faculty of Health & Life  
Sciences  
Glenside Campus 
         Blackberry Hill 
         Stapleton 
         Bristol    BS16 1DD 
 
         Tel: 0117 328 1170 
Our ref: JW/lt 
 
15th November, 2012 
 
 
Melissa Pilkington 
The Centre for Appearance Research 
Department of Psychology 
Faculty of Health & Life Sciences 
UWE 
Frenchay Campus 
 
 
Dear Melissa 
 
Application number: HLS/12/10/115 
Application title:  Evaluation of Breast Cancer Care’s HeadStrong 
Service: A qualitative approach 
 
Your ethics application was considered by the Faculty Research Ethics 
Committee and based on the information provided was given ethical 
approval to proceed with the following conditions: 
 
Question 1 - The ethics application states the non-profit organization 
(Headstrong of Breast Cancer Care) have agreed to allow this research 
focussed on participants’ experience of this service. However there is no 
documentary evidence to this effect; this should be part of the ethics 
application. 
There is no discussion about how consent processes will work for telephone 
participants. There are no consent forms etc for the participants who are 
recruited because they did not use the Headstrong service.  
Question 2 and 4 - The category of vulnerable participants includes those 
‘who are severely ill or have terminal illness’ which can apply to breast 
cancer sufferers. Their status as people with cancer also makes them in our 
view ‘vulnerable’ so this part of the form should be amended. Recognition of 
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this fact increases the onus on the researchers to protect the participants so 
we would suggest that the research team should consider whether the 
degree of protection offered is sufficient. Also, are there any participants the 
researcher would ethically seek to exclude? 
Question 5 (and also question 3) – the information sheet states: 
Yes, your results will be kept completely confidential. This means that 
nobody other than the researchers will know that you have taken part and 
what you have told us. 
This statement should be amended since presumably write-ups of the 
research will include quotations [what you have told us] which participants 
could recognise. 
Also you should probably tell participants all the ways you are planning to 
disseminate the research findings (item 10 of the ethics application) so they 
are fully informed. 
Are you planning to collect demographic information and/or information 
about illness status/progression etc? If so this should be clear to participants 
and you should probably tell them how you will protect their identity (i.e. only 
report aggregated demographic and illness status data?) 
We also think the information sheet should have a line about who 
participants can contact if they are unhappy with any aspect of the research; 
should this also include reference to FREC? 
The information sheet should probably also have a few sentences at the start 
about what taking part in the study involves (e.g. a 1-hour phone or in-person 
interview which will be digitally recorded). 
The information about the right to withdrawn, how to do so and the 4-week 
deadline needs to be mentioned in the information sheet – since this is the 
paper that they take away (not the consent form). 
Question 6 – it would potentially be helpful to identify the process in case 
there are issues – e.g. if the researcher is concerned about a participant, is 
there a potential to inform HeadStrong? Has one supervisor been identified 
formally as a clinical lead (this seems to be implied)? 
Question 9 - researcher protection; the measures sound fine. Does the 
applicant also need to do a health and safety form however? 
Please address the issues above. In particular, it would be worth looking at 
the advice on writing information and consent forms which is available 
through the university ethics pages: 
http://rbi.uwe.ac.uk/internet/Research/ethics/default.asp  
If you look in particular at:  
http://rbi.uwe.ac.uk/internet/Research/ethics/ifa.asp there is a link on the right 
hand side for ‘consent’ – the word document provides the university 
guidance on this topic. 
 
If these conditions include providing further information please do not 
proceed with your research until you have full approval from the committee.  
You must notify the Faculty Research Ethics Committee in advance if you 
wish to make any significant amendments to the original application. 
 
Appendices  
 
 
 
332 
 
If you have to terminate your research before completion, please inform the 
Faculty Research Ethics Committee within 14 days, indicating the reasons. 
 
Please notify the Faculty Research Ethics Committee if there are any serious 
events or developments in the research that have an ethical dimension. 
 
Any changes to the study protocol, which have an ethical dimension, will 
need to be approved by the Faculty Research Ethics Committee. You should 
send details of any such amendments to the committee with an explanation 
of the reason for the proposed changes.  Any changes approved by an 
external research ethics committee must also be communicated to the 
relevant UWE committee. 
 
Please note that all information sheets and consent forms should be on UWE 
headed paper. 
 
Please be advised that as principal investigator you are responsible for the 
secure storage and destruction of data at the end of the specified period.  A 
copy of the ‘Guidance on Managing Research Records’ is enclosed for your 
information. 
 
Please note: The University Research Ethics Committee (UREC) is required to 
monitor and audit the ethical conduct of research involving human 
participants, data and tissue conducted by academic staff, students and 
researchers. Your project may be selected for audit from the research 
projects submitted to and approved by the UREC and its committees. 
 
We wish you well with your research. 
 
Yours sincerely 
 
Dr Julie Woodley 
Chair 
Faculty Research Ethics Committee 
 
c.c. Di Harcourt 
    Tim Moss  
 
 
 
 
Appendices  
 
 
 
333 
 
Appendix 8. Braun and Clarke’s (2006) thematic analysis used to analyse the qualitative interviews. 
 
 
 
 
Appendices  
 
 
 
334 
 
 
 
 
Appendix 9. Applying Braun and Clarke’s (2006) thematic analysis 
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Appendix 10. Participant transcript 
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Appendix 11. Pre-HeadStrong service evaluation questionnaire 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to four weeks after you have 
completed the survey. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code. 
 
To create your ID code, please enter the first three letters of your first name and the 
day of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
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Demographic Information 
The following information will be used to understand the sample of data collected 
and will be used for statistical purposes only, not to identify you. Please remember 
that all responses are anonymous. (All questions are optional). 
A: About you (please tick the relevant box or write your answer in the space 
provided): 
1. Are you male or female? (please tick one box) 
 Male   Female 
 
2. Please state your age   
 
3. How would you describe your ethnic group? (please tick one box) 
White 
 English/Welsh/Scottish/Northern Irish/British 
 Irish 
 Gypsy or Irish Traveller 
 Any other white background 
 please write in   
Mixed/multiple ethnic groups 
 White and Black Caribbean 
 White and Black African 
 White and Asian 
 Any other Mixed/multiple ethnic background 
 please write in 
Asian/Asian British 
 Indian 
 Pakistani 
 Bangladeshi 
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 Chinese 
 Any other Asian background 
            please write in  
Black/African/Caribbean/Black British 
 African 
 Caribbean 
 Any other Black/African/Caribbean background  
 please write in 
Other ethnic group 
 Arab 
 Any other ethnic group  
 please write in 
   Or 
 Prefer not to answer  
 
4. Are you currently in education or employed? (please tick one box) 
 School 
 College 
 University 
 Working Full time 
 Working Part time 
 Unemployed 
 Other (please state)  
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5. Which area do you live in? (please tick one box) 
 England 
 Scotland 
 Wales 
 Northern Ireland 
 Ireland 
 Outside UK and Ireland 
 please state which country  
 
B: About your cancer and hair loss 
1. Which type of cancer were you diagnosed as having? (please tick one box) 
 Breast Cancer 
 Other (Please specify) 
 
2. How long ago were you given your diagnosis?                years             months 
 
3. What type of treatment, if any, did you receive? (Please tick all that apply) 
          Chemotherapy         None     Other (Please specify) 
         Radiotherapy         Not sure          
          Surgery (Please specify) 
 
4. At the moment, have you experienced any hair loss due to cancer treatment? 
(please tick one box) 
            Yes 
 No 
If you answered yes to the above question, how long after starting treatment did you 
start to lose your hair? 
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5. If you have experienced/are experiencing hair loss, please place a vertical mark on 
the line below to indicate your extent of hair loss. 
No hair loss         Complete 
          hair loss 
 
C: HeadStrong 
1. Is this your first visit to HeadStrong? (please tick one box) 
 Yes 
 No (Please state how many times you have attended HeadStrong) 
 
2. How did you hear about HeadStrong? 
3. In order of importance to you, please state below up to four reasons why you wish 
to attend a HeadStrong session? i.e. for help in preparing for the possibility of hair 
loss 
1)  
2) 
3) 
4) 
 
4. Place a vertical mark on the line below to indicate how confident you feel in 
managing the consequences of hair loss. 
Not at all  
confident         Very confident 
5. Place a vertical mark on the line below to indicate how confident you feel in 
coping with the reactions of others to your hair loss. 
 
Not at all  
confident         Very confident 
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6. Place a vertical mark on the line below to indicate how confident you feel in using 
scarves and other headwear to cope with your hair loss. 
 
Not at all 
confident          Very 
confident 
 
D: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
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When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the 
first time, I wonder what 
they think about how I look. 
     
In my everyday life, lots of 
things happen that make me 
think about what I look like. 
     
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasise about what it 
would be like to be better 
looking than I am. 
     
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
     
 
 
The first part of the scale is designed to explore whether you are sensitive or self-
conscious about any aspect of your appearance (even if this is not usually visible to 
others).  
 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
 
(b) If No, please go to the next page 
 
 
If Yes, please continue: 
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The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
 
 
The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present, my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
 
Other people mis-judge me because of my hair loss: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine or masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my feature: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
 
How irritable do you feel? 
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Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
mouth with my hand): 
 
Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes....Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A .... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How “normal” do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
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I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
 
How distressed do you get when other people make remarks about your hair 
loss? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My hair loss causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... N/A .... 
 
My hair loss limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ... N/A .... 
 
 
E: Your Feelings and Emotions 
For the following statements, please indicate by ticking the box that matches what 
you think. 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am 
a failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
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F: Your Health and Wellbeing  
Below is a list of statements that other people with your illness have said are 
important. Please tick one box per line to indicate your response as it applies to the 
past 7 days. 
 Not 
at all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I 
have trouble meeting the needs of my 
family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
     
I feel ill.      
I am forced to spend time in bed. 
 
     
 
 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I feel close to my friends.      
I get emotional support from my family. 
 
     
I get support from my friends. 
 
     
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next section. 
 
I am satisfied with my sex life. 
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 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I feel sad.      
I am satisfied with how I am 
coping with my illness. 
     
I am losing hope in the fight 
against my illness. 
     
I feel nervous.      
I worry about dying.      
I worry that my condition will get 
worse. 
     
 
 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am able to work (include work at 
home). 
     
My work (include work at home) 
is fulfilling. 
     
I am able to enjoy life.      
I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually 
do for fun. 
     
I am content with the quality of 
my life right now. 
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G: Your Thoughts and Concerns 
Please read each of the following statements carefully and indicate how typical it is 
of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
impression of 
me. 
     
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
     
I rarely worry 
about what 
kind of 
impression I 
am making 
on someone. 
     
I am afraid 
that others 
will not 
approve of 
me. 
     
I am afraid 
that people 
will find fault 
with me. 
     
Other 
people’s 
opinions of 
me do not 
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bother me. 
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried about 
what kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, it 
has little 
effect on me. 
     
Sometimes I 
think I am too 
concerned 
with what 
other people 
think of me. 
     
I often worry 
that I will say 
or do the 
wrong things. 
     
 
 
For the following statements, please indicate your thoughts by ticking the box the 
relevant box. 
 
 Yes 
Definitely 
Yes 
Sometimes 
No, Not 
Much 
No Not 
At All 
I wake early and then sleep badly for 
the rest of the evening. 
    
I get very frightened or have panic 
feelings for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the 
house on my own. 
    
I have lost interest in things.     
I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
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I have a good appetite.     
I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go 
through my mind. 
    
 
Please place any further comments you would like to make in the box below. 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part!  
Please return the questionnaire in the pre-paid envelope 
provided. 
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Appendix 12. Two week follow-up HeadStrong service evaluation questionnaire 
 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to four weeks after you have 
completed the survey. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code. 
 
To create your ID code, please enter the first three letters of your first name and the 
day of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
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All questions are optional. 
A: About your hair loss (please tick the relevant box or write your answer in 
the space provided): 
1. At the moment, have you experienced any hair loss due to cancer treatment? 
(Please tick one box) 
 Yes 
 No 
If you answered yes to the above question, how long after starting treatment did you 
lose your hair? 
 
2. If you have experienced/are experiencing hair loss, please place a vertical mark on 
the line below to indicate your extent of hair loss. 
No hair loss          
                                                                                              Complete hair loss 
 
B: HeadStrong 
 
1. At what point did you attend a HeadStrong session? (Please tick one box) 
 Prior to losing your hair 
 After you had started to lose your hair 
 
2. Where did you attend your HeadStrong session? 
 
3. In order of importance to you, please state below up to four reasons why you 
chose to attend a HeadStrong session? i.e. for help in preparing for the possibility of 
hair loss 
1)  
2) 
3) 
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4) 
 
4. Please state below your expectations of HeadStrong?  
1) 
2) 
3) 
4) 
5) 
 
5. Place a vertical mark on the line below to indicate the extent to which your 
expectations that you have listed above were met. 
Expectation 1) 
Not met  
at all         Completely met 
Expectation 2) 
Not met  
at all         Completely met 
Expectation 3) 
Not met 
at all         Completely met 
Expectation 4) 
Not met  
at all         Completely met 
Expectation 5) 
Not met  
at all         Completely met 
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6. Place a vertical mark on the line below to indicate how useful you found 
HeadStrong in helping manage your hair loss. 
Not at all  
useful          Very useful 
 
7. Place a vertical mark on the line below to indicate how confident you feel in 
managing the consequences of hair loss. 
Not at all  
confident         Very confident 
 
8. Place a vertical mark on the line below to indicate how confident you feel in 
coping with the reactions of others to your hair loss. 
Not at all  
confident         Very confident 
 
9. Place a vertical mark on the line below to indicate how confident you feel in using 
the techniques you learned at HeadStrong to manage your hair loss. 
Not at all  
confident         Very confident 
 
10. Would you recommend HeadStrong to someone else who is experiencing hair 
loss? (Please tick one box) 
 Yes     No    Not Sure 
  
11. Do you think the techniques and information you gained from HeadStrong will 
help you to manage your hair loss in the future? (Please tick one box) 
 Yes     No    Not Sure 
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C: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
     
When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the 
first time, I wonder what 
they think about how I look. 
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In my everyday life, lots of 
things happen that make me 
think about what I look like. 
     
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasise about what it 
would be like to be better 
looking than I am. 
     
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
     
 
 
 
 
The first part of the scale is designed to explore whether you are sensitive or self-
conscious about any aspect of your appearance (even if this is not usually visible to 
others). 
 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
 
(b) If No, please go to the next page 
 
 
If Yes, please continue: 
 
The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
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The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present, my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
 
Other people mis-judge me because of my hair loss: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine or masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my hair loss: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
 
How irritable do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
mouth with my hand): 
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Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes .... Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A ..... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How “normal” do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
 
I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
 
How distressed do you get when other people make remarks about your hair 
loss? 
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N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My hair loss causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... N/A .... 
 
My hair loss limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ... N/A .... 
 
D: Your Feelings and Emotions 
For the following statements, please indicate by ticking the box that matches what 
you think. 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am 
a failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
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E: Your Health and Well-Being 
Below is a list of statements that other people with your illness have said are 
important. Please tick one box per line to indicate your response as it applies to the 
past 7 days. 
 Not 
at all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I 
have trouble meeting the needs of my 
family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
     
I feel ill.      
I am forced to spend time in bed.      
 
 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I feel close to my friends.      
I get emotional support from my family. 
 
     
I get support from my friends. 
 
     
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next section. 
 
I am satisfied with my sex life. 
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 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I feel sad.      
I am satisfied with how I am 
coping with my illness. 
     
I am losing hope in the fight 
against my illness. 
     
I feel nervous.      
I worry about dying.      
I worry that my condition will get 
worse. 
     
 
 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am able to work (include work at 
home). 
     
My work (include work at home) 
is fulfilling. 
     
I am able to enjoy life.      
I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually 
do for fun. 
     
I am content with the quality of 
my life right now. 
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F: Your Thoughts and Concerns 
 
Please read each of the following statements carefully and indicate how typical it is 
of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
impression of 
me. 
     
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
     
I rarely worry 
about what 
kind of 
impression I 
am making 
on someone. 
     
I am afraid 
others will 
not approve 
of me. 
     
I am afraid 
that people 
will find fault 
with me. 
     
Other 
people’s 
opinions of 
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me do not 
bother me. 
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried about 
what kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, it 
has little 
effect on me. 
     
Sometimes I 
think I am too 
concerned 
with what 
other people 
think of me. 
     
I often worry 
that I will say 
or do the 
wrong things. 
     
 
 
For the following statements, please indicate your thoughts by ticking the relevant 
box. 
 
 Yes 
Definitely 
Yes 
Sometimes 
No, Not 
Much 
No Not 
At All 
I wake early and then sleep badly for 
the rest of the evening. 
    
I get very frightened or have panic 
feelings for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the 
house on my own. 
    
I have lost interest in things.     
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I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
    
I have a good appetite.     
I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go 
through my mind. 
    
 
Please place any further comments you would like to make about your experience(s) 
of HeadStrong in the box below. 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part! 
Please return the questionnaire in the pre-paid envelope 
provided. 
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Appendix 13. Three month follow-up HeadStrong service evaluation questionnaire 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to four weeks after you have 
completed the survey. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code.  
 
To create your ID code, please enter the first three letters of your first name and the 
day of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendices  
 
 
 
369 
 
All questions are optional. 
A: About your hair loss (please tick the relevant box or write your answer in 
the space provided): 
1. At the moment, have you experienced any hair loss due to cancer treatment? 
(Please tick one box) 
 Yes 
 No 
If you answered yes to the above question, how long after starting treatment did you 
lose your hair? 
 
2. If you have experienced/are experiencing hair loss, please place a vertical mark on 
the line below to indicate your extent of hair loss. 
No hair loss         Complete 
hair loss 
 
B: HeadStrong 
1. Place a vertical mark on the line below to indicate how useful you found 
HeadStrong in helping you to manage your hair loss. 
Not at all 
useful          Very useful 
2. Place a vertical mark on the line below to indicate how confident you feel in 
managing the consequences of hair loss. 
 
Not at all 
confident         Very confident 
3. Place a vertical mark on the line below to indicate how confident you feel in 
coping with the reactions of others to your hair loss. 
Not at all 
confident         Very confident 
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4. Place a vertical mark on the line below to indicate how confident you feel in using 
the techniques you learned at HeadStrong to manage your hair loss. 
Not at all  
confident         Very confident 
5. Would you recommend HeadStrong to someone else who is experiencing hair 
loss? 
 Yes     No    Not Sure 
 
6. Do you think the techniques and information you gained from HeadStrong will 
help you to manage your hair loss in the future? (Please tick one box) 
 Yes     No    Not Sure 
 
C: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
  
  
 
 
Appendices  
 
 
 
371 
 
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
     
When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the 
first time, I wonder what 
they think about how I look. 
     
In my everyday life, lots of 
things happen that make me 
think about what I look like. 
     
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasise about what it 
would be like to be better 
looking than I am. 
     
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
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The first part of the scale is designed to explore whether you are sensitive or self-
conscious about any aspect of your appearance (even if this is not usually visible to 
others). 
 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
 
(b) If No, please go to the next page 
 
 
If Yes, please continue: 
 
The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
 
 
 
The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present, my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
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Other people mis-judge me because of my hair loss: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine or masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my hair loss: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
 
How irritable do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
mouth with my hand): 
 
Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes....Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A .... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
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Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How “normal” do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
 
I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
 
How distressed do you get when other people make remarks about your hair 
loss? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My hair loss causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... N/A .... 
 
My hair loss limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ... N/A .... 
 
 
 
 
 
 
 
Appendices  
 
 
 
375 
 
D: Your Feelings and Emotions 
For the following statements, please indicate by ticking the box that matches what 
you think. 
 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am 
a failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
 
E: Your Health and Well-Being 
Below is a list of statements that other people with your illness have said are 
important. Please tick one box per line to indicate your response as it applies to the 
past 7 days. 
 
 Not 
at all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I 
have trouble meeting the needs of my 
family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
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I feel ill.      
I am forced to spend time in bed.      
 
 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I feel close to my friends.      
I get emotional support from my family. 
 
     
I get support from my friends. 
 
     
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next section. 
 
I am satisfied with my sex life. 
     
 
 
 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I feel sad.      
I am satisfied with how I am 
coping with my illness. 
     
I am losing hope in the fight 
against my illness. 
     
I feel nervous.      
I worry about dying.      
I worry that my condition will get 
worse. 
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 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am able to work (include work at 
home). 
     
My work (include work at home) 
is fulfilling. 
     
I am able to enjoy life.      
I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually 
do for fun. 
     
I am content with the quality of 
my life right now. 
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F: Your Thoughts and Concerns 
 
Please read each of the following statements carefully and indicate how typical it is 
of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
impression of 
me. 
     
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
     
I rarely worry 
about what 
kind of 
impression I 
am making 
on someone. 
     
I am afraid 
that others 
will not 
approve of 
me. 
     
I am afraid 
that people 
will find fault 
with me. 
     
Other 
people’s 
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opinions of 
me do not 
bother me. 
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried about 
what kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, it 
has little 
effect on me. 
     
Sometimes I 
think I am too 
concerned 
with what 
other people 
think of me. 
     
I often worry 
that I will say 
or do the 
wrong things. 
     
 
For the following statements, please indicate your thoughts by ticking the relevant 
box. 
 Yes 
Definitely 
Yes 
Sometimes 
No, Not 
Much 
No Not 
At All 
I wake early and then sleep badly for 
the rest of the evening. 
    
I get very frightened or have panic 
feelings for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the 
house on my own. 
    
I have lost interest in things.     
I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
    
I have a good appetite.     
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I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go 
through my mind. 
    
 
Please place any further comments you would like to make about your experience(s) 
of HeadStrong in the box below. 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part! 
Please return the questionnaire in the pre-paid envelope 
provided. 
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Appendix 14. UWE ethical approval for the quantitative HeadStrong service 
evaluation 
 
Faculty of Health & Life  
Sciences  
Glenside Campus 
         Blackberry Hill 
         Stapleton 
         Bristol    BS16 1DD 
 
         Tel: 0117 328 1170 
Our ref: JW/lt 
 
17 February 2017 
23rd November, 2012 
 
Melissa Pilkington 
The Centre for Appearance Research 
Department of Psychology 
Faculty of Health & Life Sciences 
UWE 
Frenchay Campus 
 
 
Dear Melissa 
 
Application number: HLS/12/10/116 
Application title:  Evaluation of Breast Cancer Care’s HeadStrong 
Service: A quantitative approach 
 
Your ethics application was considered by the Faculty Research Ethics 
Committee and based on the information provided was given ethical 
approval to proceed.   
 
You must notify the Faculty Research Ethics Committee in advance if you 
wish to make any significant amendments to the original application. 
 
If you have to terminate your research before completion, please inform the 
Faculty Research Ethics Committee within 14 days, indicating the reasons. 
 
Please notify the Faculty Research Ethics Committee if there are any serious 
events or developments in the research that have an ethical dimension. 
 
Any changes to the study protocol, which have an ethical dimension, will 
need to be approved by the Faculty Research Ethics Committee. You should 
send details of any such amendments to the committee with an explanation 
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of the reason for the proposed changes.  Any changes approved by an 
external research ethics committee must also be communicated to the 
relevant UWE committee. 
 
Please note that all information sheets and consent forms should be on UWE 
headed paper. 
 
Please be advised that as principal investigator you are responsible for the 
secure storage and destruction of data at the end of the specified period.   
 
Please note: The University Research Ethics Committee (UREC) is required to 
monitor and audit the ethical conduct of research involving human 
participants, data and tissue conducted by academic staff, students and 
researchers. Your project may be selected for audit from the research 
projects submitted to and approved by the UREC and its committees. 
 
We wish you well with your research. 
 
Yours sincerely 
 
Dr Julie Woodley 
Chair 
Faculty Research Ethics Committee 
 
c.c. Di Harcourt 
    Tim Moss  
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Appendix 15. List of HeadStrong centres including number of patients seen at each 
HeadStrong centre per annum 
 
 
Site No of patients seen per annum 
Scotland 60 
Wrexham 75 
Liverpool 140 
Chester 60 
London 100 
Southend 80 
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Appendix 16. Participant information sheet for the quantitative HeadStrong service 
evaluation 
 
An evaluation of Breast Cancer Care’s HeadStrong Service: 
Information Sheet 
You are being invited to take part in a study. Please read this information carefully 
and do not hesitate to contact me with any questions that you may have. Thank you. 
What is the purpose of the study? 
This study is evaluating Breast Cancer Care’s HeadStrong service, by exploring 
individuals experiences of the service and how it helps them to manage the 
emotional impact of hair loss. The study is being carried out by Melissa Pilkington, a 
PhD researcher from the Centre for Appearance Research (CAR) which is based at 
the University of the West of England (UWE), Bristol  
Why have I been chosen? 
You are being invited to take part because you have expressed an interest in 
attending a Breast Cancer Care HeadStrong session at one of the centres in which 
this study is taking place. Everyone approaching the HeadStrong service at these 
centres is being invited to take part. We are looking for a total of 84 people to take 
part 
Do I have to take part? 
No, taking part is voluntary. You do not have to take part if you do not want to and, 
if you do take part, you can withdraw from the study up to a month after taking part. 
Whether or not you take part will not make any difference to your HeadStrong 
session.  
What will I have to do if I take part? 
You will be asked to complete a questionnaire prior to attending a HeadStrong 
session, another questionnaire two weeks after attending the session and one more, 3 
months later. We expect that each questionnaire will take no more than 30 minutes to 
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complete. If you would prefer to complete the questionnaires online, please click on 
the link below. 
What are the possible benefits of taking part? 
You will not personally benefit from taking part in this study, however the results of 
the study will inform plans for the provision of HeadStrong and other support 
services for people affected by hair loss in the future. 
Will my identity be protected? 
Yes, your identity will be protected. During the questionnaires you will be asked for 
about your diagnosis and hair loss, however, in order to protect your identity only a 
summary of this information will be reported during the write up of the evaluation. 
What will happen with the results of the study? 
The results of the study will be given to Breast Cancer Care, so that they can use 
them to plan HeadStrong and other support services in the future. Your individual 
questionnaires will not be passed on to Breast Cancer Care, they will only receive a 
summary of the study findings overall. 
How will the findings be shared with other people? 
The overall findings will be published in a journal, presented at conference 
presentations and written up as part of a PhD thesis. Also, a summary of the findings 
will be made available to both participants and to Breast Cancer Care for them to 
present at meetings. 
Who has reviewed the study? 
The study has been approved by the University of the West of England (UWE) 
Research Ethics Committee. It has also been approved by Breast Cancer Care.  The 
study is funded by Breast Cancer Campaign.  
Your right to withdraw from the study 
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You have the right to withdraw from the study up to a month after taking part. If you 
wish to withdraw from the study, please contact the researcher and all your 
information will be withdraw from the study and destroyed. 
What do I do now? 
If you would like to take part in the study, please complete the questionnaire and 
return it to Melissa Pilkington, together with the consent form, in the envelope 
provided. You do not need to put a stamp onto the envelope. Alternatively, you can 
complete the questionnaires online at http://www.tinyurl.com/Pre-HeadStrong 
 
If you have any further questions please contact, Melissa Pilkington at:- 
Email:- Melissa.Pilkington@uwe.ac.uk 
Telephone No:- (0117) 3283882 
Work Mobile Telephone No:- 07972733919 
 
Or you can contact Melissa’s supervisor, Prof. Diana Harcourt at: 
Diana2.Harcourt@uwe.ac.uk 
Telephone No:- (0117) 3283967 
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If you would like any more information about cancer-related hair loss, or have any 
concerns that you would like to discuss, you might like to contact any of the 
following organisations that specialise in support for people affected by cancer:- 
 
Breast Cancer Care:-  
www.breastcancercare.org.uk 
Peer Support Team Telephone No:- 0845 0771893  
Peer Support Team Email:- ukpeersupportteam@breastcancercare.org.uk 
Breast Cancer Care’s Free Helpline for one-to-one support:- 0808 800 6000 
 
Maggie’s Centre:- 
http://www.maggiescentres.org/  
To arrange face-to-face support with a support specialist:- 
Email:- enquiriesatmaggiescentres.org  
Telephone No:- 0300 123 1801 
 
Macmillan:- 
www.macmillan.org.uk  
If you have any questions, would like support or someone to talk to:- 
Cancer Support Specialist Telephone No:- 0808 808 00 00 
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Appendix 17. Participant consent form for the quantitative HeadStrong service 
evaluation 
 
An evaluation of Breast Cancer Care’s HeadStrong Service: 
Consent Form 
 
This study is interested in patients’ experiences of Breast Cancer Care’s HeadStrong 
service.  Taking part in the study will involve completing a questionnaire on 3 
different occasions, either on paper or online.  
In order to protect your identity only a summary of the information you provide will 
be reported during the write up of the evaluation. Your completed questionnaires 
will be stored securely and only accessible to the research team. You do not have to 
take part and you have the right to withdraw from the study up to a month after 
taking part.  
 
If you give your consent to take part in the study please complete this form and 
return it with the completed questionnaire in the pre-paid envelope provided. 
 
Print your name.........................................................................     
Date............................... 
Your Signature...........................................................................  
Date................................ 
Telephone number ................................................................................... 
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Please indicate below how you would prefer to receive the later questionnaires. 
 Post 
 Email 
 
Address.................................................................................................. 
.............................................................................................................. 
.............................................................................................................. 
............................................................................................................. 
............................................................................................................. 
 
Email address........................................................................................ 
 
 
 
 
 
 
Thank you for your time! 
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Appendix 18.  Looney and Jones (2003) Z-score test statistic 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
an = number of subjects with observations exclusive to sample 1 
bn = number of subjects with observations exclusive to sample 2 
cn = number of subjects with observations in both samples (i.e. paired) 
1x = mean of observations in sample 1 (i.e. in an and cn ) 
2x = mean of observations in sample 2 (i.e. in bn  and cn ) 
1s = standard deviation of sample 1 (i.e. in an  and cn ) 
2s = standard deviation of sample 2 (i.e. in bn  and cn ) 
12s = covariance between the paired observations only (i.e. in cn ) 
Using the Standard Normal tables reject H if the observed values of the test statistic 
are Z ≥ 1.96.     
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Appendix 19. List of expressive writing studies  
Reference Measures 
Inclusion 
Criteria 
Exclusion 
Criteria Methodology 
Control 
Group Findings 
Criticisms of 
Studies 
Craft, M. A., 
Davis, G. C., & 
Paulson, R. M. 
(2013) 
Expressive 
writing in early 
breast cancer 
survivors. 
Journal of 
Advanced 
Nursing, 69(2), 
305-315. 
Functional 
assessment of 
Cancer Therapy 
Breast Cancer 
Version 
*Diagnosis of 
breast cancer, 
either invasive 
or non-
invasive   
*Definitive 
treatment 
*Time from 
diagnosis less 
than 2 
years  
*Able to speak 
and write 
English 
* Physically 
able to write 
either by hand 
or 
with a word 
processor for 
20-min 
periods 
*Individuals 
with 
recurrent or 
metastatic 
breast 
cancer 
* If mental 
status 
precluded 
pts 
* If been 
diagnosed 
and/or 
treated for 
clinical 
depression 
*120 pts 
randomised 
into one of 
four groups; 
control group 
(no writing), 
one of three 
EW groups; 
breast cancer, 
trauma, any 
self-selected 
trauma, 
and facts 
related to 
breast cancer. 
*Pts wrote for 
20 minutes a 
day for 4 
consecutive 
days.  
*QOL was 
measured at 
baseline, 1 
No writing * An ANOVA 
determined no 
important  
differences in 
QOL among 
the four groups  
of pts at 
baseline. 
* MANOV 
analysed the 
combined 
effect of  
time and group 
assignment on 
the outcome 
variable 
* EW about 
about one's 
breast cancer, 
breast cancer 
trauma; and 
facts related to 
breast cancer, 
* Convenience 
sample limits 
generalisability 
of findings 
* Varying 
previous 
exposure to  
journaling and 
variance in 
attrition 
in the different 
groups which 
may indicate a 
preference for 
one way of 
writing over 
another 
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month and 
6 months after 
writing. 
sig improved 
the QOL 
outcome 
* Changes in 
QOL over the 
three time 
periods were 
     
analysed using 
t-tests 
* Multiple 
regression was 
used to explore 
whether 
or not EW 
contributed to 
QOL 
* Intention to 
treat analysis 
(ITT) was used 
due to the  
high dropout 
rate between 
T1 and T2 
assessment 
periods 
and due to the 
possibility of 
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group diffs 
arising after 
randomisation 
to the 
intervention 
O'Connor, D. B., 
& Ashley, L. 
(2008). Are  
alexithymia and 
emotional 
characteristics of 
disclosure 
* Toronto 
Alexithymia 
Scale (TAS-20) 
20-item 
measure that 
assess three 
dimensions of  
* Good 
general health 
* Currently 
not taking any 
blood pressure 
medication 
See 
inclusion 
criteria 
* 87 pts wrote 
about their 
most stressful 
life experience 
 
* No evidence 
of support 
found in the 
main effects of 
* Floor effects 
may have 
accounted 
for the 
negative 
findings i.e. 
many pts may 
 or about a non-
stressful 
experience, for 
15 mins, over 
3 
consecutive 
days 
* Emotional 
characteristics 
of the 
disclosure 
essays 
were analysed 
with the 
linguistic 
Inquiry and 
Word Count 
program and 
 
disclosure on 
cardiovascular 
responses to 
stress or on 
emotional 
distress. 
* Alexithymia 
found to 
moderate the 
impact of 
writing such  
that non-
alexithymic pts 
in the 
experimental 
condition 
reported 
significant 
associated with 
blood pressure  
reactivity and 
psychological 
distress 
following  
written 
emotional 
disclosure. 
British Journal 
of  
Health 
Psychology, 13, 
495-512. 
alexithymia; 
difficulty 
identifying 
feelings (DIF),  
difficulty 
describing 
feelings (DDF) 
and  
externally 
oriented thinking 
(EOT) 
* 28-item General 
Health 
Questionnaire 
(GHQ),  
* Having 
systolic and 
diastolic blood 
pressure 
levels within 
normal range 
* No evidence 
of psychiatric 
problems 
  
not have 
experienced a 
sig traumatic  
  
stressor  
  
* Follow-up 
period of 2 
weeks was 
relatively short 
- health related 
improvements 
may not have 
emerged 
in this short 
period 
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was used to 
assess emotional 
distress 
alexithymia 
was assessed 
at baseline 
using 
the Toronto 
Alexithymia 
scale-20. 
lower emotion 
distress 2 
weeks later. 
* Alexithymic 
pts who 
disclosed a 
greater no of 
negative   
when 
compared to 
positive 
emotion words 
exhibited 
 reduced 
systolic and 
diastolic 
responses to 
stress. 
* No measure 
of neuroticism/ 
negative 
affectivity. 
    
     
      
* Analysis 
used included 
an ANOVA 
for main 
effects 
 
      
* Series of 
hierarchical 
regressions 
were used to 
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analyse the  
      
main and 
interactive 
effects of 
alexithymia on 
the three  
 
            
outcome 
variables   
O'Connor, D. B., 
Hurling, R., 
Hendricks, H., 
* Rosenberg self-
esteem scale - 
gives a global 
estimate 
of self-esteem 
* Body Image 
Avoidance 
Questionnaire - 
19-item  
measure of 
avoidance 
behaviours from 
situations that 
may cause 
anxiety to 
someone with 
negative body 
image. 
* Body Checking 
N/A N/A * 162 pts were 
randomised 
into one of 
three  
experimental 
groups; written 
emotional 
disclosure  
condition, 
writing about 
body image 
success  
* Pts in the 
control group 
were asked to 
write for 
15mins on 3 
consecutive 
days about 
what they 
had had done 
the previous 
day. 
* Levels of 
self-esteem 
were improved 
4 weeks later 
in the WED 
condition 
* Implicit self-
esteem was 
found to be 
greater 
following 
WED 
* May have 
found clearer 
and more  
substantive 
results may 
have emerged 
if we 
had recruited 
pts who were 
currently 
experiencing 
body image 
disturbance 
issues 
or if more 
detailed 
measure of 
body image  
and self-
Osborne, G., 
Hall, J., Walklet, 
E., Whaley, A., 
 & Wood, H. 
(2010). Effects 
of written 
emotional 
 disclosure on 
implicit self-
esteem and body 
image.  
  
  
  
stories (WSS) 
or a control 
condition 
* WED- pts 
asked to write 
about their 
deepest 
 
compared to 
the control 
condition, but 
not following 
WSS 
British Journal 
of Health 
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Psychology, 16, 
488-501. 
Questionnaire- 
23-item measure 
of 
body checking 
behaviours that 
consist of three 
subscales: 
overall 
appearance 
checking, 
checking specific 
body 
parts, 
idiosyncratic 
checking 
emotions and 
thoughts about 
a stressful or 
traumatic 
issues/event in 
terms 
of their body 
or body related 
experiences 
for 15mins on 
3  
consecutive 
days. 
* Pts in the 
WSS condition 
were given 6 
diff body 
image 
success stories 
vignettes 
before 
completing 
two writing  
esteem were 
used 
* A larger 
sample size 
would have 
provided 
more power to 
explore the 
moderating 
role of 
individual 
differences 
variables such 
as  
Alexithymia or 
perfectionism. 
     
     
     
     
     
 
* The Body Parts 
Satisfaction Scale 
- 25 item scale 
  
exercises. The 
vignettes were 
adapted from 
the Body 
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Image 
 
measuring 
satisfaction with 
body parts as well 
as global 
body satisfaction.  
* Center for 
Epidemiological 
Studies Short 
Depression 
Scale - 10-item 
scale that 
measures 
depression 
  
Workbook. Pts 
were presented 
with two diff 
vignettes for 
the 
   
   
current age 
group. Pts read 
the success 
stories and 
then were 
   
   
asked to 
complete two 
writing tasks. 
This condition 
was timed 
   
      
to last 15mins 
on each of the 
three days.       
Stanton, A. L., 
Danoff-Burgy, 
S., Sworowski, 
L. A.,  
Collins, C. A., 
Branstetter, A. 
D., Rodrigueq-
Hanley, 
* Psychological 
adjustment- The 
Profile of Mood 
States 
 (POMS) - 
Measure of 
negative and 
positive affect 
* First 
diagnosis of 
stage one or 
two cancer 
* 20 weeks 
after 
completion of 
medical 
* Diagnosis 
of recurrent 
or 
metastatic 
disease and 
inability 
to read or 
write 
* Researcher 
rang all pts on 
medical 
treatment 
completion to 
Fact control 
group (CTL) 
* EMO writing 
was relatively 
effective for 
women low in 
avoidance 
* Primary 
reliance on pt 
self-report 
* Lack of 
generalisability 
of findings- pts 
evidenced 
more positive 
describe trial 
and schedule 
participation. 
 
* Induced POS 
writing was 
more useful for 
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 A., Kirk, S. B., 
& Austenfeld, J. 
L. (2002).  
frequently   
used in studies of 
cancer patients. 
treatment English Pts were 
mailed 
women high in 
avoidance 
psychological 
informed 
consent form 
and baseline 
questionnaire. 
* 
Randomisation 
was through a 
computerised 
random 
number 
generator. 
* EMO group- 
pts asked to 
write about 
their deepest 
thoughts 
and feelings 
regarding 
experience 
with breast 
cancer. 
* POS group- 
pts asked to 
write about 
positive 
 
* Compared 
with CTL pts 
at 3 months, 
the EMO 
group reported 
sig 
Randomised, 
Controlled trial 
of written 
emotional 
expression and 
benefit finding in 
breast cancer  
patients. Journal 
of Clinical 
Oncology, 20 
(20),  
4160-4168. 
* Physical health-
related outcomes- 
Negative somatic 
symptoms were 
assessed on a 
measure 
developed by 
Pennebaker 
* Cancer-related 
avoidance- COPE 
   
decreased 
physical 
symptoms 
adjustment 
than other 
samples 
* Small sample 
size 
   
* The EMO 
and POS pts 
had sig fewer 
medical app 
for cancer 
related 
   
morbidities. 
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thoughts and 
feelings 
regarding her 
experience 
with breast 
cancer 
    
* CTL group- 
pts asked to 
write about 
facts regarding 
cancer 
   
        
and its 
treatment.       
Gellaitry, G., 
Peters, K., 
Bloomfield, D., 
& Home, R.  
(2010). 
Narrowing the 
gap: the effects 
of an  
expressive 
writing 
intervention on 
perceptions of  
actual and ideal 
emotional 
* Significant 
others scale- used 
to measure pts 
level of  
support across a 
range of key 
individuals 
* QOL- assessed 
using the 
Functional 
Assessment of 
Cancer  
Therapy- Breast 
* Psychological 
* Pt attending 
their last 
radiotherapy 
app at 
the outpatient 
clinic 
* Unable to 
write for the 
duration of 
20 mins 
* Unable to 
speak, read 
or write 
English 
* Defined 
psychiatric 
disorder 
* Pts recruited 
for the study in 
their last week 
of treatment 
* 93 pts were 
randomised 
* Pts in the 
writing group, 
wrote for 20 
mins on four 
consecutive 
days.  
*Postal 
follow-ups at 
* Control 
group 
received 
normal care 
* Sig effect of 
group on 
women's 
perceptions of 
social support 
with  
* Sample did 
not 
demonstrate 
cultural or 
ethnic 
diversity- 
limiting the 
generalisability  
of findings 
* Sample 
consisted of 
pts with early 
stage  
breast cancer 
 those in the 
intervention 
group being 
more satisfied 
with their 
 
emotional 
support they 
received 
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support in 
women who  
have completed 
treatment for 
early stage breast 
 cancer. Psycho-
Oncology, 19, 
77-84. 
well-being- 
assessed using the 
Profile of Mood 
States 
 
1, 3, 6 months 
 
* Satisfaction 
with their 
emotional 
support was 
negatively 
correlated 
and so no 
assumptions 
can be  
made about the 
suitability of 
the writing 
paradigm for 
pts with more 
advanced 
disease 
   
with 
depression and 
anger/hostility 
and positively 
correlated with 
  
*Pts asked to write at same 
time each day 
social and 
family well-
being, 6 
months post 
intervention 
* no sig effects 
of intervention 
on mood, QOL 
or healthcare 
utilisation 
* Most pts 
found writing 
valuable and 
did not report 
any long-term 
negative 
    
*Pts provided 
with 
guidelines for 
each day; day 
1- emotional  
disclosure, day 
2- cognitive 
appraisal, day 
3- benefit 
funding, 
day 4- looking 
to the future 
 
 
* no provision 
was made to 
offer pts an  
alternative 
means of 
disclosure, 
such as the 
 use of 
audiotapes and 
so excluding 
women  
who were 
unable to write 
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effects for whatever 
reason. 
      
                     
Sloan, D. M., 
Feinstein, B. A., 
& Marx, B. P. 
(2009). 
The durability of 
beneficial health 
effects associated 
with expressive 
writing. Anxiety, 
Stress & Coping, 
22(5), 509-523. 
* Depression, 
Anxiety and 
Stress Scale 
(DASS) 
* The Pennebaker 
inventory of 
limbic 
languidness 
(PILL) 
* Manipulation 
check 
* Pts needed 
to be a first 
year 
undergraduate 
students 
* No 
exclusion 
criteria 
* 69 pts were 
randomised to 
either an 
expressive 
writing 
condition or a 
control 
condition 
using a 
computerised 
random 
number 
generator 
* Pts were 
given an 
envelope 
containing 
general 
instructions 
for writing and 
specific 
instructions for 
the first 
* Control 
group were 
asked to 
write about 
how they 
spent each 
day without 
any emotion 
or opinions. 
* Pts in the 
EW condition 
reported sig 
fewer 
depression 
symptoms 
* Larger 
sample size 
needed 
  compared with 
pts assigned to 
the control 
condition but  
this was 
 
  
not sustained 
at follow up 
assessments 
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writing 
session 
* Pts in EW 
condition were 
asked to write 
about their 
most stressful 
or traumatic 
experience of 
their lives with 
as 
much emotion 
and feeling as 
possible. 
* Pts in both 
conditions 
were asked to 
write 
continuously 
for  
20 mins on 
three 
consecutive 
days 
    
* After 20 
mins the 
experimenter 
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entered the 
room and 
asked 
        
pts to stop 
writing       
Zakowski, S. G., 
Ramati, A., 
Morton, C., 
Johnson, P., &  
Flanigan, R. 
(2004). Written 
emotional 
disclosure 
buffers 
the effects of 
social constraints 
on distress 
among cancer 
patients. Health 
Psychology, 
23(6), 555-563. 
* Social 
constraints scale 
(SCS) 
* Brief symptoms 
inventory (BSI) 
* Impact of 
events scale (IES) 
* First time 
diagnosis of 
prostate or 
gynaecological 
cancer 
* Completion 
of an active 
cancer 
treatment 
* No evidence 
of psychiatric 
problems 
* No life-
threatening 
disease other 
than cancer 
N/A * 104 pts were 
randomised to 
either an 
emotional 
disclosure 
condition or 
the control 
condition 
* Pts wrote for 
20 mins a day 
for 3 
consecutive 
days 
* Pts were 
given detailed 
standardised 
instructions 
* Pts wrote in 
their own 
homes but 
experimenter 
rang pts after 
* Pts in 
control group 
were asked to 
describe in 
detail their 
daily 
activities in a 
non-
emotional 
manner 
* 
Nonsignificant 
main effect of 
experimental 
condition on 
distress 
suggests that 
EW was  not 
effective for all 
cancer patients 
in the study 
* EW buffered 
the effects  of 
social 
constraints on 
stress at 6 
month  
follow-up  and 
that avoidance 
partly 
mediated these 
effects 
* Small effect 
size 
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they had  
finished their 
writing session 
to see if they 
had been 
   
  
* Ability to 
fluently read 
and write in 
English 
    
   
interrupted 
   
   
* Pts in the 
EW condition 
were 
instructed to 
write about 
their  
   
        
thoughts and 
feelings 
regarding their 
cancer 
experience       
Lepore, S. J. 
(1997). 
Expressive 
writing 
moderates the 
relation between 
intrusive 
thoughts and 
depressive 
symptoms. 
* Manipulation 
check 
* Depressive 
symptoms - 13-
item depressive 
symptom 
subscale 
of the SCL-90R 
* Intrusive 
thoughts- Impact 
* Pts must be 
taking an 
exam 
N/A * Pts wrote for 
25 mins on 
one occasion 
* Control 
group told 
specifically 
not to write 
about their 
feelings 
or emotions 
* EW did not 
affect the 
frequency of 
intrusive 
thoughts but it 
moderated 
* Stressor was 
not as grave as 
those typically 
associated with 
chronic and 
clinically sig 
levels of 
distress. 
* A single 
writing session 
 
  
the impact of 
intrusive 
thoughts on 
depressive 
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Journal of 
Personality and 
Social 
Psychology,  
73(5), 1030-1037 
of events scale 
(IES) 
  
symptoms. would not 
moderate 
the effects of 
intrusive 
thoughts on 
depressive 
symptoms 
under such 
severe distress 
* The effect of 
the 
manipulation 
on exam  
performance is 
unknown 
     
     
      
      
      
            
Sloan, D. M., 
Marx, B. P., 
Epstein, E. M. & 
Dobbs, J. L. 
(2008). 
Expressive 
writing buffers 
against 
maladaptive  
rumination. 
Emotion, 8(2), 
302-306. 
* Ruminative 
response scale 
(RRS) 
N/A N/A *Pts in the EW 
condition were 
asked to write 
about their 
most stressful 
or traumatic 
experience of 
their lives 
with as much 
emotion and 
feeling as 
possible 
* Pts in the 
control group 
were asked to 
write about 
how they 
spent 
* A brooding 
ruminative 
style 
moderated the 
effects of 
expressive 
among those 
assigned to the 
EW condition 
* Pts with 
greater 
brooding 
* Small sample 
size 
* Depression and 
anxiety stress 
scale (DASS) 
  
their time 
each day 
without and 
emotion 
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* Pts in both 
groups asked 
to write for 
20mins a day 
for 3 
consecutive 
days 
 
scores reported 
sig fewer 
depressive 
symptoms at 
all follow-up 
assessments 
relative to 
individuals 
with lower 
brooding 
scores 
 
        
* Changes in 
depressive 
symptoms 
assessed at 2, 
4, 6 months       
Klein, K., & 
Boals, A. (2001). 
Expressive 
writing can 
increase working 
memory 
capacity. Journal 
of 
Experimental 
Psychology, 
130(3), 520-533. 
* Arithmetic 
operation-word-
memory span task 
(OSPAN) 
* College 
adjustment test 
N/A N/A * EW 
condition 
instructed to 
write about 
their deepest 
thoughts and 
feelings about 
coming to 
college  
* Control 
condition 
 
* Pts in EW 
showed greater 
working 
memory 
improvements 
and 
* Single 
measure of 
working 
memory  
   
declines in 
intrusive 
thinking 
compared to 
those who 
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  instructed to 
write about 
everything 
they  
had done that 
day and 
describe how 
they may have 
done a 
better job 
wrote about 
   
a positive 
experience or 
trivial topic  
 
    
* EW reduces 
intrusive and 
avoidant 
thinking about 
stressful 
 
        
experience, 
freeing up 
working 
resources   
Laccetti, M.  
(2007). 
Expressive 
writing in 
women with 
advanced breast 
cancer. Oncology 
Nursing Forum, 
34(5), 
1019-1024. 
* Functional 
assessment of 
cancer therapy- 
breast (FACT-B) 
* Historical 
diagnosis of 
primary breast 
cancer 
* Women 
with mental 
status 
precluding 
meaningful 
participation 
* Pts wrote for 
20-30 mins for 
4 consecutive 
days 
N/A * Sig 
relationship 
found between 
positive-affect 
word use and  
emotional 
well-being 
* A positive 
relationship 
between 
affective 
language in 
disclosure and 
QOL was 
* Small sample 
size 
* The 
sociodemographic  
information 
survey 
* Clinical 
evidence of 
stage IV breast 
cancer 
* Life 
expectancy 
greater than 6 
months 
* Medical 
status 
precluding 
meaningful 
participation 
*Pts were 
instructed to 
write about 
experiences 
with 
metastatic 
breast cancer, 
thoughts and 
 
* Lack of 
diversity 
reducing 
generalisability 
of findings 
*Writing may 
have been diff 
for individuals 
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* Ability to 
read and write 
English 
  
feelings 
related to  
not fully 
recovering 
from cancer 
and possibility 
of facing death 
found, 
demonstrating 
a cognitive 
process 
occurring in 
EW 
  
who struggle 
with writing or 
for those 
whose English 
is there 2nd 
language 
               
Poon, A., & 
Danoff-Burg, S. 
(2011). 
Mindfulness as a 
moderator in 
expressive 
writing. Journal 
of Clinical  
Psychology, 
67(9), 881-895. 
* Freiburg 
mindfulness 
inventory (FMI) 
* Physical 
symptom 
checklist (PSC) 
* Pittsburg sleep 
quality index 
(PSQI) 
* 18 years old 
* Ability to 
write 
continuously 
in English for 
20 mins 
N/A * Pts in the 
EW writing 
group were 
instructed to 
write about  
Not stated * Main effects 
favouring EW 
were found 
and these were 
qualified by 
sig interactions 
with 
mindfulness 
* Individuals 
with higher 
mindfulness 
scores 
responded 
better to EW, 
experiencing 
greater 
physical and 
psychological 
* Studies 
relied on self-
report 
measures 
*Experimenter 
effects as the 
experimenter 
was  
not double 
blind 
 
a highly 
stressful or 
traumatic 
event and to 
let go and 
explore 
 
 
their deepest 
emotions and 
thoughts about 
their event. 
 
 
* Brief symptom 
inventory (BSI) 
* Positive and 
  
* 
Randomisation 
was through a 
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negative affect 
schedule 
(PANAS) 
random 
number 
generator 
benefits  
  
            
Stanton, A. L., 
Danoff-Burg, S., 
Cameron, C. L., 
Bishop, M.,  
* COPE 
* Emotional 
approach coping 
scales 
* Hope scale 
* FACT 
* Perceived social 
receptivity 
* Not 
mentioned 
Not 
mentioned 
 
Not stated * Expressive 
coping was 
related to 
improved QOL 
for those who  
perceived their 
social contexts 
as highly 
receptive 
* Coping 
through 
emotional 
processing was 
related to one 
index of  
greater distress 
over time 
* Measures 
relied on self-
reports 
Collins, C. A., 
Kirk, S. B., 
Sworowski, 
L.A., & 
Twillman,  
  
 
  
R. (2000). 
Emotionally 
expressive 
coping predicts  
     psychological 
and physical 
adjustment to 
breast cancer.  
     Journal of 
Consulting and 
Clinical 
Psychology, 
68(5),  
      875-882.               
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Low, C. A., 
Stanton, A. L., & 
Danoff-Burg, S. 
(2006). 
Expressive 
disclosure and 
benefit finding 
among breast 
cancer 
patients: 
Mechanisms for 
positive health 
effects. Health  
Psychology, 
25(2), 181-189. 
* Physical health 
benefits 
* HR- personal 
computer 
physiological 
monitoring 
system 
* Linguistic 
content analysis 
* Self report 
mood 
* Stage I or II 
breast cancer 
*Completed 
primary 
medical 
treatment 
* Diagnosed 
with 
recurrent or 
metastatic 
disease  
* Unable to 
read or 
write 
English 
*Pts in the 
EMO 
condition were 
instructed to 
write about  
their deepest 
thoughts and 
feelings 
regarding their 
experience 
with breast 
cancer 
* Pts in the 
POS condition 
were 
instructed to 
write about 
positive 
thoughts and 
feelings 
regarding their 
experience 
with 
breast cancer 
* Pts in the 
control 
condition were 
Facts relating 
to their 
experience of 
breast cancer 
* Within 
session heart 
rate 
habituation 
mediated 
effects of 
expressive 
disclosure on 
physical 
symptoms 
* Post writing 
mood and use 
of positive 
emotion and 
cognitive 
mechanism 
words in 
essays were 
not sig 
mediators 
* Greater 
cognitive 
mechanism 
words were 
related to 
greater 
heart rate 
* Small sample 
size 
* As sample 
was limited to 
women with 
early 
breast cancer, 
difficult to 
generalise 
findings to 
individuals 
with more 
advanced 
cancer 
* Reliance on 
pts self-report 
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asked to write 
about facts 
regarding their 
experience 
with breast 
cancer 
habituation 
and negative 
word use 
              
Low, C. A., 
Stanton, A. L., 
Bower, J. E., & 
Gyllenhammer, 
L. (2010). A 
randomized 
controlled trial of 
emotionally 
expressive 
writing for 
women with 
metastatic breast 
cancer. Health 
Psychology, 
29(4), 460-466. 
* The center for 
epidemiological 
studies- 
depression scale 
* The Pittsburgh 
Sleep Quality 
Index 
*Emotional 
support 
* Pts 
diagnosed 
with stage IV 
breast cancer 
* Able to 
complete 
writing 
exercise and 
assessments in 
English 
*Any current 
medical 
treatments for 
cancer were 
allowed 
Not 
mentioned 
* 
Randomisation 
was through a 
computerised 
random 
number 
* Pts called 
research office 
to schedule 
four 20 min 
sessions 
within a 3 
week interval 
* A trained 
research 
assistant 
telephoned pts 
at 
beginning of 
session to read 
instructions to 
Not stated * No main 
effect of 
experimental 
condition 
* Sample 
predominantly 
white and well 
educated- diff 
to generalise 
findings 
* Physical 
health 
outcomes 
relied on self-
report 
* 
Underpowered 
to detect main 
effects 
  * A sig 
condition x 
social 
interaction 
emerged on 
intrusive 
thoughts 
  
* sig condition 
x time since 
metastatic 
diagnosis 
interactions 
were 
   
observed for 
somatic 
symptoms and 
sleep 
Appendices  
 
 
 
412 
 
the pts, they  
then called 
again 20 mins 
later to instruct 
pts to stop 
writing. 
disturbances 
    
* Expressive 
writing may be 
beneficial for a 
subset of 
metastatic 
 
    
patients and 
contraindicated 
for others 
         
 
      
Baum, E. S., & 
Rude, S. S. 
(2013). 
Acceptance-
enhanced 
expressive 
writing prevents 
symptoms in 
participants with 
low initial 
depression. 
Cognitive 
Therapy 
Research, 37, 
35-42. 
* The center for 
epidemiologic 
studies depression 
scale (CES-D) 
* Students 
from a subject 
pool were 
eligible if they 
responded 
negatively at 
pre-screening 
to a question 
asking if they 
were currently 
feeling down 
or depressed, 
but 
Not 
mentioned 
* Pts in the 
EW condition 
were 
instructed to 
write about 
their  
deepest 
thoughts and 
feelings about 
an extremely 
difficult or 
emotional 
event that has 
affected their 
life  
Not stated * Writing 
condition 
interacted sig 
with initial 
depression 
such that 
at the 5 week 
post-test, 
EWEA was 
more 
beneficial than 
control writing 
for pts 
* EW was 
more 
beneficial than 
control writing 
* 26% of 
students who 
began the 
study didn’t  
complete post-
test measures 
* High attrition 
rates 
* Lack of 
interaction 
with a 
researcher 
contributed 
to pts feeling 
less personally 
supported 
which may 
* Linguistic 
inquiry and word 
count (LIWC) 
 
 
   
  
endorsed 
 
* The EW plus 
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experiencing a 
period of 
time, 2 weeks 
or longer over 
the past 2 
years in which 
they felt sad or 
down most 
days. 
emotional 
acceptance 
group 
(EWEA) 
received  
for pts with 
very low 
initial 
depression 
symptoms 
(CESD) 
have led to 
poorer results 
for the 
traditional EW 
condition 
among pts with 
elevated 
depression 
symptoms 
   
the same 
instructions as 
the EW group 
plus additional 
 
   
directions 
adapted from 
mindfulness 
and self-
compassion 
 
   
interventions 
and were 
designed to 
increase pts 
awareness of  
  
        
a broader 
context for 
their emotional 
experience      
Lee, H. S., & 
Cohn, L. D. 
(2010). 
Assessing 
* 60-item COPE 
* 66-item Ways of 
Coping-Revised 
* 33-item Coping 
* not stated * Not stated * Pts were 
instructed to 
write about a 
stressful event 
Not stated * Depression 
scores were 
related to the 
use of words 
* Lack of 
generalisability 
of findings 
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coping 
strategies   
by analysing 
expressive 
writing 
samples. Stress 
and Health, 26, 
 250-260 
Strategies Indicator 
* 20-item Center 
for Epistemological 
Studies Depression 
* 8-item language 
proficiency test 
related to 
college life 
* 20 mins was 
required to 
complete the 
single session 
writing 
Task 
denoting 
negative 
   
emotion but 
were unrelated 
to the use of 
pronoun 'I' 
 
   
* Pts who used 
more words 
denoting 
negative 
emotions in 
their essays 
 
   
obtained lower 
problem-
focused coping 
scores on the 
COPE 
 
     
* The use of 
insight-related 
words were 
associated with 
lower scores 
 
            
on measures of 
emotion-
focused coping   
Gortner, E., 
Rude, S. S., & 
* The Beck 
Depression 
* 
Undergraduate 
Not stated * Pts in the 
EW condition 
* Control 
group wrote 
* Pts scoring 
above the 
* Few pts in 
the study 
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Pennebaker, J. 
W. (2006). 
Benefits 
of expressive 
writing in 
lowering 
rumination and 
depressive  
symptoms. 
Behavior 
Therapy, 37, 
292-303. 
Inventory (BDI) 
* Inventory to 
Diagnose 
Depression-
Lifetime Version 
(IDD-L) 
* Ruminative 
Response Scale 
(RRS) 
* Emotion 
Regulation 
Questionnaire 
(ERQ) 
students who 
reported 
elevated 
symptoms of 
depression in 
the past but 
whose present 
level of 
depressive 
symptoms was 
within normal  
levels 
were 
instructed to 
write about 
their 
thoughts and 
feelings on 
current and 
past emotional 
upheavals 
* Half of the 
EW condition 
and half of the 
control 
individuals  
were randomly 
assigned to a 
20-min booster 
session 5 
weeks 
after their 
initial 
intervention 
objectively 
about time 
management 
median on the 
suppression 
scale of the 
Emotion 
Regulation 
Questionnaire 
showed sig 
lower 
depression 
symptoms at 
the 6-month 
assessment 
when they 
wrote in the 
EW versus 
the control 
condition 
* A booster 
writing session 
failed to have a 
sig effect 
experienced 
large increases 
increases in 
depressive 
symptoms 
* Sample was 
neither 
selected or 
assessed by 
clinical 
interview 
 
 
  
  
 
* Follow-up  
Questionnaire on  
Participants' Subjective  
Experience (FQPSE) 
                  
Knowles, E. 
D., Wearing, J. 
R., &Campos, 
B. (2011). 
* Language 
proficiency and 
preference 
questions Not stated Not stated 
* Pts were 
randomised to 
either a trivial 
or traumatic * No control 
* European 
Americans 
who wrote 
about trauma * Not stated 
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Culture writing increased their 
use of  
insight words 
over four 
sessions and 
reported fewer 
illness 
symptoms 
a month later 
& the health 
benefits of 
expressive 
writing. Social 
Psychological 
* Symptoms of 
illness 
  
condition 
  and 
Personality 
Science, 2(4), 
408-415 
   
* Each morning for the 
following 3 days, pts were 
emailed a link 
 
    
to a website 
where they 
completed a 
20-min writing 
exercise 
 
* Neither 
effect obtained 
for Asian 
Americans 
 
    
consistent with 
their condition 
   
    
* Trivial 
writing 
condition- pts 
wrote about 
topics such as 
the  
   
    
weather, 
routine and 
minor 
happenings; 
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while avoiding 
    
emotional 
commentary 
   
    
* Traumatic writing condition- 
pts were instructed to write 
about 
  
    
their deepest 
thoughts and 
feelings about 
the most 
traumatic 
   
        
experience in 
their life       
Arigo, D., & 
Smyth, J. M. 
(2012). The 
benefits of 
expressive 
writing on 
sleep difficulty 
and appearance 
concerns for 
college 
women. 
Psychology & 
Health, 27(2), 
210-226 
* Eating disorder 
examination 
questionnaire- 29-
item 
* Body image 
quality of life 
inventory- 19-item 
* Iowa-Netherlands 
comparison 
orientation measure 
* Perceived stress 
scale- 10-item 
* Pittsburgh sleep 
quality index 
Not stated Not stated * Pts 
randomised 
into either an 
EW or control 
condition 
* Pts in the 
EW condition 
were 
instructed to 
write about 
related 
aspects of a 
stress full 
experience 
* Control 
group asked 
to write 
about their 
plans for 
over the 
next week 
* Pts in the 
EW condition 
reported less 
sleep difficulty 
and less body 
focused 
upward social 
comparison at 
8 week follow 
up, relative to 
control 
participants. 
* For 
individuals 
* Moderating 
effect of 
perceived 
stress on some 
outcome 
variables 
suggest that 
this 
intervention 
may be 
optimally 
effective for 
those 
experiencing 
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* Pts asked to 
write for 15 
mins 
who reported 
higher 
perceived 
stress at 
baseline, the 
high stress, this 
may have 
limited our 
ability to 
detect sig main 
effects 
   
* First two writing sessions 
were in the first day and then 
the third 
EW condition 
resulted in less 
eating 
disturbance 
and less social 
 
* Manipulation 
check 
  
as week later 
* Follow up 
was 8 weeks 
after the pts 
third writing 
session 
 
comparison, 
relative to the 
control 
condition 
 
     
* EW about 
body image 
and 
appearance 
concerns may 
positively  
 
    
* 1st session 
pts were asked 
to focus on 
their deepest 
 
influence the 
trajectory of 
risk for or 
resilience 
against future 
 
    
thoughts and feelings about 
their body image and eating 
complications 
as result of 
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concerns sleep 
difficulty, 
eating 
disturbance 
and body 
dissatisfaction 
    
* 2nd session 
pts were asked 
to evaluate 
their thoughts 
and  
 
 
 
    
feelings 
related to body 
image and 
eating 
   
    
* 3rd session 
pts asked to 
synthesise 
their thoughts 
and feelings 
   
        
about body 
image and 
eating 
concerns       
Danoff-Burg, 
S., Mosher, C. 
E., Seawell, A. 
* Center for 
Epidemiological 
Studies Depression 
* Able to write 
by hand, in 
English for up 
Not stated * Pts 
instructed to 
write 
* Pts in 
control group 
were asked to 
* The narrative 
and EW 
groups 
* Use of 
college 
students 
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H., & Agee, J. 
D.  
(2010). Does 
narrative 
writing 
instruction 
enhance the 
benefits  
of expressive 
writing. 
Anxiety, stress 
and coping: An 
 international 
journal, 23(3), 
341-352 
Scale (CES-D) 
* Perceived Stress 
Scale ( PSS) 
* University Health 
Center visits 
to 20 minutes continuously 
for 20 mins in 
accordance  
write a 
detailed, 
factual, 
reported lower 
levels of 
perceived  
stress and 
depressive 
symptoms 
relative to 
controls but 
did not 
differ from 
each other 
regards to 
outcomes 
 
 
to their 
assigned 
instructions 
and were 
asked to return 
two days 
description 
of the inside 
of an 
apartment or 
house in 
which they 
had lived. 
 
  
later to 
complete 
another 20 min 
writing session 
  
   
* EW pts were  
asked to let go  
and express their  
deepest thoughts 
  
   
and feelings 
relating to a 
personally 
stressful or 
traumatic 
           experience       
Creswell, J. D., 
Lam, S., 
Stanton, A. L., 
* Satisfaction with 
life scale (SWLS) 
* Early stage 
breast cancer 
patients who 
* Pts were 
excluded if 
they had a 
* Pts wrote 4 
essays about 
their breast 
No control * Self-
affirmation 
writing was 
* Rather than 
manipulating 
self-
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Taylor, S. E., 
Bower,  
were within diagnosis of 
recurrent or 
metastatic 
disease 
* Unable to 
write in 
English 
cancer 
experiences 
during a 3 
week period 
* Pts were 
randomly 
assigned to 
one of three 
conditions 
* Condition 1- 
deepest 
thoughts and 
feelings 
regarding their 
associated with 
fewer physical 
symptoms at a 
3 month follow 
up assessment 
* Self-
affirmation 
writing fully 
mediated the 
effects of 
emotional 
affirmation, 
cognitive 
processing or 
discovery of 
meaning 
writing directly 
we assessed 
the naturalistic 
occurrence of 
these 
statements in 
the context of 
J. E., & 
Sherman, D. K. 
(2007). Does 
self-
affirmation, 
cognitive 
processing or 
discovery of 
meaning 
explain cancer-
related health 
benefits of 
expressive 
writing. Pers 
Soc Psychol 
Bull, 33, 238-
250. 
* Profile of Mood 
States (POMS) 
20 weeks of 
completing 
cancer 
treatment 
   
  
 
   
expression and 
benefits 
finding writing 
conditions on 
reduced 
physical 
 
   
experience 
 
symptoms EW trial 
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with breast 
cancer 
* Condition 2 - 
positive 
thoughts and 
feelings 
regarding their 
experience 
with breast 
cancer 
 
* Self -
affirmation 
plays an 
important role 
in buffering 
stress 
* The study 
didn’t define 
the potential 
mediators 
as mutually 
exclusive 
categories, 
making it 
difficult 
to interpret 
correlations 
among the 
mediators 
or assess their 
independent 
contributions 
as 
orthogonal 
constructs 
     
* Self-
affirmation as 
a viable 
mechanism 
underlying the 
health benefits 
of EW 
    
* Condition 3- facts  
regarding their cancer  
and its treatment 
* for each condition  
pts were instructed to  
write conditionally for  
20 mins 
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Appendix 20. Dissemination of findings from the program of research 
Peer-reviewed Publications 
Pilkington, M. (2014). Expressive writing interventions for individuals with 
appearance concerns. Journal of Aesthetic Nursing, 3(8), 390-393. 
Pilkington, M. (2013). Supporting patients who are affected by chemotherapy-
induced hair loss. Journal of Aesthetic Nursing, 2(9), 456-457. 
 
Conference Publications and Invited Presentations 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2012). 
Psychosocial interventions to support breast cancer patients affected by treatment-
related hair loss. Presented at the British Psychosocial Oncology Society PhD event, 
Chester. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2012). A 
systematic review of the effectiveness of interventions to improve psychological 
outcomes for individuals affected by hair loss. Poster presented at the British 
Psychosocial Oncology Society Conference, 2012, Southampton. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2012). A 
systematic review of the effectiveness of interventions to improve psychological 
outcomes for individuals affected by hair loss. Presented at the Appearance Matters 
5 Conference, 2012, Bristol. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2013). 
Patients’ experiences of cancer-related hair loss and a camouflage-based support 
service’. ‘Work in Action’ poster presented at the Division of Health Psychology 
Conference, 2013, Brighton.  
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2013). 
“This is a journey, this isn't just a quick fix”: Breast cancer patients’ experiences of 
treatment-related hair loss and a camouflage based support service. Poster 
presented at the British Psychosocial Oncology Society Conference, Preston. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2013). 
Feasibility and Acceptability of an Expressive Writing Intervention for Breast 
Cancer Patients with Chemotherapy-Induced Hair Loss. Presented at the Bristol 
Haematology & Oncology, Research Forum. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2014). 
“This is a journey, this isn't just a quick fix”: Breast cancer patients’ experiences of 
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treatment-related hair loss and a camouflage based support service. Presented at the 
University of the West of England (UWE) Health and Applied Sciences faculty 
conference. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J (2014). 
Breast cancer patients’ experiences of a camouflage based support service for 
treatment-related hair loss. Presented at the University of the West of England 
(UWE) Postgraduate conference.  
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2014). 
“This is a journey, this isn't just a quick fix”: Breast cancer patients’ experiences of 
treatment-related hair loss and a camouflage based support service. Presented to 
Breast Cancer Care. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2014). 
“This is a journey, this isn't just a quick fix”: Breast cancer patients’ experiences of 
treatment-related hair loss and a camouflage based support service. Presented at the 
Appearance Matters 6 conference, Bristol. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2014). 
“Your hair’s your crowning glory”: Breast cancer patients’ experiences of 
treatment-related hair loss and a camouflage based support service. Presented at the 
early career researcher event at International Psychosocial-Oncology Society 
conference, 2014, Lisbon. 
Pilkington, M., Harcourt, D., Rumsey, N., O’Connor, D., & Brennan, J. (2015). 
You're actually mourning a loss”: Breast cancer patients’ experiences of a 
camouflage based support service for treatment-related hair loss”. Poster presented 
at the British Psychosocial Oncology Society Conference, Leeds. 
 
 
 
 
 
 
 
 
Appendices  
 
 
 
425 
 
Appendix 21. Poster advertisement for the expressive writing study 
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Appendix 22. Press release for the expressive writing study  
 
 
Women with breast cancer who are 
expecting to/experiencing treatment-related hair loss are wanted for 
study 
 
A new study exploring the use of expressive writing as a psychosocial intervention 
for breast cancer patients who are affected by chemotherapy-induced hair loss has 
begun at UWE, Bristol. 
 
There is a large body of research around the use of expressive writing with other 
populations, but to our knowledge it has not yet been looked at with breast cancer 
patients affected by hair loss.  
 
Melissa Pilkington is a PhD researcher from the Centre for Appearance Research at 
the University of the West of England (UWE), Bristol. With the support of Breast 
Cancer Campaign, she is carrying out a study looking at the use of expressive 
writing to support women who have received a breast cancer diagnosis to see 
whether writing might help them manage their thoughts and feelings about hair loss.  
 
She said “If found to be effective, expressive writing could (we think) be an easy and 
very cost-effective way of supporting breast cancer patients through this 
experience”. 
 
Taking part in this study would involve writing for a period of 20 minutes a day for 
4 consecutive days on a topic that will be given to you and will involve completing 3 
questionnaires. All participants who complete the study will receive a £20 Marks 
and Spencer’s voucher. 
 
To find out more about Melissa’s research or to volunteer for this study, please 
follow this link: http://tinyurl.com/ExpressivewritingQ1 or contact Melissa directly: 
Melissa.Pilkington@uwe.ac.uk 
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Appendix 23. Confirmation of NRES ethical approval for the expressive writing 
study 
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Appendix 24. Confirmation of UWE ethical approval for the expressive writing 
study 
 
Faculty of Health & Applied Sciences  
Glenside Campus 
         Blackberry Hill 
         Stapleton 
         Bristol    BS16 1DD 
 
         Tel: 0117 328 1170 
 
Our ref: JW/lt 
 
28th February 2014 
 
Miss Melissa Pilkington 
PhD Researcher 
University of the West of England 
Centre for Appearance Research, Faculty of Health and Applied Sciences, 
Frenchay Campus, 
Bristol BS16 1QY 
 
 
Dear Melissa 
 
Application number: HLS/14/02/38 
Application title: A pilot study of an expressive writing intervention for breast cancer 
patients affected by treatment-related hair loss 
REC reference: 14/SW/0007 
 
Your NHS Ethics application and approval conditions have been considered by the Faculty 
Research Ethics Committee on behalf of the University.  It has been given ethical approval 
to proceed with the following conditions: 
 
You comply with the conditions of the NHS Ethics approval. 
You notify the Faculty Research Ethics Committee of any further correspondence with the 
NHS Ethics Committee. 
You must notify the Faculty Research Ethics Committee in advance if you wish to make any 
significant amendments to the original application. 
If you have to terminate your research before completion, please inform the Faculty 
Research Ethics Committee within 14 days, indicating the reasons. 
Please notify the Faculty Research Ethics Committee if there are any serious events or 
developments in the research that have an ethical dimension. 
Any changes to the study protocol, which have an ethical dimension, will need to be 
approved by the Faculty Research Ethics Committee. You should send details of any such 
amendments to the committee with an explanation of the reason for the proposed 
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changes.  Any changes approved by an external research ethics committee must also be 
communicated to the relevant UWE committee.  
Please note that any information sheets and consent forms should have the UWE logo.  
Further guidance is available on the web: 
http://www1.uwe.ac.uk/aboutus/departmentsandservices/professionalservices/marketing
andcommunications/resources.aspx 
Please note that the University Research Ethics Committee (UREC) is required to monitor and 
audit the ethical conduct of research involving human participants, data and tissue 
conducted by academic staff, students and researchers. Your project may be selected for 
audit from the research projects submitted to and approved by the UREC and its 
committees. 
 
Please note that your study should not commence at any NHS site until you have obtained 
final management approval from the R&D department for the relevant NHS care 
organisation.  A copy of the approval letter(s) must be forwarded to Leigh Taylor in line 
with Research Governance requirements. 
 
We wish you well with your research. 
 
Yours sincerely 
 
 
 
 
Dr Julie Woodley 
Chair 
Faculty Research Ethics Committee 
 
c.c. Diana Harcourt 
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Appendix 25. Participant information sheet for the expressive writing study 
 
Writing Study: Information Sheet 
You are being invited to take part in a study. Please read this information carefully 
and do not hesitate to contact us with any questions that you may have. Thank you. 
What is the purpose of the study? 
This study is exploring the process of writing as a way of helping individuals who 
have received a breast cancer diagnosis and are experiencing/or are expected to 
experience, treatment-related hair loss. The study is being carried out by Melissa 
Pilkington, a PhD researcher from the Centre for Appearance Research (CAR) which 
is based at the University of the West of England (UWE), Bristol.  
Why have I been chosen? 
You are being invited to take part because you have been diagnosed with breast 
cancer and undergoing chemotherapy treatment at the Bristol Haematology & 
Oncology Centre. We are looking for a total of 120 people to take part.  
Do I have to take part? 
No, taking part is voluntary. You do not have to take part if you do not want to and, 
if you do take part, you can withdraw from the study up to a month after taking part. 
Whether or not you take part will not make any difference to your care, now or in the 
future.  
What will I have to do if I take part? 
You will be randomised into one of two writing groups. Both groups will be asked to 
write about a specific topic that we will give you – one group will be asked to write 
about their thoughts and feelings in relation to that topic (we refer to this as the 
expressive writing group) and the other group will be asked to write about their topic 
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in terms of facts, without their thoughts and feelings (we call this the neutral writing 
group). You will be asked to write either by hand or typing for 20 minutes a day for 
4 consecutive days. We would like you to give us what you write, but this is 
completely optional and you can still take part without giving us what you have 
written. If you do decide to send your writing to us, it will be treated as confidential. 
Also, you will be asked to complete a questionnaire on four separate time points; one 
now, and then two weeks, one month and 3 months later. The questionnaires will 
each take about 20 minutes to complete. We will post them to you and send a 
stamped addressed envelope to return them to us. If you would prefer to complete 
the questionnaires online, please use the following link: http://tinyurl.com/or2ap6u 
What are the possible benefits of taking part? 
You might find it interesting to participate, although we cannot promise that this 
study with help you personally. However, the results of the study will inform future 
plans for ways we might support cancer patients affected by hair loss in the future. 
Will my identity be protected? 
Yes. Only a summary of this information will be reported during the write up of the 
study, and your name or any other identifying information will not be known to 
anyone other than the researcher. 
What will happen with the results of the study? 
The results of the study will be reported to Breast Cancer Campaign, who are 
funding this research. However, your individual questionnaires will not be passed on 
to Breast Cancer Campaign or anyone outside of the research team. 
What will happen if any disturbing information comes to light? 
Should any disturbing information come to light whilst reading participants’ writing 
samples or questionnaires, the researcher will raise any concerns with her 
supervisory team. 
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How will the findings be shared with other people? 
The overall findings will be published in a journal and presented at conferences for 
health professionals and written up as part of a PhD thesis. Also, a summary of the 
findings will be made available to participants and to Breast Cancer Campaign. 
Who has reviewed the study? 
The study has been approved by the NRES Committee South West- Frenchay REC, 
the Bristol Haematology & Oncology Centre local Research and Development office 
and the University of the West of England (UWE) Research Ethics Committee. Also, 
the study was reviewed by Breast Cancer Campaign before they agreed to fund the 
research. 
Your right to withdraw from the study 
You have the right to withdraw from the study up to a month after taking part. If you 
wish to withdraw from the study, please contact the researcher and all your 
information will be withdrawn from the study and destroyed. 
What do I do now? 
If you would like to take part in the study, please complete the questionnaire and 
return it to Melissa Pilkington, together with the consent form, in the envelope 
provided. You do not need to put a stamp onto the envelope. Alternatively, you can 
complete the questionnaire online, please use the following link: 
http://tinyurl.com/or2ap6u 
More details about what we would like you to write about will be sent once you have 
returned your consent form 
What if I have a complaint? 
If you have a complaint about the research study,  in the first instance please contact 
the researcher Melissa Pilkington at Melissa.Pilkington@uwe.ac.uk or telephone 
0117 3283882. If you would like to speak to someone other than the researcher, 
please contact Melissa’s supervisor Prof. Diana Harcourt at 
Diana2.Harcourt@uwe.ac.uk or telephone 0117 3283967. 
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If you would like to speak to someone at the Bristol Haematology and Oncology 
Centre, the Patient Support and Complaints Team have a drop in service, which you 
can access at the main entrance of the Bristol Royal Infirmary or you can contact the 
Patient Support and Complaints Team via the following methods - Telephone: 0117 
342 3604 or Email: pals@uhbristol.nhs.uk 
 Further information about taking part in research 
If you would like further information about taking part in research, please follow the 
link below:  
http://www.nbt.nhs.uk/research-and-innovation/our-research/take-part-research  
 
Contact for further information 
If you have any further questions please contact, Melissa Pilkington at:- 
Email:- Melissa.Pilkington@uwe.ac.uk 
Telephone No:- (0117) 3283882 
Work Mobile Telephone No:- 07972733919 (Monday – Friday 9-5pm) 
Or you can contact Melissa’s supervisor, Prof. Diana Harcourt at: 
Diana2.Harcourt@uwe.ac.uk 
Telephone No:- (0117) 3283967 
 
If you would like any more information about cancer, or have any concerns that you 
would like to discuss, you might like to contact any of the following specialist 
organisations:- 
Listening ear service at the Bristol Haematology & Oncology Centre:- 
 
The Information and Support Centre on the Ground Floor of BHOC offers a 
‘listening ear’ service for any patients that would benefit from having time to speak 
to someone about their current experience. 
Telephone: 0117 3423369 
Email: cancerinfoandsupport@uhbristol.nhs.uk 
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Penny Brohn Cancer Centre:- 
Penny Brohn Cancer Centre offer a free counselling and psychotherapy service and 
patients can self-refer to this service. 
Website: www.pennybrohncancercare.org 
Telephone No: 08451232310 or 01275370100 
 
 
Breast Cancer Care:-  
Website: www.breastcancercare.org.uk 
Peer Support Team Telephone No:- 0845 0771893  
Peer Support Team Email:- ukpeersupportteam@breastcancercare.org.uk 
Breast Cancer Care’s Free Helpline for one-to-one support:- 0808 800 6000 
 
Maggie’s Centre:- 
Website: http://www.maggiescentres.org/  
To arrange face-to-face support with a support specialist:- 
Email:- enquiriesatmaggiescentres.org  
Telephone No:- 0300 123 1801 
 
Macmillan:- 
Website: www.macmillan.org.uk  
If you have any questions, would like support or someone to talk to:- 
Cancer Support Specialist Telephone No:- 0808 808 00 00 
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Appendix 26. Participant invitation letter for the expressive writing study 
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Appendix 27. Participant consent form for the expressive writing study 
Writing Study: Consent Form 
This study is exploring the use of a writing study as a way of helping individuals 
who have received a breast cancer diagnosis and are having chemotherapy treatment.  
Taking part in this study will involve a writing task for 20 minutes a day, over the 
course of 4 consecutive days. Also, you will be asked to complete a questionnaire on 
4 different occasions, either on paper or online. 
In order to protect your identity only a summary of the information you provide will 
be reported during the write up of the study. Your completed questionnaires will be 
stored securely and only accessible to the research team. You do not have to take 
part and you have the right to withdraw from the study up to a month after taking 
part.  
                                                                                        Please tick the relevant box 
                                                                                                                                              Yes       No 
I Confirm that I have read and understood the information sheet  
relating to the above study and have had the opportunity to ask  
questions. 
 
I understand that my participation is voluntary and that I am free 
to withdraw from the study up to a month after taking part, without  
giving any reason and without my health care being affected. 
 
I agree to take part in the above study. 
 
We would like you to give us what you write, however, this is completely  
optional and you can still take part without giving us what you have  
written. I consent to the researcher reading what I write during the study. 
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I understand that relevant sections of my medical notes and data  
collected during the study may be looked at by individuals from 
the University of the West of England, from regulatory authorities 
 or from the NHS Trust, where it is relevant to my taking part in 
 this research. I give permission for these individuals to have access  
 to my records. 
 
Name of Participant    Signature        Date 
 
Researcher    Signature          Date 
Please indicate below how you would prefer to receive the instructions about the 
writing task and later questionnaires. 
 Post 
 Email 
Address........................................................................................................................... 
........................................................................................................................................ 
........................................................................................................................................ 
Email address................................................................................................................ 
Telephone Number......................................................................................................... 
If you give your consent to take part in the study please return this form along with 
the completed questionnaire in the pre-paid envelope provided. 
Return Address:-  
 
FAO Melissa Pilkington 
Centre for Appearance Research  
Room 2L13  
University of the West of England, Bristol 
Frenchay Campus 
Coldharbour Lane 
BRISTOL 
BS16 1QY 
Thank you for your time. 
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Appendix 28. Baseline expressive writing questionnaire 
Questionnaire 1 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to one month after you have 
completed the study. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code. 
 
To create your ID code please enter the first three letters of your first name and the 
date of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
 
 
 
 
 
Please write below the date on which you completed this questionnaire: 
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Demographic Information 
The following information will be used to understand the sample of data collected 
and will be used for statistical purposes only, not to identify you. Please remember 
that all responses are treated as confidential. 
A: About you (please tick the relevant box or write your answer in the space 
provided): 
1. Please state your age   
2. How would you describe your ethnic group? (please tick one box) 
White 
 English/Welsh/Scottish/Northern Irish/British 
 Irish 
 Gypsy or Irish Traveller 
 Any other white background 
 Please write in  
Mixed/multiple ethnic groups 
 White and Black Caribbean 
 White and Black African 
 White and Asian 
 Any other Mixed/multiple ethnic background 
 Please write in 
Asian/Asian British 
 Indian 
 Pakistani 
 Bangladeshi 
 Chinese 
 Any other Asian background 
            please write in  
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Black/African/Caribbean/Black British 
 African 
 Caribbean 
 Any other Black/African/Caribbean background  
 please write in 
Other ethnic group 
 Arab 
 Any other ethnic group  
 please write in 
   Or 
 Prefer not to answer  
 
3. Are you currently in education or employed? (please tick one box) 
 School 
 College 
 University 
 Working Full time 
 Working Part time 
 Unemployed 
 Other (please state)  
 
4. What is your marital status? (please tick one box) 
       Married 
        Divorced 
        Separated 
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        Widowed 
        Single 
        In a same-sex civil relationship 
       Other (please state) 
 
B: About your cancer and hair loss 
1. Which type of cancer were you diagnosed as having? (please tick one box) 
 Breast Cancer 
 Other (Please specify) 
 
2. How long ago were you given your cancer diagnosis?                 years              
months 
 
3. What type of treatment, if any, have you received? (Please tick all that apply) 
          Chemotherapy         None       Other (Please 
specify) 
         Radiotherapy         Not sure          
          Surgery (Please specify) 
 
4. What type of treatment, if any, are you currently undergoing? (Please tick all that 
apply) 
          Chemotherapy         None       Other (Please 
specify) 
         Radiotherapy         Not sure          
          Surgery (Please specify) 
 
5. Until now have you experienced any hair loss due to cancer treatment? (please 
tick one box) 
 Yes 
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 No 
If you answered yes to the above question, approximately how long after your first 
chemotherapy treatment did your hair start to fall out?                        
                      Days  Or                          Weeks 
 
6. If you have experienced/are experiencing hair loss, how much of your hair have 
you lost? (please tick one box) 
 All of it   Some 
 A lot    None 
 
7. How upset or distressed are you by your hair loss? (please tick one box)                                                                                                                    
             Not at all                              A little 
             Quite a lot                                   Extremely 
 
8. Are you currently receiving any practical or emotional support regarding your 
cancer? (please tick one box) 
          Yes 
         No 
If you answered yes to the above question, please state below what type of support 
you are receiving? 
 
9. Since receiving you cancer diagnosis, have you been keeping a diary? 
 Yes     No 
 
If yes, what are your reasons for keeping a diary? 
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C: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
     
When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the 
first time, I wonder what 
they think about how I look. 
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In my everyday life, lots of 
things happen that make me 
think about what I look like. 
     
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasize about what it 
would be like to be better 
looking than I am. 
     
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
     
 
 
The first part of the scale is designed to find out if you are sensitive or self-conscious 
about any aspect of your appearance (even if this is not usually visible to others). 
 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
 
(b) If No, please go to the next page 
 
 
If Yes, please continue: 
 
The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
 
 
From now on, we will refer to this aspect of your appearance as your ‘feature’ 
 
(c) The thing I don’t like about my feature is 
 
........................................................................................................................................ 
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(d) If you are sensitive or concerned about any other features of your body or your 
appearance, please say what they are 
 
.................................................................................................................................... 
 
.................................................................................................................................... 
 
 
The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
 
Other people mis-judge me because of my feature: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine/masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my feature: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
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How irritable do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
mouth with my hand): 
 
Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes....Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A .... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How normal do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
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Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
 
I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
 
How distressed do you get when other people make remarks about your 
feature? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My feature causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... 
 
My feature limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ...  
 
 
D: Your Feelings and Emotions  
For the following statements, please indicate by ticking the box that matches what 
you think. 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am a 
failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
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E: Your Health and Wellbeing 
Below is a list of statements that other people with your cancer have said are 
important. By ticking one box per line to indicate your response as it applies to the 
past 7 days. 
 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I have 
trouble meeting the needs of my family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
     
I feel ill.      
I am forced to spend time in bed.      
I feel close to my friends. 
 
     
I get emotional support from my family. 
 
     
I get support from my friends. 
 
     
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next item. 
 
I am satisfied with my sex life. 
     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
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I feel sad.      
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I am satisfied with how I am coping with 
my illness. 
     
I am losing hope in the fight against my 
illness. 
     
I feel nervous.      
I worry about dying.      
I worry that my condition will get worse.      
I am able to work (include work at home).      
My work (include work at home) is 
fulfilling. 
     
I am able to enjoy life.      
I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually do for 
fun. 
     
I am content with the quality of my life 
right now. 
     
 
F: Your Thoughts and Concerns 
Please read each of the following statements carefully and indicate how 
characteristic it is of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
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impression of 
me. 
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
 
 
     
I rarely worry 
about what 
kind of 
impression I 
am making 
on someone. 
     
I am afraid 
that others 
will not 
approve of 
me. 
     
I am afraid 
that people 
will find fault 
with me. 
     
Other 
people’s 
opinions of 
me do not 
bother me. 
     
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried about 
what kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, it 
has little 
effect on me. 
     
Sometimes I 
think I am too 
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concerned 
with what 
other people 
think of me. 
I often worry 
that I will say 
or do the 
wrong things. 
     
 
 
For the following statements, please indicate by ticking the box that matches what 
you think. 
 Yes 
Definitely 
Yes 
Sometimes 
No, 
Not 
Much 
No, Not 
At All 
I wake early and then sleep badly for the rest 
of the evening. 
    
I get very frightened or have panic feelings 
for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the house on 
my own. 
    
I have lost interest in things.     
I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
    
I have a good appetite.     
I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go through my 
mind. 
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 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am often confused about what 
emotion I am feeling 
     
I have physical sensations that even 
doctors do not understand 
     
When I am upset, I do not know if I 
am sad, frightened or angry 
     
I am often puzzled by sensations in 
my body 
     
I have feelings that I cannot quite 
identify 
     
I do not know what is going on inside 
me 
     
I often do not know why I am angry      
It is difficult for me to find the right 
words for my feelings 
     
I am able to describe my feelings 
easily 
     
I find it hard to describe how I feel 
about people 
     
People tell me to describe my feelings 
more 
     
It is difficult for me to reveal my 
innermost feelings, even to close 
friends 
     
Being in touch with emotions is 
essential 
     
I prefer talking to people about their 
daily activities rather than their 
feelings 
     
I prefer to watch “light” 
entertainment shows rather than 
psychological dramas 
     
I can feel close to someone, even in 
moments of silence 
     
I find examination of my feelings 
useful in solving personal problems 
     
I prefer to analyse problems rather 
than just describe them 
     
I prefer to just let things happen 
rather than to understand why they 
turned out that way 
     
Looking for hidden meanings in 
movies or plays distracts from their 
enjoyment 
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Please place any further comments you would like to make in the box below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part  
Please return the questionnaire in the pre-paid envelope 
provided. 
Return Address:-  
 
FAO Melissa Pilkington 
Centre for Appearance Research  
Room 2L13  
University of the West of England, Bristol 
Frenchay Campus 
Coldharbour Lane 
BRISTOL 
BS16 1QY 
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Appendix 29. Two week follow-up expressive writing questionnaire 
 
Questionnaire 2 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to four weeks after you have 
completed the survey. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code. 
 
To create your ID code please enter the first three letters of your first name and the 
date of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
 
 
 
 
 
Please write below the date on which you complete this questionnaire 
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All questions are optional 
A:About your hair loss and use of health resources 
1. Until now, have you lost any hair due to cancer treatment? 
 Yes 
 No 
If you answered yes to the above question, approximately how long after your first 
chemotherapy treatment did your hair start to fall out?                        
                      Days  Or                          Weeks 
 
2. If you have experienced/are experiencing hair loss, how much of your hair have 
you lost? (please tick one box) 
 All of it   Some 
 A lot    None 
 
3. How upset or distressed are you by your hair loss? (please tick one box) 
             Not at all                              A little 
             Quite a lot                                   Extremely 
 
4. Are you currently receiving any practical or emotional support regarding your 
cancer? (please tick one box) 
          Yes 
         No 
If you answered yes to the above question, please state below what type of support 
you are receiving? 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Appendices  
 
 
 
460 
 
 
5. For the following questions please tick the answer that applies to you. 
 Not 
at all 
A 
little 
A 
lot 
Extremely 
Are you happy with the level of information and 
support you have received from your GP? 
    
Are you happy with the level of information and 
support you have received from your Consultant? 
    
Are you happy with the level of information and 
support you have received from your Breast Care 
Nurse? 
    
Are you happy with the level of information and 
support you have received from your Support 
Organisations? 
    
 
B: About your writing experience 
1. During the writing task, where in terms of location were you when you did the 
writing task on each of the four days? i.e home, hospital, cafe etc  
Day one                                                     Day three 
Day two                                                     Day four                                                       
2. What did you think of the writing task? 
 
 
 
3. Did you find the writing task useful? 
 Yes    No 
If yes, please state why below 
 
 
If no, please state why below 
 
 
4. Since receiving you cancer diagnosis, have you been keeping a diary? 
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 Yes     No 
If yes, what are your reasons for keeping a diary? 
C: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
     
When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the      
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first time, I wonder what 
they think about how I look. 
In my everyday life, lots of 
things happen that make me 
think about what I look like. 
     
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasize about what it 
would be like to be better 
looking than I am. 
     
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
     
 
The first part of the scale is designed to find out if you are sensitive or self-conscious 
about any aspect of your appearance (even if this is not usually visible to others). 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
(b) If No, please go to the next page 
 
If Yes, please continue: 
 
The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
 
From now on, we will refer to this aspect of your appearance as your ‘feature’ 
 
(c) The thing I don’t like about my feature is 
 
........................................................................................................................................ 
 
(d) If you are sensitive or concerned about any other features of your body or your 
appearance, please say what they are 
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........................................................................................................................................ 
........................................................................................................................................ 
The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
 
Other people mis-judge me because of my feature: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine/masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my feature: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
 
How irritable do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
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mouth with my hand):  
 
Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes....Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A .... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How normal do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
 
I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
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How distressed do you get when other people make remarks about your 
feature? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My feature causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... 
 
My feature limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ...  
 
D: Your Feelings and Emotions  
For the following statements, please indicate by ticking the box that matches what 
you think. 
 
 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am a 
failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
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E: Your Health and Wellbeing 
Below is a list of statements that other people with your cancer have said are 
important. By ticking one box per line to indicate your response as it applies to the 
past 7 days. 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I have 
trouble meeting the needs of my family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
     
I feel ill.      
I am forced to spend time in bed.      
I feel close to my friends.      
I get emotional support from my family. 
 
     
I get support from my friends.      
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next item. 
 
I am satisfied with my sex life. 
     
I feel sad.      
I am satisfied with how I am coping with 
my illness. 
     
I am losing hope in the fight against my 
illness. 
     
I feel nervous.      
I worry about dying.      
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I worry that my condition will get worse.      
I am able to work (include work at home).      
My work (include work at home) is 
fulfilling. 
     
I am able to enjoy life.      
I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually do for 
fun. 
     
I am content with the quality of my life 
right now. 
     
 
F: Your Thoughts and Concerns 
Please read each of the following statements carefully and indicate how 
characteristic it is of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
impression of 
me. 
     
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
     
I rarely worry 
about what 
kind of 
impression I 
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am making 
on someone. 
I am afraid 
that others 
will not 
approve of 
me. 
     
I am afraid 
that people 
will find fault 
with me. 
     
Other 
people’s 
opinions of 
me do not 
bother me. 
     
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried about 
what kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, it 
has little 
effect on me. 
     
Sometimes I 
think I am too 
concerned 
with what 
other people 
think of me. 
     
I often worry 
that I will say 
or do the 
wrong things. 
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For the following statements, please indicate by ticking the box that matches what 
you think. 
 
 Yes 
Definitely 
Yes 
Sometimes 
No, 
Not 
Much 
No, Not 
At All 
I wake early and then sleep badly for the rest 
of the evening. 
    
I get very frightened or have panic feelings 
for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the house on 
my own. 
    
I have lost interest in things.     
I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
    
I have a good appetite.     
I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go through my 
mind. 
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Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am often confused about what 
emotion I am feeling 
     
I have physical sensations that even 
doctors do not understand 
     
When I am upset, I do not know if I 
am sad, frightened or angry 
     
I am often puzzled by sensations in 
my body 
     
I have feelings that I cannot quite 
identify 
     
I do not know what is going on inside 
me 
     
I often do not know why I am angry      
It is difficult for me to find the right 
words for my feelings 
     
I am able to describe my feelings 
easily 
     
I find it hard to describe how I feel 
about people 
     
People tell me to describe my feelings 
more 
     
It is difficult for me to reveal my 
innermost feelings, even to close 
friends 
     
Being in touch with emotions is 
essential 
     
I prefer talking to people about their 
daily activities rather than their 
feelings 
     
I prefer to watch “light” 
entertainment shows rather than 
psychological dramas 
     
I can feel close to someone, even in 
moments of silence 
     
I find examination of my feelings 
useful in solving personal problems 
     
I prefer to analyse problems rather 
than just describe them 
     
I prefer to just let things happen 
rather than to understand why they 
turned out that way 
     
Looking for hidden meanings in 
movies or plays distracts from their 
enjoyment 
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Please place any further comments you would like to make in the box below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part  
Please return the questionnaire in the pre-paid envelope 
provided. 
Return Address:-  
 
FAO Melissa Pilkington 
Centre for Appearance Research  
Room 2L13  
University of the West of England, Bristol 
Frenchay Campus 
Coldharbour Lane 
BRISTOL 
BS16 1QY 
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Appendix 30. One month follow-up expressive writing questionnaire 
 
Questionnaire 3 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to four weeks after you have 
completed the survey. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code. 
 
To create your ID code please enter the first three letters of your first name and the 
date of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
 
 
 
 
 
Please write below the date on which you complete this questionnaire 
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All questions are optional 
A:About your hair loss 
1. Until now, have you lost any hair due to cancer treatment? 
 Yes 
 No 
If you answered yes to the above question, approximately how long after your first 
chemotherapy treatment did your hair start to fall out?                        
                      Days  Or                          Weeks 
 
2. If you have experienced/are experiencing hair loss, how much of your hair have 
you lost? (please tick one box) 
 All of it   Some 
 A lot    None 
 
3. How upset or distressed are you by your hair loss? (please tick one box) 
             Not at all                              A little 
             Quite a lot                                   Extremely 
 
4. Are you currently receiving any practical or emotional support regarding your 
cancer? (please tick one box) 
          Yes 
         No 
If you answered yes to the above question, please state below what type of support 
you are receiving? 
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5. For the following questions please tick the answer that applies to you. 
 Not at all A little A lot Extremely 
Are you happy with the level of 
information and support you have 
received from your GP? 
    
Are you happy with the level of 
information and support you have 
received from your Consultant? 
    
Are you happy with the level of 
information and support you have 
received from your Breast Care Nurse? 
    
Are you happy with the level of 
information and support you have 
received from your Support 
Organisations? 
    
 
B: About your writing experience 
1. Did you find the writing task useful? 
 Yes    No 
If yes, please state why below 
 
 
If no, please state why below 
 
 
2. Have you done any writing since you completed the writing task? 
 
3. Since receiving you cancer diagnosis, have you been keeping a diary? 
 Yes     No 
 
If yes, what are your reasons for keeping a diary? 
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C: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
     
When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the 
first time, I wonder what 
they think about how I look. 
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In my everyday life, lots of 
things happen that make me 
think about what I look like. 
     
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasize about what it 
would be like to be better 
looking than I am. 
     
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
     
 
The first part of the scale is designed to find out if you are sensitive or self-conscious 
about any aspect of your appearance (even if this is not usually visible to others). 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
(b) If No, please go to the next page 
 
If Yes, please continue: 
 
The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
 
From now on, we will refer to this aspect of your appearance as your ‘feature’ 
 
(c) The thing I don’t like about my feature is 
 
........................................................................................................................................ 
 
(d) If you are sensitive or concerned about any other features of your body or your 
appearance, please say what they are 
 
........................................................................................................................................ 
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The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
 
Other people mis-judge me because of my feature: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine/masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my feature: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
 
How irritable do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
mouth with my hand):  
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Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes....Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A .... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How normal do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
 
I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
 
How distressed do you get when other people make remarks about your 
feature? 
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N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My feature causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... 
 
My feature limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ...  
 
D: Your Feelings and Emotions  
For the following statements, please indicate by ticking the box that matches what 
you think. 
 
 
 
 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am a 
failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
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E: Your Health and Wellbeing 
 Below is a list of statements that other people with your cancer have said are 
important. By ticking one box per line to indicate your response as it applies to the 
past 7 days. 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I have 
trouble meeting the needs of my family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
     
I feel ill.      
I am forced to spend time in bed.      
I feel close to my friends. 
 
     
I get emotional support from my family. 
 
     
I get support from my friends. 
 
     
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next item. 
 
I am satisfied with my sex life. 
     
I feel sad.      
I am satisfied with how I am coping with 
my illness. 
     
I am losing hope in the fight against my 
illness. 
     
I feel nervous.      
I worry about dying.      
I worry that my condition will get worse.      
I am able to work (include work at home).      
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My work (include work at home) is 
fulfilling. 
     
I am able to enjoy life.      
I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually do for 
fun. 
     
I am content with the quality of my life 
right now. 
     
 
F: Your Thoughts and Concerns 
Please read each of the following statements carefully and indicate how 
characteristic it is of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
impression of 
me. 
     
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
     
I rarely worry 
about what 
kind of 
impression I 
am making 
on someone. 
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 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I am afraid 
that others 
will not 
approve of 
me. 
     
I am afraid 
that people 
will find 
fault with 
me. 
     
Other 
people’s 
opinions of 
me do not 
bother me. 
     
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried 
about what 
kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, 
it has little 
effect on 
me. 
     
Sometimes 
I think I am 
too 
concerned 
with what 
other people 
think of me. 
     
I often 
worry that I 
will say or 
do the 
wrong 
things. 
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For the following statements, please indicate by ticking the box that matches what 
you think. 
 Yes 
Definitely 
Yes 
Sometimes 
No, Not 
Much 
No, Not 
At All 
I wake early and then sleep badly for 
the rest of the evening. 
    
I get very frightened or have panic 
feelings for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the 
house on my own. 
    
I have lost interest in things.     
I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
    
I have a good appetite.     
I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go 
through my mind. 
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 Not at 
all 
A Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am often confused about what 
emotion I am feeling 
     
I have physical sensations that even 
doctors do not understand 
     
When I am upset, I do not know if I 
am sad, frightened or angry 
     
I am often puzzled by sensations in 
my body 
     
I have feelings that I cannot quite 
identify 
     
I do not know what is going on inside 
me 
     
I often do not know why I am angry      
It is difficult for me to find the right 
words for my feelings 
     
I am able to describe my feelings 
easily 
     
I find it hard to describe how I feel 
about people 
     
People tell me to describe my feelings 
more 
     
It is difficult for me to reveal my 
innermost feelings, even to close 
friends 
     
Being in touch with emotions is 
essential 
     
I prefer talking to people about their 
daily activities rather than their 
feelings 
     
I prefer to watch “light” 
entertainment shows rather than 
psychological dramas 
     
I can feel close to someone, even in 
moments of silence 
     
I find examination of my feelings 
useful in solving personal problems 
     
I prefer to analyse problems rather 
than just describe them 
     
I prefer to just let things happen 
rather than to understand why they 
turned out that way 
     
Looking for hidden meanings in 
movies or plays distracts from their 
enjoyment 
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Please place any further comments you would like to make in the box below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part  
Please return the questionnaire in the pre-paid envelope 
provided. 
 
Return Address:-  
 
FAO Melissa Pilkington 
Centre for Appearance Research  
Room 2L13  
University of the West of England, Bristol 
Frenchay Campus 
Coldharbour Lane 
BRISTOL 
BS16 1QY 
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Appendix 31. Three month follow-up questionnaire 
Questionnaire 4 
Create Your Own ID Code 
 
You have the right to withdraw from the study up to four weeks after you have 
completed the survey. Should you wish to withdraw, you will need to inform us by 
email at Melissa.Pilkington@uwe.ac.uk, quoting your unique ID code. 
 
To create your ID code please enter the first three letters of your first name and the 
date of the month you were born. 
For example, if your first name is Lucy and you were born on 12 August you would 
enter LUC12 
 
Please enter your code in the box below. 
 
 
 
 
 
Please write below the date on which you complete this questionnaire 
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All questions are optional 
A:About your hair loss 
1. Until now, have you lost any hair due to cancer treatment? 
 Yes 
 No 
If you answered yes to the above question, approximately how long after your first 
chemotherapy treatment did your hair start to fall out?                        
                      Days  Or                          Weeks 
 
2. If you have experienced/are experiencing hair loss, how much of your hair have 
you lost? (please tick one box) 
 All of it   Some 
 A lot    None 
 
3. How upset or distressed are you by your hair loss? (please tick one box) 
             Not at all                              A little 
             Quite a lot                                   Extremely 
 
4. Are you currently receiving any practical or emotional support regarding your 
cancer? (please tick one box) 
          Yes 
         No 
If you answered yes to the above question, please state below what type of support 
you are receiving? 
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5. For the following questions please tick the answer that applies to you. 
 Not at all A little A lot Extremely 
Are you happy with the level of 
information and support you have 
received from your GP? 
    
Are you happy with the level of 
information and support you have 
received from your Consultant? 
    
Are you happy with the level of 
information and support you have 
received from your Breast Care Nurse? 
    
Are you happy with the level of 
information and support you have 
received from your Support 
Organisations? 
    
 
B: About your writing experience 
1. Did you find the writing task useful? 
 Yes    No 
If yes, please state why below 
 
 
If no, please state why below 
 
 
2. Have you done any writing since you completed the writing task? 
 
 
3. Since receiving you cancer diagnosis, have you been keeping a diary? 
 Yes     No 
If yes, what are your reasons for keeping a diary? 
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C: Your Appearance 
The statements below are beliefs that people may or may not have about their 
physical appearance and its influence on life. Decide on the extent to which you 
personally disagree or agree with each statement and indicate by ticking the box 
that matches what you think. There are no right or wrong answers. Just be truthful 
about your personal beliefs. 
 Strongly 
Disagree 
Mostly      
Disagree 
Neither 
Agree or 
Disagree 
 
Mostly 
Agree 
Strongly 
Agree 
I spend little time on my 
physical appearance. 
     
When I see good-looking 
people, I wonder about how 
my own looks measure up. 
     
I try to be as physically 
attractive as I can be. 
     
I have never paid much 
attention to what I look like. 
     
I seldom compare my 
appearance to that of other 
people. 
     
I often check my 
appearance in a mirror just 
to make sure I look okay. 
     
When something makes me 
feel good or bad about my 
looks, I tend to dwell on it. 
     
If I like how I look on a 
given day, it’s easy to feel 
happy about other things. 
     
If somebody had a negative 
reaction to what I look like, 
it wouldn’t bother me. 
     
When it comes to my 
physical appearance, I have 
high standards. 
     
My physical appearance has 
had little influence on my 
life. 
     
Dressing well is not a 
priority for me. 
     
When I meet people for the 
first time, I wonder what 
they think about how I look. 
     
In my everyday life, lots of 
things happen that make me 
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think about what I look like. 
If I dislike how I look on a 
given day, it’s hard to feel 
happy about other things. 
     
I fantasize about what it 
would be like to be better 
looking than I am. 
 
 
 
    
Before going out, I make 
sure that I look as good as I 
possibly can. 
     
What I look like is an 
important part of who I am. 
     
By controlling my 
appearance, I can control 
many of the social and 
emotional events in my life. 
     
My appearance is 
responsible for much of 
what’s happened to me in 
my life. 
     
 
The first part of the scale is designed to find out if you are sensitive or self-conscious 
about any aspect of your appearance (even if this is not usually visible to others). 
 
(a) Is there any aspect of your appearance (however small) that concerns you at all? 
 
Yes / No 
 
(b) If No, please go to the next page 
 
If Yes, please continue: 
 
The aspect of my appearance about which I am most sensitive or self-conscious is 
 
..................................................................................................................................... 
 
From now on, we will refer to this aspect of your appearance as your ‘feature’ 
 
(c) The thing I don’t like about my feature is 
 
........................................................................................................................................ 
 
(d) If you are sensitive or concerned about any other features of your body or your 
appearance, please say what they are 
 
........................................................................................................................................ 
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The following questions are concerned with the way you feel or act. Please tick the 
answer that applies to you. If the item does not apply to you at all, tick the N/A (not 
applicable option). Don’t spend long on any one question. 
 
How confident do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
How distressed do you get when you see yourself in the mirror/window? 
 
Extremely .... Moderately.... A Little .... Not at all Distressed .... 
 
My self-consciousness makes me irritable at home: 
 
N/A .... Never/Almost never .... Sometimes .... Often .... Almost always .... 
 
How hurt do you feel? 
 
Extremely .... Moderately .... Slightly .... Not at all .... 
 
At present my self-consciousness has an adverse effect on my work: 
 
Almost always .... Often .... Sometimes .... Never/almost never .... N/A ..... 
 
How distressed do you get when you go to the beach? 
 
N/A .... Not at all .... A little .... Moderately .... Extremely .... 
 
Other people mis-judge me because of my feature: 
 
Almost always .... Often .... Sometimes .... Never/almost never ...... N/A ..... 
 
How feminine/masculine do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I am self -conscious of my feature: 
 
N/A .... Never/ Almost never .... Sometimes .... Often .... Almost always .... 
 
How irritable do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I adopt certain gestures (e.g. folding my arms in front of other people, covering 
my  
mouth with my hand):  
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Never/almost never .... Sometimes .... Often .... Almost always ... 
 
I avoid communal changing rooms: 
 
Almost always .... Often .... Sometimes....Never/almost never ..... N/A ..... 
 
How distressed do you get by shopping in department stores/supermarkets? 
 
N/A .... Not at all .... Slightly .... Moderately .... Extremely .... 
 
How rejected do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
I avoid undressing in front of my partner: 
 
N/A .... Never/almost never .... Sometimes .... Often .... Almost always .... 
 
How distressed do you get while playing sports/games? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
I close into my shell: 
 
Almost always .... Often .... Sometimes.... Never/Almost never .... 
 
How distressed are you by being unable to wear your favourite clothes? 
 
Extremely .... Moderately .... Slightly .... Not at all .... N/A ..... 
 
How distressed do you get when going to social events? 
 
N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
How normal do you feel? 
 
Not at all .... Slightly .... Moderately .... Extremely .... 
 
At present my self-consciousness has an adverse effect on my sex life: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... N/A ..... 
 
I avoid going out of the house: 
 
Almost always .... Often .... Sometimes.... Never/almost never .... 
 
How distressed do you get when other people make remarks about your 
feature? 
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N/A .... Not at all .... Moderately .... A fair amount .... Extremely .... 
 
I avoid going to pubs/restaurants: 
 
Almost always .... Often .... Sometimes....Never/almost never .... N/A ..... 
 
My feature causes me physical pain/discomfort: : 
 
Never/almost never .... Sometimes .... Often .... Almost always .... 
 
My feature limits my physical ability to do the things I want to do: 
 
Almost always .... Often .... Sometimes....Never/ almost never ...  
 
D: Your Feelings and Emotions  
For the following statements, please indicate by ticking the box that matches what 
you think. 
 
 
 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I feel that I am a person of worth, at least 
on an equal plane with others. 
    
I feel that I have a number of good 
qualities. 
    
All in all, I am inclined to feel that I am a 
failure. 
    
I am able to do things as well as most 
other people. 
    
I feel I do not have much to be proud of.     
I take a positive attitude toward myself.     
On the whole, I am satisfied with myself.     
I wish I could have more respect for 
myself. 
    
I certainly feel useless at times.     
At times I think I am no good at all.     
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E: Your Health and Wellbeing 
 Below is a list of statements that other people with your cancer have said are 
important. By ticking one box per line to indicate your response as it applies to the 
past 7 days. 
 Not 
at all 
A 
Little 
Bit 
Somewhat Quite 
a Bit 
Very 
Much 
I have a lack of energy.      
I have nausea.      
Because of my physical condition, I have 
trouble meeting the needs of my family. 
     
I have pain.      
I am bothered by the side effects of 
treatment. 
     
I feel ill.      
I am forced to spend time in bed.      
I feel close to my friends.      
I get emotional support from my family.      
I get support from my friends.      
My family has accepted my illness.      
I am satisfied with family communication 
about my illness. 
     
I feel close to my partner (or the person 
who is my main support). 
     
Regardless of your current level of sexual 
activity, please answer the following 
question. If you prefer not to answer it, 
please mark this box  
        and go to the next item. 
 
I am satisfied with my sex life. 
     
I feel sad.      
I am satisfied with how I am coping with 
my illness. 
     
I am losing hope in the fight against my 
illness. 
     
I feel nervous.      
I worry about dying.      
I worry that my condition will get worse.      
I am able to work (include work at home).      
My work (include work at home) is 
fulfilling. 
     
I am able to enjoy life.      
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I have accepted my illness.      
I am sleeping well.      
I am enjoying the things I usually do for 
fun. 
     
I am content with the quality of my life 
right now. 
     
 
 
F: Your Thoughts and Concerns 
Please read each of the following statements carefully and indicate how 
characteristic it is of you by ticking the appropriate box. 
 Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
I worry about 
what other 
people will 
think of me 
even when I 
know it 
doesn’t make 
any 
difference. 
     
I am 
unconcerned 
even if I 
know people 
are forming 
an 
unfavourable 
impression of 
me. 
     
I am 
frequently 
afraid of 
other people 
noticing my 
shortcomings. 
     
I rarely worry 
about what 
kind of 
impression I 
am making 
on someone. 
 
     
I am afraid      
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that others 
will not 
approve of 
me. 
I am afraid 
that people 
will find fault 
with me. 
     
Other 
people’s 
opinions of 
me do not 
bother me. 
     
When I am 
talking to 
someone, I 
worry about 
what they 
may be 
thinking 
about me. 
     
I am usually 
worried about 
what kind of 
impression I 
make. 
     
If I know 
someone is 
judging me, it 
has little 
effect on me. 
     
Sometimes I 
think I am too 
concerned 
with what 
other people 
think of me. 
     
I often worry 
that I will say 
or do the 
wrong things. 
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For the following statements, please indicate by ticking the box that matches what 
you think. 
 
 Yes 
Definitely 
Yes 
Sometimes 
No, Not 
Much 
No, Not 
At All 
I wake early and then sleep badly for 
the rest of the evening. 
    
I get very frightened or have panic 
feelings for apparently no reason at all. 
    
I feel miserable and sad.     
I feel anxious when I go out of the 
house on my own. 
    
I have lost interest in things.     
I get palpitations, or sensations of 
‘butterflies’ in my stomach or chest. 
    
I have a good appetite.     
I feel scared or frightened.     
I feel life is not worth living.     
I still enjoy things I used to.     
I am restless and can’t keep still.     
I am more irritable than usual.     
I feel as if I have slowed down.     
Worrying thoughts constantly go 
through my mind. 
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 Not 
at all 
A 
Little 
Bit 
Somewhat Quite a 
Bit 
Very 
Much 
I am often confused about what emotion 
I am feeling 
     
I have physical sensations that even 
doctors do not understand 
     
When I am upset, I do not know if I am 
sad, frightened or angry 
     
I am often puzzled by sensations in my 
body 
     
I have feelings that I cannot quite 
identify 
     
I do not know what is going on inside 
me 
     
I often do not know why I am angry      
It is difficult for me to find the right 
words for my feelings 
     
I am able to describe my feelings easily      
I find it hard to describe how I feel about 
people 
     
People tell me to describe my feelings 
more 
     
It is difficult for me to reveal my 
innermost feelings, even to close friends 
     
Being in touch with emotions is essential      
I prefer talking to people about their 
daily activities rather than their feelings 
     
I prefer to watch “light” entertainment 
shows rather than psychological dramas 
     
I can feel close to someone, even in 
moments of silence 
     
I find examination of my feelings useful 
in solving personal problems 
     
I prefer to analyse problems rather than 
just describe them 
     
I prefer to just let things happen rather 
than to understand why they turned out 
that way 
     
Looking for hidden meanings in movies 
or plays distracts from their enjoyment 
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Please place any further comments you would like to make in the box below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for taking part  
Please return the questionnaire in the pre-paid envelope 
provided. 
 
Return Address:-  
 
FAO Melissa Pilkington 
Centre for Appearance Research  
Room 2L13  
University of the West of England, Bristol 
Frenchay Campus 
Coldharbour Lane 
BRISTOL 
BS16 1QY 
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Appendix 32. Writing instructions for the expressive writing group 
Writing instructions 1 
Over the next four days, I would like you to write about your very deepest 
thoughts and feelings in relation to your treatment-related hair loss. It is advised 
that you write from somewhere comfortable, where you won’t be disturbed, with 
plenty of paper to hand or alternatively, you can use a computer if you prefer. 
 
In your writing, I'd like you to really let go and explore your very deepest emotions 
and thoughts. Ideally, I would like you to write about any parts of your experience of 
hair loss which you may have found hard to share with others. Perhaps this will 
provide an opportunity to really examine those thoughts and emotions. You might 
want to write about your hair loss in relation to other parts of your life.  For example, 
how is it related to your family life, relationship with your spouse, your children, 
parents, friends, daily activities, hobbies, or your work? These are just some 
examples. 
For each of the four days of writing, we would like you to write about a slightly 
different topic:- 
 
• Day one- your deepest thoughts and feelings in relation to hair loss 
• Day two- your deepest thoughts and feelings around hair loss specifically in 
 relation to your appearance 
• Day three- your deepest thoughts and feelings around treatment-related hair 
loss in  relation to your life in general 
• Day four- your deepest thoughts and feelings around managing hair loss.  
 
All of your writing will be completely confidential. Don't worry about spelling, 
sentence structure, or grammar. Don’t worry about erasing things or crossing things 
out, just write freely. Once you begin writing, please continue to do so for a period 
of 20 minutes. 
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Appendix 33. Writing Instructions for the Control Group 
 
Writing instructions 2 
 
Over the next four days, I would like for you to write about the following topics:- 
 
• Day one – please describe your home 
• Day two – please describe your neighbourhood or the area that you live in 
• Day three – please describe the town, village or city that you live in 
• Day four – please describe a place which you have recently visited 
 
 
In your writing, I'd like you to write about each of the above topics without 
including emotions, feelings or opinions.  Just describe them – for example, where 
they are, what they look like or what’s there. It is advised that you write from 
somewhere comfortable, where you won’t be disturbed, with plenty of paper to hand 
or alternatively, you can use a computer if you prefer. 
 
All of your writing will be completely confidential. Your descriptions should be as 
detailed and objective as possible. Don't worry about spelling, sentence structure, or 
grammar. Don’t worry about erasing things or crossing things out, just write freely. 
Once you begin writing, please continue to do so for a period of 20 minutes. 
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Appendix 34. Debrief sheet for the expressive writing study 
Writing Study: Debrief Sheet 
The aim of the study was to explore the use of expressive writing as a way to help 
individuals who have received a breast cancer diagnosis are having chemotherapy 
treatment. Previous research has demonstrated that the process of making sense of an 
event, of gaining insight about a trauma, and organise and interpret an upsetting 
experience through expressive writing can be helpful. We wanted to see if an 
expressive writing task would help breast cancer patients’ with treatment-related hair 
loss. 
We did this by randomly allocating participants into one of two groups; an 
expressive writing or control group. Participants in the expressive writing group 
were asked to write for 20 minutes a day for 4 consecutive days about their thoughts 
and feelings in relation to their treatment-related hair loss, whereas those in the 
control group were asked to write for the same period of time but to write about a 
neutral topic without an emotional expression. Also, all participants regardless of 
whether they were in the expressive writing or control group were asked to complete 
a questionnaire at four separate time points. The purpose of the questionnaires were 
to see whether any changes in hair loss distress, self-esteem and quality of life 
reported soon after expressive writing are maintained in the longer term. 
Our analysis will compare the questionnaire data from the two groups. Once the 
study is complete, I will send you a summary of the findings. 
If you have any further questions about the study, please do not hesitate to contact 
Melissa Pilkington at Melissa.Pilkington@uwe.ac.uk. 
Thank you again for taking part in the study. 
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Appendix 35. Executive summary report presented to Breast Cancer Care 
 
 
 
Executive summary of preliminary 
findings 
 
 
 
 
Prepared by: 
Melissa Pilkington 
Centre for Appearance Research, University of the West of England 
(UWE) 
 
Supervised by: 
Prof. Diana Harcourt (Centre for Appearance Research, UWE) 
Prof. Nichola Rumsey (Centre for Appearance Research, UWE) 
Prof. Daryl O’Connor (University of Leeds) 
Dr. James Brennan (Consulting Clinical Psychologist) 
 
Prepared for: 
Breast Cancer Care 
 
15th September, 2014 
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Background 
 The psychosocial impact of cancer treatment is wide-ranging, including 
changes to appearance, such as hair loss. Hair loss (including loss of eyelashes, 
eyebrows and all body hair) can be a very distressing side-effect of cancer treatment 
and some women find it harder to cope with this than with the loss of a breast 
(Benjamin et al, 2002). The visible nature of hair loss can affect individuals’ body 
image, self-esteem and quality of life (Williams et al, 1999). Even though 
chemotherapy-induced alopecia is often temporary, the negative emotional 
repercussions can continue after hair has re-grown.  
Aims: 
• To explore, breast cancer patients’ experiences of treatment-related hair loss 
and their experiences of Breast Cancer Care’s HeadStrong service. 
• To examine the short and longer-term impact of the HeadStrong service on 
appearance-related distress, self-esteem, quality of life, confidence in 
managing hair loss and psychosocial distress. 
Qualitative study 
Design 
A semi-structured interview schedule was developed to explore participants’ 
motivation for accessing HeadStrong, their expectations of it, whether it helped them 
in managing their hair loss and whether they had any recommendations for the 
HeadStrong service in the future. 
Demographic details 
 25 women elected to participate 
 Mean age of participants was 51 (range = 34-68 years) 
 All partcipants described themselves as White 
 Mean time since diagnosis was 8 months at the time of the interview 
 Participants were from a variety of geographical locations across the country 
 
Data analysis 
The interviews were transcribed verbatim and subjected to thematic analysis (TA). 
 
 
Preliminary findings not for distribution until they have been published 
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Findings 
Three main themes emerged: challenges of hair loss, support for treatment-related 
hair loss and unmet needs.  
Theme 1: Challenges of hair loss 
 Hair loss-related distress began when individuals first anticipated their hair 
loss.  
 
 Participants were surprised by the extent of the impact that hair loss had had 
on their lives and their sense of self  
 
Theme 2: Experiences of receiving support for treatment-related hair loss 
 Participants found HeadStrong to be very helpful in providing practical 
advice and information  
 HeadStrong was found to help increase confidence  
 Some participants knew little about HeadStrong prior to attending their 
session 
 Some participants were pleased that HeadStrong had been provided on a one-
to-one, however, some participants felt alone within the hair loss journey and 
would have liked HeadStrong to have been a group session 
 
Theme 3: Unmet needs 
 Some participants felt that they would have liked to receive more emotional 
support 
 A few of participants spoken about how they would have like the room to 
have been bigger where the HeadStrong session was held 
 Many participants would have preferred the HeadStrong setting to have been 
separate from the hospital or at least separate from the Oncology department 
 
Quantitative study 
Design 
A pre, 2 week and 3 month follow-up questionnaire design was utilised. Participants 
were recruited from the HeadStrong centres in Chester and Southend. 
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Demographic details 
 N = 16 women treated for breast cancer 
 Mean age = 52.9 yrs (SD= 7.29; range 41- 64yrs)  
 Mean time since diagnosis 2.3yrs 
 10 participants completed the 2 week follow-up HeadStrong questionnaire 
(38% dropout rate)  
 9 participants completed the 3 month follow-up questionnaire (44% dropout 
rate from baseline, 10% dropout rate from post) 
 
Reasons for attending HeadStrong 
 Seeking advice for scalp care (9)  
 To prepare for hair loss (7)  
 To learn how to use scarves (7)  
 To find out about where to purchase head scarves (5)  
 To increase confidence (4)  
 To meet others in the same situation (2) 
 Seeking psychological support (2)  
 
Using Visual Analogue Scales (VAS), this study found that, after attending a 
HeadStrong session, respondents reported: 
 A significant increase in confidence in managing the consequences of hair 
loss 
 A significant increase in confidence in managing other people’s reactions to 
their hair loss 
 Significantly increased confidence in using headwear to camouflage hair loss 
 
Using standardised measures of value placed on appearance, self-esteem, fear of 
negative evaluation, quality of life, appearance-related distress, anxiety and 
depression, this study found that, after attending a HeadStrong session, respondents 
reported: 
 A significant decrease in quality of life scores following from 2 week to 3 
month follow-up 
 A significant decrease in fear of negative evaluation from pre-intervention to 
3 month follow-up  
 No significant differences were found for measures of value placed on 
appearance, self-esteem, appearance-related distress, anxiety or depression 
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Conclusions 
 Participants described a number of challenges regarding their hair loss, which 
had led them to attend the HeadStrong service  
 Participants said they would recommend HeadStrong to others 
 Participants not always clear what HeadStrong involves 
 Quantitative date shows improvements in confidence and fear of negative 
evaluation 
 HeadStrong was found to be a helpful, however, it did not meet all 
participants needs, therefore suggesting additional interventions and sources 
of emotional support are required 
 
Limitations 
 Small sample size for quantitative study 
 Drop-out rates 
 Recruitment for quantitative study from 2 HeadStrong centres only 
 Findings can’t be generalised for all breast cancer patients who attend a 
HeadStrong session 
 
Recommendations for HeadStrong in the future 
 Beneficial to build into the service an ongoing larger scale evaluation of 
HeadStrong 
 
 
 
 
 
 
 
 
 
 
 
